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Orf virus (ORFV) is the type species of the Parapoxvirus genus that belongs to the Poxviridae 
family. ORFV is an epitheliotropic virus inducing cutaneous pustular skin lesions in sheep and 
goats and is transmissible to humans. Type I interferons (IFN) are critical in the host defence 
against viruses. They induce hundreds of interferon stimulated genes (ISGs) many of which have 
an antiviral role. The aim of this study was to investigate whether ORFV modulates the type I 
IFN response. Previous studies suggested a role for the ORFV gene ORF116 in modulating the 
ISG response using a recombinant ORF116 deletion mutant. These preliminary findings were 
validated in this study by constructing an ORF116 revertant recombinant virus. The approach 
taken was to generate a revertant virus in which the ORF116 gene was re-inserted at the same 
locus as the deleted ORF116 gene in the knockout virus by homologous recombination and then 
infecting HeLa cells with the two recombinant viruses and the wt strain and studying specific 
changes in ISG expression by qRT-PCR. The data suggested that ORFV was either directly 
modulating the expression of about 10 ISGs involved in the anti-viral response or indirectly 
modulating ISG expression by inhibiting IFN production or both. The ability of ORFV to 
modulate type I IFN production in several cell types was undertaken to investigate whether 
ORFV could inhibit IFN-β via dsRNA and dsDNA dependant signalling pathways. HEK293 
cells were utilized to model an RNA sensing system. It has been shown that these cells respond 
to poly(dA:dT), that is converted to dsRNA via RNA polymerase III and poly(I:C) and produce 
high fold IFN-β expression of RIG-I-dependent signalling as confirmed by siRNA knock-down 
of RIG-I and RNA polymerase III. HEK293 cells are permissive for ORFV replication and 
ORFV caused a potent inhibition of IFN-β mRNA when stimulated with poly(dA:dT) or 
poly(I:C) in a dose-dependent manner. THP-1 cells and human dermal fibroblasts (hNDF) were 
used to investigate the effects of ORFV on a cytoplasmic DNA sensing system. These cells 
respond to transfected poly(dA:dT) or poly(I:C) by producing high levels of IFN-β expression in 
a dose-dependent manner. Both cells are permissive for ORFV early gene synthesis and only 
hNDFs are permissive for ORFV replication. ORFV infection resulted in strong inhibition of 
IFN-β in hNDFs treated with either poly(I:C) or poly(dA:dT). The IFN signalling pathway in 
hNDFs was characterized by RNA interference. siRNA knock-down of STING, a critical adaptor 
for cytosolic DNA sensing, resulted in a reduction in IFN-β expression in cells stimulated with 




down. Although it was clearly shown that IFN induction was via DNA sensing, cytosolic DNA 
sensing has yet to be confirmed. Preliminary findings suggest that the two early genes ORF116 
and ORF020 expressed from plasmid vectors are potentially involved in antagonising IFN 
expression. Overall, this study has shown for first time the ability of ORFV to counteract type I 
IFN expression by antagonising dsRNA and dsDNA activated IFN signalling pathways. This 






I would like to express my very great appreciation to my supervisor Dr. Stephen Fleming for all 
the critical advice, guidance, support, enthusiastic encouragement and most importantly his 
patience over the period of my PhD. His valuable and constructive suggestions are highly 
appreciated. His willingness to give his time, especially the time for lunch or home, so generously 
has been much appreciated. His sustainable supervision and guidance during the COVID-19 
lockdown are undeniable.  
My grateful thanks are also extended to my co-supervisor Prof. Andy Mercer for his advice, 
support and any useful critiques of this work. His usual support and assistance are much 
appreciated. A grateful thanks to the department heads Prof. Frank Griffin, Prof. Vernon Ward, 
Prof. Clive Ronson and Prof. Greg Cook for all the support provided, and Prof. Miguel Quiñones-
Mateu for his kindness and patience. 
I am still indebted to the aunts Ellena Whelan, Cathy McCaughan, Gabriella Stuart, Nicky Real 
and Zabeen Lateef for the valuable technical support provided in my early days in the VRU prior 
my PhD study and techniques that I have learnt. I also thank every member of staff in the VRU 
and Department of Microbiology and Immunology who have contributed towards the successful 
completion of this work. I wish to thank also Sonya Mros for enabling me run assays in their 
laboratory and for the use their reagents. I would like to thank Chris Harry for assisting with lab 
consumables and Megan Colemen for always reminding us about lab safety and to keep us safe 
and sound. I thank all the students in the VRU and virology group on the 7th floor who made my 
time in the lab so enjoyable.    
There are no words that I can say to convey my appreciation for my parents for their continuous 
support and encouragement throughout my study overseas. I know that they have missed me a 
lot during the long time I have been away studying. I am grateful to have parents like them who 
love and let me find my own way, their love and support have helped me not only through 
university but also through life. All these successes would have been impossible without them 




I would also like to express my gratitude to my parents-in-law who gave me wonderful support 
and stood beside me during critical period of my time in New Zealand. They have always inspired 
me in every decision I have made and I am extremely fortunate for have been blessed with such 
incredible persons.    
Lastly, a very special thank you to my lovely wife Halah from the bottom of my heart for her 
patience, understanding and words of encouragement during the crucial stages of this work. I feel 
much gratitude and respect towards her for taking care of my family and thank you for helping 
me with everything, being with me in every situation and all the love and passion you bring, 
thank God for giving me you. This really proves the saying “there is a women behind the success 
of every man”. I also thank my two girls Nawraa and Zahraa and little son Siraj for their part in 





TABLE OF CONTENTS 
ABSTRACT ........................................................................................................................... II 
ACKNOWLEDGMENTS .................................................................................................. IV 
TABLE OF CONTENTS .................................................................................................... VI 
LIST OF FIGURES ............................................................................................................ XI 
LIST OF TABLES ............................................................................................................ XIV 
LIST OF ABBREVIATIONS ............................................................................................ XV 
1 INTRODUCTION ............................................................................................................. 2 
1.1 Overview ........................................................................................................................ 2 
1.1.1 Classification Pathogenesis and Structure of ORFV .......................................... 2 
1.1.2 Replication and Morphogenesis of Poxviruses ................................................... 7 
1.1.3 Genetic Structure of ORFV ................................................................................ 7 
1.2 Interferon System ........................................................................................................... 9 
1.3 Innate Immunity to Virus Infection and Type I Interferon Induction .......................... 10 
1.3.1 Toll-like Receptors (TLRs) sensing of nucleic acids in endosomes ................. 11 
1.3.1.1 TLR9-dependent DNA Sensing .......................................................... 12 
1.3.1.2 TLR3, 7, 8-dependent RNA Sensing .................................................. 13 
1.3.1.3 Toll-Like Receptor Signalling Pathways ............................................ 17 
1.3.2 Intracellular Nucleic Acid Sensing ................................................................... 19 
1.3.2.1 Intracellular Detection of DNA ........................................................... 19 
1.3.2.2 Recognition of Cytosolic RNA ........................................................... 27 
1.3.3 JAK/STAT Signalling Pathway ........................................................................ 38 
1.3.4 Interferon Effector Response ............................................................................ 38 
1.4 Virus Manipulation of the Type I IFN Response ......................................................... 39 
1.4.1 Inhibition of Interferon Production ................................................................... 39 
1.4.1.1 Viral Evasion of RNA Sensing ........................................................... 39 
1.4.1.2 Viral Evasion of DNA Sensing ........................................................... 41 
1.4.1.3 Viral Evasion of Nucleic Acid-Stimulated Signalling Pathways 
leading to Type I IFN Expression ....................................................... 44 
1.4.2 Inhibition of Interferon-Induced Signalling ...................................................... 47 
1.4.2.1 Inhibition of Interferon Binding to Receptors ..................................... 47 
1.4.2.2 Inhibition of JAK/STAT Pathway ...................................................... 48 
1.4.2.3 Inhibition of Interferon-induced Antiviral Effectors ........................... 48 
1.5 ORFV Virus: Modulation of the Immune Response .................................................... 49 
1.6 Hypothesis .................................................................................................................... 51 
1.7 Aims of the Study ......................................................................................................... 51 




2.1 DNA Cloning ............................................................................................................... 53 
2.1.1 Plasmids ............................................................................................................ 53 
2.1.2 Preparation and Transformation of Calcium-Competent Escherichia coli by 
Heat Shock ...................................................................................................... 59 
2.1.3 Extraction and Purification of Plasmid DNA ................................................... 60 
2.1.4 Dephosphorylation of Linearized Plasmids ...................................................... 61 
2.1.5 Ligation ............................................................................................................. 61 
2.1.6 Polymerase Chain Reaction (PCR) ................................................................... 62 
2.1.7 Restriction Endonuclease Digestion ................................................................. 62 
2.1.8 Separation of DNA Fragments by Gel Electrophoresis .................................... 62 
2.1.9 Gel Extraction of DNA Fragments ................................................................... 63 
2.1.10 DNA Sequencing and Analysis ........................................................................ 63 
2.2 Cells .............................................................................................................................. 63 
2.3 Viruses .......................................................................................................................... 63 
2.3.1 Preparation of Virus Stock ................................................................................ 64 
2.3.2 Sucrose Purification of Virus Stock .................................................................. 64 
2.3.3 Titration of Viral Stock and Plaque Assay ....................................................... 65 
2.4 Generation of ORFV Virus ORF116 Revertant ........................................................... 66 
2.4.1 Construction of Transfer Vector Containing ORF116, LacZ Gene and 
Flanking Arms ................................................................................................ 66 
2.4.2 Transfection of Transfer Plasmid into Lamb Testes (LT)-Infected Cells ......... 68 
2.4.3 Selection, Screening and Purification of Revertant-116 Virus ......................... 69 
2.5 Analysis of Virus Growth Kinetics .............................................................................. 70 
2.6 Detection of Early Viral Protein Synthesis .................................................................. 70 
2.7 RNA Interference ......................................................................................................... 71 
2.8 Western Immunoblotting.............................................................................................. 71 
2.9 Immunoprecipitation .................................................................................................... 72 
2.10 Analysis of Viral Genomic DNA ................................................................................. 76 
2.10.1 Virus DNA Extraction ...................................................................................... 76 
2.10.2 Endonuclease Restriction of Viral DNA. .......................................................... 76 
2.10.3 PCR Amplification of Viral DNA .................................................................... 77 
2.11 Cloning ORFV Virus ORF020 Gene into pAPEX3-Flag ............................................ 79 
2.12 Transient Expression of Proteins from Plasmids ......................................................... 79 
2.13 Generation of Cell Lines .............................................................................................. 79 
2.14 Poly(dA:dT) or Poly(I:C) Cell Stimulation .................................................................. 80 




2.16 Quantitative Real Time-PCR (qRT-PCR) and Data Analysis ..................................... 81 
2.17 Transcription of ORFV ORF116 Gene ........................................................................ 82 
2.18 Quantification of Cytokine IL-1β Secretion ................................................................ 84 
2.19 Bioinformatic Analysis ................................................................................................ 84 
2.20 Statistical Analysis ....................................................................................................... 84 
3 RESULTS I: OV-NZ2 ORF116 Modulation of the Interferon Response .................. 87 
3.1 Immunomodulatory Genes discovered in Parapoxviruses ........................................... 87 
3.2 Bioinformatic Analysis of ORF116 ............................................................................. 90 
3.3 Generation of Revertant 116 virus ............................................................................... 95 
3.3.1 Overview ........................................................................................................... 95 
3.3.2 Construction of Transfer Vector Containing ORFV ORF116 and Reporter 
Gene ................................................................................................................ 97 
3.3.3 Generation of Revertant-116 Virus ................................................................... 98 
3.3.4 Characterization of OV-NZ2-Rev116 virus.................................................... 100 
3.4 OV-NZ2 ORF116 Gene Modulation of the Type I Interferon Response .................. 108 
3.5 Discussion .................................................................................................................. 118 
4 RESULTS II: Effect of ORFV Infection on IFN- Expression (RIG-I-Dependent 
Pathway) ............................................................................................................... 125 
4.1 Overview .................................................................................................................... 125 
4.2 Induction of IFN-β Expression in HEK293 Cells ...................................................... 125 
4.3 Poly(dA:dT)-mediated IFN-β Expression in HEK293 Cells through RNA 
Polymerase III ........................................................................................................ 128 
4.4 Inhibitory Effect of OV-NZ2 Infection on IFN-β Expression in poly(dA:dT)-
stimulated HEK293 Cells ...................................................................................... 131 
4.5 Inhibitory Effect of OV-NZ2 Infection on IFN-β Expression in poly(I:C)-
stimulated HEK293 Cells ...................................................................................... 131 
4.6 RIG-I Receptor is Required for IFN- Expression in HEK293 Cells........................ 135 
4.7 Role of OV-NZ2 ORF020 (E3L homologue) on RIG-I-Dependent Signalling......... 141 
4.8 Detection of Phosphorylated-TBK and Phosphorylated-IRF3 in HEK293 Cells ...... 145 
4.9 Early Viral Gene Synthesis was Required for Inhibition of IFN- Expression in 
HEK293 Cells ........................................................................................................ 146 




4.11 Discussion .................................................................................................................. 155 
5 RESULTS III: Effect of ORFV Infection on IFN- Expression (DNA Sensor-
Dependent Pathway) ................................................................................................. 163 
5.1 Overview .................................................................................................................... 163 
5.2 Induction of IFN- Expression in THP-1 Cells stimulated with Poly(dA:dT) .......... 164 
5.3 Inhibitory Effect of ORFV Infection on IFN- Expression in THP-1 Cells 
stimulated with Poly(dA:dT) ................................................................................. 166 
5.4 OV-NZ2 does not Inhibit IL-1β Release from Poly(dA:dT)-stimulated THP-1 
Cells ....................................................................................................................... 168 
5.5 Detection of Phosphorylated-TBK in THP-1 Cells.................................................... 170 
5.6 Induction of IFN- Expression in hNDF Cells stimulated with Poly(dA:dT) or 
Poly(I:C) ................................................................................................................ 172 
5.7 Inhibitory Effect of ORFV Infection on IFN- Expression in hNDF Cells 
stimulated with Poly(dA:dT) ................................................................................. 174 
5.8 Inhibitory Effect of ORFV Infection on IFN- Expression in hNDF Cells 
stimulated with Poly(I:C) ....................................................................................... 177 
5.9 Detection of STING and RIG-I Expression Proteins in hNDF Cells ......................... 180 
5.10 Poly(dA:dT)-mediated IFN- Expression is through the STING Adaptor in hNDF 
Cells ....................................................................................................................... 181 
5.11 Other RNA Sensors are Involved in IFN- Expression in hNDF Cells ..................... 185 
5.12 Stronger Reduction of IFN-β Expression in hNDF Cells with Double Knockdown 
of STING and RIG-I When Stimulated with Poly(dA:dT) .................................... 188 
5.13 Virus Early Gene Synthesis is Required to Inhibit IFN- Expression in hNDF 
Cells ....................................................................................................................... 191 
5.14 Discussion .................................................................................................................. 195 
6 GENERAL DISCUSSION ............................................................................................ 203 
7 FUTURE DIRECTIONS .............................................................................................. 209 
8 REFERENCES .............................................................................................................. 210 
9 APPENDICES................................................................................................................ 264 
9.1 Solutions for Preparation and Transformation of E. coli Competent Cells ............... 264 




9.3 Solutions for DNA Gel Electrophoresis ..................................................................... 266 
9.4 Tissue Culture Media ................................................................................................. 280 
9.5 Maintenance of Tissue Culture .................................................................................. 281 
9.6 Solutions for Preparation of Gel for SDS-PAGE ....................................................... 282 






LIST OF FIGURES 
Figure 1.1. Orf disease manifestation and schematic ultrastructure of parapoxvirus virion. ....... 6 
Figure 1.2. Poxvirus replication and morphogenesis. ................................................................... 8 
Figure 1.3. Recognition of viral nucleic acids by TLRs. ............................................................ 18 
Figure 1.4. Recognition of viral nucleic acids by cytosolic receptors. ....................................... 28 
Figure 2.1. Diagrams of Plasmids used in this study. ................................................................. 57 
Figure 2.2. Sequences of cloning steps ....................................................................................... 67 
Figure 3.1. Clustal W alignment of OV ORF116 nucleotide sequences. ................................... 93 
Figure 3.2. Clustal W alignment of OV ORF116 amino acid sequences. .................................. 94 
Figure 3.3. Generation of OV-NZ2-Rev116 by homologous recombination. ............................ 96 
Figure 3.4. Characterization of Transfer Vector. ........................................................................ 99 
Figure 3.5. OV-NZ2-Rev116 virus selection and purification. ................................................ 100 
Figure 3.6. Restriction endonuclease maps of wild type, knockout-116 and revertant-116. .... 102 
Figure 3.7. Schematic representation of the ORF116 locus within the OV-NZ2, OV-
NZ2Δ116 and OV-NZ2-Rev116 genomes............................................................. 104 
Figure 3.8. PCR analysis of viral DNA of wild type, knockout-116 and revertant-116. ......... 105 
Figure 3.9. Transcription kinetic analysis of the ORF116 gene by RT-PCR. .......................... 106 
Figure 3.10. Growth analysis of OV-NZ2, OV-NZ2Δ116 and OV-NZ2-Rev116. .................. 107 
Figure 3.11. Analysis of change in the expression levels of ISGs. ........................................... 111 
Figure 4.1.Experimental model to study RIG-I/MDA5 pathways involved in the induction of 
IFN-β in HEK293 cells. ......................................................................................... 126 
Figure 4.2. Induction of IFN-β by poly(dA:dT) in HEK293 cells. ........................................... 127 
Figure 4.3. Induction of IFN-β by poly(I:C) in HEK293 cells. ................................................ 129 
Figure 4.4. RNA Polymerase III is required for poly(dA:dT)-mediated IFN-β induction in 
HEK293 cells. ........................................................................................................ 130 
Figure 4.5. Inhibitory effect of OV-NZ2 infection in IFN-β induction in poly(dA:dT)-
stimulated HEK293 cells. ...................................................................................... 132 
Figure 4.6. Inhibitory effect of OV-NZ2 infection on IFN-β induction in poly(I:C)-
stimulated HEK293 cells. ...................................................................................... 133 
Figure 4.7. OV-NZ2 infection is required first to inhibit poly(I:C)-induced IFN-β expression 




Figure 4.8. Detection of signalling proteins in HEK293 cells by western blotting. ................. 136 
Figure 4.9. siRNA knockdown of RIG-I gene in HEK293 cells. ............................................. 138 
Figure 4.10. RIG-I is required in HEK293 cells for IFN-β induction. ..................................... 139 
Figure 4.11. RIG-I is involved in the induction of IFN-β in HEK293 cells stimulated with 
either poly(dA:dT) or poly(I:C). ............................................................................ 140 
Figure 4.12. Schematic representation of potential effect of OV-NZ2 ORF020 on the 
induction of IFN-β in HEK293 cells. ..................................................................... 142 
Figure 4.13. Electrophoresis of PCR amplified OV-NZ2 ORF020 gene and transient 
expression in HEK293 cells. .................................................................................. 143 
Figure 4.14. Effect of OV-NZ2 ORF020 expression on the induction of IFN-β in HEK293 
cells stimulated with poly(dA:dT) or poly(I:C). .................................................... 144 
Figure 4.15. Effect of OV-NZ2 ORF020 expression on RIG-I-dependent sensing in HEK293 
cells. ....................................................................................................................... 145 
Figure 4.16. One step growth analysis of OV-NZ2 in HEK293. .............................................. 149 
Figure 4.17. Detection of ORFV early protein synthesis in HEK293 cells infected with heat 
inactivated or untreated virus. ................................................................................ 150 
Figure 4.18. Induction of IFN-β by poly(dA:dT) or poly(I:C) in HEK293 cells infected with 
heat inactivated or untreated virus. ........................................................................ 151 
Figure 4.19. Effect of stable protein expression on the induction of IFN-β. ............................ 154 
Figure 5.1. Experimental model to study the effect of OV-NZ2 on STING-dependent 
pathway. ................................................................................................................. 165 
Figure 5.2. IFN-β induction in THP-1 cells .............................................................................. 167 
Figure 5.3. OV-NZ2 infection effect on IFN-β induction in THP-1 cells. ............................... 168 
Figure 5.4. Characteritics of OV-NZ2 early protein synthesis and virus replication in THP-1 
cells. ....................................................................................................................... 169 
Figure 5.5. OV-NZ2 does not inhibit the release of IL-1β from THP-1 cells. ......................... 171 
Figure 5.6. IFN-β induction in hNDF cells with poly(dA:dT). ................................................ 173 
Figure 5.7. IFN-β induction in hNDF cells with poly(I:C). ...................................................... 175 
Figure 5.8. Inhibitory effect of OV-NZ2 infection on IFN-β induction in hNDF cells 




Figure 5.9. Inhibitory effect of OV-NZ2 infection on IFN-β induction in hNDF cells 
stimulated with poly(I:C). ...................................................................................... 178 
Figure 5.10. OV-NZ2 infection is required first to inhibit the IFN-β induction in poly(I:C)-
stimulated hNDF cells. ........................................................................................... 179 
Figure 5.11. Detection of RIG-I, STING and IRF3 molecules in hNDF cells by western 
blotting. .................................................................................................................. 181 
Figure 5.12. STING is required for IFN-β induction in poly(dA:dT)-stimulated hNDF cells, 
but not with poly(I:C). ........................................................................................... 183 
Figure 5.13. RIG-I siRNA knockdown has no significant effect on poly(dA:dT) effect on 
poly(dA:dT)- or poly(I:C)-induced IFN-β in hNDF cells. ..................................... 186 
Figure 5.14. STING/RIG-I siRNA double knockdown has a significant effect on 
poly(dA:dT)-induced IFN-β expression in hNDF cells. ........................................ 189 
Figure 5.15. One-step growth analysis of OV-NZ2 in hNDF cells .......................................... 192 
Figure 5.16. Detection of ORFV early protein synthesis in hNDF cells infected with heat 
inactivated or untreated virus. ................................................................................ 193 
Figure 5.17. Induction of IFN-β by poly(dA:dT) or poly(I:C) in hNDF cells infected with 
heat-inactivated or untreated virus. ........................................................................ 194 
Figure 9.1. Conserved domain on ORF116 found from NCBI search. .................................... 267 
Figure 9.2. HindIII restriction analysis of wild type OV-NZ2 and knockout-116 OV-
NZ2Δ116. ............................................................................................................... 270 
Figure 9.3. Sequence of HindIII/EcoRI fragment in wild type OV-NZ2. ................................ 271 
Figure 9.4. Sequence of HindIII/EcoRI fragment in knockout OV-NZ2Δ116. ........................ 273 
Figure 9.5. Sequence of HindIII/EcoRI fragment in Revertant OV-NZ2-Rev116. .................. 276 
Figure 9.6. Detection of p-TBK1 in THP-1 cells...................................................................... 277 
Figure 9.7. Inhibitory effect of ANO on early protein synthesis in HEK293 cells. ................. 278 





LIST OF TABLES 
Table 1.1. Classification of Poxviridae family and their characteristics. ..................................... 4 
Table 1.2. The interaction of viruses with mouse and human Toll-like receptors (TLRs) in 
different model systems. .......................................................................................... 15 
Table 1.3. Known cytosolic DNA sensors triggering type I IFN induction and pro-
inflammatory cytokines............................................................................................ 21 
Table 1.4. RNA species and viruses and their known RLRs. ..................................................... 30 
Table 1.5. Non-RLR DExD/H-box Helicases involved in the detection of cytosolic non-self 
RNA. ........................................................................................................................ 35 
Table 1.6. RNA-binding proteins with roles in antiviral response. ............................................ 36 
Table 1.7. Viral regulators of DNA-dependent sensing. ............................................................ 43 
Table 2.1. Short interfering RNAs (siRNAs) sequences. ........................................................... 73 
Table 2.2. Antibodies used in western blot analysis. .................................................................. 74 
Table 2.3. Primers used in PCR analysis of viral DNA. ............................................................. 78 
Table 2.4. Gene specific primers for qRT-PCR. ......................................................................... 83 
Table 3.1. Virus proteins interfering with cell signalling involved in innate immunity. ............ 89 
Table 3.2. Expression levels of interferon-stimulated genes (ISGs) in HeLa-infected cells 
from experiment one. ............................................................................................. 112 
Table 3.3. Fold change of interferon-stimulated genes (ISGs) determined by qRT-PCR 
relative to wild type from experiment one. ............................................................ 113 
Table 3.4. Expression levels of interferon-stimulated genes (ISGs) in HeLa-infected cells 
from experiment two. ............................................................................................. 114 
Table 3.5. Fold change of interferon-stimulated genes (ISGs) determined by qRT-PCR 
relative to wild type from experiment two. ............................................................ 115 
Table 3.6. Expression levels of interferon-stimulated genes (ISGs) in HeLa-infected cells 
from experiment three. ........................................................................................... 116 
Table 3.7. Fold change of interferon-stimulated genes (ISGs) determined by qRT-PCR 
relative to wild type from experiment three. .......................................................... 117 
Table 9.1. Reagents used in this study. ..................................................................................... 268 





LIST OF ABBREVIATIONS 
A  
aa Amino acid 
AIM2 Absent in melanoma 2 
Amp R Ampicillin resistance   
ANK Ankyrin  
ANO Adenosine N1-oxide 
AP-1 Activator protein 1 
AraC Cytosine arabinoside 




bp Base pair  
  
C  
°C Degree Celsius  
CARD Caspase recruitment domain 
cDNA Complementary DNA  
cGAMP Cyclic GMP-AMP 
cGAS Cyclic GMP-AMP synthase 
CHX Cycloheximide 
CMV Cytomegalovirus 
CPE Cytopathic effect 
CpG Cytidine-phosphate-Guanosine  
CPXV Cowpox virus 
CSPD Chemiluminescent phenyl phosphate-substituted dioxetane  
  
D  
DAI DNA-dependent activator of IFN-regulatory factor 
DNA-PK DNA-dependent protein kinase 
DDX3 DEAD-box protein 3 
DENV Dengue virus 
DC Dendritic cells 
DMSO Dimethyl Sulfoxide 
dsDNA Double-stranded DNA 
dsRNA Double-stranded RNA 
  
E  
E. coli Escherichia coli 
eIF2α α subunit of eukaryotic initiation factor 2 
EBV Epstein-Barr virus 
EMCV Encephalomyocarditis virus 
ER Endoplasmic reticulum 





FADD Fas-associated death domain-containing protein 
FCS Fetal calf serum  
  
G  
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GIF Granulocyte-macrophage colony-stimulating factor and Interleukin-2 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
GUS beta-Glucuronidase gene 
  
H  
HAV Hepatitis A virus  
HaCaT Human keratinocytes cell line  
HCMV Human cytomegalovirus  
HIV-1 Human immunodeficiency virus type 1 (HIV-1) 
hNDF Human neonatal dermal fibroblast 
HPV Human papillomavirus 
HSP Heat-shock protein 
HSV-1 Herpes simplex virus type 1 
HSV-2 Herpes simplex virus type 2 
HTLV-1 Human T-cell leukaemia virus type 1 
h.p.i. Hour Post Infection 
  
I  
IFI Interferon inducible 
IFITM IFN-inducible transmembrane 
IFI16 Interferon-inducible protein 16 
IFN Interferon 
IFN-β Interferon-beta  
IFNAR IFN-α/β and receptor 
IκB I kappa B 
IKK IκB kinase 
IKKα IκB kinase alpha  
IKKβ IκB kinase beta  
IKKε IκB kinase epsilon  
IKKλ IκB kinase lambda  
IL-2 Interleukin-2 
IL-18 Interleukin 18 
IL-1R Interleukin-1 Receptor 
IL-1β Interleukin 1β 
IPS‐1 IFN‐β promoter stimulator 1 
IRAK Interleukin-1 receptor-associated kinase 
IRF Interferon Regulatory Factor 
IRF3 Interferon regulatory factor 3 
ISG Interferon-stimulated gene 




ISGF3 Interferon-stimulated gene factor 3  
ISRE Interferon‐Stimulated Response Element 
  
J  
JAK Janus Tyrosine Kinase 
JEV Japanese encephalitis virus 




KSHV Kaposi’s sarcoma-associated herpesvirus  
  
L  
LacZ beta-Galactosidase gene 
LGP2 Laboratory of genetic and physiology 2 
LRR Leucine-rich repeat 
LT cells Lamb Testis cells 
  
M  
MAPK Mitogen-activated protein kinase 
MAVS Mitochondrial antiviral signalling  
MDA5 Melanoma Differentiation Associated Gene 5 
MDDC Monocyte-derived dendritic cells 
MHV68 Murine gammaherpesvirus 68 
Mito Mitochondria  
MOI Multiplicity of infection 
MPXV Monkeypox virus 
MV Measles virus 
MVA Modified Vaccinia virus Ankara 
MyD88 Myeloid differentiation primary-response gene 88 
  
N  
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells  
NLR NOD-like Receptor 
NOD Nucleotide-binding oligomerization domain 
NYVAC Highly attenuated Vaccinia virus strain 
  
O  
OAS 2′‐5′‐oligoadenylate synthetase 
OASL 2′-5′-oligoadenylate synthetase-Like 
OPV Orthopoxvirus 
ORFV Orf virus 
OVIFNR Interferon resistance factor 
OV-NZ2 ORFV virus strain NZ2 wild type  
OV-NZ2Δ116 ORFV virus strain NZ2 ORF116 deletion mutant 




OV-NZ2-Rev116 ORFV virus strain NZ2 ORF116 re-inserted revertant  
OVIFNR Orf virus Interferon inhibitor  
  
P  
PAMP Pathogen-associated molecular pattern 
PBMC Peripheral blood mononuclear cell 
pDCs Plasmacytoid dendritic cells 
PKR Double‐stranded RNA‐activated protein kinase 
Poly(dA:dT) Poly(deoxyadenylic:deoxythymidlic) acid 
Poly(I:C) Poly(inosinic:polycytidylic) acid 
PRR Pattern-recognition receptor 
PSK Penicillin, Streptomycin. Kanamycin  
PYD Pyrin domain 
  
Q  
qRT-PCR Quantitative Real Time-Polymerase Chain Reaction  
  
R  
RIG‐I Retinoic Acid‐inducible Gene I 
RIP Receptor-interacting protein 
RLR RIG-I-like Receptor 
RNA Pol III RNA Polymerase III 
RPV Rabbitpox virus 
RRV Ross River Virus 
RT-PCR Reverse Transcription-Polymerase Chain Reaction 
  
S  
SARM Sterile-α-and armadillo-motif-containing protein 
STAT Signal Transducers and Activators of Transcription 
STING Stimulator of interferon genes 
  
T  
TAK TGF beta-activated kinase 
TANK TRAF family member-associated NF-kappa-B activator 
TBK1 TANK binding kinase 1 
THP-1 Human leukemia monocytic cell line 
TIR Toll/Interleukin-1 receptor/Resistance 
TIRAP Toll-interleukin 1 receptor (TIR) domain-containing adapter protein  
TLR Toll‐like Receptor 
TLR3 Toll‐like Receptor 3 
TLR4 Toll‐like Receptor 4 
TLR7 Toll‐like Receptor 7 
TLR8 Toll‐like Receptor 8 
TLR9 Toll‐like Receptor 9 
TRAF TNF receptor-associated factor 




TRAM TRIF-related adaptor molecule 
TRIF TIR‐domain‐containing adapter‐inducing interferon‐β 
  
V  
VACV Vaccinia virus 
VARV Variola virus 
VEGF-E Vascular endothelial growth factor-E 
vIL-10 Viral Homologue of interleukin-10 
VSV Vesicular Stomatitis virus 
  
W  
WNV West Nile virus 














1.1 Overview  
Poxviruses are members of the Poxviridae family that can infect human, animals and insects. 
They are large complex enveloped viruses. Unlike most other families of viruses, poxviruses 
have large DNA genomes which enable them to encode almost all the factors required for 
replication in the cytoplasm (Buller, R. M. et al., 1991; Moss, B., 2007). A number of poxviruses 
cause lethal disease that include myxomatosis and smallpox. Smallpox was one of the most 
devastating diseases of humans until its eradication by the World Health Organization in 1977 in 
which vaccinia virus (VACV) was used as a vaccine against smallpox. Orf virus (ORFV) is a 
parapoxvirus that causes benign skin lesions, or severe disease in the immunocompromised, in 
sheep and goats and can be transmitted to humans. All poxviruses encode a range of factors that 
counteract the host immune response. These factors are considered accessory factors since they 
are not essential for replication in cell culture but often critical for replication in the host. Many 
such factors have been discovered in orthopoxviruses whereas only a small number have been 
described in parapoxviruses. Most of the accessory genes of parapoxviruses cluster at the termini 
of the genome.  
This thesis investigates the effect of ORFV strain NZ2 (OV-NZ2) infection on the induction of 
type I IFN. A cell-based assay was designed to examine the effect of OV-NZ2 infection on the 
expression of IFN-β in cells stimulated with either poly(dA:dT) or poly(I:C). In addition, in 
attempts to identify virus genes involved in modulating the interferon (IFN) response, the 
function of ORF116 and ORF020 genes were investigated. These genes are found within the 
cluster of accessory genes at the termini. ORF116 knockout and revertant viruses were made to 
examine the differences in mRNA levels of selected interferon-stimulated genes (ISGs) between 
HeLa cells infected with OV-NZ2 wild type, OV-NZ2Δ116 knockout and OV-NZ2-Rev116 
revertant viruses. The ORF116 and ORF020 genes were cloned in an expression vector and their 
effects on IFN signalling examined in HEK293 cells.   
1.1.1 Classification Pathogenesis and Structure of ORFV 
There are two subfamilies of the Poxviridae family: Entomopoxvirinae that infect insects and 




members of a given genus displaying similar morphology except the Parapoxvirus genus as 
shown in Table 1.1. Poxviruses are classified according to their phenotypic characteristics such 
as nucleic acid type, morphology, mode of replication, host they infect and disease they cause. 
In addition, the classification is based on serum cross-reactivity and cross-protection between 
species.  
The orthopoxviruses have a broad host range affecting several vertebrates while other genera 
have a restricted host range and infect only birds such as avipoxvirus (Jarmin, S. et al., 2006) or 
sheep such as capripoxvirus. There is serologic cross reactivity among viruses within a given 
genus but very limited reactivity across genera.  
ORFV is the type species of the Parapoxvirus genus of the Poxviridae family. It has a unique 
ovoid morphology among chordopoxviruses (Figure 1.1 D) and is the causative agent of Orf 
disease, a contagious debilitating skin condition of sheep and goats (Figure 1.1 A and B) and can 
cause zoonotic infection to human and induces localized skin lesions (Figure 1.1 C) (Fleming, S. 
B. et al., 2007; Mercer, A. et al., 2011).  
Poxviruses have a linear dsDNA genome (Moss, B., 2007). VACV referred to as the prototype 
of the poxvirus family, has been shown to have a genome linked by hairpin loops into one 
continuous molecule. Adjacent to the hairpin loops is a conserved sequence motif, followed by 
a set of tandem repeats referred to as the inverted terminal region (ITR) (Boyle, K. et al., 2009; 
Moss, B., 2007; Moss, B. et al., 2011; Smith, G. L., 2007). Unusually the parapoxvirus DNA 
genome is composed of 64 % G+C content (Fleming, S. B. et al., 2007). They have an ovoid 
structure with smaller dimensions compared with other poxviruses of approximately 260 nm in 
length and 160 nm in width (Figure 1.1 D) (Peters, D. et al., 1964). The outer membrane consists 
of a tubule-like structure arranged in a criss-cross pattern (Figure 1.1 D) (Mitchiner, M. B., 1969; 






Table 1.1. Classification of Poxviridae family and their characteristics. 










Chordopoxvirinae Avipoxvirus Fowlpox virus Medium Birds Skin lesion 
Medium – 
High 
Arthropods Brick-shaped ~260 kb 





Medium Arthropods Brick-shaped ~150 kb 




 Reptiles       








Arthropods Brick-shaped ~140 kb 
 Molluscipoxvirus 
Molluscum 






Low Contact Brick-shaped ~180 kb 
 Orthopoxvirus Variola virus Narrow Humans Smallpox High Inhalation Brick-shaped ~200 kb 
  Cowpox virus Broad >30 species 
Localized skin 
lesions 
Low Contact   





Low contact   








  Ectromelia virus   Rodents       






Low Contact Ovoid ~140 kb 







     
  
Bovine popular 
stomatitis virus  
 
Cattle, 
Humans   
     
 Suipoxvirus Swinepox virus Narrow Pigs 
Localized skin 
lesions 
Low Arthropods Brick-shaped ~146 kb 


























Low Arthropods Brick-shaped  ~145 kb 
Entomopoxvirinae  Alphaentomopoxvirus Melontha melontha   Coleoptera     Ovoid  
~260-
370 kb 
 Betaentomopoxvirus Amsacta moorei   
Lepidoptera, 
Orthoptera   
   Ovoid  ~232 kb 
 Gammaentomopoxvirus  Chrionimus luridus   Diptera     Brick-shaped  
~250-
380 kb 






Figure 1.1. Orf disease manifestation and schematic ultrastructure of parapoxvirus virion. 
 
  
Figure 1.1. Orf disease manifestation and schematic ultrastructure of parapoxvirus virion. 
(A). Orf disease manifested by multiple nodular lesions in sheep on the upper and lower labia of 
lips. (B). Severe proliferative orf disease in the lips of sheep. Obtained from (Zhao, K. et al., 
2010). (C). A thumb with lesion caused by Orf virus. Obtain from https://www.cdc.gov. (D). 
Schematic diagram of ORFV particle section. The outer membrane consists primarily of a single 
long tubule that appears to wrap around the virus creating a criss-cross pattern. Adopted from 














1.1.2 Replication and Morphogenesis of Poxviruses  
Poxviruses replicate in the cytoplasm and encode their own machinery for DNA transcription 
and replication. After the virion core is released into the cytoplasm and before complete 
uncoating, the encapsidated early transcription machinery is activated and early gene expression 
is initiated within the core. Early mRNAs are extruded from the core into the cytoplasm and then 
translated using cellular machinery. Some of the early translated proteins are used for subversion 
of the host innate immune responses, while other proteins are used for DNA replication and for 
the transcription of intermediate mRNAs. Early gene expression ceases when the core is 
completely uncoated and the viral genome is released into the cytoplasm in which the replication 
of the genome is initiated. DNA replication enables the virus to initiate intermediate gene 
expression that provides proteins for transcription of late genes. Late gene expression produces 
structural proteins, enzymes and essential proteins required for subsequent infection. Through a 
process of viral morphogenesis, late gene products are packaged into newly synthesized viral 
particles that either egress out the cell or are released upon cell lysis as illustrated in Figure 1.2 
(Boyle, K. et al., 2009; Moss, B., 2007). 
1.1.3 Genetic Structure of ORFV  
VACV was the first poxvirus sequenced by Paoletti, E. et al. (1977). This illustrated the basic 
genetic structure of the poxvirus genome. All other poxviruses are essentially similar but the 
genetic differences mainly lie within the termini of the genome. The genes that are located within 
the central core encode factors involved in virion structure, polymerases involved in DNA 
replication and transcriptional factors involved in gene expression. Factors that determine host 
range, pathogenesis and virulence are encoded within termini of the genome. These genes are 
non-essential for growth in cell culture.  
The genome of several ORFV strains has now been fully sequenced (Delhon, G. et al., 2004; 
Mercer, A. A. et al., 2006). It was predicted that the OV-NZ2 strain contains 132 genes and the 
distribution of these genes is typical of poxviruses with the central region containing genes 
essential for its life cycle and the host range restriction or virulence genes located within terminal 





Like other poxviruses, OV-NZ2 virus has several virulence and immunomodulation genes that 
act either intracellularly or extracellularly. Bioinformatics analysis has indicated that most genes 
within the termini of OV-NZ2 seem to be unique and are not found in other poxviruses or have 
homologues in other organisms. They are predicted to be non-essential and involved in 
manipulation of host physiology and immunomodulation.  
Figure 1.2. Poxvirus replication and morphogenesis. Figure 1.2. Diagrammatic representation of poxvirus replication and morphogenesis. Virus 
replication occurs in the cytoplasm. Upon virion attachment, virion fuses with the cell membrane 
and the core is released into the cytoplasm. The core encode the early genes that are translated 
into proteins involved in host cell modulation, factors for DNA replication and intermediate gene 
transcription. The core is uncoated and DNA is replicated then the intermediate genes are 
transcribed to produce factors for late gene transcription. The assembly of virion is formed and 






1.2 Interferon System 
The interferons (IFNs) are a large group of multifunctional secreted cytokines that contribute in 
a first line of antiviral defence and immunomodulatory activity. They are divided into three 
classes according to their sequence homology, receptors and functional activities: type I, type II 
and type III. Type I IFNs are the key cytokines that mediate antiviral responses, an innate immune 
response and subsequent development of adaptive immunity to viruses.  
Type I IFNs were the first type of interferon discovered by Isaacs, A. et al. (1957) on the basis 
of their antiviral activity. They are a large family of IFN members that are produced in direct 
response to virus infection: IFN-α consists multiple subtypes which are predominantly produced 
by immune cells, IFN-β is one type and produced by most cell types particularly fibroblasts, and 
other members such as IFN-κ, IFN-ε, IFN-ω, IFN-τ and IFN-δ. Although these types are all 
recognized by a single shared receptor (IFNAR1 and IFNAR2 expressed on almost all cell types), 
they have pleiotropic activities. It is unclear yet whether these diverse types are expressed 
differentially in different cell types and induced in response to different types of viruses or each 
type has a specific function. Type III interferons (IFNs) were discovered many years after the 
discovery of type I IFN by two groups (Kotenko, S. V. et al., 2003; Sheppard, P. et al., 2003) 
and shown to have antiviral activity. This type comprises four subtypes of IFN-λ (λ1, λ2, λ3, λ4) 
and have been found to be induced in direct response to viral infection (Ank, N. et al., 2006; 
Onoguchi, K. et al., 2007; Uzé, G. et al., 2007; Zhou, J. et al., 2018). A comprehensive review 
was recently published highlighting shared and distinct features between type I and type III IFNs 
(Lazear, H. M. et al., 2019). Importantly, they explained the reasons why the host maintains two 
types of IFN and they attributed that to not only provide supplementary antiviral protection but 
also to provide an IFN response with less collateral damage than the more potent type I IFN 
response, as type III IFN functions broadly at epithelia barriers where their receptor (IFNLR1 
and IL-10Rβ) is expressed predominantly. Lastly, type II interferons (IFNs) consists of one 
member called IFN-γ and largely induced by activated T cells and natural killer (NK) cells in 
response to the recognition of infected cells, not direct viral infection (Alspach, E. et al., 2019). 
The IFN system is regulated by two signalling pathways. First, signalling is initiated by detection 





(PRRs) which activate a series of transcription factors (IRFs, NF-κB and ATF2/c-Jun). The 
activated factors translocate to the nucleus where they bind to the promoter regions of IFNs and 
pro-inflammatory cytokines forming an enhanceosome and then activate the transcription by 
RNA polymerase. Upon IFN induction, a second line of signalling is initiated in which the 
induced IFNs interact with IFN receptors (IFNRs), in an autocrine or paracrine manner, leading 
to transcription of a diverse set of genes called IFN-stimulated genes (ISGs) via the Janus kinase 
(JAK)-signal transducer activator of transcription (STAT) pathway. These ISGs are involved in 
eliminating viral infection from infected cells and also conferring resistance to neighbouring 
cells. The established antiviral state will inhibit viral replication at various stages. Some ISGs 
can also be induced directly by viral infection, but less effectively than the IFN response itself, 
and this induction is amplified significantly by IFN (Wathelet, M. G. et al., 1992).        
1.3 Innate Immunity to Virus Infection and Type I Interferon Induction  
Host cells adopt multiple defence mechanisms in order to respond to invading viruses. Innate 
immunity is a first line of defence and an immediate response against viral infection. The key 
step in this response is detection of the virus infection. Sensing of pathogens by innate immunity 
is mediated by host PRRs, also called innate immune sensors that recognize PAMPs such as viral 
nucleic acids that are distinct from host-derived.  
These receptors (or sensors) can be classified based on their subcellular localization and distinct 
virus-derived molecules they recognize. C-type lectin receptors (CLR) and Toll-like receptors 
(TLR) are endosomal or membrane-bound receptors whereas nucleotide-binding oligomerization 
domain (NOD)-like receptors (NLR), AIM2-like receptors (ALR) and retinoic acid inducible 
gene (RIG-I)-like receptors are cytosolic receptors. Each class of these receptors activates 
specific signalling cascades which in turn activate specific transcription factors to induce 
expression of target genes namely type I IFNs and proinflammatory cytokines. 
Activation of innate immunity is achieved by the recognition of virus infection in order to trigger 
the signalling pathways and initiate an innate immune response to eliminate the virus. The major 
PAMPs generated during viral infection are nucleic acids and are the most important molecules 
that are recognized by the host (Yoneyama, M. et al., 2010). The innate immune system is 





Upon recognition of nucleic acids derived from virus, the activation of signalling cascades is 
triggered leading to induction of type I IFN and proinflammatory cytokines. The secreted IFN 
binds its receptor and acts as an autocrine or paracrine factor activating the JAK/STAT pathway 
which in turn induces a number of IFN-inducible genes involved in anti-viral immunity (Kawai, 
T. et al., 2006; Kawai, T. et al., 2008).  
1.3.1 Toll-like Receptors (TLRs) sensing of nucleic acids in endosomes  
The importance of TLRs’ role in sensing viruses was demonstrated (Bowie, A. et al., 2000; Kurt-
Jones, E. A. et al., 2000). TLR receptors are of the best characterized PRRs and have a critical 
role in detecting invading pathogens outside the cell and in intracellular endosomes. There are 
13 mammalian members and their cytoplasmic domains show high similarity to that of the 
interleukin-1 receptor (IL-1R) family. They sense a wide range of pathogens and trigger distinct 
signalling pathways that lead to induction of specific responses. They are defined by the presence 
of N-terminal leucine-rich repeats (LRRs) and a transmembrane domain, then, a cytoplasmic 
Toll/Interleukin-1 receptor (TIR) domain (Akira, S., 2003; Medzhitov, R., 2001; Takeda, K. et 
al., 2005; Yoneyama, M. et al., 2010).  
Among all TLRs characterized to date, only TLR3, -7, -8, and -9 are the known receptors that 
interact with viruses (Table 1.2) and mediate the production of type I IFNs. TLR3, TLR7, TLR8, 
and TLR9 are mainly expressed in endosomes of some cell types. They are involved in the 
detection of nucleic acids derived from viruses by means of LRR domain to transmit intracellular 
responses through the recruitment TIR-containing adaptor (Boehme, K. W. et al., 2004; Bowie, 
A. G. et al., 2005; Kawai, T. et al., 2010; Vaidya, S. A. et al., 2003). Three mechanisms of 
delivering viral nucleic acid to the endosomal compartment have been described. The first one is 
dependent on the endocytosis pathway and protease-mediated degradation of invading viruses. 
The second one operates through autophagy in which the viral nucleic acid is transferred to 
endolysosomes. The last mechanism is dependent on cell-to-cell contact and transfer of viral 





1.3.1.1 TLR9-dependent DNA Sensing  
TLR9 was the first DNA sensor identified and the only known sensor so far responsible for DNA 
sensing in endosome (Gilliet, M. et al., 2008; Kadowaki, N. et al., 2001). It is mainly expressed 
in B cells and plasmacytoid DCs (pDCs), a cell type that produces large amounts of type I IFNs 
in response to virus infection. It is well-established that TLR9 senses unmethylated cytosine-
guanine dinucleotide (CpG) motif of pathogen DNA, which is frequently observed in bacteria 
and viruses, unlike host genomic DNA (Haas, T. et al., 2008). TLR9 is mainly present on the 
membrane of the endoplasmic reticulum (ER) when it is inactive, however, when stimulated by 
its ligand, it traffics to the endosome under the control of protein unc93 homolog B (UNC93B) 
(Kim, Y.-M. et al., 2008; Tabeta, K. et al., 2006).  
The antiviral role of TLR9 was identified in which the production of type I IFN was examined 
in response to several infections of circular or linear dsDNA viruses: herpes simplex virus 1 
(HSV-1) and murine cytomegalovirus (MCMV) (Hochrein, H. et al., 2004; Krug, A. et al., 2004), 
adenovirus (ADV) (Zhu, J. et al., 2007), poxviruses (Samuelsson, C. et al., 2008), murine 
gammaherpesvirus 68 (MHV-68) (Guggemoos, S. et al., 2008), Epstein-barr virus (EBV) (Fiola, 
S. et al., 2010) kaposi’s sarcoma-associated herpesvirus (KSAH) (West, J. A. et al., 2011), 
human papillomavirus (HPV) (Hasan, U. A. et al., 2007) and Merkel cell polyomavirus (MCV) 
(Shahzad, N. et al., 2013).    
Although the pivotal role of TLR9 in the antiviral response was shown in some cell types, it 
seems that TLR9 might only have a minor role and it is not the critical sensor for viruses in cell 
types that are most often infected. Therefore, the TLR9-independent mechanism is much more 
important in controlling virus infection. pDCs, which express TLR9 and a potent inducer of IFN, 
are not usually the first cells that come in contact with invading viruses. It has also been shown 
that DCs and monocytes deficient in TLR9 can still respond to transfected viral DNA or DNA 
virus infection (Hochrein, H. et al., 2004; Ishii, K. J. et al., 2006). Many cell types such as 
fibroblasts and epithelial cells do not express TLR9, but they still respond to exogenous DNA 





1.3.1.2 TLR3, 7, 8-dependent RNA Sensing  
TLR3 recognizes a synthetic analogue of viral dsRNA, polyinosinic acid-cytidylic acid 
(poly(I:C)), widely used to mimic viral infection and viral dsRNA generated during virus 
replication (Schröder, M. et al., 2005). It was identified from a study on mice deficient in IFN-
inducible dsRNA-dependent protein kinase (PKR) in which it was found that they still responded 
to poly(I:C). Moreover, the induction of proinflammatory cytokines and type I IFNs were 
abolished in response to poly(I:C) in TLR3-/--deficient macrophages and splenocytes  
(Alexopoulou, L. et al., 2001; Weber, F. et al., 2006). It has been widely known that TLR3 is 
expressed in the endosome, however TLR3 expression was also found on the cell surface in some 
fibroblasts (Matsumoto, M. et al., 2002). The location of TLR3 expression appears to be cell 
type-dependent, as discussed in (Randall, R. E. et al., 2008). The role of TLR3 in the antiviral 
response upon dsRNA or virus infection detection and the induction of type I IFN mediated via 
TLR3 have been reviewed previously (Bowie, A. G. et al., 2008; Goffic, R. L. et al., 2006; Rudd, 
B. D. et al., 2006; Schröder, M. et al., 2005; Vercammen, E. et al., 2008; Wang, T. et al., 2004; 
Yoneyama, M. et al., 2010).  
TLR7 and TLR8 are structurally homologous and closely related to TLR9 in terms of sequence 
similarity and known to recognize ssRNA. TLR7 is mostly found in pDCs whereas TLR8 is 
mainly expressed in myeloid dendritic cells (DC) and monocytes and both are expressed 
exclusively in endosomes. Their role in antiviral immunity were identified from the initial 
observation that imidazoquinolines such as imiquimod (R-837) and resiquimod (R-848), a known 
antiviral compound, can activate innate immunity in a human TLR7- and TLR8-dependent and 
mouse TLR7-dependent manner but not in mouse TLR8 in TLR-transfected HEK293 cells  
(Hemmi, H. et al., 2002; Jurk, M. et al., 2002). Initially, it was thought that TLR8 is non-
functional in mice as it failed to initiate immunity upon stimulation with natural ssRNA or R-
848, however, a subsequent study showed that mouse TLR8 expressed in HEK293 cells can be 
activated when cells are stimulated with a combination of polyT oligodeoxynucleotides (ODNs) 
and imidazoquinolines (Gorden, K. K. B. et al., 2006). Paradoxically, type I IFN was also 
induced in mouse TLR8-expressing HEK293 cells when stimulated with VACV dsDNA 
(Martinez, J. et al., 2010). Subsequent studies have shown that guanosine- and uridine-rich 





murine TLR7 and human TLR8 (Heil, F. et al., 2004); in addition, either synthetic ssRNA or 
RNA derived from influenza and vesicular stomatitis virus (VSV) were also ligands for TLR7 
(Diebold, S. S. et al., 2004; Lund, J. M. et al., 2004). The minimal sequence content required for 
a TLR7 ligand was investigated for ssRNA recognition in which it was found that ssRNA must 
at least contain several uridines in close proximity for TLR7 stimulation (Diebold, S. S. et al., 








Table 1.2. The interaction of viruses with mouse and human Toll-like receptors (TLRs) in different model systems. 
 TLR Virus Family 
Macromolecules 
detected 




Human TLR3 Vaccinia virus (VACV) Poxviridae Unknown Human keratinocytes dsDNA (Howell, M. D. et al., 2006) 
  Herpes simplex virus (HSV) Herpesviridae Unknown Human polymorphisms dsDNA (Zhang, S.-Y. et al., 2007) 
  Epstein–Barr virus (EBV) Herpesviridae dsRNA 
Human PBMCs and 
lymphocytes 
dsDNA (Iwakiri, D. et al., 2009) 
 TLR7 Human immunodeficiency virus (HIV) Retroviridae Unknown Patient study ssRNA (RT) (Meier, A. et al., 2009) 
  Human immunodeficiency virus (HIV) Retroviridae Unknown Human polymorphisms ssRNA (RT) (Oh, D. et al., 2009) 
  Kaposi's sarcoma‐associated herpesvirus (KSHV) Herpesviridae Unknown 
Latent infected primary 
effusion lymphoma cell 
lines 
dsDNA (Gregory, S. M. et al., 2009) 
 TLR8 Human immunodeficiency virus (HIV) Retroviridae ssRNA HEK 293 cells ssRNA (RT) (Heil, F. et al., 2004) 
  Kaposi's sarcoma‐associated herpesvirus (KSHV) Herpesviridae Unknown 
Latent infected primary 
effusion lymphoma cell 
lines 
dsDNA (Gregory, S. M. et al., 2009) 
 TLR9 Human immunodeficiency virus (HIV) Retroviridae Unknown  Human B cells ssRNA (RT) (Jiang, W. et al., 2008) 
  Human immunodeficiency virus (HIV) Retroviridae CpG  Human B cells ssRNA (RT) (Malaspina, A. et al., 2008) 
  Human immunodeficiency virus (HIV) Retroviridae gp120  Human pDCs ssRNA (RT) (Martinelli, E. et al., 2007) 
  Human immunodeficiency virus (HIV) Retroviridae Unknown  Human polymorphisms ssRNA (RT) (Bochud, P.-Y. et al., 2007) 
  Hepatitis B virus (HBV)  Hepadnaviridae Unknown  Human pDCs dsDNA‐RT (Xie, Q. et al., 2009) 
  Hepatitis C virus (HCV)  Flaviviridae Unknown  Patient liver samples ssRNA (+) (Huang, X. X. et al., 2007) 
  Respiratory syncytial virus (RSV)  Paramyxoviridae Unknown  Human pDCs ssRNA (−) (Schröder, M. et al., 2005) 
        
Murine  TLR3 Vaccinia virus (VACV)  Poxviridae Unknown  Knock-out mice dsDNA (Hutchens, M. et al., 2008) 
  Punta Toro virus (PTV)  Bunyaviridae Unknown  Knock-out mice ssRNA (−) (Gowen, B. B. et al., 2006) 








 TLR Virus Family 
Macromolecules 
detected 




  Influenza A virus (IAV)  Orthomyxoviridae Unknown  Knock-out mice ssRNA (−) (Goffic, R. L. et al., 2006) 
  West Nile virus (WNV)  Flaviviridae Unknown  Knock-out mice ssRNA (+) 
(Daffis, S. et al., 2008; Wang, T. et 
al., 2004; Welte, T. et al., 2009) 
 TLR7 Influenza A virus (IAV)  Orthomyxoviridae ssRNA  Knock-out mice ssRNA (−) (Diebold, S. S. et al., 2004) 
  Human immunodeficiency virus (HIV)  Retroviridae ssRNA  Knock-out mice ssRNA (RT) (Heil, F. et al., 2004) 
  Vesicular stomatitis virus (VSV)  Rhabdoviridae ssRNA  Knock-out mice ssRNA (−) (Lund, J. M. et al., 2004) 
  West Nile virus (WNV)  Flaviviridae Unknown  Knock-out mice ssRNA (+) 
(Daffis, S. et al., 2008; Wang, T. et 
al., 2004; Welte, T. et al., 2009) 
 TLR9 Herpes simplex virus (HSV-1)  Herpesviridae Unknown  Knock-out mice dsDNA (Hochrein, H. et al., 2004) 
  Murine cytomegalovirus (MCMV)  Herpesviridae Unknown  Knock-out mice dsDNA (Krug, A. et al., 2004) 
  Adenovirus (ADV)  Adenoviridae Unknown  Knock-out mice dsDNA (Zhu, J. et al., 2007) 
  Poxviruses  Poxviridae Unknown  Knock-out mice dsDNA (Samuelsson, C. et al., 2008) 
  Murine gammaherpesvirus 68 (MHV-68)  Herpesviridae Unknown  Knock-out mice dsDNA (Guggemoos, S. et al., 2008) 
  Human immunodeficiency virus (HIV)  Retroviridae CpG  Transgenic mice ssRNA (RT) (Equils, O. et al., 2003) 





1.3.1.3 Toll-Like Receptor Signalling Pathways  
Recognition of PAMPs by different TLRs results in activation of distinct signalling cascades that 
is also dependent on cell type. These differences are caused mainly by different TIR-domain 
adaptor proteins recruited to TLRs. Five TIR-domain adaptor proteins that control signalling 
from activated TLRs have been identified: myeloid differentiation primary-response gene 88 
(MyD88), Toll-interleukin 1 receptor (TIR) domain-containing adapter protein (TIRAP), TIR-
domain-containing adaptor protein inducing IFNβ (TRIF), TRIF-related adaptor molecule 
(TRAM) and sterile-α-and armadillo-motif-containing protein (SARM) which mediate cellular 
signalling that leads to the induction of type I IFN and proinflammatory cytokines (Kawai, T. et 
al., 2010; O'Neill, L. A. J. et al., 2007). Each TLR mediates distinctive responses in association 
with a different TIR-containing adaptor. TLR7, 8 and 9 recruit MyD88 to transmit cellular 
signalling whereas TLR3 recruits TRIF (or TICAM-1) to mediate signalling leading to interferon 
regulatory factor 3 (IRF3) and interferon regulatory factor 7 (IRF7) activation and type I IFN 
induction (Figure 1.3) (Oshiumi, H. et al., 2003; Yamamoto, M. et al., 2003; Yamamoto, M. et 
al., 2002). In TLR-dependent nucleic acid sensing, two distinct TLR signalling pathways are 
defined that depend on the usage of MyD88 and TRIF adaptor proteins.     
The MyD88-dependent Signalling Pathway 
Unlike TLR3; TLR7, 8 and 9 utilize the MyD88-dependent signalling pathway in which MyD88 
is the adaptor molecule for triggering the downstream signalling cascades. Upon engagement 
with their ligand, the receptors transmit their signal via MyD88 which then recruits the 
downstream signalling molecules interleukin-1 receptor- associated kinase 4 (IRAK4), a 
serine/threonine kinase with an N-terminal death domain. IRAK4 activates interleukin-1 
receptor-associated kinase 1 and 2 (IRAK1/2) (Kawagoe, T. et al., 2008). The IRAKs then 
dissociate from MyD88 and interact with TNFR-associated factor 6 (TRAF6), that acts as an E3 
ubiquitin protein ligase to catalyses the formation of a lysine 63 (K63)-linked polyubiquitin chain 
on TRAF6 (Kawai, T. et al., 2004). Subsequently, the IKKα/IKKβ/IKKγ complex 
phosphorylates IκB leading to activation of three transcription IRF7, nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) and activator protein 1 (AP-1). In contrast to the 





works alternatively for IFN induction. It is important to note that the action of IRF7 is different 
from the feedback activation of IRF7 in TLR3 stimulation (Marié, I. et al., 1998). IRF7 is 
recruited to the signalling complex formed by signalling intermediates and activated by IRAK1 
and IKK-α via phosphorylation (Hoshino, K. et al., 2006; Uematsu, S. et al., 2005). NF-κB and 
AP-1 are both activated by IRAK4 and TRAF6 then TAK1, but differ in their IκB kinases-α-β-γ 
(IKKα/IKKβ/IKKγ) and mitogen-activated protein kinase (MAPK) respectively (Koyama, S. et 
al., 2008). 
Figure 1.3. Recognition of viral nucleic acids by TLRs. 
Figure 1.3. Recognition of viral nucleic acids by TLRs. TLR3/ TLR7/8 and TLR9 detect viral 
dsRNA, ssRNA and CpG DNA respectively in endosome. TLR3 interacts with adaptor molecule 
TRIF to activate the downstream signalling indicated, whereas TLR7/8 and TLR9 interact with 
adaptor molecule MyD88 to activate the downstream signalling indicated. See the text for detail. 





The TRIF-dependent Signalling Pathway   
Only the TLR3 receptor, with the exception of TLR4 that triggers both MyD88-dependent and 
TRIF-dependent signalling, depend on the TRIF domain to initiate the signalling pathway. It is 
initiated upon engagement of TLR3 with dsRNA that leads to recruitment of TRIF. Then TRIF 
recruits and interacts with a set of signalling intermediates including TRAF6, TRAF3 and 
receptor-interacting protein 1 (RIP1). The interaction of TLR3 and TRIF can activate two 
transcription factors NF-κB and IRF3 (Jiang, Z. et al., 2004). During the activation of NF-κB, 
TRAF6 and RIP1 co-operatively activate TGF beta-activated kinase 1 (TAK1) leading to the 
activation of IKKα/IKKβ/IKKγ whereas IRF3 is activated via TRAF3, then activating TANK 
binding kinase 1/ IκB kinase-ε (TBK1/IKK-ε) which then phosphorylates IRF3 (Fitzgerald, K. 
A. et al., 2003; Sharma, S. et al., 2003; Vercammen, E. et al., 2008). It has been demonstrated 
that TBK1/IKKε are responsible kinases for TRIF-mediated IFN-β induction (Hemmi, H. et al., 
2004; Perry, A. K. et al., 2004). 
1.3.2 Intracellular Nucleic Acid Sensing  
Intracellular PRRs are localized in the cytoplasm or nucleus including retinoic acid inducible 
gene (RIG-I)-like Receptors (RLRs), AIM2-like receptors (ALRs) and nucleotide-binding 
oligomerization domain (NOD)-like Receptors (NLRs). These intracellular sensors are widely 
expressed to detect virus infection in the cytoplasm and nucleus in almost all cell types and are 
the key intracellular sensors of viral RNA or viral DNA.   
1.3.2.1 Intracellular Detection of DNA  
Non-self DNA is usually detected when it is within the cells (Watson, R. O. et al., 2012). 
Therefore, the host expresses several DNA sensors located at various intracellular sites, 
endosomes, cytosol and nucleus. The non-self DNAs that are detected by intracellular sensing 
usually originate from viruses and intracellular bacteria. DNA viruses, the focus of this study, 
include those replicating in the cytoplasm such as poxviruses and those replicating in the nucleus 
such as herpesviruses. Observations by Hochrein, H. et al. (2004) and his colleagues provided 
evidence that viral DNA can also be sensed in the cytoplasm and lead to induction of type I IFN 





an IFN response in a TLR-independent manner which strongly suggested that there is another 
DNA sensing mechanism that can recognize cytoplasmic DNA.  
Upon infection, viral genomic DNA is uncoated and released into the cytosol, rendering its 
exposure to cytosolic DNA sensors. This was demonstrated from the observation that viral 
genomic DNA from HSV-1 or CMV associated with the DNA sensor IFI16 (Horan, K. A. et al., 
2013; Li, T. et al., 2013; Orzalli, M. H. et al., 2012), suggesting that the viral genome could 
trigger cytosolic DNA sensing. Others believe that virus infection could cause cellular stress 
leading to the release of mitochondrial DNA into the cytosol which then results in activation of 
cytosolic DNA sensing as observed in herpesvirus infection (West, A. P. et al., 2015).        
Cytosolic sensing of DNA and the signalling pathways involved have only been identified over 
the last 15 years. There is growing evidence that cytosolic PRRs are important in detecting 
cytosolic viral DNA in the cytoplasm, despite that the underlying mechanisms are still to be 
elucidated. A number of proteins have been proposed so far, reviewed previously, to be important 
for cytosolic DNA recognition that lead to induction of type I IFN as discussed below (Table 1.3 
and Figure 4.1 A). Only three (AIM2, DNAPK and cGAS) among about 13 cytosolic DNA 
sensors were clearly shown to have a role in DNA-dependent IFN production. It is worth noting 
that due to the complexity of the DNA sensing system and lack of clear understanding, the 
importance of the sensors and signalling components involved during virus infection were 
identified by the evasion strategies used by viruses to inhibit these molecules.             
DNA-dependent activator of IRFs (DAI) (also known as ZBP1 or DLM1) was the first reported 
cytosolic DNA sensor (Takaoka, A. et al., 2007). DAI was shown to have binding activity with 
DNA. Its role in the antiviral response was investigated in L929 cells in which the expression of 
the IFN response was enhanced in cells transiently expressing DAI when stimulated with 
poly(deoxyadenylic:deoxythymidylic) acid (poly(dA:dT)) and this response decreased in DAI-
depleted L929 cells in response to HSV-1. However, its role in macrophages was not observed 
(Unterholzner, L. et al., 2010) as DAI-/- mice responded normally to DNA (Ishii, K. J. et al., 
2008) and its role is not important in many human cell types (Lippmann, J. et al., 2008). These 
observations suggested the existence of other cytosolic DNA sensors and DAI was either largely 







Table 1.3. Known cytosolic DNA sensors triggering type I IFN induction and pro-inflammatory cytokines. 
Receptor Cell type Ligand Pathogen Response 
Signalling molecules 
involved 
Evidence for DNA binding Reference 
DAI Mouse L929 Poly(dA:dT), VACV 





IFN-β TBK1, IRF3, RIP1, 
RIP3, NF-κB 
FRET between B-DNA and DAI, 
pull-down of DAI B-DNA ± 
competition  
(Parker, D. et al., 2011; Takaoka, A. et al., 
2007; Upton, Jason W. et al., 2012; Wang, 
Z. et al., 2008) 
RNA Pol III HEK293, HeLa, BMDM, 
BMDC, MEF, human 
MDDC, PBMC, L929, 
Mutu III, RAW264.7 







Production of IFN-inducing RNA 
transcripts sensitive to Pol III 
inhibition, purified core RNA Pol III 
complex producing IFN-inducing 
RNA   
(Ablasser, A. et al., 2009; Chiu, Y.-H. et 
al., 2009) 
IFI16/p204 RAW264.7, THP-1, 
HFF, corneal epithelial 
cells, neutrophils, human 
MDM, human MDDC, 
HeLa, BMDM 









STING, TBK1, IRF3, 
NF-κB 
Co-precipitation of cytosolic IFI16 
with dsDNA-coupled beads, 
interaction between rIFI16 and 
dsDNA in α-screen 
(Duan, X. et al., 2011; Horan, K. A. et al., 
2013; Kerur, N. et al., 2011; Orzalli, M. 
H. et al., 2012; Søby, S. et al., 2012; 
Unterholzner, L. et al., 2010) 
AIM2 Macrophages, DCs   IL-1β, IL-
18 
 Affinity purification of Myc-tagged 
AIM2 with dsDNA-coupled beads, 
interaction between rAIM2 and 
dsDNA in α-screen 
(Bürckstümmer, T. et al., 2009; 
Fernandes-Alnemri, T. et al., 2009; 
Hornung, V. et al., 2009; Roberts, T. L. et 
al., 2009) 
MRE11 BMDC, human ATLD, 
MEF, DCs 





 Precipitation of MRE11 by 
streptavidin beads in lysates from 
cells transfected with biotin-dsDNA  
(Kondo, T. et al., 2013) 
DNA-PKcs 
/Ku70/Ku80 
MEF, mouse ears in 
vivo, 293T  
Poly(dA:dT), ISD, 
plasmid, E.coli DNA, 
VACV DNA  
MVA, HSV-1 IFN-λ1, 
IFN-β,   
IL-6 
IRF1, IRF7  Co-precipitation of cytosolic Ku70, 
Ku80 and DNA-PKcs with dsDNA-
coupled beads 
(Ferguson, B. J. et al., 2012; Zhang, X. et 
al., 2011) 
cGAS L929, THP-1, HEK293 Poly(dA:dT), poly(dG-
dC), ISD, HT DNA 
HSV-1 IFN-β STING Precipitation of GST-cGAS with 
biotinylated DNA 
(Ablasser, A. et al., 2013; Civril, F. et al., 
2013; Diner, Elie J. et al., 2013; Sun, L. et 
al., 2013; Zhang, X. et al., 2013) 









Receptor Cell type Ligand Pathogen Response 
Signalling molecules 
involved 
Evidence for DNA binding Reference 
HMGBs MEF Poly(dA:dT), ISD, 
plasmid, E.coli DNA, 
VACV DNA, HSV DNA, 
poly(I:C), 5’ppp RNA 
HSV-1, VSV    (Yanai, H. et al., 2009) 






 β-catenin, p300, 
IRF3 
 (Yang, P. et al., 2010) 
LSm14A HEK293, THP-1 Poly(dA:dT), poly(I:C), 
5’ppp RNA 
HSV-1, SeV    (Li, Y. et al., 2012) 
DHX9 Human pDCs  CpG-A HSV TNF-α MyD88, NF-κB 
(p50) 
Co-precipitation of DHX9 with 
biotin-CpG-B 
(Kim, T. et al., 2010) 
DHX36 Human pDCs CpG-B HSV IFN-α MyD88, IRF7 Co-precipitation of DHX36 with 
biotin-CpG-A 
(Kim, T. et al., 2010) 
DDX41 D2SC, BMDC, THP-1 Poly(dA:dT), 







 Co-precipitation of dsDNA with HA-
tagged DDX41 
(Parvatiyar, K. et al., 2012; Zhang, Z., 
Yuan, B., Bao, M., et al., 2011) 
DDX60       (Miyashita, M. et al., 2011) 
Rad50-
CARD9 
      (Roth, S. et al., 2014) 
Sox2       (Xia, P. et al., 2015) 
BAF       (Kobayashi, S. et al., 2015) 
DHX29       (Sugimoto, N. et al., 2014) 





A further DNA sensor was soon identified following the discovery of DAI which is RNA 
Polymerase III/RIG-I (RNA Pol III) (Ablasser, A. et al., 2009; Chiu, Y.-H. et al., 2009). 
Surprisingly this sensor acts through an RNA sensing pathway in response to DNA. RNA 
Polymerase III has a role in transcribing cellular RNA such as transfer RNAs (tRNAs), 5S 
ribosomal RNAs and synthetic poly(dA:dT) AT-rich dsDNA, when transfected into cells, but not 
GC- rich dsDNA. RNA Pol III transcribes poly(dA:dT) into 5’ triphosphate dsRNA which is 
then recognized by the cytosolic RNA sensor RIG-I, but not MDA5, which induces the 
expression of IFN-β (Nie, Y. et al., 2013; Rathinam, V. A. K. et al., 2011). However, the role of 
RNA Pol III in detection of virus DNA remains to be elucidated as cells that have RNA Pol III 
such as HEK293 do not respond to DNA species originating from viruses, bacteria or mammals, 
with the exception of Epstein Barr virus encoded small RNAs (EBERs) (Unterholzner, L. et al., 
2010). In addition, the RNA Pol III-dependent pathway seems to be redundant where the DNA-
dependent sensing pathway is functional.       
The PYHIN family proteins (IFI16/p204 and AIM2) harbour an N-terminal signalling PYRIN 
domain and one or two C-terminal DNA binding HIN200 domains. This structure proposes their 
role as cytosolic DNA sensors. Besides, they are strongly induced by interferon and bind DNA 
in a sequence-independent manner by interacting with the phosphate-sugar DNA backbone 
(Burdette, D. L. et al., 2012; Jin, T. et al., 2012). Cytosolic DNA can also activate not only IFN 
signalling but also inflammasome signalling in an NLRP3-independent manner. Absent in 
melanoma 2 (AIM2) was identified as a sensor detecting DNA in the cytoplasm and facilitates 
the recruitment of ASC and subsequently caspase 1 activation resulting in secretion of IL-1β 
(Figure 4.1 B). Furthermore, its role was demonstrated in AIM2-/- mice (Bürckstümmer, T. et al., 
2009; Fernandes-Alnemri, T. et al., 2009; Hornung, V. et al., 2009; Roberts, T. L. et al., 2009). 
Another member of the PYHIN family, IFN-γ-inducible protein 16 (IFI16) or mouse ortholog 
p204, has been identified to have a role in cytosolic DNA sensing. IFI16 activation leads to IRF-
3 and NF-κB-dependent signalling cascades that result in production of type I IFN. IFI16 role in 
the antiviral response was demonstrated in studies that have shown an impairment of IFN 
induction in IFI16-depleted cells when stimulated with DNA or infected with HSV-1 (Orzalli, 
M. H. et al., 2012; Unterholzner, L. et al., 2010), inhibition of HCMV replication (Gariano, G. 





was found to shuttle between the nucleus and cytoplasm in a cell-type specific manner (Veeranki, 
S. et al., 2012).  
DExD/H-Box Helicases (DDX) protein family comprises RNA and DNA helicases. Although 
many are involved in gene regulation, several helicases have been identified to be involved in 
innate immunity. Using a proteomic screen for proteins binding CpG-containing DNA, DHX9 
and DHX36 were the first helicases identified in pDCs to act as putative cytosolic DNA sensors 
(Kim, T. et al., 2010). These two proteins have shown differential activity. DHX9-depleted cells 
have shown a decrease in TNF-α production in response to HSV-1 whereas DHX-36-depleted 
cells have shown a decrease in IFN-α production in response to the same virus. In addition, it 
was found that production of IFN-α and IRF-7 activation in these cells in response to CpG-A 
DNA was DHX36-dependent, whereas production of TNF-α and IL-6 and NF-κB in response to 
CpG-B DNA was DHX9-dependent. Both proteins were found to associate with MyD88, a TLR 
adaptor, and TLR9-depleted cells were severely impaired in their response upon stimulation with 
CpG DNA. These observations could suggest that DHX9 and DHX36 might be required in a 
TLR9-dependent pathway in pDCs rather that DNA sensors per se. This has prompted further 
investigation to identify other DExD/H-box helicases involved in cytosolic DNA sensing. Zhang, 
Z., Yuan, B., Bao, M., et al. (2011) and his colleagues have identified DDX41 as a putative DNA 
sensor after screening 59 members of the DExD/H-box helicases using an siRNA screen 
approach. DDX41 was shown to bind with DNA, bacterial cyclic dinucleotides (CDN), cyclic-
di-GMP and cyclic di-AMP and also interact with stimulator of interferon genes (STING), a 
critical adaptor for cytosolic DNA sensing, and TBK1 (Parvatiyar, K. et al., 2012; Zhang, Z., 
Yuan, B., Bao, M., et al., 2011). The role of DDX41 in the IFN response was demonstrated in 
DCs and THP-1 cells when transfected with DNA or infected with HSV-1 or adenovirus.          
Since viruses interact with the host DNA damage machinery, possibly for the reason that any 
damage caused to DNA could lead to production of IFN-β, it is assumed that the DNA damage 
factors involved in this response act as cytosolic DNA sensors (Brzostek-Racine, S. et al., 2011; 
Karpova, A. Y. et al., 2002; Kim, T. et al., 1999; Weitzman, M. D. et al., 2010). DNA-dependent 
protein kinase (DNA-PK) is a heterotrimeric complex that consists of Ku70, Ku80 and the 
catalytic subunit DNA-PKcs and has a role in DNA damage repair through the two repair 





first described to have a role in cytosolic DNA sensing and DNA-induced production of IFN-λ 
(Zhang, X. et al., 2011). One year later the DNA-PK complex was also identified as a DNA 
sensor and it was required for the production of IFN-β. Fibroblast cells deficient in DNA-PK has 
shown a reduction in IRF3-dependent signalling, not NF-κB, in response to transfected DNA or 
MVA infection (Ferguson, B. J. et al., 2012). The activity of DNA-PK was not dependent on its 
kinase activity. Meiotic recombination 11 homology A (MER11) is another DNA damage sensor 
that have a role in cytosolic DNA sensing and shown to mediate a STING-dependent response 
to transfected DNA but not HSV-1 infection (Kondo, T. et al., 2013). Rad50-CARD9, discovered 
in 2014, was implicated in DNA sensing besides its role in DNA damage repair. It resides in the 
nucleus but translocates to the cytosol during virus infection where it detects viral DNA then 
initiates inflammasome activation instead of IFN induction (Roth, S. et al., 2014).     
Cyclic GMP-AMP (2’3’-cGAMP) was described as a second messenger, a type of bacterial-
derived cyclic dinucleotide (CDN) with a 2’3’ phosphodiester linkage, produced following 
stimulation with DNA and mediates STING-dependent signalling that result in IRF3 activation 
(Ablasser, A. et al., 2013; Wu, J. et al., 2013). Sun, L. et al. (2013) have subsequently identified 
the enzyme, called Cyclic GMP-AMP Synthase (cGAS), that catalyzes the synthesis of cGAMP 
following binding to DNA. Cytosolic DNA sensing by cGAS-cCAMP-STING-dependent and 
the signalling pathway involved are reviewed in (Cai, X. et al., 2014; Chen, Q. et al., 2016; Xiao, 
T. S. et al., 2013). cGAS binding to DNA was further confirmed by structural studies (Civril, F. 
et al., 2013; Kranzusch, Philip J. et al., 2013). All the DNA receptors identified at this time were 
putative; however, cGAS appeared to be an essential STING-dependent cytosolic DNA receptor 
as the induction of type I IFNs were severely impaired in several cell types (fibroblasts, 
macrophages and DC) lacking cGAS (Li, X.-D. et al., 2013). It was required in response to DNA 
viruses for the induction of IFN-β and was shown to be the most potent inducer of IFN-β 
expression in comparison with the other cytosolic receptors such as DAI, IFI16 and DDX41 (Sun, 
L. et al., 2013). The role of cGAS in the antiviral response upon DNA stimulation and virus 
infection was also determined in vitro and in vivo in mice deficient in cGAS (Li, X.-D. et al., 
2013; Schoggins, J. W. et al., 2014). Cells from mice deficient in cGAS showed a reduction in 
antiviral responses and the cGAS-/- mice were susceptible not only to the infection of DNA virus 





induced IFN was cGAS-dependent (Gao, D. et al., 2013). HIV harbours a ssRNA genome that 
gets reverse transcribed to ssDNA forming an RNA:DNA hybrid molecules, which can trigger 
the production of cGAMP (Mankan, A. K. et al., 2014). It is thought that cGAS can have an 
indirect effect on other DNA sensors especially those induced by IFN such as IFI16. From these 
observations, cGAS has been implicated as having a pan-antiviral activity in response to viral 
infection.   
It is well established that STING acts as a critical adaptor for DNA-dependent signalling 
pathways, but it can also function as a direct sensor for DNA in which it directly binds DNA and 
activates IFN signalling. This was further supported by studies that have shown a direct binding 
of STING with CDNs but the binding was impaired with mutated STING (T596A, critical for 
CDNs binding) (Abe, T. et al., 2013; Burdette, D. L. et al., 2011; Sauer, J.-D. et al., 2011). 
However, the underlying mechanism has yet to be defined as it is not clear whether this binding 
happens independently of other DNA sensors. 
Adaptor protein STING and its regulation in cytosolic DNA sensing and signalling  
STING (also known as MITA, MPYS, ERIS and TMEM173) was identified as a critical adaptor 
protein for induction of type I IFN (Ishikawa, H. et al., 2008; Sun, W. et al., 2009; Zhong, B. et 
al., 2008). It is a 379 amino acid protein and localized in the endoplasmic reticulum (ER). It 
consists of an N-terminal 129 amino acid region with multiple transmembrane domains and a C-
terminal 250 amino acid cytosolic domain. It shows a broad expression distribution in various 
tissues (Burdette, D. L. et al., 2012; Chen, Q. et al., 2016). STING plays a critical role in the 
cytosolic DNA-mediated innate response. The role of STING in the IFN response to cytosolic 
DNA was clearly shown in studies with STING-/- mice and different cells types. The induction 
of IFN-β was robustly induced in HEK293T cells expressing STING from a plasmid in an IRF3- 
and NF-κB-dependent manner: The HEK293T cell type does not express detectable levels of 
endogenous STING protein. Furthermore cells such as MEF, macrophages and dendritic cells 
lacking STING have shown a severe reduction in the induction of IFN-β in response to dsDNA 
transfection or even DNA virus infection. In vivo studies also confirmed the role of STING in 
the IFN response in which mice deficient in STING were susceptible to HSV-1 infection 





It is well established that the STING-TBK1-IRF3 axis is the signalling pathway leading to type 
I IFN induction upon stimulation with cytosolic DNA. Upon DNA sensing, STING acts as 
platform through the C-terminal tail (CTT) to recruit TBK1 and assemble IRF3 in close 
proximity to TBK1 for TBK1-dependent IRF3 phosphorylation (Tanaka, Y. et al., 2012). TBK1 
was found to be required for IFN-β induction in response to poly(dA:dT) (Ishii, K. J. et al., 2006) 
through IRF3 in most cell types. Moreover, the induction of type I IFN in response to DNA 
viruses such as HSV-1 and MHV-68 was TBK1-dependent (Ishii, K. J. et al., 2008; Miyahira, 
A. K. et al., 2009), indicating the essential role of the TBK1-IRF3 axis in the antiviral response 
to DNA viruses. Upon DNA recognition, STING dimerizes and undergoes Lys63-linked 
ubiquitylation mediated by TRIM32 and TRIM56, crucial steps for STING activation (Tsuchida, 
T. et al., 2010; Zhang, J. et al., 2012). Following STING activation, STING  re-localizes to 
distinct intracellular compartments in which it traffics from the endoplasmic-reticulum, where it 
originally resides, to an ER-Golgi intermediate compartment and then to the Golgi apparatus and 
eventually to the perinuclear region, although the mechanism is not fully understood (Ishikawa, 
H. et al., 2009; Konno, H. et al., 2013). Once STING-dependent signalling is accomplished, 
STING is subjected to degradation through the autophagy pathway, which is required for the 
regulation of STING-dependent signalling in order to maintain cellular homeostasis and immune 
responsivness (Konno, H. et al., 2013). Upon IRF3 activation, it dimerizes and translocates to 
the nucleus and binds to the IFN-stimulated regulatory elements (ISRE) in the promoters of 
IFR3-responsive genes including type I IFN (Figure 1.4 A). It is known that STING can activate 
IRF3 leading to type I IFN induction and activates STAT6 leading to chemokine induction (Chen, 
H. et al., 2011) but it is not known whether it activates NF-κB (Paludan, Søren R. et al., 2013). 
It has been shown that a number of IFN-stimulated genes (ISGs) can be induced via IRF3 in an 
IFN-independent manner (Andersen, J. et al., 2008; Grandvaux, N. et al., 2002; Wathelet, M. G. 
et al., 1992). 
1.3.2.2 Recognition of Cytosolic RNA 
The importance of TLRs in the production of type I IFN in pDCs have been shown (Liu, Y.-J., 
2005) however TLRs are not important in other cell types for the production of type I IFN in 
response to viral infection, instead cytosolic RNA sensors are essential (Kato, H. et al., 2005). 





M. et al., 2010). A number of years ago the identification and characterization of RIG-I-like 
Figure 1.4. Recognition of viral nucleic acids by cytosolic receptors. 
Figure 1.4. Recognition of viral nucleic acids by cytosolic receptors. (A). Intracellular DNA 
and RNA receptors are involved in detecting DNA or RNA in cytosol. Cytosolic DNA and RNA 
receptors trigger STING-dependent signalling and MAVS-dependent signalling respectively 
resulting in induction of IFN-β. Obtained from (Unterholzner, L., 2013). (B). Inflammasome 
signalling can also be activated upon cytosolic DNA recognition. AIM2 is a cytosolic dsDNA 
sensor that activates ASC/caspase1-dependent pathway leading to secretion of IL-1β. Obtained 







receptors (RLR) as cytosolic dsRNA sensors identified a novel antiviral signalling pathway that 
links detection of dsRNA in the cytosol to induction of type I IFN (Yoneyama, M. et al., 2004). 
The expression of these RLRs was found at low levels in most cell types until virus infection or 
interferon stimulation at which their expression rapidly increased (Kang, D. et al., 2004; 
Yoneyama, M. et al., 2005; Yoneyama, M. et al., 2004)  
The RLR family consist of three groups of molecules: retinoic acid-inducible gene 1 (RIG-I or 
DDX58), melanoma differentiation associated gene 5 (MDA5 or IFIH1) and laboratory of 
genetic and physiology 2 (LGP2) (Table 1.4) (Takeuchi, O. et al., 2009; Yoneyama, M. et al., 
2008). They are DExD / H-box-containing RNA helicases with similar structures (Zhang, X. et 
al., 2000). RIG-I and MDA5 are the most closely related receptors and share a similar structure 
in which they have two N-terminal caspase recruitment domains (CARDs), a central DEAD box 
helicase/ATPase domain and C-terminal regulatory domain (CTD). LGP2 also has a similar 
structure with the exception of N-terminal CARDs. They are localized in the cytoplasm and their 
expression is enhanced in response to IFN stimulation.   
Viral PAMPs mainly consist of nucleic acids originating from the uncoating of the infectious 
unit resulting in exposure of virus genomes to the host receptors, from dsRNA intermediates as 
by products generated from transcription of viral genomes or from transcription of transcripts 
(Kawai, T. et al., 2008; Kawai, T. et al., 2010). It has been previously shown that DNA viruses 
can produce appreciable amounts of dsRNA because of the convergent transcription which 
occurs when two adjacent open reading frames are transcribed oppositely producing dsRNA with 
a partial 3’ overlap between their transcripts (Weber, F. et al., 2006). 
It is well established that RIG-I and MDA5 sensors recognize dsRNA molecules either natural-
derived such as genomic RNA of dsRNA viruses and dsRNA generated as replication 
intermediates of ssRNA viruses or synthetically-derived such as in vitro transcribed RNA or 
poly(I:C). RIG-I and MDA5 appears to have a differential role in induction of type I IFN in 
response to different virus infections. Over the last decade, numerous investigations have been 
conducted to determine the precise function and ligand of each sensor and whether they act 
independently and/or cooperatively in response to virus infection or have differential roles in 







Table 1.4. RNA species and viruses and their known RLRs. 
Sensors RNA Species Viruses Features 
RNA 
source  
Virus Family Virus Genome Structure References  
RIG-I 5′ppp copy-back RNA - 
In vitro transcribed 
RNA 
Synthetic  - - 
(Schlee, M. et al., 2009; Schmidt, A. 
et al., 2009) 
 5′ppp AU-rich RNA - 
Pol III product from 
poly(dA:dT) 
Synthetic - - 
(Ablasser, A. et al., 2009; Chiu, Y.-H. 
et al., 2009) 
 Poly(I:C) short - Short dsRNA (<1 kb) Synthetic - - (Kato, H. et al., 2008) 
 Genomic RNA IAV 
5′ppp with panhandle 
structure 
Virus-origin - - (Rehwinkel, J. et al., 2010) 
 3′UTR U/UC rich RNA HCV 5′ppp dependent Virus-origin - - (Saito, T. et al., 2008) 
 3′UTR U/A rich RNA IAV 5′ppp independent Virus-origin - - (Davis, W. G. et al., 2012) 
 DI RNA SeV, VSV 5′ppp copy-back dsRNA Virus-origin - - 
(Panda, D. et al., 2010; Patel, J. R. et 
al., 2013; Strahle, L. et al., 2006) 
 - NDV - Infection Paramyxoviridae (−) ssRNA, non-segmented 
(Kato, H. et al., 2006; Yoneyama, M. 
et al., 2004) 
 - SeV - Infection Paramyxoviridae (−) ssRNA, non-segmented (Kato, H. et al., 2006) 
 - RSV - Infection Paramyxoviridae (−) ssRNA, non-segmented (Loo, Y.-M. et al., 2008) 
 - VSV - Infection Rhabdoviridae (−) ssRNA, non-segmented 
(Kato, H. et al., 2006; Yoneyama, M. 
et al., 2005) 
 - Rabies virus - Infection Rhabdoviridae (−) ssRNA, non-segmented (Hornung, V. et al., 2006) 
 - IAV - Infection Orthomyxoviridae (−) ssRNA, segmented (Kato, H. et al., 2006) 
 - Influenza B virus - Infection Orthomyxoviridae (−) ssRNA, segmented (Loo, Y.-M. et al., 2008) 
 - Rift Valley fever virus - Infection Bunyaviridae (−) ssRNA, segmented (Weber, M. et al., 2013) 
 - La Crosse virus - Infection Bunyaviridae (−) ssRNA, segmented (Weber, M. et al., 2013) 
 - HCV - Infection Flaviviridae (+) ssRNA, non-segmented (Saito, T. et al., 2008) 
 - JEV - Infection Flaviviridae (+) ssRNA, non-segmented (Kato, H. et al., 2006) 
 - EBV - Infection Gammaherpesviridae dsDNA (Samanta, M. et al., 2008) 
        
MDA5 Poly(I:C) long - Long dsRNA (>7 kb) Synthetic  - - (Kato, H. et al., 2008) 








Sensors RNA Species Viruses Features 
RNA 
source  
Virus Family Virus Genome Structure References  
 - VV, EMCV 
High molecular weight 
RNA 
Virus-origin - - (Pichlmair, A. et al., 2009) 
 - CVB3, Mengo 
Replication 
intermediates 
Virus-origin - - (Feng, Q. et al., 2012) 
 L mRNA PIV5  RNase L product Virus-origin - - (Luthra, P. et al., 2011) 




- Infection Picornaviridae (+) ssRNA, non-segmented (Kato, H. et al., 2006) 
 - Mengovirus - Infection Picornaviridae (+) ssRNA, non-segmented (Kato, H. et al., 2006) 
 - Coxackie virus - Infection Picornaviridae (+) ssRNA, non-segmented (Feng, Q. et al., 2012) 
 - Entero virus - Infection Picornaviridae (+) ssRNA, non-segmented (Feng, Q. et al., 2012) 
 - Human parechovirus - Infection Picornaviridae (+) ssRNA, non-segmented (Feng, Q. et al., 2012) 
 - Equine rhinitis A virus - Infection Picornaviridae (+) ssRNA, non-segmented (Feng, Q. et al., 2012) 
 - Saffold virus - Infection Picornaviridae (+) ssRNA, non-segmented (Feng, Q. et al., 2012) 
 - Norovirus - Infection Caliciviridae (+) ssRNA, non-segmented (McCartney, S. A. et al., 2008) 
 - Vaccinia virus - Infection Poxviridae dsDNA (Pichlmair, A. et al., 2009) 
        
RIG-I/MDA5 5′OH-3′p short RNA - RNase L product Host-origin  - - (Malathi, K. et al., 2007) 
 - West Nile virus - Infection Flaviviridae (+) ssRNA, non-segmented (Loo, Y.-M. et al., 2008) 
 - Dengue viurs - Infection Flaviviridae (+) ssRNA, non-segmented (Loo, Y.-M. et al., 2008) 
 - Measles virus - Infection Paramyxoviridae (−) ssRNA, non-segmented (Ikegame, S. et al., 2010) 
 - Semliki forest virus - Infection Togaviridae (+) ssRNA, non-segmented (Schulz, O. et al., 2010) 
        
LGP2/MDA5 L antisense EMCV LGP2-interacting RNA Virus-origin Picornaviridae (+) ssRNA, non-segmented (Deddouche, S. et al., 2014) 





Independent groups have determined the signature of dsRNA and found the triphosphate moiety 
at the 5’ end is an essential determinant of RIG-I recognition (Hornung, V. et al., 2006; Pichlmair, 
A. et al., 2006; Rehwinkel, J. et al., 2010). Another study reported that the 5’-diphosphate dsRNA 
can also be recognized by RIG-I (Goubau, D. et al., 2014). Other groups, however, found that 
the 5’triphosphate was not sufficient (Schlee, M. et al., 2009; Schmidt, A. et al., 2009). 
Chemically synthesized dsRNA with a 5’ monophosphate or without 5’ phosphate can still 
induce the activation of RIG-I (Kato, H. et al., 2008; Takahasi, K. et al., 2008). Single stranded 
RNA with 5’ triphosphate was found to bind RIG-I, however, it could not activate RIG-I (Marq, 
J.-B. et al., 2010; Schmidt, A. et al., 2009; Takahasi, K. et al., 2008).  
Two independent groups have identified a new class of non-self RNA that selectively activate 
RIG-I ligands generated from AT-rich dsDNA (Ablasser, A. et al., 2009; Chiu, Y.-H. et al., 
2009). This AT-rich dsDNA serves as a template for RNA polymerase III which transcribes it 
into AU-rich dsRNA with a 5’ triphosphate making it a ligand for RIG-I. Both strands of AT-
rich dsDNA will be transcribed and the RNA transcripts from both strands will anneal producing 
5’ triphosphate dsRNA. RNA polymerase III is expressed naturally in cells and functions to 
transcribe 5S rRNA, tRNA or other small noncoding RNA.      
A chemically synthetic analogue of viral dsRNA poly(I:C), that does not bear 5’ppp, shows RIG-
I-dependent activation (Marques, J. T. et al., 2006; Takahasi, K. et al., 2008). In addition, 
poly(I:C) was found to enhance RIG-I-dependent signalling in cells transfected with a RIG-I 
expression vector (Yoneyama, M. et al., 2005; Yoneyama, M. et al., 2004) and its binding with 
RIG-I has been shown (Rothenfusser, S. et al., 2005). Similarly, the functional role of MDA5 in 
dsRNA detection was studied in vivo. In contrast to RIG-I, the nature of MDA5 ligand is poorly 
understood, however, MDA5 was shown to recognize a synthetic dsRNA such as poly(I:C) 
(Gitlin, L. et al., 2006; Kato, H. et al., 2006). Kato and his colleagues have provided an interesting 
observation on the differential role of RIG-I and MDA5 sensors. They found that the activation 
of either RIG-I or MDA5 was dsRNA size-dependent in which short dsRNA (~ 300 bp) activated 
RIG-I-dependent signalling while long dsRNA (> 3 kb) activated MDA5-dependent signalling 
and this observation was further confirmed from RNA virus infection in which short dsRNA-
producing viruses such as IAV and VSV activate RIG-I whereas long dsRNA-producing viruses 





2008). EMCV is positive-sense ssRNA that belongs to the family of picornavirus and produces 
long dsRNA during replication which makes it consistent with the observation of MDA5 sensing 
dsRNA whereas IAV is negative-sense ssRNA and generates short dsRNA. MDA5 was also 
shown to bind with some sequence specificity such as measles virus mRNA containing an AU-
rich region and the L region of the EMCV antisense RNA (Deddouche, S. et al., 2014; Runge, 
S. et al., 2014). Nevertheless, the precise underlying mechanism of MDA5 activation and ligand 
specificity remains to be elucidated. RIG-I and MDA5 are not only important in sensing RNA 
viruses but also DNA viruses such as HSV-1 and KSHV (Rasmussen, S. B. et al., 2009; West, J. 
A. et al., 2014).  
LGP2 does not have CARDs, but can still bind dsRNA. This may suggest that it has no role in 
antiviral signalling. However, some reports have indicated that its probable role as a positive or 
negative regulator in which it controls the extent and/or duration of antiviral signalling mediated 
by RIG-I or MDA5 (Saito, T. et al., 2007; Satoh, T. et al., 2010; Venkataraman, T. et al., 2007). 
The functional role of LGP2 in the antiviral response is still poorly understood.  
From these observations, it seems that there are other features that could determine the specificity 
of sensor recognition such as dsRNA composition and structure and whether this specificity 
differs for different viral infections. A secondary structure like a panhandle structure was found 
to be necessary along with 5’ppp for RIG-I activation. This observation was seen in infection of 
Sendai virus (SeV) and vesicular stomatitis virus (VSV) in which they produce RIG-I agonist 
RNA that contains a panhandle structure (also called copy-back structure generated when the 
sequence is duplicated in reverse complement) with 5’ triphosphates (Baum, A. et al., 2010; 
Panda, D. et al., 2010; Vignuzzi, M. et al., 2019). In addition, hepatitis C virus (HCV) RNA with 
5’ triphosphate containing uridine-rich or adenine-rich region activates RIG-I-dependent 
signalling, indicating that this sequence is important for recognition of HCV by RIG-I (Saito, T. 
et al., 2008). 
It is now clear that the activation of RIG-I or MDA5 requires RNA species with distinct features 
that differ from cellular RNAs (or self RNA). RIG-I and MDA5 are not normally activated by 
host RNA as cellular RNAs are generally single stranded and have 5’ ends with a 





ribosomal RNAs, tRNAs and microRNAs. In addition, these populations of cellular RNAs are 
subjected to modification to prevent recognition by RIG-I or MDA5. 
The role of RIG-I and MDA5 in inducing IFNs to a wide range of viruses has now been proven 
in vitro and in vivo. RIG-I has been shown to be essential for IFN production in response to 
negative stranded RNA viruses such as influenza viruses (Kato, H. et al., 2006; Weber-Gerlach, 
M. et al., 2016), bunyaviruses (Spengler, J. R. et al., 2015; Yamada, S. et al., 2018), filoviruses 
(Spiropoulou, C. F. et al., 2009) and rhabdoviruses (Furr, S. R. et al., 2010) as well as positive 
stranded viruses such as Japanese encephalitis virus (Kato, H. et al., 2006). On the other hand, 
MDA5 was found to have a role in IFN induction upon detection of positive stranded RNA 
viruses such as picornaviruses (Deddouche, S. et al., 2014; Loo, Y.-M. et al., 2008) and 
arteriviruses (Luo, R. et al., 2008; van Kasteren, P. B. et al., 2012) as well as hepatitis D virus 
(Zhang, Z. et al., 2018) and positive stranded viruses such as Kaposi’s sarcoma-associated 
herpesvirus (KSHV) (Zhao, Y. et al., 2018).   
A number of DExD/H-box helicases other than the RLRs have been shown to bind RNA and 
mediate antiviral signalling (Table 1.5). Some may function as RNA sensors, while others 
regulate RLR signalling. Nevertheless, further investigations are required to elucidate the 
signalling mechanisms involved (Chow, K. T. et al., 2018; Sparrer, K. M. J. et al., 2015). In 
addition, several proteins have been identified that have a role in RNA binding and antiviral 
signalling during virus infection (Table 1.6).   
Several studies have shown the importance of cell-type specificity for RLR versus TLR pathway 
for the induction of type I IFN in response to different viruses. It has been shown that RIG-I was 
indispensable for the production of type I IFN in mouse embryonic fibroblasts (MEFs) following 
exposure to Newcastle disease virus (NDV) in which RIG-I-/- fibroblasts did not significantly 
produce type I IFN when infected with the virus. Similarly, conventional DC (cDCs) lacking the 
RIG-I gene were also defective in their ability to produce type I IFN. However, RIG-I was not 
essential for virus-induced IFN production by pDCs. Cells lacking RIG-I were able to produce 
type I IFN upon NDV infection, however, induction was severely impaired in cells deficient in 
both MyD88 and TRIF (MyD88-/-TRIF-/-), indicating that these cells use a TLR system rather 







       
Table 1.5. Non-RLR DExD/H-box Helicases involved in the detection of cytosolic non-self RNA. 
DExD/H-box Helicases Ligand Reference 
DDX1 (together with DDX21 and DHX36 Poly(I:C) (Mitoma, H. et al., 2013) 
   
DDX3 Poly(I:C) (Gringhuis, S. I. et al., 2017; Oshiumi, H. et al., 2010) 
 HIV mRNA (Gringhuis, S. I. et al., 2017) 
 Abortive HIV RNA (Gringhuis, S. I. et al., 2017) 
 Cellular RNA lacking poly(A) tail (Gringhuis, S. I. et al., 2017) 
   
DHX9 Poly(I:C) (Zhang, Z., Yuan, B., Lu, N., et al., 2011) 
   
DHX15 Poly(I:C) (Lu, H. et al., 2014; Mosallanejad, K. et al., 2014) 
 dsRNA (Lu, H. et al., 2014; Wang, P. et al., 2015) 
   
DHX33 Poly(I:C) 
(Chakrabarti, A. et al., 2015; Liu, Y. et al., 2014; Mitoma, H. et al., 
2013) 
 Reovirus genomic dsRNA  (Mitoma, H. et al., 2013) 
 RNase L-cleaved RNA (Chakrabarti, A. et al., 2015) 
   
DDX60 VSV ss- and ds-RNA (Miyashita, M. et al., 2011) 
 Poly(I:C) (Miyashita, M. et al., 2011; Oshiumi, H. et al., 2015) 
 Biotinylated dsRNA (Oshiumi, H. et al., 2015) 
   
SNRNP200 Biotinylated poly(I:C) (Tremblay, N. et al., 2016) 
 SeV genomic RNA (Tremblay, N. et al., 2016) 











Table 1.6. RNA-binding proteins with roles in antiviral response. 
RNA-binding Proteins  Known functions in antiviral response Reference 
OAS/RNase L Generates RNA ligands for RLR activation  
(Malathi, K. et al., 2007; Malathi, K. et 
al., 2010) 
   
PKR Inhibits translation in virus-infected cells (Hull, C. M. et al., 2016) 
 Enhances MDA5-mediated IFN induction (Pham, A. M. et al., 2016) 
   
IFITs Inhibit viral translation, sequester viral RNA (Pham, A. M. et al., 2016) 
   
LRRFIP1 Activates β-catenin to enhance transcriptional activation of Ifnb1 (Yang, P. et al., 2010) 
   
DAI Activates RIPK1/3/MLKL (Thapa, R. J. et al., 2016) 
 Activates NLRP3 inflammasome (Kuriakose, T. et al., 2016) 
   
HMGBs Mediates immunogenic nucleic acid signalling, in soluble form act as cytokines  (Ugrinova, I. et al., 2017) 





fibroblasts lacking the MDA5 gene were defective in their ability to produce IFN upon infection 
with encephalomyocarditis virus (EMCV), whereas pDCs lacking the MDA5 gene (but not 
MyD88-/-) produced type I IFN when infected with the same virus (Gitlin, L. et al., 2006; Kato, 
H. et al., 2006). These observations indicate that type I IFN is induced either by TLR or RLR 
systems in a cell type-dependent manner. 
RLR Signalling Pathway (MAVS-IRF3-IFN-β axis)  
The mechanism of RIG-I activation was proposed previously using high-resolution crystal 
structure analysis (Kolakofsky, D. et al., 2012). In resting cells, RIG-I remains inactive in the 
cytosol by auto-repression in which the second CARD domain interacts with Hel-2i domain, 
whereas MDA5 remains in an open conformation state. Once the ligand is recognized by the 
CTD domain, RIG-I and MDA5 undergo ATP-dependent conformational change mediated by 
RNA-activated protein kinase R (PKR) activator (PACT) (Kok, K.-H. et al., 2011), resulting in 
releasing the auto-repression and making the CARD domains available to interact with MAVS 
adaptor protein (Kowalinski, E. et al., 2011). Then both receptors undergo Lys63-linked 
ubiquitylation onto CARDs and C-terminal domain, mediated by tripartite motif protein 25 
(TRIM25) and Riplet respectively (Gack, M. U. et al., 2007; Oshiumi, H. et al., 2013). It seems 
that MDA5 has a different repression mechanism than RIG-I because the C-terminal region of 
MDA5 has shown no role in auto-repression (Saito, T. et al., 2007). Once RIG-I and MDA5 are 
activated, they interact with a CARD-containing adaptor localized on the outer membrane of 
mitochondria called mitochondrial antiviral signalling protein (MAVS) (also known as IPS-1, 
CARDIF or VISA) which serves as a platform for protein complex assembly at the mitochondria. 
Then MAVS multimerizes into prion-like filament structures (Hou, F. et al., 2011) and recruits 
the IKK-related serine/threonine kinases TBK1/IKKε which phosphorylate and activate IRF3 
and IRF7 (Kawai, T. et al., 2008; Kawai, T. et al., 2010). NF-κB is activated by the 
IKKα/IKKβ/IKKγ complex on MAVS through this pathway. IRFs and NF-κB translocate to the 
nucleus and induce the expression of type I IFN and inflammatory cytokines (Figure 1.4 A) 





1.3.3 JAK/STAT Signalling Pathway 
Type I IFN induction results in the activation of the JAK/STAT signalling pathway. The 
interaction between IFN-α/β and the receptor (IFNAR) recruits JAK1 and TYK2. Activation of 
the receptor-associated JAK1 leads to phosphorylation of STAT 1 and 2. Upon phosphorylation, 
STAT1 and STAT2 form a heterodimer that translocates to the nucleus forming the 
heterotrimeric transcription factor complex IFN-stimulated genes factor 3 (ISGF3) with 
interferon regulatory factor (IRF-9). This trimeric complex binds to the ISRE sequence in the 
promoters of interferon-stimulated genes (ISGs), inducing their upregulation. The ISGs act to 
promote viral clearance and establish an antiviral state in uninfected cells (Samuel, C. E., 1991; 
Samuel, C. E., 2001). However, the JAK/STAT pathway is not the only pathway involved in IFN 
signalling. The p38 mitogen activated protein (MAP) kinase pathway also mediates IFN 
signalling. In addition, viral infection can directly induce some ISGs in the absence of IFN 
production (Halfmann, P. et al., 2011; Sen, G. C. et al., 2007).   
1.3.4 Interferon Effector Response    
Upregulation of ISGs establishes the antiviral state that prevents viral replication at various stages 
of the viral life cycle. Initially, our knowledge of the effector function of ISGs was limited to a 
few proteins such as PKR, OAS and MX1. However, a large-scale screening study was recently 
conducted to assess the inhibitory capacity of high numbers of ISGs on viral replication. The 
study has revealed a large number of ISGs that exploit different strategies to inhibit viral 
replication and their broad effect on different RNA viruses (Schoggins, J. W., 2019; Schoggins, 
J. W., Wilson, S. J., et al., 2011).  
More than 1600 genes regulated by type I IFN have been identified (Hertzog, P. et al., 2011). 
They are different in their molecular characteristics and targets but they are involved in protection 
against invading microbes and eliminating infection (Schoggins, J. W., 2019; Schoggins, J. W. 
& Rice, C. M., 2011; Schoggins, J. W., Wilson, S. J., et al., 2011). These effectors are not only 
generated from the signals that originated from IFN induction, but also generated from TNF, IL-
1 and TLR families. Nevertheless, IFN is the main mediator of ISGs (MacMicking, J. D., 2012). 
ISG-mediated antiviral activities target multiple cell types and several stages of the viral life 





IFN-inducible transmembrane (IFITM) effectors target viral entry and uncoating. PKR and 2’-5’ 
oligoadenylate synthase 1 (OAS1), (OAS2), (OAS3) and OASL target viral replication. If the 
virus is able to replicate, the host can still counteract the virus through ISGs that target assembly 
and release such as tetherin (MacMicking, J. D., 2012). IFN-induced proteins function not only 
as antiviral effectors but also mediate apoptosis in the cell in which IFNs induce death inducing 
ligands. Microarray analysis has revealed a number of ISGs with apoptotic function such as 
TRAIL/Apo2L, Fas/Apo-1, Fas/FasL, OAS and PML-2 (Chawla-Sarkar, M. et al., 2003; de 
Veer, M. J. et al., 2001; Der, S. D. et al., 1998). 
1.4 Virus Manipulation of the Type I IFN Response  
A successful virus infection requires the virus to enter the cell, replicate and produce infectious 
particles in the presence of the innate immune system. This cannot be achieved without 
overcoming the innate immune response or at least delay the development of the response. 
Interferon restricts virus replication and spread, so viruses have evolved several strategies to 
evade or inhibit the activation of intracellular PRRs leading to the IFN. VACV, the prototypic 
and most studied poxvirus, has been shown to encode a considerable number of proteins that are 
involved in the inhibition of the IFN signalling pathway leading to its production. Poxviruses 
replicate in the cytoplasm making their genomes or dsRNA intermediates accessible for detection 
by PRRs and leading to activation of IFN signalling. Poxviruses have evolved strategies to hide 
their nucleic acid PAMPs from detection or interfering with the signalling molecules that lead to 
IFN expression as discussed below.    
1.4.1 Inhibition of Interferon Production 
1.4.1.1 Viral Evasion of RNA Sensing  
Detection of viral nucleic acids is a critical step for the host to initiate the innate immune 
response. Therefore, many viruses encode proteins to evade immune sensing. Several viruses 
including VACV produce dsRNA intermediates as a byproduct from encoding transcripts from 
both strands of the genome in opposite directions which can potentially hybridize to form 
dsRNA, a critical PAMP sensed by RIG-I or MDA5 and also by PKR and OAS leading to 





dsRNA in infected cells. The open reading frames (ORFs) of the VACV genome are organized 
in such a way that the formation of dsRNA intermediates are minimized (Goebel, S. J. et al., 
1990). The genes located at both termini are usually transcribed towards the end of the genome 
from one strand, resulting in the production of transcripts that lack complementarity. The genes 
located in the central region are encoded from both strands but they are arranged in blocks in 
which each block of genes are transcribed in one direction either from left to right or vice versa. 
Those transcribed in opposite directions from both strands are usually minimized by multiple 
transcriptional terminators. Such genome organization helps to minimize the production of 
dsRNA intermediates and is a means of evading immune detection (Smith, G. L. et al., 1998; 
Smith, G. L. et al., 2018).           
Some viruses have mechanisms to evade cytosolic RNA sensing even when dsRNA is formed. 
These viruses have the ability to modify their RNA molecules to mimic cellular RNAs and 
prevent detection or hinder RLRs activation. Since the 5’-triphosphate end of RNA is a critical 
moiety for RIG-I recognition, some viruses produce a phosphatase that converts the 5’-
triphosphate RNA into 5’-monophosphate RNA (Habjan, M. et al., 2008). Arenaviruses have a 
genome with a 5’ triphosphate but with overhang and this structure does not activate RIG-I 
although RIG-I binds to it (Marq, J.-B. et al., 2011). Alternatively, many viruses protect their 
5’end mRNA from recognition by RIG-I by capping the end of their newly synthesized mRNA. 
That could be by using the cellular machinery such as by paramyxoviruses or viruses that encode 
their own capping enzymes such as by poxviruses and rotaviruses or by cap-snatching from 
cellular mRNA such as by influenza viruses (Plotch, S. J. et al., 1981).    
As it has been shown that RIG-I and MDA5-dependent signalling is controlled by post-
translational modification, namely ubiquitylation and serine/threonine phosphorylation, it is not 
unexpected that many viruses have evolved to encode proteins that interfere with host post-
translational modification. For instance, NS1 from IAV interact with TRIM25 and NS3-NS4A 
protease from HCV that cleave Riplet (Gack, M. U. et al., 2009; Oshiumi, H. et al., 2013). 
Alternatively, other viruses encode de-ubiquitins (DUBs) to remove the Lys63-linked 
ubiquitylation of RIG-I such as ORF64 from KSHV (Inn, K.-S. et al., 2011). Dephosphorylation 





protein of measles virus (MeV) was found to bind to PP1α and PP1γ phosphatases and sequester 
their activity from MDA5 (Davis, Meredith E. et al., 2014).          
Another strategy used by viruses is not to modify their RNA structure, instead, they produce 
RNA-binding proteins that sequester RNA from being recognized. It is believed that this strategy 
is more advantageous than the strategies mentioned above. It will not only minimize the 
activation of dsRNA-dependent RIG-I/MDA5 but also inhibit the activation of PKR or OAS. 
Examples of these proteins are VACV E3L and EBOV VP35 (Chang, H. W. et al., 1992; 
Haasnoot, J. et al., 2007). VACV E3L protein is an early protein encoded before dsRNA is 
formed. Its essential role was demonstrated when the mutant virus lacking E3L was sensitive to 
IFN (Beattie, E et al., 1995). It has been shown that VACV E3L can counteract the effects of 
RNA sensing not only triggered by viral dsRNA, but also by polymerase III-produced dsRNA 
from poly(dA:dT) (Marq, J.-B. et al., 2009; Valentine, R. et al., 2010). VACV also encodes a 
PKR inhibitor, K3L. It has homology to the N-terminal region of eIF2α and acts as a 
pseudosubstrate for PKR in lieu of eIF2α. E3L also competes with PKR and OAS for binding to 
dsRNA (Langland, J. O. et al., 2002). Degradation of dsRNAs is also a way of evasion by RNA 
sensing. Bovine viral diarrhea virus (BVDV) secrets a protein with dsRNA binding and RNase 
activity that degrades dsRNA in the extracellular environment released from apoptotic bodies in 
order to prevent TLR3 activation (Iqbal, M. et al., 2004).    
Several viruses use a proteolytic mechanism to degrade RLRs and thus inhibit downstream 
signalling. The 3Cpro protease of poliovirus cleaves RIG-I, and 3Cpro and 2Apro of enterovirus 71 
cleave RIG-I and MDA5 respectively (Barral, P. M. et al., 2009; Feng, Q. et al., 2014). In 
addition, RLRs might be sequestered instead of degraded. Influenza A virus NS1 was identified 
to inhibit RIG-I activation and thus block downstream signalling (Mibayashi, M. et al., 2007) 
and also V proteins of several paramyxoviruses were found to bind to the helicase domain of 
MDA5 resulting in inhibition of its ATPase activity (Andrejeva, J. et al., 2004).   
1.4.1.2 Viral Evasion of DNA Sensing  
DNA virus replication in the cytoplasm results in the accumulation of dsDNA making the virus 
genome accessible to host DNA sensors such as cGAS, IFI16 and DNA-PK. Because cytosolic 





cytosolic DNA sensing and a clearer understanding remains to be elucidated. Nevertheless, there 
is some evidence that describe viral evasion mechanisms of DNA sensing in the cytosol. Several 
DNA virus antagonists have been identified that interfere with DNA sensing signalling pathways 
as shown in Table 1.7.  
VACV E3L has such antagonistic activity. It contains a Z-DNA-binding domain that can prevent 
the interaction of DAI with DNA, resulting in inhibition of DNA-induced IFN-β (Wang, Z. et 
al., 2008). It has been reported that myxoma virus encodes a PYD-containing protein, M13L, 
which can disrupt NALP-ASC interaction and caspase 1 activation (Johnston, J. B., Barrett, J. 
W., et al., 2005). DNA-PK was identified to be targeted by the VACV C16 protein in which it 
binds to the Ku subunit and prevents it from binding to DNA (Fahy, A. S. et al., 2008; Peters, N. 
E. et al., 2013). Some DNA viruses that replicate in the nucleus have also been reported to encode 
proteins that target DNA-dependent STING-dependent sensing such as HSV-1. HSV-1 encodes 
a protein called ICP0 that triggers the proteasomal degradation of IFI16 in the nucleus. The ICP0 
knockout virus or catalytically inactive ICP0 mutant virus failed to induce degradation of IFI16. 
However, the expression of ICP0 alone did not induce IFI16 degradation which may suggest 
either the ICP0 directly targets IFI16 or another viral product is needed to cause the degradation 
of IFI16 (Cuchet-Lourenço, D. et al., 2013; Diner, B. A. et al., 2015; Orzalli, M. H. et al., 2012). 
Another tegument protein encoded by HCMV targets IFI16 but through a different mechanism 
to HSV-1. HCMV pUL83 binds to the pyrin domain of IFI16 preventing its oligomerization 
rather than degradation (Li, T. et al., 2013). Furthermore, HCMV encodes pUL97 that has a role 
in translocating IFI16 from the nucleus to the cytoplasm which prevents the sensing the virus 
DNA in the nucleus, but interestingly when expressed alone in cells did not show any function 
(Dell'Oste, V. et al., 2014).         
At this time most of our understanding of virus DNA sensing mechanisms comes from studies 
on herpesvirus. Whether this knowledge is relevant to other DNA viruses has yet to be 
determined since they have different routes of infection, sites of replication and pattern of 








Table 1.7. Viral regulators of DNA-dependent sensing. 
Molecule Target Virus Viral Protein Proposed mechanism Reference 
DNA sensors cGAS KSHV ORF52 (KicGAS) cGAS interaction; DNA binding; disrupts cGAS binding to DNA (Wu, J.-j. et al., 2015) 
  KSHV LANA An N-terminally truncated cytoplasmic isoform of LANA interacts with cGAS (Zhang, G. et al., 2016) 
  MHV68 ORF52 cGAS interaction; DNA binding; disrupts cGAS binding to DNA (Wu, J.-j. et al., 2015) 
  RRV ORF52 cGAS interaction; DNA binding; disrupts cGAS binding to DNA (Wu, J.-j. et al., 2015) 
  EBV ORF52 cGAS interaction; DNA binding; disrupts cGAS binding to DNA (Wu, J.-j. et al., 2015) 
 IFI16 HSV-1 ICP0 Promotes the degradation (?) of IFI16 in a proteasome-dependent manner, in normal 
human fibroblasts cells but not tumour cells  
(Cuchet-Lourenço, D. et al., 2013; 
Diner, B. A. et al., 2015; Orzalli, M. H. 
et al., 2012) 
  HCMV pUL83 Interacts with IFI16 and blocks IFI16 oligomerization; redirects IFI16 to the major 
HCMV immediate early promoter 
(Biolatti, M. et al., 2016; Cristea, I. M. 
et al., 2010; Li, T. et al., 2013) 
  HCMV pUL97 Binds to IFI16 and relocalizes IFI16 to the cytoplasm (Dell'Oste, V. et al., 2014) 
 DNA-PK VACV C16 Binds to the Ku70-Ku80 complex and blocks DNA sensing by DNA-PK in fibroblasts (Peters, N. E. et al., 2013) 
Adaptors STING HSV-1 ICP0, ICP4, US3-PK Stabilizes STING in HEp-2 cells, which is required for optimal HSV-1 replication (Kalamvoki, M. et al., 2014) 
  KSHV vIRF1 STING interaction; disrupts STING phosphorylation; disrupts STING binding to 
TBK1 
(Ma, Z. et al., 2015) 
  HPV E7 STING interaction (Lau, L. et al., 2015) 
  Adenovirus E1A STING interaction (Lau, L. et al., 2015) 
  Hepatitis B virus Pol STING interaction; disrupts lysine 63–linked polyubiquitination of STING (Liu, Y. et al., 2015) 
 MyD88 VACV A46R Binds to MyD88 and inhibits TLR signalling (Stack, J. et al., 2005) 
 ASC1 Myxoma virus M13L Binds to ASC1 and disrupts appropriate formation of the host inflammasome complex (Johnston, J. B., Barrett, J. W., et al., 
2005) 




1.4.1.3 Viral Evasion of Nucleic Acid-Stimulated Signalling Pathways leading to Type I IFN 
Expression   
Viral Manipulation of TRIF and MyD88 Adaptor Proteins for TLR Signalling  
At this time the only two proteins that VACV encodes, known to counteract TLR-mediated 
signalling, are A46R and A52R (Hurst, T. et al., 2008). They have distinct modes of action and 
target different cellular proteins involved in TLR signalling. A46R is a TIR domain-containing 
protein which enables it to associate with several TIR-domain-containing adaptors: MyD88, 
TIRAP, TRIF and TRAM that associate with the cytoplasmic domain of TLRs, leading to 
inhibition of TLR-induced NF-κB and IRF3 activation (Stack, J. et al., 2005). A52R has the 
ability to inhibit TLR-induced NF-κB activation, but not IRF activation, by interacting with 
IRAK2 and TRAF6 (Bowie, A. et al., 2000; Harte, M. T. et al., 2003).  
Other viruses, other than DNA viruses, also interfere with TLR signalling. Hepatitis C virus 
(HCV) NS3/4A protein, a non-TIR-domain containing viral protein, has the ability to not only 
cleave precursor polypeptides of structural proteins but also cleaves TRIF that would otherwise 
activate TLR3-mediated antiviral signalling (Li, K. et al., 2005). TLR4-dependent signalling is 
also a target by viruses such as human T-cell leukaemia virus type 1 (HTLV-1) in which its 
protein p30 binds to and inhibits the transcriptional activity of transcription factor PU.1, mainly 
expressed in immune cells such as B cells and macrophages (Datta, A. et al., 2006). West Nile 
virus (WNV) NS1 prevents the translocation of NF-κB and IRF3 causing the inhibition of IFN-
β expression (Wilson, J. R. et al., 2008).  
Viral manipulation of MAVS, STING and ASC adaptor proteins For Cytosolic Signalling  
A signalling complex is assembled on innate immune adaptor proteins upon RNA or DNA 
detection in order to trigger innate immunity. Therefore, disrupting the adaptors interaction with 
other molecules or even targeting the adaptors themselves is one such virus strategy to inhibit 
downstream signalling.  
STING is the key adaptor of the cytosolic DNA sensing system and studies have shown that this 
adaptor is targeted by many DNA viruses as shown in Table 1.7. HSV-1 encodes ICP27 that 





(Christensen, M. H. et al., 2016). Furthermore, adenovirus E1A and HPV E7 oncoproteins were 
identified to bind with STING through their LXCXE motif resulting in inhibition of STING 
signalling (Lau, L. et al., 2015). It has become apparent that STING also has a role in sensing 
RNA viruses and that is because some RNA virus members of the Flaviviridae and 
Coronaviridae families encode proteins targeting STING (Ma, Z. et al., 2016). STING regulation 
is controlled by post-translational modification such as ubiquitylation and phosphorylation and 
it is not surprising that these processes can be targeted by viruses. HBV polymerase has been 
shown to disrupt the Lys63-linked ubiquitylation of STING through its reverse transcriptase and 
ribonuclease H domains resulting in inhibition of IFN-β induction (Liu, Y. et al., 2015). KSHV 
vIRF1 has been shown to block phosphorylation and activation of STING by preventing TBK1 
binding and thus TBK1-mediated phosphorylation (Ma, Z. et al., 2015).   
MAVS is another crucial adaptor protein for RIG-I- and MDA5-mediated signalling leading to 
expression of IFN-β which make it a target for many viruses. IAV PB1-F2 protein translocates 
into the space of the mitochondrial inner membrane leading to the fragmentation of  mitochondria 
and also binds to the transmembrane domain of MAVS thereby inhibiting MAVS signalling and 
IFN induction (Varga, Z. T. et al., 2012; Yoshizumi, T. et al., 2014). In contrast, other viruses 
encode viral proteases that cleave MAVS and block RLR signalling such as HCV NS3-NS4A 
and HAV 3Cpro (Li, X.-D. et al., 2005; Yang, Y. et al., 2007). 
Innate immune signalling from the inflammasome complex is also a viral target. For instance, 
myxoma virus encodes M13L that contains a PYRIN domain and interacts with ASC, a critical 
adaptor protein for inflammasome signalling (Johnston, J. B., Barrett, J. W., et al., 2005).            
Inhibition of TBK1/IKKε and IKKα/IKKβ/IKKγ Kinases Activation  
The PRR-mediated signalling pathways described above converge at the level of the IKK family 
of proteins. The complex of TBK1/IKKε and associated subunits is important for the induction 
of type I IFN expression upon phosphorylation and activation of IRF3 and IRF7, whereas the 
complex of IKKα/IKKβ/IKKγ is important for the activation of NF-κB. Furthermore, these 





inhibition of downstream transcription factor activation. Thus, they are an important target of 
viruses to antagonize the induction of IFN.  
VACV C6 is an early gene and has a role in IFN antagonism. C6 interacts with subunits of 
TBK1/IKKε: NAK-associated protein 1 (NAP1), TRAF family member-associated NF-κB 
activator (TANK) and similar to NAP1 TBK1 adaptor (SINTBAD) and inhibits IRF3 activation 
(Unterholzner, L. et al., 2011). In addition, TBK1 is also inhibited by VACV N1L and other 
proteins from RNA viruses such as HCV NS3 protein (DiPerna, G. et al., 2004; Otsuka, M. et 
al., 2005). Furthermore, the induction of IFN-β is inhibited by VACV K7R by binding with 
DEAD-box protein 3 (DDX3), resulting in inhibition of TBK1/IKKε-mediated IRF3 activation 
(Schröder, M. et al., 2008). DDX3 is believed to be part of TBK1/IKKε complex and involved 
in IRF3 activation (Soulat, D. et al., 2008). G1 protein from hantavirus, negative ssRNA virus, 
was found to disrupt the interaction between TRAF3 and TBK1 leading to inhibition of IRF3 
activation (Alff, P. J. et al., 2008). As a strategy employed by viruses to target NF-κB signalling, 
viruses could encode proteins that interfere with NF-κB kinases. VACV B14R interacts with 
IKKβ and inhibits its phosphorylation whereas KSHC K13 interacts with the IKKα/IKKβ 
complex and both result in inhibition of NF-κB activation (Chen, R. A. J. et al., 2008; Matta, H. 
et al., 2007).   
Inhibition of Transcription Factor Activation (IRF3 and NF-κB)  
The transcription factors driving the transcription of antiviral genes are crucial molecules. IRF3, 
NF-κB and AP-1 are transcription factors that form an active complex and bind the IFN-β gene 
promoter to initiate its expression (Maniatis, T. et al., 1998; Thanos, D. et al., 1995). Whereas, 
IFN-α expression is dependent on IRF7 through IKKα kinase. So interfering with transcription 
factor activation or their transcription activity is an attractive target for many viruses.  
Encoding viral IRF mimics by viruses is one strategy to directly target cellular IRFs. IRF 
homologues of human herpes virus 8 inhibit cellular IRF3 activation by preventing the interaction 
of cellular IRF3 with CBP/p300 co-activators.  In much the same way adenovirus E1A (Juang, 
Y.-T. et al., 1998; Lin, R. et al., 2001; Zimring, J. C. et al., 1998) and V proteins of 





TBK1/IKKε (Lu, L. L. et al., 2008). Furthermore, human papilloma virus (HPV) E6 also inhibits 
IRF3’s activity (Ronco, L. V. et al., 1998). Other mechanisms viruses use to target IRF3 is 
degradation instead of sequestration as shown by bovine herpesvirus ICP0 (Saira, K. et al., 2007). 
VACV N2 protein has a role in inhibition of IRF3 activation further downstream after IRF3 
phosphorylation and translocation into the nucleus (Ferguson, B. J. et al., 2013). 
As mentioned previously, NF-κB has a role in the antiviral response and induction of IFN-β. 
African swine fever virus A283L is an early expressed IκB homologue that represses the 
activation of NF-κB pathway and sequesters NF-κB in the cytoplasm (Powell, P. P. et al., 1996; 
Tait, S. W. G. et al., 2000). Myxoma virus M150R co-localizes with NF-κB in the nucleus of 
infected cells and inhibits the response of proinflammatory cytokines (Camus-Bouclainville, C. 
et al., 2004; Johnston, J. B. & McFadden, G., 2005; Kalvakolanu, D. V., 1999). VACV encodes 
a number of proteins that interfere with NF-κB activation and none are redundant as reviewed in 
(Smith, G. L. et al., 2013; Smith, G. L. et al., 2018). They include A46, A49, A52, B14, C4, E3, 
K1, K7, M2 and N1. They are early genes and act at different stages in the signalling pathway to 
inhibit NF-κB activation. It is likely that there are more NF-κB inhibitors encoded as the virus 
was still able to inhibit NF-κB activation even when all known inhibitors were deleted from the 
genome (Sumner, R. P. et al., 2014).     
1.4.2 Inhibition of Interferon-Induced Signalling  
1.4.2.1 Inhibition of Interferon Binding to Receptors  
Poxviruses not only modulate the host response intracellularly, but also extracellularly. Poxvirus 
proteins that are secreted from the infected cells or presented on the cell surface, in general, 
manipulate the immune response by intercepting IFNs and cytokines and preventing them from 
binding to their receptors. The VACV IFN-α/β binding proteins encoded by the B18R gene in 
Western Reserve strain and the B19L gene in the Copenhagen strain have similarity to the IFN-
α/βRs (Colamonici, O. R. et al., 1995). VACV B15R has been shown to encode a secretory 
protein that functions as a soluble IL-1βR. It binds to cellular IL-1β and prevents it from 
interacting with its natural receptor as does the IFN-γ receptor homologue VACV B8R which 





1.4.2.2 Inhibition of JAK/STAT Pathway 
IFN activates the innate immune response to counteract viral infection preventing its spread. 
Many poxviruses inhibit the action of interferon induction through blocking the IFN-signalling 
cascade. The major components of type I IFN signalling (IFN-α/β receptor, JAK1, Tyk2, STAT1 
and STAT2) are targeted by viruses to inhibit IFN signalling. VACV VH1, encoded late by the 
H1L gene, has been shown to bind and dephosphorylate STAT1, resulting in blockage of IFN 
signalling (Najarro, P. et al., 2001). 
1.4.2.3 Inhibition of Interferon-induced Antiviral Effectors  
As described above, IFNs are antiviral factors which induce their inhibitory activity by the 
induction hundreds of effector proteins (Honda, K. et al., 2005; Katze, M. G. et al., 2002; 
MacMicking, J. D., 2012; Schoggins, J. W., 2019; Schoggins, J. W., Wilson, S. J., et al., 2011), 
however, viruses have evolved to encode molecules that interfere with their actions (Smith, G. 
L. et al., 1998). PKR and OAS are involved in the inhibition of protein synthesis and RNA 
degradation respectively and induction of IFN (Der, S. D. et al., 1995; Samuel, C. E., 2001). 
VACV E3 and K3 proteins have overlapping roles in blocking the action of PKR and OAS. 
VACV E3L binds dsRNA and prevents it from activating PKR and OAS. In addition to that, E3 
can bind directly to PKR and prevent its activity for the required phosphorylation of eIF2α 
subunit (Chang, H. W. et al., 1992; Davies, M. V. et al., 1993). An orthologue of VACV E3L, is 
encoded by OV-NZ2 and binds to dsRNA to inhibit the activation of PKR (Haig, D. M. et al., 
1998; McInnes, C. J. et al., 1998). VACV K3L, which is a homologue of eIF2α, acts as a 
competitive element for PKR, resulting in inhibition of eIF2α phosphorylation (Davies, M. V. et 
al., 1992). PKR is also targeted by other viruses, for example, influenza virus NS1 prevents the 
activation of PKR by binding to dsRNA (Hatada, E. et al., 1999). Furthermore, the VACV C7L 
and K1L, host range genes, were also reported to be involved in inhibition of eIF2 
phosphorylation (Meng, X. et al., 2009; Meng, X. et al., 2012). In addition KIL and C7L also 
inhibit the IFN effector mechanism by targeting SAMD9 (Meng, X. et al., 2009; Meng, X. et al., 
2012). ISG15 is an ubiquitin-like protein and is targeted by different viruses such as Crimean 
Congo hemorrhagic virus and influenza B virus (Speer, S. D. et al., 2016). It has been also shown 





1.5 ORFV Virus: Modulation of the Immune Response  
Functional analyses have identified a number of ORFV genes that modulate the immune 
response. Vascular endothelial growth factor-E (VEGF-E, ORF132) is a factor that stimulates 
the proliferation and permeability of blood vessels beneath infected lesions (Lyttle, D. J. et al., 
1994). A homologue of interleukin-10 (vIL-10, ORF127) binds to the ovine IL-10 receptor and 
inhibits production of pro-inflammatory cytokines (Fleming, S. B. et al., 1997). Interferon 
inhibitor (OVIFNR, ORF020) is dsRNA-binding protein that inhibits the activation of PKR 
(McInnes, C. J. et al., 1998). Inhibitor of granulocyte-macrophage colony-stimulating factor 
(GM-CSF) and IL-2 (GIF, ORF117) is a factor that can block the signalling transmission of ovine 
GM-CSF and IL-2 whereas chemokine binding protein (ORF112) binds to several chemokines 
and prevents their action (Deane, D. et al., 2000; Seet, B. T. et al., 2003). A Bcl-2-like inhibitor 
of apoptosis (ORF125) can regulate and inhibit the apoptotic process (Westphal, D. et al., 2007). 
A number of NF-κB inhibitors have been identified in ORFV (ORF121, ORF002 and ORF024) 
(Diel, D. G. et al., 2010; Diel, D. G. et al., 2011a; Diel, D. G. et al., 2011b). ORFV also encodes 
a number of ankyrin (ANK) repeats that are involved in modulating cell cycle (Mercer, A. A. et 
al., 2005). It has recently been shown that ORFV modulates the JAK/STAT pathway and IFN 
effector response (Harvey, R. et al., 2015). Nevertheless, no genes have been shown to interfere 
with IFN expression. 
The functional analysis of OV-NZ2 ORF116 gene has been investigated previously (AlDaif, B., 
2013). The transcriptome of HeLa cells infected with either OV-NZ2 wild type or OV-NZ2Δ116 
knockout has been analyzed using microarray. The microarray data revealed a major effect on 
the expression pattern of a number of cellular genes by ORFV infection. Analysis of differential 
gene expression found that the expression level of a number of ISGs had been up-regulated in 
the mutant virus-infected cells to higher levels than in wild type-infected cells. Infection with 
OV-NZ2Δ116 led to higher induction of ISGs IFI44, RIG-I, IFIT2, IFIT1, ISG20, OASL, IL-8, 
MDA5, OAS1 and DDX60 compared to OV-NZ2. Quantitative RT-PCR results have concurred 
the data obtained by microarray for the selected genes. These observations may suggest that 
ORF116 is likely to be involved in modulating the antiviral effectors of the type I IFN response 
and targeting a number of cellular ISGs by blocking the production of type I IFN from infected 





phenotype characterization of the ORF116 deletion virus in which the growth of the mutant virus 
was clearly affected which may suggest that these ISGs are the targets of ORF116. It is 
worthwhile to mention that microarray data have shown no differential expression in IFN. In 
addition, data have shown that OV-NZ2 downregulated IFI16 > 3-fold. IFI16 is a cytosolic 
dsDNA sensor that leads to IFN-β production. It is also thought that IFI16 is involved in the 
inflammasome activation in response to DNA viruses. The inflammasome controls downstream 
processing and maturation of the IL-1β and IL-18. These two cytokines are likely to play a role 






It is hypothesized that ORFV encodes factors that inhibit the expression of ISGs and type I IFNs 
and that the ORF116 gene plays a role in this process.   
1.7 Aims of the Study   
As described above preliminary data was obtained from a previous study that suggests that the 
ORF116 gene encoded by ORFV plays a role in IFN modulation by possibly inhibiting type I 
IFN expression or directly targeting ISG expression. This study set out to investigate whether 
ORFV has the ability to inhibit type I IFN expression and whether the ORF116 gene plays a role 
in this process as described below.     
 Carry out functional analysis of the ORFV ORF116 gene by constructing an OV-NZ2-
Rev116 revertant virus. 
 Examine the expression levels of specific ISGs using qRT-PCR in HeLa cells infected 
with the ORFV viruses: OV-NZ2 wt, OV-NZ2Δ116 and OV-NZ2-Rev116.  
 Examine the induction of type I IFN in various cell types, e.g., THP-1, hNDF and 
HEK293 cells upon stimulation with the synthetic polymers poly(dA:dT) or poly(I:C). 
 Establish assays that require either RNA or DNA sensing signalling pathways for IFN-β 
induction using poly(I:C) and poly(dA:dT). 
 Investigate the effect of ORFV on IFN-β expression induced through either RNA or DNA 
sensing signalling pathways. 
 Examine the effect of ORF116 gene on IFN-β expression using ORFV recombinant virus. 
 Examine the effect of stably expressing ORF116 on the induction of IFN-β upon 
stimulation with poly(dA:dT) or poly(I:C).  
 Examine the effect of ORFV infection on IL-1β induced with poly(dA:dT) 











2 MATERIALS AND METHODS  
2.1 DNA Cloning  
2.1.1 Plasmids 
The cloning was carried out under GMO approval number GMD000522. Production and 
maintenance of DNA plasmids were conducted according to the molecular cloning protocol 
(Sambrook, J. et al., 2012). Detail of the plasmids used in this study either produced or obtained 
from other sources is shown in Figure 2.1. The ampicillin-containing plasmids were propagated 
in DH5α competent cells and harvested and prepared as detailed below. All solutions used in 
plasmid manipulation are given in Appendices: section 9.1, 9.2 and 9.3.  
Whenever required, the plasmid was ethanol precipitated by adding 0.1 vol of 3M sodium acetate 
and 2.5 vol of ice-cooled 100% ethanol and precipitated at -20 °C overnight. Then they were 
centrifuged in benchtop centrifuge for 10 min at 13,000 rpm and washed with 0.3 ml with 70% 
ethanol twice then let it air dry. The plasmid composition was verified by the characteristic band 
patterns after digestion with respective restriction enzyme and separation on gel by 
electrophoresis and also further confirmed by sequencing. For a short-term storage, the plasmids 











































  Figure 2.1. Diagrams depicting plasmids used in this study with essential features shown. 
A. pOV1 is a vector originally derived from pBR328 that has been constructed by Soberon, X. 
et al. (1980). Orf virus NZ2 EcoRI-D fragment has been cloned at EcoRI restriction site in the 
chloramphenicol resistance gene by Mercer, A. A. et al. (1987). pBR328 confers resistance to 
chloramphenicol, tetracycline and ampicillin, however the cells carrying EcoRI-D fragment 
DNA was identified by their ampicillin resistance phenotype. B. pTZ19R confers ampicillin 
resistance and multiple cloning sites are located within LacZ gene which will provide a selection 
method for the presence of interested fragment DNA. Ori, ColE origin of replication, fi Ori, 
origin of replication and morphogenetic signal from phage f1 intergenic region. It contains 
sequences for forward and reverse universal sequencing primers M13. C. A fragment of 
HindIII/KpnI from pOV1 was double digested with the same restriction enzymes and cloned into 
the same restriction sites in pTZ19R. D. pTZ19R containing HindIII/KpnI fragment was digested 
with KpnI and EcoRI restriction enzymes and a synthesised linker harbouring KpnI and EcoRI 
restriction sites, stop codon and poxvirus early gene termination signal TTTTTCT was inserted 
at KpnI and EcoRI restriction sites. E. pV32 vector was utilized to construct a transfer vector to 
be used for generating orf virus revertant-116. F. pV32 vector was digested with HindIII and 
EcoRI restriction enzymes and HindIII/EcoRI fragment from pTZ19R was cloned at the same 
restriction sites. G. PCR amplified EcoRI/SacI right arm was cloned at EcoRI/SacI restriction 
sites. H. pSP70 was obtained from Promega and it confers ampicillin resistance. LacZ gene 
under control of PF1 orf virus late promoter previously cloned was digested with EcoRI 
restriction enzyme and LacZ gene excised from this construct to provide a means of selection 
method. I. pV32 was digested with EcoRI restriction enzyme and LacZ gene was cloned into it 
at the same restriction site. This vector contains all the genetic elements required to generate the 
revertant-116 virus. J. pEF-Bos-HuRIG-Flag. pEF-BOS was constructed by (Mizushima, S. et 
al., 1990). It is a powerful mammalian expression vector using the promoter of human EF-1α 
chromosomal gene. The human RIG-I gene was discovered by Takashi Fujita as detailed in 
(Yoneyama, M. et al., 2004). The full length gene with flag tag was cloned at 5’ XhoI and 3’ 
BamHI into pEF-BOS plasmid by Brian G. Monks as detailed in (Goutagny, N. et al., 2010) and 
the complete construct was kindly provided by the Fitzgerald laboratory. The main features of 
the construct are shown in the diagram. K. pAPEX3-OV-E3L-Flag was constructed in this study. 
pAPEX3 is a mammalian expression vector constructed by Steven Squinto (Evans, M. J. et al., 
1995). OV-NZ2 ORF020 (vaccinia E3L homologue) was PCR amplified from pVU215 and 
cloned at AscI restriction site, downstream of kozak sequence and upstream flag tag of pAPEX3. 
The plasmid contains ampicillin and also hygromycin resistance markers for selection. L. 
pAPEX3-ORF116-Flag is a mammalian expression vector in which OV-NZ2 ORF116 was 
cloned at the BamHI restriction site. This plasmid was constructed by Fleming and McCaughan 







2.1.2 Preparation and Transformation of Calcium-Competent Escherichia coli by Heat Shock 
Escherichia coli strain DH5α competent cells were prepared in a solution of 80 mM calcium 
chloride to be used for transformation by the heat shock method. E. coli DH5α from frozen stock 
was streaked on a 2-YT agar plate to obtain a single colony. A single colony was picked and 
transferred into 10 ml of 2-YT broth and incubated at 37 °C overnight with shaking at 200 rpm. 
The culture was diluted with 250 ml of SOB medium (Appendix: section 9.1) and incubated at 
37 °C on a shaker for about 2 hours until growth reached exponential phase at an optical density 
(OD600) of 0.4. The culture was placed on ice to cool down, then transferred to a flat-bottom 
centrifuge bottle and centrifuged at 3000 rpm (1350 x g) for 10 min at 4 °C using an F250 rotor. 
The supernatant was discarded and the cell pellets were resuspended in 80 ml of ice-cold 
transformation buffer (Appendix: section 9.1) then incubated on ice for 20 min. The cell pellets 
were centrifuged at 3000 rpm (1350 x g) for 10 min at 4 °C and the supernatant discarded. The 
cell pellets were resuspended in 10 ml of ice-cold transformation buffer. The cells were aliquoted 
in 100 µl in 1.5-ml tubes then stored at -80 °C. The cells were checked for high transformation 
efficiency. The competent cells were transformed with known amount of plasmid by heat shock, 
then plates incubated at 37 °C overnight. The colonies formed were counted and a formula was 
applied to determine the transformation efficiency (TE) of DH5α competent cells. TE=colonies 
counted/μg plasmid/dilution. 
The transformation technique is described in (Hanahan, D., 1983; Sambrook, J. et al., 2012). 
Briefly, about 10 ng of plasmid DNA was added into 50 µl of competent cells after been thawed 
on ice. The content was mixed by swirling gently then stored on ice for 30 min. The tube was 
transferred into a heat block and incubated at 42 °C for 90 seconds then rapidly transferred onto 
ice and incubated for 2 min. Eight hundred µl of 2-YT (Appendix: section 9.1) was added into 
the tube then incubated at 37 °C for 45 min on a shaker at 200 rpm to allow the bacteria to recover 
and to express the antibiotic resistance gene encoded by the plasmid. An appropriate volume of 
transformed competent cells was transferred onto LB agar plate containing ampicillin (50 µg/ml). 
Using a sterile plastic spreader, the transformed competent cells were gently spread over the 





2.1.3 Extraction and Purification of Plasmid DNA 
Small-Scale Preparation and Purification of Plasmid DNA 
Five ml of Luria broth (LB) containing ampicillin at 100 µg/ml was inoculated with a single 
bacteria colony harbouring the plasmid of interest then incubated at 37 °C with shaking at 200 
rpm for overnight. The bacterial pellets were centrifuged and the supernatant discarded then the 
pellets harvested, then plasmid DNA prepared and purified using QIA Prep Spin Mini Prep Kit 
50 (QIAGEN). The concentration was measured by UV spectroscopy using a NanoDrop 
Spectrophotometer (Thermo Scientific).    
Alkaline Lysis Plasmid Purification 
For recombinant clone screening, plasmid DNA was prepared by alkali lysis. Five ml of Luria 
Broth (LB) containing ampicillin at 100 µg/ml was inoculated with a single bacterial colony and 
incubated overnight at 37 °C with shaking at 200 rpm. One and half ml of bacterial cells were 
harvested in a 1.5-ml microcentrifuge tube by benchtop microcentrifugation at 13000 rpm 
(14000g) for 1 min. The supernatant was discarded and pellets were re-suspended in 100 µl of 
25 mM Tris/ 10 mM EDTA/ 50 mM Glucose solution. Two hundred µl of 0.2M NaOH/1%SDS 
was added then mixed by inversion to release the DNA. One hundred and fifty µl of 5M 
potassium acetate pH 5.0 was added and mixed by inversion to precipitate the chromosomal 
DNA. The sample was centrifuged for 10 min at 13000 rpm (14000g), then 375 µl of supernatant 
was transferred to a clean tube. To recover the plasmid DNA, 750 µl of pre-cooled 100% ethanol 
was added then mixed and spun for 5 min at 13000 rpm (14000g). The DNA pellet was washed 
twice with 100 µl of 70 % ethanol, and air dried at 37 °C for 15 min. The DNA was re-suspended 
in 50 µl of 10 mM Tris. RNA was degraded by adding 10 µl RNase (1 µg/ml) and incubated for 
30 min at room temperature.  
Large-Scale Preparation of Plasmid DNA 
A single bacterial colony from a freshly selective plate was picked and inoculated in 5 ml of LB 
medium containing ampicillin at 100 µg/ml then incubated at 37 °C for 8 hours with shaking. 





°C for 16 hours with shaking. After incubation, the bacterial cells were harvested by 
centrifugation 6000g for 15 min at 4 °C using on F250 rotor in a Beckman Avarti J-26 XPI 
centrifuge. The supernatant was discarded and cell pellets were stored at -20 °C until DNA 
preparation using a Plasmid Midi Kit 100 (QIAGEN). The cell pellets were resuspended in 4 ml 
of buffer P1 then transferred to 50-ml polycarbonate cap-screw tubes. Four ml of buffer P2 was 
added and mixed thoroughly by vigorously inverting the tube 4-6 times then incubated at RT for 
5 min. Four ml of chilled buffer P3 was added then mixed immediately and thoroughly by 
inverting 4-6 times then incubated on ice for 15 min. The lysate was cleared by filtration using a 
cartridge filter. The QIAGEN-tip 100 column was equilibrated by applying 4 ml of buffer QBT 
and allowed to empty by gravity flow. The lysate obtained was applied to the column and allowed 
to enter the resin by gravity flow. The column was washed with 2X 10 ml of buffer QC. Plasmid 
DNA was eluted with 5 ml of buffer QF. DNA plasmid was precipitated by adding 3.5 ml (0.7 
volume) at room temperature of isopropanol to the eluted DNA, mixed then kept at -20 °C for 
overnight. Plasmid DNA was centrifuged at 15,000g for 30 min at 4 °C using a JA20 rotor in a 
Beckman Avarti J-26 XPI centrifuge, then the supernatant discarded. The DNA pellets were 
washed with 5 ml of 70% ethanol at RT followed by centrifugation at 15,000g for 10 min using 
an JA20 rotor then the supernatant discarded. The DNA pellets were air dried then resuspended 
in 100 µl of Milli-Q water.     
2.1.4 Dephosphorylation of Linearized Plasmids  
Linearized vector was dephosphorylated at 5’-end using Shrimp Alkaline Phosphatase rSAP 
(NEB) to prevent self-ligation. After digestion of 1 µg of plasmid vector, the reaction containing 
1 µl of alkaline phosphatase and 2 µl of 10X buffer in a 20 µl final volume was set up. The 
reaction was incubated at 37 °C for 30 min then enzyme inactivated at 65 °C for 5 min. The 
dephosphorylation reaction was directly used in the ligation reaction.   
2.1.5 Ligation 
Approximately 7 µl of insert and 1 µl of linearized plasmid vector were incubated in a 10 µl 
ligation reaction containing 1 µl of T4 DNA ligase (Roche) and 2 µl of 10X ligation buffer 
(Roche) and incubated at 4 °C overnight. The ligation reaction was directly used in 





2.1.6 Polymerase Chain Reaction (PCR) 
The primers used for PCR amplification were supplied by Invitrogen. The primers were shipped 
as lyophilized powder. They were reconstituted in Tris-EDTA (TE) buffer (pH 8.0) to obtain a 
final concentration of 100 µM and stored in 2-ml screw-capped tubes at -20 °C.  
A PCR reaction was performed with 40 cycles in a final volume of 50 μl containing 0.5 μl of Taq 
DNA Polymerase, 5 U/μl (Roche), 5 μl of 10X buffer, 1 μl of 10 mM dNTPs (Roche), 1 μl of 
each 10 pmol forward and reverse primer. The cycling conditions were conducted in a PCR 
thermal cycler as follows: 15 sec at 94 °C (denaturation), 30 sec at 60 °C (annealing) and 45 sec 
at 72 °C (elongation). Initial denaturation was 2 min at 94 °C for one cycle and final elongation 
was 7 min at 72 °C for one cycle then cooled to 4 °C. The amount of DNA used in PCR reactions 
varied. Virus genomic DNA was 5 μl (5 ng), screening of LacZ gene correct orientation was half 
a colony of transformed bacteria, RT-PCR was 1 μl of cDNA and plasmid DNA was 1 ng.   
2.1.7 Restriction Endonuclease Digestion  
Restriction enzyme digestion was conducted in a final volume of 50 µl at 37 °C for 2 hours then 
the restriction enzyme inactivated at 65 °C for 15 min. One µl of restriction enzyme 10 U/µl 
(Roche) was used for digestion of 1 µg DNA. Bovine serum albumin (BSA) was added whenever 
needed at a concentration of 200 µg/ml. Where DNA digestion required more than one enzyme, 
double digestion was performed simultaneously, if one digestion buffer can provide high 
digestion activity for both enzymes, otherwise the DNA was digested sequentially starting with 
the enzyme that has the lowest salt concentration.         
2.1.8 Separation of DNA Fragments by Gel Electrophoresis 
The DNA fragments were resolved by gel electrophoresis. One percent agarose gel containing 
0.5 µg/ml ethidium bromide was cast in a tray. About 10-20 µl of DNA was mixed with 5 µl of 
bromophenol blue tracking dye (Appendix: section 9.3) and loaded onto the gel in an 
electrophoresis tank filled with 1X Tris Acetate EDTA (TAE) electrophoresis buffer (Appendix: 
section 9.3). DNA was electrophoresed at the appropriate voltage and time. The bands of DNA 





2.1.9 Gel Extraction of DNA Fragments 
The gel was placed on a UV plate and the relevant bands were excised from the gel with a clean 
scalpel blade, then transferred to 1.5 ml microfuge tubes. The DNA was extracted from the gel 
using PureLink Quick Gel Extraction Kit (Invitrogen) following the manufacturer’s instructions.         
2.1.10 DNA Sequencing and Analysis  
DNA sequencing was conducted in the Allan Wilson Centre, Massey University, Palmerston 
North, New Zealand. Following their recommendations, the sequencing reaction was set up in 
20 µl volumes containing 4 pmol of primer and about 50 ng of PCR product or 300 ng of DNA 
plasmid. Sequencing data was analysed using SeqMan (DNAStar Inc).   
2.2 Cells  
Primary Lamb Testis cells (LT) were cultured in minimal essential medium (MEM) (GIBCO, 
Invitrogen). Human embryonic kidney HEK293 cells, human neonatal dermal fibroblasts 
(hNDF), HaCaT and HeLa cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
(GIBCO, Invitrogen). THP-1 cells were cultured in RPMI1640 (GIBCO, Invitrogen). All cell 
types were supplemented with 10 % heat-inactivated fetal calf serum (FCS) with penicillin (500 
units/ml), streptomycin (0.5 mg/ml), and kanamycin (0.1 mg/ml) and maintained at 37 °C in a 
5% CO2 humidified incubator. Cells were counted by haemocytometer using trypan blue and 
seeded at the number required. THP-1 cells were differentiated to macrophages in 300 ng/ml 
phorbol myristate acetate (PMA) (Sigma) for 3 hours and rested for 2 to 3 days without PMA 
before experiments were performed. PMA was resuspended in 1 ml of DMSO making the 
concentration 1 μg/μl then aliquoted and stored at -20 °C (Table 9.1). An HEK293 cell line stably 
expressing OV-NZ2 ORF116, was generated as detailed in material and methods. Cells were 
stored in liquid nitrogen and revived when needed.    
2.3 Viruses       
ORFV strain NZ2 wild type (OV-NZ2) (Robinson, A. J. et al., 1982) was used in this study. A 
deletion mutant-116 virus (OV-NZ2Δ116) was constructed previously in which ORF116 was 





promoter PH5. A revertant-116 virus (OV-NZ2-Rev116) was constructed in this study in which 
ORF116 was re-inserted at the same locus along with LacZ gene as a reporter under an ORFV 
late promoter PF1. All viruses were propagated in LT cells and titred by plaque assay on LT 
cells. To produce heat-inactivated virus, the virus inoculum was heated at 56 °C for 1 hour in a 
water bath.   
2.3.1 Preparation of Virus Stock  
Six 175-cm2 flasks containing LT cells were maintained in complete MEM supplemented with 
1% PSK. The flasks were infected with virus and incubated at 37 °C for 1 hour rocking at 15 min 
intervals. After 1 hour of adsorption, the infected cells were incubated in 25 ml of MEM 2% FCS 
and 1% PSK for five days or until a complete cytopathic effect (CPE) was observed. The content 
was harvested using a cell scraper and transferred into a 50-ml Falcon tube and stored at -80 °C. 
To promote cell lysis and release of virus remaining in cells, the contents were subjected to three 
freeze-thaw cycles. The tubes were centrifuged at 1500 rpm (512g) for 10 min at 4 °C to separate 
cell debris from the supernatant. The supernatants were transferred to a 500-ml flask on ice. The 
pellets were transferred into a 15-ml tube and sonicated for 1 min. The sonication was repeated 
if lumps of debris were visible. The contents were spun again at 1500 rpm (512g) for 10 min at 
4 °C and the supernatant was transferred to the 500-ml flask of the supernatants. The collected 
supernatants were transferred into 8 Oakridge Ti70 tubes (25 ml each) and ultra-centrifuged at 
20,000 rpm (41,000g) for 1 hour at 4 °C in a Beckman Coulter Optima L-80 XP Ultracentrifuge 
using Ti70 rotor. Under a laminar flow hood, the supernatants were aspirated and the pellets were 
re-suspended in 5 ml of PBS. The virus suspension was sonicated for 1 min and aliquoted in 1 
ml volume vials and stored at -80 °C.  
2.3.2 Sucrose Purification of Virus Stock  
All viruses used in this study were sucrose-purified to eliminate any confounding effect from 
cellular cytokines in particular IFNs that might be present in the virus preparation. The protocol 
has been described previously (Joklik, W. K., 1962; Nagington, J. et al., 1964; Zwartouw, H. T. 
et al., 1962). Briefly, 1 ml of 40 % sucrose made up in ET buffer (0.25 M Tris, pH 7.5 and 0.01 
M EDTA) was added in a Beckman Coulter Ultra-Clear Centrifuge tube (13x51 mm) then 





(64,000g) for 45 min at 4 °C in a Beckman Coulter Optima L-90K Ultracentrifuge. The 
supernatant was discarded and the virus pellet was resuspended in 5 ml of PBS. 
2.3.3 Titration of Viral Stock and Plaque Assay  
Two 6-well plates were seeded with LT cells containing 2 ml of MEM medium with 10% FCS 
and then incubated at 37 °C with 5% CO2. When the cells had formed an 80% confluent 
monolayer, they were infected with virus. Ten-fold dilutions of sonicated virus were made in 
PBS (10-1 – 10-8). The medium was removed from cells then washed with PBS and 200 µl of 
each viral dilution was added to the cells. The infection was carried out in duplicate from 10-3 to 
10-8 dilutions. The infected cells were incubated at 37 °C and 5% CO2 for 1 hour to allow virus 
to adsorb, with tipping every 15 min to ensure cells did not dry out and viruses were evenly 
distributed. During adsorption, MEM-agarose overlay was prepared by mixing equal volumes of 
2X MEM 4% FCS and 2% agarose and cooled at 37 °C. After 1 hour of incubation, the inocula 
were removed from the wells, and cells washed with PBS then 2.5 ml of agarose overlay at 37 
°C was added to each well. The agarose was left to set at room temperature then the infected cells 
incubated at 37 °C 5% CO2 for 5 days. Virus plaques were visualized by staining with neutral 
red (0.015%), X-Gluc (200 µg/ml) or X-Gal (200 µg/ml) in which 2% of low melting point 
agarose overlay was prepared and mixed with the stain. One and half ml of agarose overlay was 
added to each well and left to set at room temperature. The plates were incubated at 37 °C 5% 
CO2 for 4 hours or until plaques were visible. The plaques were counted and plaque-forming 






2.4 Generation of ORFV Virus ORF116 Revertant  
The generation of an ORFV ORF116 revertant was made according to the method adapted from 
standard procedures used in the generation of VACV recombinants (Broder, C. C. et al., 1999; 
Lorenzo, M. M. et al., 2004; Mackett, M. et al., 1984; Rziha, H. et al., 2016; Wyatt, L. S. et al., 
2017) and the protocol has been described previously in (Fleming, S. B. et al., 2017; Savory, L. 
J. et al., 2000). 
2.4.1 Construction of Transfer Vector Containing ORF116, LacZ Gene and Flanking Arms  
The sequence of cloning steps to make the construct for the revertant-116 virus is shown in Figure 
2.2. ORFV116 of OV-NZ2 is located within the restriction fragment EcoRI-D which was cloned 
into pOV1 plasmid. The gene encoding ORF116 is mostly located within a 1.255 kb HindIII-
KpnI subfragment of EcoRI-D in which this fragment contains ORF116 except the last 13 
nucleotides at the C-terminus. The 1.255 kb fragment was isolated by endonuclease digestion. 
One µg of pOV1- EcoRI-D plasmid and pTZ19R plasmid were double digested with HindIII and 
KpnI restriction enzymes, then fragments separated by electrophoresis on 1% agarose gel. The 
digested HindIII-KpnI subfragment and pTZ19R vector were excised and purified using 
PureLink Quick Gel Extraction Kit (Invitrogen). The 1.255 kb HindIII-KpnI subfragment was 
cloned into the pTZ19R vector at the same restriction sites. This step was followed by 
incorporation of a linker containing KpnI and EcoRI restriction sites, the 13 nucleotides of 
ORF116 at C-treminus, a stop codon and a poxvirus early transcription termination signal T5NT 
(CAGCACCTCCTAAGTGAGTACGTAATTTTTCTG, (bolded stop codon and T5NT signal) 
resulting in a DNA fragment containing the full length sequence of ORF116 gene with HindIII 
and EcoRI restriction sites. The linker was produced by self-annealing of two chemically 
synthesized oligonucleotides (Invitrogen) (ORF116 linker F Phos-
CAGCACCTCCTAAGTGAGTACGTAATTTTTCTG and ORF116 linker R Phos-
AATTCAGAAAAATTACGTACTCACTTAGGAGGTGCTGGTAC, underlined EcoRI and 
KpnI sites) in which 5 µl of each oligo (10 pmol) was annealed in a 50 µl final volume of 
annealing buffer (10 mM Tris, pH8.0, 50 mM NaCl, 1 mM EDTA) at 95 °C for 5 min then cooled 
at RT. The linker was first confirmed on a 2% agarose gel then incorporated into pTZ19 plasmid 
at the EcoRI and KpnI restriction sites after the plasmid was double digested with the same 











Figure 2.2. Sequences of cloning steps. Diagram showing the steps for construction of the final 
transfer vector used for the revertant-116 virus. The plasmid pOV1 contains the ORF116 gene 
and upstream sequence (left arm) both located between HindIII and KpnI. The subfragment of 
HindIII/KpnI was inserted into pTZ19R and an EcoRI/KpnI linker was incorporated into 
pTZ19R. The HindIII/EcoRI fragment from pTZ19R was digested and inserted into pV32. 
Finally, a LacZ reporter gene was cloned into the same vector pV32 at the EcoRI restriction site 
























































digestion with HindIII and EcoRI restriction enzymes and cloned into the pV32 vector at the 
same sites. pV32 plasmid and the pTZ19R containing EcoRI/HindIII fragment were double 
digested with EcoRI and HindIII restriction enzymes and run on 1% gel then the pV32 vector 
and EcoRI/HindIII fragments from pTZ19R were excised and gel purified, then EcoRI/HindIII 
fragment was cloned into the pV32 vector. A fragment that spans 535 bp downstream of the 
ORF116 coding region (right arm with EcoRI and SacI sites incorporated) which includes 373 
bp of the ORF117 gene was PCR amplified from pVO1 plasmid using primers ORF116 right 
arm F 5’-CCCGAATTCGCATTTCGGAGTAACGTCGTA (EcoRI site underlined) and 
ORF116 right arm R 5’- CCAGAGCTCGGTCGTCGATCACCCAAGGGT (SacI site 
underlined) then the PCR product was gel purified. The right arm was subjected first to double 
digestion with EcoRI and SacI and cleaned up using a PCR Purification Kit (QIAGEN) then 
sequenced to check for errors before cloning into the pV32 vector at the EcoRI and SacI 
restriction sites. Finally, the E. coli β-galactosidase gene (lacZ) placed under the control of a 
strong ORFV late promoter PF1 (Fleming, S. B. et al., 1993) was cloned into an EcoRI site 
located between the ORF116 gene and the right arm. The correct orientation of LacZ gene was 
screened and confirmed by colony PCR (Bergkessel, M. et al., 2013; Santos, C. N. S. et al., 2014) 
in which a pair of primers (ORF116 linker F and R 5’-
GCGCATCGTAACCGTGCATCTGCCAGTTTG) was used to yield a specific product of 
known size only if the LacZ gene was cloned in the correct orientation. The final plasmid 
construct was subjected to thorough restriction analysis to confirm the presence of all fragments 
within the construct and also to confirm the correct orientation of the LacZ gene. The final 
construct was sequenced utilizing primers used in constructing the transfer vector and all are 
depicted in Figure 3.4 A. Before the construct was used to generate the revertant virus, the 
function of E. coli β-galactosidase gene (lacZ) was checked in the LT-OV-NZ2 virus infected 
cells and the generation of blue colour was examined in the presence of X-Gal. 
2.4.2 Transfection of Transfer Plasmid into Lamb Testes (LT)-Infected Cells 
The final plasmid construct was used to generate the revertant-116 virus. LT cells were seeded 
at 2X106 cell per 25-cm2 flask. On the day of transfection, the cells were washed with PBS then 
infected with OV-NZ2116 mutant as a parental virus at an MOI 0.5 per cell for 1 hour rocking 





incubated for 2 hours. After 2 hours post infection, the infected cells were transfected with the 
transfer vector using Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. 
The DNA:Lipid mixture was prepared by incubating 3 g of the plasmid transfer vector into 0.5 
ml of OPTI-MEM and 3 l of Lipofectamine 2000 in 0.5 ml of OPTI-MEM for 30 min at room 
temperature. Then both contents were mixed and incubated for 15 min at RT. The infected cells 
were washed with PBS then with OPTI-MEM twice, 1 ml of transfection mixture was added and 
incubated overnight. Next day, the transfection mixture was removed and 4 ml of MEM medium 
with 2% FCS was added into the flask and incubated for 6 days until a complete cytopathic effect 
(CPE) observed. The cells were removed using a cell scraper and the whole content was 
transferred into a 15-ml tube then stored at -80 °C. The cells were disrupted by three freeze-thaw 
cycles and sonication. The cell debris was pelleted by low speed spin for 5 min at 4 °C and the 
supernatant transferred into a clean tube and stored at -80 °C.    
2.4.3 Selection, Screening and Purification of Revertant-116 Virus  
The E. coli LacZ gene was incorporated into the transfer vector downstream of ORF116 under 
control of the ORFV late promoter PF1 in order to provide a selection method for the 
identification of the resultant revertant-116 virus through the production of ß-galactosidase (ß-
gal). The putative revertant-116 virus was screened and selected by their blue plaques in the 
presence of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal) (200 g/ml). The 
parental virus genome contains the E. coli gusA gene encoding ß-glucuronidase (GUS) that 
catalyses the production of blue colour in the presence of 5-bromo-4-chloro-3-indolyl 
glucuronide (X-Gluc). The resultant revertant-116 virus was subjected to plaque assay as 
explained above and detected by the X-Gal stain and distinguished from the parental virus by 
their blue plaque phenotype. A number of well-separated and strong blue-displayed plaques were 
picked with a sterilized pipette tip by piercing it through the agarose to the bottom of the well, 
scraping the monolayer and aspirating the agarose plug containing infected cells into the pipette 
then transferring it to a clean tube containing 200 µl of PBS then stored at -80 °C. They were 
subjected to three freeze-thaw cycles and sonication in order to break the cell membrane and 
release the intracellular infectious particles. Those putative revertant-116 virus isolates were 
amplified first in a 25-cm2 flask of LT cells 2X106 cell per flask using 50 µl of the virus isolate 





five days at 37 °C in 5% CO2 atmosphere. Virus isolates showing a strong cytopathic effect 
(CPE) were chosen and their cells and supernatant harvested and transferred into 15-ml tubes 
then stored at -80 °C. They were subjected to three freeze-thaw cycles and sonication. The cell 
lysates were spun at 1500 rpm for 10 min at 4 °C and 50 µl of virus isolate was subjected to 
plaquing in 6-well plates as explained above. Well-separated and strong blue-displayed plaques 
were picked as explained above. Three rounds of plaque purification were performed to ensure 
complete removal of the parental virus and final pure revertant-116 virus obtained. PCR analysis 
was further conducted to ensure virus purity.   
2.5 Analysis of Virus Growth Kinetics   
One-step or multiple-step growth curves were conducted to characterize the growth of virus in 
HEK293, THP-1, NDF or HaCaT cells. Cells were seeded in 6-well plates at 4x105 cells per well 
and incubated at 37 °C with 5% CO2 overnight. On the day of infection, the medium was removed 
and cells washed with PBS. Then the cells were infected with sonicated virus using 200 μl 
inocula. After 1 hour of adsorption at 37 °C, the cells were incubated with 2 ml of medium, 2% 
FCS at 37 °C until harvesting time. To harvest virus, the cells were scraped off the surface and 
all contents were transferred to a 2-ml tube then stored at -80 °C. To release virus from cells, the 
samples were subjected to 3 cycles of thawing-freezing. The viral progeny was determined by 
plaque assay on LT cells.  
2.6 Detection of Early Viral Protein Synthesis  
Cells were infected with sonicated virus or for the inhibition study of early gene synthesis, the 
cells were infected with heat-inactivated virus in which virus inoculum was heated at 56 °C for 
1 hour. Then the cells were incubated for 1 hour at 37 ºC with tipping every 10-15 min. After 
adsorption, 2 ml of medium containing 2% FCS was added. Then cells were incubated at 37 °C 
with 5% CO2 until harvested. The cells were removed and transferred to a 1.5-ml tube and the 
cell suspension was centrifuged at 1200 rpm for 5 min, and the supernatant aspirated. OV119 





2.7 RNA Interference     
Short interfering RNAs (siRNAs) including negative control siRNA are listed in Table 2.1 
showing their sequences and sources. They were reconstituted in RNase-free water to final 
concentration of 100 μM for RIG-I and 20 μM for STING. Lipofectamine 2000 (ThermoFisher) 
was used to transfect siRNA into the cells according to the manufacturer’s instructions. The cells 
were seeded at 2X104 cells in a 24-well plate and incubated overnight at 37 °C. The cells were 
washed twice with PBS and 400 μl of OPTI-MEM added with no FCS or antibiotics. One 
hundred microliters of OPTI-MEM containing the siRNA:lipid mix was prepared and 
transfection carried out according to the manufacturer’s instructions. Three siRNAs targeting a 
gene of interest were used and absence of siRNA (none, only Lipofectamine 2000) and negative 
control siRNA (NC) were included in each experiment as controls. The final concentration of 
siRNA used was 100 nM and 1 μl of Lipofectamine 2000 was used per well. The following day 
of transfection the cells 25 μl of FCS was added and the cells incubated for a further day. The 
knockdown effects were analysed by western blotting using antibody against the protein of 
interest. After 48 hours post transfection, the cells were used for the assays of IFN-β induction.     
2.8 Western Immunoblotting  
The cell pellets were washed with PBS twice and lysed in lysis buffer [1% Nonidot P-40 (NP-
40), 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 2 mM PMSF, 1 mM Na3VO4, 10 mM NaF, 1 tablet 
protease inhibitor (cOmplete, Mini, EDTA-free, Roche) per 10 ml] for early viral protein 
synthesis and siRNA knockdown experiments, whereas, for the experiments involving detection 
of phosphorylated proteins the cells were lysed in Phosphosafe Extraction reagent (Merck 
Millipore). The cell lysates were kept on ice for 30 min, then centrifuged at 16,000 rpm for 10 
min at 4 °C. Supernatants were transferred to new 1.5-ml tubes. The concentration of protein 
extracted was determined using Pierce BCA Protein assay Kit (ThermoFisher) following the 
manufacturer’s instructions.  
Equal amounts of samples were prepared in loading buffer (LDS sample buffer 4X and reducing 
buffer 10X, novex, life technologies) then boiled for 8 min. The protein and molecular weight 
marker were resolved by Tris-glycine SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 





transferred onto nitrocellulose membranes (45 micron, Amersham) using a Mini Trans-Blot Cell 
(BioRad). The membrane was blocked with 5% skimmed milk in TBST buffer for 1 hour at room 
temperature, then the membrane was incubated with primary antibody in TBST containing 1% 
skimmed milk or 5% bovine serum albumin (BSA) for phosphorylated protein overnight at 4 °C 
with shaking. The membrane was then washed with TBST for three 5-min washes and incubated 
with HRP-conjugated secondary antibody in TBST containing 1 % skimmed milk for 1 hour at 
room temperature on a shaker. Then the membrane was washed with TBST for three 5-min 
washes and bands were detected using chemiluminescent substrate (Pierce, Thermo Scientific) 
and imaged by Odyssey imaging system (Li-Cor Biosciences). Bands were quantified using 
ImageJ software (version 1.51e) and normalized to those of the loading control. All primary and 
secondary antibodies are listed in Table 2.2.  
2.9 Immunoprecipitation 
Cells were washed twice with PBS and lysed with lysis buffer [1% Nonidot P-40 (NP-40), 150 
mM NaCl, 50 mM Tris-HCl pH 8, 2 mM phenymethylsulfonyl Fluoride ( PMSF), 1 mM Na3VO4, 
10 mM NaF, 1 tablet protease inhibitor (cOmplete, Mini, EDTA-free, Roche) per 10 ml]. After 
30 min of incubation on ice, the lysates were centrifuged at 13,000 rpm for 20 min at 4 °C then 
the supernatants were transferred into new tubes. Anti-RIG-I (cell signalling) (1:50) and normal 
rabbit IgG (Invitrogen) as negative control were added into the lysates. The antibodies and 
proteins mixtures were incubated overnight at 4 °C on a rotator. Fifty microliters of protein G 
Sepharose beads were added into the lysates and incubated for 2 hours at 4 °C on a rotator. 
Proteins bound to antibodies and protein G Sepharose were collected by centrifugation for 30 sec 
then washed three times with 750 μl of lysis buffer for 5 min at 4 °C on a rotator. The precipitated 





Table 2.1. Short interfering RNAs (siRNAs) sequences. 
Gene 
GenBank 





Sequence (5’-3’), sense and anti-
sense a 
Source 
hRIG-I NM_014314 2798 1 GACAUUUGAGAUUCCAGUU[dT][dT] 
AACUGGAAUCUCAAAUGUC[dT][dT] 
SIGMA 
      
  2381 2 GACUAGUAAUGCUGGUGUA[dT][dT] 
UACACCAGCAUUACUAGUC[dT][dT] 
SIGMA 
      
  1970 3 CAGCAAUGAGAAUCCUAAA[dT][dT] 
UUUAGGAUUCUCAUUGCUG[dT][dT] 
SIGMA 
      
hSTING 
(TMEM173) 
NM_198282 1035 1 GCAUCAAGGAUCGGGUUU[TT] 
AAACCCGAUCCUUGAUGC[TT] 
GENEPHARMA 
      
  679 2 GCCCUUCACUUGGAUGCUU[TT] 
AAGCAUCCAAGUGAAGGGC[TT] 
GENEPHARMA 
      
  886 3 GCAUUACAACAACCUGCUA[TT] 
UAGCAGGUUGUUGUAAUGC[TT] 
GENEPHARMA 
      
Negative 
Control (NC) 




a Sequence in brackets indicate overhangs.   
 



















19781 1:1000 1 hour at RT in 5 % BSA Overnight at 4 °C in 5 % BSA 
in TBST on shaker 






1 hour at RT in 5 % 
skimmed milk 
Overnight at 4 °C in 5 % BSA 
in TBST on shaker 




13647 1:1000 1 hour at RT in 5 % 
skimmed milk  
Overnight at 4 °C in 5 % BSA 
in TBST on shaker 
TBK1/NAK Rabbit mAb Cell Signaling 
Technology 
3013 1:1000 1 hour at RT in 5 % 
skimmed milk 
Overnight at 4 °C in 5 % BSA 
in TBST on shaker 




4302 1:1000 1 hour at RT in 5 % 
skimmed milk 
Overnight at 4 °C in 5 % BSA 
in TBST on shaker 
Phospho-TBK1/NAK 




5483 1:1000 1 hour at RT in 5 % BSA Overnight at 4 °C in 5 % BSA 
in TBST on shaker 
Phospho-IRF3 (Ser396) 
(D601M) Rabbit mAb  
Cell Signaling 
Technology 
29047 1:1000 1 hour at RT in 5 % BSA Overnight at 4 °C in 5 % BSA 
in TBST on shaker 
Mouse monoclonal Anti-
Flag M2 Ab 
Sigma-Aldrich F1804 1:1000 1 hour at RT in 5 % 
skimmed milk in TBST 
Overnight at 4 °C in 1 % 
skimmed milk in TBST on 
shaker 
Rb pAb to alpha Tubulin Abcam Ab4074 1:2000 1 hour at RT in 5 % 
skimmed milk in TBST 
Overnight at 4 °C in 1 % 
skimmed milk in TBST on 
shaker 
Actin (C-11) Santa Cruz 
Biotechnology 
Sc-1615 1:2000 1 hour at RT in 5 % 
skimmed milk in TBST 
Overnight at 4 °C in 1 % 
skimmed milk in TBST on 
shaker 
Rabbit Anti-OV119  (Harfoot, R. T., 
2015) 
- 1:2000 1 hour at RT in 5 % 
skimmed milk in TBST 
Overnight at 4 °C in 1 % 
skimmed milk in TBST on 
shaker 











Blocking Condition Antibody incubation 
Normal rabbit IgG  Invitrogen - 1:50 (IP)* - - 












Dako  P0448 1:2000 - 1 hour at RT in 1 % skimmed 





7076 1:2000 - 1 hour at RT in 1 % skimmed 







2.10 Analysis of Viral Genomic DNA  
2.10.1 Virus DNA Extraction  
The protocol for viral DNA preparation was adapted from  Mercer, A. A. et al. (1987). Virus stock 
was sucrose purified and the supernatant discarded and the pellet resuspended in 0.2 ml of ET buffer 
(0.25 M Tris, pH 7.5 and 0.01 M EDTA). A gradient of sodium diatrizoate (25% to 50%) was 
prepared in a Beckman Coulter Ultra-Clear Centrifuge tube (13x51 mm) using a peristaltic pump, 
then overlaid with 0.5 ml of 10% dextran and last the resuspended virus was laid on top. The virus 
was centrifuged at 22,000 rpm in an SW55Ti rotor for 18 hours at 4 °C. After centrifugation, the two 
visible bands were harvested separately by using a 1-ml pipette tip. The bands were diluted in 4 ml 
of ET buffer then layered on a 1 ml 40% sucrose cushion for another sucrose purification. The 
supernatant was discarded and the pellet was resuspended in 0.2 ml of TE buffer (0.01 M Tris, pH 
8.0 and 0.001M EDTA). The purified virus pellet was digested by adding 10 µl of proteinase K (25 
mg/ml) and 2.5 µl of 10% SDS then incubated for 2 hours at 56 °C. Another 2.5 µl of 10% SDS was 
added with 30 min incubation at 56 °C. After digestion, the virus DNA was layered onto a density 
gradient of guanidine HCl/Cesium chloride (1.35 g/ml to 1.55 g/ml) prepared in a Beckman Coulter 
Ultra-Clear Centrifuge tube (13x51 mm) by peristaltic pump then ultra-centrifuged at 35,000 rpm 
using an SW55Ti rotor for 18 hours at 20 °C. After centrifugation was completed, 0.5 ml of fractions 
were collected by 1-ml pipette tip and transferred into 1.5-ml tubes. All Fractions were checked by 
gel electrophoresis to identify the fractions containing virus DNA. Five µl from each fraction was 
mixed with 40 µl of TE buffer and 5 µl of loading dye then loaded onto a 0.7% gel and run for 1 hour 
at 75 V. Those fractions containing DNA were pooled, transferred into dialysis tubing and sealed at 
both ends with clips. The tubing was placed in 2 L of dialysis buffer (TE: 0.01 M Tris, pH8 and 0.001 
M EDTA) in a cool room and stirred with a magnetic stirrer for 2 days, and changing the buffer every 
day. After dialysis, the dialyzed DNA was transferred into a 1.5-ml tube and stored at 4 °C.          
2.10.2 Endonuclease Restriction of Viral DNA.  
The concentration of viral DNA prep was determined by NanoDrop spectrophotometer. Viral DNA 
was digested in a reaction containing 5 µl (50 U) of restriction enzyme (Roche) and 28 µl of buffer 
in a total volume of 280 µl. The reaction was incubated at 37 °C for 2 hours, then the digested DNA 
was ethanol precipitated in 560 µl of absolute ethanol and 25 µl of 3 M sodium acetate (pH 5) at -20 





supernatant was discarded and the pellet washed with 70% ethanol and centrifuged at 13,000 rpm for 
15 min. The pellet was air-dried then resuspended in 10 µl of TE buffer (pH 7.5) and 3 µl of loading 
dye added. Two hundred ml of 0.7% agarose gel containing 0.5 µg/ml ethidium bromide was 
prepared in a tray sized 15 cm x 24 cm. The digested virus DNA was run at 45 V overnight. The 
bands were visualized under UV light. The size of DNA fragments were compared to those predicted 
by GeneQuest (DNAStar, Inc).               
2.10.3 PCR Amplification of Viral DNA 
PCR amplification of the target region of viral DNA was performed with 40 cycles in a final 
volume of 50 μl containing 0.5 μl of Taq DNA Polymerase (Roche), 5 μl of 10X buffer, 1 μl of 
0.2 mM dNTPs (Roche), 1 μl of each 10 pmol forward and reverse primer (see Table 2.3 for 
primer sets) and 5 μl of viral DNA. The cycling conditions were conducted in a PCR thermal 
cycler as follows: 15 sec at 94 °C (denaturation), 30 sec at 60 °C (annealing) and 45 sec at 72 °C 
(elongation). Initial denaturation was 2 min at 94 °C for one cycle and final elongation was 7 min 
at 72 °C for one cycle then cooled to 4 °C. Ten μl of PCR products mixed with 5 μl of loading 
dye were electrophoresed on a 1% agarose gel at 75 mV for 1 hr. The PCR products were 





Table 2.3. Primers used in PCR analysis of viral DNA.  
NO. Sequence (5’-3’)  
Universal Primers for WT, KO and Rev. 
1_F CTACGGCGCTTATGTGGACT  
5_R CCAGAGCTCGGTCGTCGATCACCCAAGGGT  
Primers for WT 
1_F CTACGGCGCTTATGTGGACT  
2_R TCTGAGGCACGCCATCTTTC  
Primers for KO 
 Left Region of ORF116 locus   
1_F CTACGGCGCTTATGTGGACT  
3_R CACCATTGGCCACCACCTGCC  
 Right Region of ORF116 locus  
4_F CAGCGTTGGTGGGAAAGCGCG  
5_R CCAGAGCTCGGTCGTCGATCACCCAAGGGT  
Primers for Rev 
 Left Region of ORF116 locus  
6_F GTGCAGACTGTCCATGGTGT  
7_R TTGGGTAACGCCAGGGTTTT  
 Right Region of ORF116 locus  
8_F CTCACGCGTGGCAGCATCAG  
5_R CCAGAGCTCGGTCGTCGATCACCCAAGGGT  
Primers for GUS 
4_F CAGCGTTGGTGGGAAAGCGCG  
3_R CACCATTGGCCACCACCTGCC  
F, forward. R, reverse. WT, wild type. KO, knockout. Rev, revertant.  
See Figure 3.7 for targeted regions and Figures 9.3, 9.4 and 9.5 for targeted 







2.11 Cloning ORFV Virus ORF020 Gene into pAPEX3-Flag   
The ORFV ORF020 gene (VACV homologue E3L) was PCR amplified from pVU215 using the 
forward primer 5’-AAGGCGCGCCTGGCCTGCGAGTGCGCGT containing an AscI restriction 
site underlined and the reverse primer 5’-AAGGCGCGCCAAGCTGATGCCGCAGTTG 
containing an AscI restriction site underlined. The ORF020 PCR amplified product was purified 
and digested with AscI restriction enzyme. The ORF020 gene was cloned into the vector 
pAPEX3-flag at the AscI restriction site and ORF020 gene correct orientation was confirmed by 
restriction analysis. The flag tag sequence was just before stop codon and kozak sequence was 
just before the first start codon. The cloned ORF020 was sequenced and confirmed there were 
no PCR errors.    
2.12 Transient Expression of Proteins from Plasmids  
The plasmids were prepared at large scale. The plasmids were transfected into the cells using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. After 24 hours 
post transfection, the cells were lysed in lysis buffer and protein expression was detected by 
western blotting using anti-flag antibody. The transfected cells were used for IFN-β signalling 
assays.     
2.13 Generation of Cell Lines    
Tissue culture flasks (75 cm
2
) were seeded with cells of 20% confluency in 15 ml of complete 
medium and incubated overnight at 37 °C. Fifteen micrograms of each plasmid expressing OV-
NZ2 ORF116, OV-NZ2 ORF020 or human RIG-I and 60 µl of Lipofectamine 2000 (Invitrogen) 
were pipetted into tubes of 1500 µl of OPTI-MEM separately then incubated at room temperature 
for 5 min. The contents were combined and incubated for 20 min at room temperature. The cells 
were washed twice with PBS and 5 ml of medium added with no FCS or antibiotics. The 
lipid:DNA mix was added to the cells according to the manufacturer’s instructions and cells 
incubated for 1 hour at 37 °C with 5% CO2. Then, 7 ml of complete medium was added. The 
cells were incubated for two days at 37 °C with 5% CO2. Stable transfection cells expressing 
ORF116 and ORF020 proteins were selected using Hygromycin B (Sigma-Aldrich) at 0.1 mg/ml 





1 mg/ml. Cells co-expressing RIG-I/ORF116 and RIG-I/ORF020 were selected by both 
antibiotics hygromycin B and geneticin at concentrations of 1 mg/ml and 0.1 mg/ml respectively. 
Stable transfection was maintained in selection medium until a stable cell line was obtained. 
After the cell line was generated, cell lysates were prepared using lysis buffer (1% Nonidot P-40 
(NP-40), 150 mM NaCl, 50 mM Tris-HCl pH 8, 2mM PMSF, 1 mM Na3VO4, 10 mM NaF, 1 
tablet proteinase inhibitor / 10 ml).  
2.14 Poly(dA:dT) or Poly(I:C) Cell Stimulation 
LyoVec was used as a transfection reagent as this drives the delivery of nucleic acids into the 
cytosol. The sterile lyophilized reagent was reconstituted with sterile Milli-Q H2O according to 
the manufacturer’s instructions. Sterile lyophilized poly(dA:dT) was resuspended with sterile 
endotoxin-free physiological H2O provided at a concentration 1 μg/μl then aliquoted and stored 
at -20 °C. Sterile lyophilized Poly(I:C) was resuspended in 5 ml of sterile Milli-Q H2O making 
a concentration of 1μg/μl, then aliquoted and stored at -20 °C. RNA Polymerase III inhibitor 
(powder) was dissolved in DMSO. Reagent details are shown in Table 9.1.     
Sufficient LyoVec-nucleic acid complex was prepared for culture format and cell transfection 
was conducted according to the manufacturer’s instructions. Following cell seeding and 
overnight culture, the cells were washed with PBS and fresh complete medium was added. The 
cells were stimulated with either poly(dA:dT) or poly(I:C) at the indicated concentration and 
incubated until the harvesting time indicated. For nucleic acid stimulation assays involving virus 
infection, the viral inoculum with appropriate MOI was prepared and cells were washed twice 
with PBS. Viral inoculum was added to the cells and incubated for 1 hour adsorption at 37 °C 
with tilting every 15 min. After 1 h of adsorption, fresh complete medium was added. It is 
important to note that infection follows poly(dA:dT) stimulation whereas this is vice versa for 
poly(I:C) stimulation unless otherwise indicated. For stimulation assays involving treatment with 
the RNA Polymerase III inhibitor (ML60218), cells were pre-treated with the appropriate 
concentration of ML60218 for 2 hours and the drug was maintained across the duration of the 
assay. The cells were incubated at 37 °C until harvesting time. The cells were harvested by 





then transferred into a 2-ml tube. The cell pellets were centrifuged at 1200 rpm for 5 min at 4 ºC 
then the supernatant removed and total RNA extraction from cell pellets carried out.  
2.15 Total RNA Isolation and cDNA Synthesis  
Total RNA was extracted from cell lysates using a Total RNA Mini Kit (Geneaid) according to 
the manufacturer’s instructions. The quality and quantity of total RNA was evaluated with UV 
spectroscopy. One hundred nanogram of RNA sample was subjected to DNase I off-column 
treatment using PerfeCta DNase I (Quanta Biosciences) according to the manufacturer’s 
instructions to degrade genomic DNA. The reaction was set up as follow: 16 μl of RNA, 2 μl of 
10X reaction buffer and 2 μl of DNase I. The reaction was incubated at 37 °C for 30 min then 2 
μl of 10X stop buffer was added and incubated at 65 °C for 10 min. The successful removal of 
DNA was confirmed by comparing with negative control reaction in which RNA sample has no 
reverse transcriptase. Then RNA samples were reversed transcribed into cDNA using 
SuperScript IV VILO Master Mix (Invitrogen)  according to the manufacturer’s 
instructions. The reaction was set up as follows: 11 µl of digested RNA sample, 4 µl of RT 
mix and made up to 20 µl with RNase-free water. The reaction was started with 25 °C for 10 min 
then cDNA synthesized at 50 °C for 10 min. The transcription was terminated at 85 °C for 5 min 
then cooled at 4 °C. cDNA was diluted 1:5 in Milli-Q H2O.  
2.16 Quantitative Real Time-PCR (qRT-PCR) and Data Analysis 
Gene specific primers were designed by using qPrimerDepot and were produced by Invitrogen. 
Their sequences are shown in Table 2.4. Their target specificity was confirmed using NCBI 
Primer-BLAST. Their amplification specificity also was validated by melting curve analysis and 
agarose gel electrophoresis of PCR products. Their concentration and amplification efficiency 
was determined as well.   
qRT-PCR was performed using PerfeCta SYBR Green FastMix, Low ROX (Quanta Biosciences) 
as a dye-based detection method and ABI QuantStudio 6 Flex Real Time PCR System. The 
reaction was set up in a 10 µl final volume at least in duplicate as follow: 5 μl of SYBR Mix, 0.1 
µl of forward primer (200 nM), 0.1 µl of reverse primers (200 nM), 2 µl of cDNA and 2.8 μl of 





thermal cycler and cycling conditions were, initial 95 °C for 2 min for one cycle, followed by 40 
cycles of denaturation at 95 °C for 15 sec and annealing and extension at 60 °C for 30 sec. A 
melting curve was constructed at the end of the assay. The expression level of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was determined in each individual sample as a reference 
gene.    
qRT-PCR Data analysis was conducted in which Ct values of gene of interest mRNA were 
normalized to the Ct value of GAPDH mRNA producing ΔCt values, then relating those 
normalized values to control producing ΔΔCt values. Stability of GAPDH expression was 
confirmed by assessing its Ct values across the time points, untreated and treated samples, and 
assure the Ct values are consistent. The expression fold was calculated by applying the formula 
2-ΔΔCt (Pfaffl, M. W., 2001). To obtain relative expression levels for comparison, the values of 
treated or infected samples were related to the values of untreated or uninfected samples 
respectively after considering the values of untreated or uninfected samples as 1.     
2.17 Transcription of ORFV ORF116 Gene  
HeLa cells were seeded at 4x105 cells in a 6-well plate and incubated overnight at 37 °C. The 
cells were pre-treated with cyclohexamide (100 μg/ml), then the cells washed with PBS and mock 
infected or infected with virus at a multiplicity of infection 10. After 1 hour of adsorption, 2 ml 
of medium, 2% FCS was added to the cells and incubated until harvesting in the presence or 
absence of cyclohexamide (100 μg / ml). The cells were harvested by trypsinization and total 
RNA extracted. cDNA was synthesized and conventional PCR was conducted using 2 μl of 
cDNA and the following primers: ORF116 F 5’-ATGAGTAGTTCAAGTAGCGAGACC and 
ORF116 R 5’- GGAGGTGCTGGTACCAGTGGTAGTTTCAGT. The PCR product was 





Table 2.4. Gene specific primers for qRT-PCR. 
Gene GenBank Accession Number Sequence  
IFN-β NM_002176.4 F 5-‘CCTGAAGGCCAAGGAGTACA 
R 5’-AAGCAATTGTCCAGTCCCAG 
RIG-I  NM_014314 F 5’-GGCCCTTGTTGTTTTTCTCA 
R 5’-GAAGACCCTGGACCCTACCT 
ISG56 (IFIT1) NM_001270927.2 F 5’-GCCCTATCTGGTGATGCAGT 
R 5’-GCAGCCAAGTTTTACCGAAG 
ISG54 (IFIT2) NM_001547.5 F 5’-CAAGTTCCAGGTGAAATGGC 
R 5’-CGAACAGCTGAGAATTGCAC 
ISG20  NM_001303233.2 F 5’-GCTTGCCTTTCAGGAGCTG 
R 5’-ATCACCGATTACAGAACCCG 
IFI44  NM_006417.5 F 5’-TACCAGTTTAATCCCATGGAATCA 
R 5’-CAAATACAAATGCCACACAATGAA 
OAS1  NM_001032409.3 F 5’- GAGACCCAAAGGGTTGGAGG 
R 5’- GTGTGCTGGGTCAGCAGAAT 
OASL  NM_003733.3 F 5’-AAACAGCTCAGAAACGCCAC 
R 5’-CGGGTGCTGAAGGTAGTCAA 
MDA5 (IFIH1)  NM_022168.4 F 5’-AGCTGACACTTCCTTCTGCC 
R 5’-GGGGCATGGAGAATAACTCA 
IFI16  NM_001206567.2 F 5’-CATGAACGGTCCTGGAAAAT 
R 5’-TCCAGCAGTTTCTTCACCAA 
DDX60  NM_017631.6 F 5’-AAGGTGTTCCTTGATGATCTCC 
R 5’-TGACAATGGGAGTTGATATTCC 
GAPDH  NM_002046.7 F 5’-CTCTGCTGATGCCCCCATGTTC 
R 5’-GGTGGTGCAGGAGGCATTGCTG 
IL-8  NM_000584.4 F 5’-AAATTTGGGGTGGAAAGGTT 
R 5’-TCCTGATTTCTGCAGCTCTGT 
IL-6  NM_000600.5 F 5’-GTCAGGGGTGGTTATTGCAT 
R 5’-AGTGAGGAACAAGCCAGAGC 
STING NM_198282.4 F 5’-GAGCAGGCCAAACTCTTCTG 
R 5’-TGCCCACAGTAACCTCTTCC 
 





2.18 Quantification of Cytokine IL-1β Secretion 
Human IL-1β in supernatants was quantified by ELISA using Human IL-1β OptEIA ELISA Set 
II (BD, Biosciences). An ELISA microwell plate (Nunc) was coated at 50 µl per well with capture 
antibody and incubated overnight at 4 °C. Unbound capture antibody was removed by washing 
3X in wash buffer (PBS+0.05% Tween-20). The wells were blocked with 200 µl per well with 
assay diluent (PBS+10% FCS) and incubated for 1 hour at room temperature. The plate was 
washed 3X with wash buffer and 50 µl of cell-free supernatant were added to each well and 50 
µl of serial dilution of standard human IL-1β to produce a standard curve. Then the assay was 
incubated for 2 hours at room temperature. The plate was washed 5X with wash buffer and 50 µl 
per well of detection antibody then incubated for 1 hour at room temperature. The plate was 
washed 5X and 50 µl per well of enzyme reagent (Streptavidin-horseradish peroxidase conjugate) 
diluted 1:250 in assay diluent was added then incubated for 30 min at room temperature. The 
plate was washed 7X with wash buffer and 100 µl of TMB substrate added then incubated for 10 
min in the dark at room temperature. The reaction was stopped by adding 50 µl per well of 2N 
H2SO4. The assay was then read with an ELISA microplate spectrophotometer at an absorbance 
of 450 nm then the IL-1β concentration was calculated based upon a standard curve. 
2.19 Bioinformatic Analysis  
DNA and amino acid sequences were obtained from the database of GenBank of the National 
Center for Biotechnology Information. The FASTA files of nucleotide sequences were imported 
into EditSeq, then all sequences were aligned with MegAlign (Lasergene 10).  
2.20 Statistical Analysis  
Each experiment was performed at least three times in replicate, unless otherwise stated. 
Quantitative data were visualized and analyzed using GraphPad Prism software ver.7.0e. 
Statistical analysis was performed by student’s t test for pairwise comparisons or by two-way 
ANOVA when comparing more than two sets of values. Statistically significant differences are 
indicated in figure legends. The P value in assays of IFN-β mRNA relative expression was 
calculated after converting the values of untreated or uninfected samples to 1 and then relate the 





previously (Brass, A. L. et al., 2009; Mounce, B. C. et al., 2013; Nagesh, P. T. et al., 2016; Wang, 










3 RESULTS I: OV-NZ2 ORF116 Modulation of the Interferon Response  
3.1 Immunomodulatory Genes discovered in Parapoxviruses 
Poxviruses replicate in the cytoplasm of infected cells and during infection derivatives from the 
virus, mainly viral nucleic acids trigger host innate immunity upon detection. However, viruses 
have evolved strategies to counteract host detection inhibiting signalling molecules leading to 
the innate immune response (Bowie, A. G. et al., 2008). Genes located within the termini are 
mostly nonessential and encode factors involved in host range, virulence and immune evasion. 
Table 3.1 shows examples of these proteins encoded by ORFV and VACV.    
The identification of those immunomodulators was initially determined by analyzing their 
sequence similarity with host immune effectors. For example, the soluble viral receptors have 
homology to cellular IFN and interleukin receptors (Alcami, A. et al., 1992; Alcamí, A. et al., 
1995; Alcamı,́ A. et al., 2000; Colamonici, O. R. et al., 1995; Symons, J. A. et al., 1995). In other 
cases, the identification of such proteins was found based on ligand-binding characteristics such 
as the viral chemokine inhibitor that interacts with β chemokines although this inhibitor has no 
homologue with cellular chemokine receptors (Smith, C. A. et al., 1997). In addition, structural 
analysis of viral factors was done to identify the structural similarity of these immunomodulators 
to host effectors. For example, apoptosis is regulated by Bcl-2 family proteins. Structural 
comparison analysis has revealed that poxviruses encode a number of α-helical proteins that 
adopt a Bcl-2 fold despite lacking sequence similarities to apoptosis-regulated cellular proteins 
(Franklin, E. et al., 2013). The gene ORF125 of OV-NZ2 has the characteristic BH domain 
residues and Bcl-2-like fold structure, so it was predicted that this viral protein could act as an 
anti-apoptotic factor (Westphal, D. et al., 2009). 
Genomic analysis of the OV-NZ2 genome has shown that its double stranded DNA consists of a 
cluster of genes located in the variable terminal regions at both termini and it is widely believed 
that these genes are nonessential and involved in host cell manipulation. OV-NZ2 ORF116 is 
one of the genes located within these clusters. It contains an A/T rich sequence resembling an 
early promoter upstream from the coding sequence and has no transcription stop sequence T5NT 





secretary signal peptide indicating that the gene most likely functions intracellularly and possibly 
targeting signalling pathways involved in the host response.  
The functional analysis of OV-NZ2 ORF116 gene has been investigated previously (AlDaif, 
Master Thesis, University of Otago). The transcriptome of HeLa cells infected with OV-NZ2 
wild type or OV-NZ2Δ116 has been analysed using microarray. The microarray data revealed a 
major effect on the expression pattern of a number of cellular genes by ORFV infection. Analysis 
of differential gene expression found that the expression level of a number of ISGs had been up-
regulated in knockout virus infected cells to higher levels than in wild type infected cells. This 
observation may suggest that ORF116 is likely to be involved in modulating the antiviral 
effectors of the type I IFN response and targeting a number of cellular ISGs by blocking the 
production of type I IFN from infected cells or blocking the expression of ISGs.  
The main objective of this chapter was to further validate the function of the gene ORF116 of 
OV-NZ2. A revertant-116 virus was constructed in which ORF116 gene was re-inserted at the 
deleted gene locus in the knockout-116 virus. Then the level of cellular ISG expression was 
examined in HeLa cells infected with revertant-116 and compared to cells infected with wild 
type and knockout-116 viruses. It is essential to re-insert the deleted gene to show that the 
phenotype of wild type can be restored. This will provide strong evidence that the observation in 
knockout mutant-infected cells was real and not an artefact of genetic modification of virus. It 






Table 3.1. Virus proteins interfering with cell signalling involved in innate immunity. 
A. Orf virus proteins  
 Protein  References  
 ORF002  (Diel, D. G. et al., 2011a) 
(Chen, D. et al., 2016) 
 ORF024  (Diel, D. G. et al., 2010) 
 ORF119  (Li, W. et al., 2018) 
(Nagendraprabhu, P. et al., 2017) 
 ORF121  (Diel, D. G. et al., 2011b) 
 ORF073  (Khatiwada, S. et al., 2017) 
 ORF020  (McInnes, C. J. et al., 1998) 
    
B. Vaccinia virus proteins a  
 Protein  References  
 N1  (Cooray, S. et al., 2007) 
(DiPerna, G. et al., 2004) 
 A46  (Bowie, A. et al., 2000) 
(Stack, J. et al., 2005) 
 A52  (Bowie, A. et al., 2000) 
(Harte, M. T. et al., 2003) 
 B14  (Chen, R. A. J. et al., 2008) 
(Graham, S. C. et al., 2008) 
 K7  (Schröder, M. et al., 2008) 
 M2  (Gedey, R. et al., 2006) 
 K1  (Shisler, J. L. et al., 2004) 
 E3  (Valentine, R. et al., 2010) 
 C4  (Ember, S. W. J. et al., 2012) 
 A49  (Mansur, D. S. et al., 2013) 
 A46  (Stack, J. et al., 2005) 
 K7  (Schröder, M. et al., 2008) 
 C6  (Unterholzner, L. et al., 2011) 
 N2  (Ferguson, B. J. et al., 2013) 
 C16  (Peters, N. E. et al., 2013) 
 C4  (Scutts, S. R. et al., 2018) 





3.2 Bioinformatic Analysis of ORF116 
The ORF116 gene of OV-NZ2 is located within the right terminus of the variable region of the 
virus genome between nucleotides 115865 and 116557 within the HindIII-H fragment  (Mercer, 
A. A. et al., 2006). It is a unique gene of 696 nucleotides encoding a predicted protein of 231 aa 
with a predicted molecular weight 24.27 kDa. Attempts were made to predict the two- or three-
dimensional structure of OV-NZ2 ORF116 protein, but due to there being no homologues of OV-
NZ2 ORF116, no structure could be predicted. An NCBI search for potential conserved domains 
was conducted to provide any suggestion of a putative function for OV-NZ2 ORF116 protein. 
From the search, no potential domains were identified, except a domain in DNA polymerase III 
subunits gamma and tau that showed resemblance with the OV-NZ2 ORF116 C-terminus 
(Appendix: Figure 9.1). The analysis of the amino acid sequence of OV-NZ2 ORF116 has shown 
no secretary signal peptide sequence which may suggest that this protein acts intracellularly. In 
addition, short sequences of amino acids were identified that have basic positively charged lysine 
(Lys, K) and arginine (Arg, R) amino acids following hydrophobic sequence of proline (Pro, P), 
isoleucine (Ile, I), alanine (Ala, A) and methionine (Met, M) at the N-terminus as indicated in 
Figure 3.2. This pattern of amino acid sequence is an indication of a classic signal peptide for 
protein localization to the mitochondria or nucleus.  
OV-NZ2 ORF116 has no homologues outside the parapoxvirus genus. BLAST results have 
shown homologues at the nucleotide level only within ORFV species whereas at the amino acid 
level it is also weakly conserved with Pseudocowpox virus (PCPV) species. The nucleotide and 
amino acid sequence of OV-NZ2 ORF116 were aligned with other OV strains using the Clustal 
W alignment method as indicated in Figures 3.1 and 3.2. From the alignment analysis, OV-NZ2 
ORF116 shows identity with ORF116 of OV-IA82, OV-D1701, OV-SY17, OV-B029, OV-
HN3/12 and OV-NA1/11 at the nucleotide level from 92.5 % to 96.1 % and at the amino acid 
level from 78.0 % to 94.3 %, whereas ORF116 of OV-SA00, OV-NA17, OV-SJ1, OV-YX and 
OV-GO shows less identity at the nucleotide level from 65.0 % to 68.7 % and at the amino acid 
level from 52.4 % to 55.2 %.  
The ORF116 genes varies in size ranging from 585 to 717 nucleotides and all genes are 





predicted molecular weights of 21.6 to 26.5 kDa. Residues within the N-terminus are more 







A T G A G T A G T T C A A G T A G C G A G A C C A C C C C T A A G C C C A A G C C C A T C C C T G C T C C T C C C A T G  60OV-NZ2_116
A T G A G T A G T T C A A G T A G C G A G A C C A C C C C T A A G C C C A A G C C C A T C C C T G C T C C T C C C A T G  60OV-IA80_116
A T G A G T A G T T C A A G T A G C G A A A C C A C A C C T A A G C C C A A G C C T A T C C C T G C T C C C C C C A T G  60OV-D1701_116 
A T G A G T A G T T C A A G T A G C G A G A C C A C - - - - - - G C C C A A G C C T A T C C C T G C T C C T C C C A T G  54OV-SY17_116
A T G A G T A G T T C A A G T A G C G A G A C T A C - - - - - - G C C C A A G C C T A T C C C T G C T C C T C C C A T G  54OV-B029_116
A T G A G T A G T T C A A G T A G C G A G A C C A C - - - - - - G C C C A A G C C T A T C C C T G C T C C T C C C A T G  54OV-HN3/12_116
A T G A G T A G T T C A A G T A G C G A G A C C A C - - - - - - G C C C A A G C C T A T C C C T G C T C C T C C C A T G  54OV-NA1/ 11_116
A T G A G T A G T T C A A G T A A C G A G C C C A C - - - - - - C C C T A A G C C C A A G C C C C C T G C T C C C A T G  54OV-SA00_116 
A T G A G T A G T T C A A G T A A C G A G A C C A C - - - - - - C C C T A A G C C C - - - C C T G C T C C T C C C A T G  51OV-NA17_116
A T G A G T A G T T C A A G T A A C G A G A C C A C - - - - - - C C C T A A G C C C - - - C C T G C T C C T C C C A T G  51OV-SJ1_116
A T G A G T A G T T C A A G T A A C G A G A C C A C - - - - - - C C C T A A G C C C - - - C C T G C T C C T C C C A T G  51OV-YX_116 
A T G A G T A G T T C A A G T A A C G A G A C C A C - - - - - - C C C T A A G C C C - - - C - - - C T T C T C C C A T G  48OV-GO_116 
A C T C A G G A G G A G T T T A A C A A A G A A G T G A A G A A A C G A A A A G A A C A G A A A A A G G A A A A A T C T  120OV-NZ2_116
A C T C A G G A G G A G T T T A A C A A A G A A G T G A A G A A A C G A A A A G A A C A G A A A A A G G A A A A A T C T  120OV-IA80_116
A C T C A G G A G G A G T T C A A C A G A G A A G T A G A G A A A T G G G A A G A A A A G A A A A G G G A A A A A T C T  120OV-D1701_116 
A C C C A G G A G G A G T T T A A C A A A G A A G T A G A G A A A C G G G A A G A A A G G A A A A G G G A A A A A T C T  114OV-SY17_116
A C T C A G G A G G A G T T T A A C A A A G A A G T A G A G A A A C G G G A A G A A A A G A A A A A G G A A A A A C A T  114OV-B029_116
A C T C A G G A G G A G T T C A A C A A A G A A G T A A A G A A A C G G G A A G A A A G G A A A A G G G A A A A A T C T  114OV-HN3/12_116
A C T C A G G A G G A G T T C A A C A A A G A A G T A A A G A A A C G G G A A G A A A G G A A A A G G G A A A A A T C T  114OV-NA1/ 11_116
A C T C A G G A G G A G T T T A A C A A A G A A G T A G A G A A A C G A A G A G A A C A A A A A A A G G A A A A A T C T  114OV-SA00_116 
A C C C A G G A T G A G T T T A A C A A A G A A G T A G A G A A A C G A A G A G A A C A A A A A A A G G A A A A A T C T  111OV-NA17_116
A C C C A G G A T G A G T T T A A C A A A G A A G T A G A G A A A C G A A G A G A A C A A A A A A A G G A A A A A T C T  111OV-SJ1_116
A C C C A G G A T G A G T T T A A C A A A G A A G T A G A G A A A C G G G A A G A A A G G A A A A G G G A A A A A T C T  111OV-YX_116 
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G A A C C C A C T C C T G - C C G C T C A G C C T G C A T - - - C A G T A A C T C A A C C C G C T C C A A C A C C A G A  491OV-SY17_116
G A A C C C A C T C C T G - C C A C T C A G C C T G C A T - - - C A G T A A C T C A A C C C G C T C C A A C A C C A G A  485OV-B029_116
G A G C C C A C T C C T G - C C A C T C A G C C T G C A T - - - C A G T A A C T C A A C C C G C T C C A A C A C C A G A  512OV-HN3/12_116
G A G C C C A C T C C T G - C C A C T C A G C C T G C A T - - - C A G T A A C T C A A C C C G C T C C A A C A C C A G A  512OV-NA1/ 11_116
A A G C A G T G - - - - - - - - - - - - - - - - - - - - - - - - - - - A G A C T C C A C C C A C T - C A A C C T C C A A  487OV-SA00_116 
A A G C A G T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A C A C C A T C C A C T - C A A C C T C C A A  478OV-NA17_116
A A G C A G T A C A C C A T C C A C T C A A C C T C C A A G C A G T G A G A C T C C A C C C A C T - C A A C C T C C A A  511OV-SJ1_116
A A G C A G T G - - - - - - - - - - - - - - - - - - - - - - - - - - - A G A C T C C A T C C A C T - C A A C C C C C A A  481OV-YX_116 
A A G C A G T G - - - - - - - - - - - - - - - - - - - - - - - - - - - A G A C T C C A T C C A C T - C A A C C T C C G A  478OV-GO_116 
G C C A A G T C C A G C C C C T A A G C C T A C T C C G G C T T C T G A A C C A A C C C C A G C A T C T G A G C C T A C  545OV-NZ2_116
G C C A A G T C C A G C C C C T G A A A C T A C T C C G G C T T C C G A A C C A A C C C C T G C A C C A G A A C C C A C  557OV-IA80_116
G C C A A G T T C T G T C C C T G A G C C T A C T C C G G C C T C T G A T C - - - - - - - - - C A - - - - - - - - - A C  542OV-D1701_116 
G C C A A G T C C A G C C C C T G A G A C T A C T C C G G C T T C C G A A C C A A C C C C A G C A T C T G A G C C T A C  551OV-SY17_116
G C C A A C C C C C G C A C C T G A G C C T A C T C C G G C T T C C G A A - - - - C C - - - - - - - - - - - - - - C A C  527OV-B029_116
G C C A A G T C C A G C C C C T G A G C C T A C T C C G G C T C C T G A A C C A A C C C C T G C A C C A G A A C C C A C  572OV-HN3/12_116
G C C A A G T C C A G C C C C T G A G C C T A C T C C G G C T C C T G A A C C A A C C C C T G C A C C A G A A C C C A C  572OV-NA1/ 11_116
G C - - A G T A C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  494OV-SA00_116 
G C - - A G T G - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  484OV-NA17_116
G C - - A G T G A G A C T C C A T C C A C T C A A C C T C C A T C C A C T C - A A C C T C - - C A T C C A C T C A A C C  566OV-SJ1_116
G C - - A G T G - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  487OV-YX_116 
G C - - A G T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  483OV-GO_116 
T T C T G C T C C A G A A C C T A C A C C A T C C G C A G A A C C A A C T C C T C A A C C A A C T G T A G A A A C A C C  605OV-NZ2_116
T C C C G C T C C A A A A C C T A C A C C A G C C A C A G A A C C G A C T C C T C A A C C A A C C G T A G A A A C A A C  617OV-IA80_116
C C C T G C A C C A G A A C T T A C A C C A G C C G C A G A A C C - - - - - - - - - - - - A A C T G T A G A A G C A C C  590OV-D1701_116 
T C C T G C T C C A G A A C C T A C A C C A T C C A C A A A A C C G A C T C C T C A A C C A A C C G T A G A A A C A C C  611OV-SY17_116
T C C T G C T C C A G A A C C T A C A C C A G C C G C A G A A C C G A G T C C T C A A C C A A C C G T A G A A A C A A C  587OV-B029_116
T C C C G C T C C A G A A C C T A C A C C A T C C A C A G A A C C G A C T C C T C A A C C A A C C G T A G A A A C A C C  632OV-HN3/12_116
T C C C G C T C C A G A A C C T A C A C C A T C C A C A G A A C C G A C T C C T C A A C C A A C C G T A G A A A C A C C  632OV-NA1/ 11_116
- - - - - - - - - - - - - - - - - - A C C C T C C A C T C A A C C T C C - A A G C A G - - T A C A C C A T C C A C T G A  533OV-SA00_116 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A - - C A C A C C A T C C A C T G A  500OV-NA17_116
T C C A T C C A C T C A A C C T C C A T C C A C T C A A C C T C C A A G - C A G T G A - - G A C T C C A T C C A C T G A  623OV-SJ1_116
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A - - G A C T C C A T C C A C T C A  503OV-YX_116 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A C A C C A T C C A C T C A  497OV-GO_116 
A C C A T C T G C T C C A G C A C C A A C T C C C G A G G C C C A A C C A C C C G C C A A C A G C A A T C C C A C T A C  665OV-NZ2_116
A C C A T C T G C T C C A G C A C C A A C T C C C G A G G C C C A A C C A C C C G C C A A C A - - - A T C C C A C T A C  674OV-IA80_116
A C C - - - T G C T A C A G C A C C A A C T T C C G A A A C C C A A C C A G C C A C C A A C A G C A A T C C C G C T A C  647OV-D1701_116 
A C C A T C T G C T A C A G C A C C G A C T A C C G A A G C C C A G C C A - - - A C C A A C A - - - A T T C C A C C A C  665OV-SY17_116
A C C A T C T G C A C C A G C A C C A A C T A C C G A A G C C C A G C C A - - - A C C A A C A - - - A T C C C A C T A C  641OV-B029_116
A C C A T C T G C T A C A G C A C C A A C T A C C G A A G C C C A G C C A - - - A C C A A C A - - - A T C C C A C T A C  686OV-HN3/12_116
A C C A T C T G C T A C A G C A C C A A C T A C C G A A G C C C A G C C A - - - A C C A A C A - - - A T C C C A C T A C  686OV-NA1/ 11_116
A C C - - - T A C T C C A G A G C C A G C T C C T T C T A C C G A A C C A A C A A C C A A C G C C A A C G G T A C A C C  590OV-SA00_116 
A C C - - - T A C T C C A G A G C C A G C T C C T T C C A C C G A A C C A A C A A C C A A C G C C A A C G G T A C A C C  557OV-NA17_116
A C C - - - T A C T C C A G A G C C A G C T C C T T C C A C C G A A C C A A C A A C C A A C G C C A A C G G T A C A C C  680OV-SJ1_116
A C C - - - T A C T C C A G A G C C A G C T C C T T C T A C C G A A C C A A C A A C C A A C G C C A A C G G T A C A C C  560OV-YX_116 
A C C - - - T A C T C C A G A G C C A G C T C C T T C T A C C G A A C C A A C A A C C A A C G C C A A C G G T A C A C C  554OV-GO_116 
T G A A A C T A C C A C T G G T A C C A G C A C C T C C T A A                               696OV-NZ2_116
T G A A A C T A C C A C T G G T A C C A G C A C C T C C T A A                               705OV-IA80_116
C G A A A - - - C C A C T G G T G C C A G C A C C T C C T A A                               675OV-D1701_116 
T G A A A C T A C C A C T G G C A C C A G C A C C T C C T A A                               696OV-SY17_116
T G A A A C T A C C A C T G G T A C C A G C A C T T C T T A A                               672OV-B029_116
T G A A A C C A C C A C T G G T A C C A G C A C T T C T T A A                               717OV-HN3/12_116
T G A A A C C A C C A C T G G T A C C A G C A C T T C T T A A                               717OV-NA1/ 11_116
T G C C G C C A C T A C T T C A G A A A C C A C T G C C T A A                               621OV-SA00_116 
T G C C G C C A C T A C T T C A G A A A C C A C T G C C T A A                               588OV-NA17_116
T G C C G C C A C T A C T T C A G A A A C C A C T G C C T A A                               711OV-SJ1_116
T G C C G C C A C T A C T T C A G A A A C C A C T G C C T A A                               591OV-YX_116 
T G C C G C C A C T A C T T C A G A A A C C A C T G C C T A A                               585OV-GO_116 
Decoration 'Decoration #1': Box residues t hat match OV-NZ2_116 exact ly . 
Figure 3.1. Clustal W alignment of ORFV ORF116 nucleotide sequences. Nucleotide sequence of OV-
NZ2 ORF116 is aligned with ORF116 of ORFV strains: OV-IA82, OV-D1701, OV-SY17, OV-B029, OV-
OV-HN3/12, OV-NA1/11, OV-SA00, OV-NA17, OV-SJ1, OV-YX, OV-GO. See Appendix: Table 9.2 for 
accession numbers. Nucleotides identical to those of OV-NZ2 ORF116 are boxed. Numbers on the right 








M S S S S S E T T P K P K P I P A P P M T Q E E F N K E V K K R K E Q K K E K S R T V E R E S E T V T V S S D G S E I K K T Y E R E S E R T T E T E K N N T - S  79OV-NZ2_116. pro
M S S S S S E T T P K P K P I P A P P M T Q E E F N K E V K K R K E Q K K E K S R T V E R E S E T V T V S S D G S E I K K T Y E R E S E R T T E T E K N N T - S  79OV-IA82_116.pro
M S S S S S E T T P K P K P I P A P P M T Q E E F N R E V E K W E E K K R E K S R I V E R E A E T V T V S A D G T E R T R T Y E R E S E K T T E T E K N N Y P S  80OV-D1701_116. pro
M S S S S S E T T P K P - - I P A P P M T Q E E F N K E V E K R E E R K R E K S R T V E R E S E T V T V S S D G S E K T R I Y E R E S E R T T E T E K N N S P S  78OV-SY17_116. pro
M S S S S S E T T P K P - - I P A P P M T Q E E F N K E V E K R E E K K K E K H R T V E H E L E T V T V S A D G T E R T R I Y E R D S E R T T E T E K N N T - S  77OV-B029_116.pro
M S S S S S E T T P K P - - I P A P P M T Q E E F N K E V K K R E E R K R E K S R T V E R E S E T V T V S S D G S E I K K T Y E R E S E R R T E T E K N N T - S  77OV-HN3/12_116. pro
M S S S S S E T T P K P - - I P A P P M T Q E E F N K E V K K R E E R K R E K S R T V E R E S E T V T V S S D G S E I K K T Y E R E S E R R T E T E K N N T - S  77OV-NA1/ 11_116.pro
M S S S S N E P T P K P K - - P P A P M T Q E E F N K E V E K R R E Q K K E K S R T V E R E S E T V T V S A D G T E K T R T Y E R E S V K T T E S E K N N N P S  78OV-SA00_116. pro
M S S S S N E T T P K P - - - P A P P M T Q D E F N K E V E K R R E Q K K E K S R I V E R E S E T V T V S G D G T E K T R T Y E R E S E K T T E T E K N N N P S  77OV-NA17_116. pro
M S S S S N E T T P K P - - - P A P P M T Q D E F N K E V E K R R E Q K K E K S R T V E R E S E T V T V S G D G T E K T R I Y E R E S E R T T E K E T N N N P S  77OV-SJ1_116.pro
M S S S S N E T T P K P - - - P A P P M T Q D E F N K E V E K R E E R K R E K S R T V E R E S E T V T V S G D G T E K T R T Y E R E S E K T T E T E K N N N P S  77OV-YX_116. pro
M S S S S N E T T P K P - - - P S P - M T Q E E F N K E V E K R E E R K R E K S R T V E R E S E T V T V S G D G T E K T R T Y E R E S E K T T E T E K N N N P S  76OV-GO_116.pro
T D D - N K Q N T P V E K P E E T K P A S T P E G V K P A E T P A P T T D P Q P T T Q P P A E S N P G S Q P A P A S E P T P A P E P A P - - - - - - - - E P T -  149OV-NZ2_116. pro
T D D D N K Q N T P V E K P E E T K P A S T P E G E K P A E T P A P T T D P Q P T T Q P P A E S G P G S Q P T P V P E P T P A P E P A P - - - - - - - - E P T P  151OV-IA82_116.pro
T N D - N K Q N T S V E K P E E T K P A S T P E G E K P A E T P A P T T D P Q P T T Q P P A E S N S G S Q P T P A P E P T P E S E P T P - - - - - - A S K P T P  153OV-D1701_116. pro
T S D - N K Q N T P V E K P E E T K P A S T P E G E K P A E T P A P T T S P Q P T T Q P P A E S S P G S Q P T P A P E P T P A P E P A P - - - - - - - - E P T P  149OV-SY17_116. pro
T N D - - K Q N T P V E K P E E T K P A S T P E G D K P A E T P A P T T N P Q P T T Q P P A E S N P G S Q P T P A S E P T P A P E P A P - - - - - - - - E P T P  147OV-B029_116.pro
T D D - N K Q N T P V E K P E E T K P A S T P E G E K P A E T P A P T T D P Q P T T Q P P A E S N S G S Q P T P A P E P T P A P E P T P A P E P T P A S E P T P  156OV-HN3/12_116. pro
T D D - N K Q N T P V E K P E E T K P A S T P E G E K P A E T P A P T T D P Q P T T Q P P A E S N S G S Q P T P A P E P T P A P E P T P A P E P T P A S E P T P  156OV-NA1/ 11_116.pro
T N D - N K D K V T D N Q P K E - - - - - - - D D K K L E E T P K D S E K P T P T E K P - A N T S S G D N K K E G E E A T L E S Q P T P - - - - - - - - A P T -  140OV-SA00_116. pro
T N D - N K D K V T D N Q P K E - - - - - - - D D K K P E E - T K D S E K P T P T E K P - A D T S S G D N K K E G G E A T L E S Q P T P - - - - - - - - A P T -  138OV-NA17_116. pro
T N D - N K D K V T D N Q P K E - - - - - - - D D K K L E E P P K D G E K P T P T E K P - A D T S S G D N K K E G E E A T L E S Q P T P - - - - - - - - V P T -  139OV-SJ1_116.pro
T N D - N K D K V T D N Q P K E - - - - - - - D D K K P E E - T K D S E K P T P T E K P - A D T S S G D N K K E G E E T T L K S Q P T P - - - - - - - - A P T -  138OV-YX_116. pro
T N D - N K D K V T D N Q P K E - - - - - - - D D K K P E E - T K D S E K P T P T E K P - A D T S S G D N K K E G G E A T L E S Q P T P - - - - - - - - A P T -  137OV-GO_116.pro
- - Q P A S V T Q P A P T P E P S P A P K P T P A S E P T P A S E P - - - - - - - - - T S A P E P T P S A E P T - - - - - - - - - - - - - - - - P Q P T V E T P  202OV-NZ2_116. pro
A T Q P A S V T Q P A P T P E P S P A P E T T P A S E P T P A P E P - - - - - - - - - T P A P K P T P A T E P T - - - - - - - - - - - - - - - - P Q P T V E T T  206OV-IA82_116.pro
A T E P A - A T E P T S E P K P - - - - - - S S V P E P T P A S D P - - - - - - - - - T P A P E L T P A A E P - - - - - - - - - - - - - - - - - - - - T V E A P  197OV-D1701_116. pro
A A Q P A S V T Q P A P T P E P S P A P E T T P A S E P T P A S E P - - - - - - - - - T P A P E P T P S T K P T - - - - - - - - - - - - - - - - P Q P T V E T P  204OV-SY17_116. pro
A T Q P A S V T Q P A P T P E P - - - - - - T P A P E P T P A S E P - - - - - - - - - T P A P E P T P A A E P S - - - - - - - - - - - - - - - - P Q P T V E T T  196OV-B029_116.pro
A T Q P A S V T Q P A P T P E P S P A P E P T P A P E P T P A P E P - - - - - - - - - T P A P E P T P S T E P T - - - - - - - - - - - - - - - - P Q P T V E T P  211OV-HN3/12_116. pro
A T Q P A S V T Q P A P T P E P S P A P E P T P A P E P T P A P E P - - - - - - - - - T P A P E P T P S T E P T - - - - - - - - - - - - - - - - P Q P T V E T P  211OV-NA1/ 11_116.pro
- - Q P S N S E A P T Q P P S S E - - - - - T P P T Q P - P S S - - - - - - - - - - - T P S T Q - - - - - P P S - - - - - - - - - - - - - - - - S T P S T E P T  180OV-SA00_116. pro
- - Q P S N S E A P T Q P P S S - - - - - - T P S T Q P - P S S - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - D T P S T E P T  169OV-NA17_116. pro
- - Q P S N S E A P T Q P P S S - - - - - - T P S T Q P - P S S E T P P T Q P P S S E T P S T Q P P S T Q P P S T Q P P S T Q P P S T Q P P S S E T P S T E P T  210OV-SJ1_116.pro
- - Q P S N S E A P T Q P P S S E - - - - - T P S T Q P - P S S E - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - T P S T Q P T  170OV-YX_116. pro
- - Q P S N S E A P T Q P P S S E - - - - - T P S T Q P - P S S - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - T P S T Q P T  168OV-GO_116.pro
P S A P A P T P E A Q P P A N S N P T T E T T T G T S T S                                                     231OV-NZ2_116. pro
P S A P A P T P E A Q P P A N - N P T T E T T T G T S T S                                                     234OV-IA82_116.pro
P - A T A P T S E T Q P A T N S N P A T E T T - G A S T S                                                     224OV-D1701_116. pro
P S A T A P T T E A Q P T N N - - S T T E T T T G T S T S                                                     231OV-SY17_116. pro
P S A P A P T T E A Q P T N N - - P T T E T T T G T S T S                                                     223OV-B029_116.pro
P S A T A P T T E A Q P T N N - - P T T E T T T G T S T S                                                     238OV-HN3/12_116. pro
P S A T A P T T E A Q P T N N - - P T T E T T T G T S T S                                                     238OV-NA1/ 11_116.pro
P - E P A P S T E P T T N A N - - G T P A A T T S E T T A                                                     206OV-SA00_116. pro
P - E P A P S T E P T T N A N - - G T P A A T T S E T T A                                                     195OV-NA17_116. pro
P - E P A P S T E P T T N A N - - G T P A A T T S E T T A                                                     236OV-SJ1_116.pro
P - E P A P S T E P T T N A N - - G T P A A T T S E T T A                                                     196OV-YX_116. pro
P - E P A P S T E P T T N A N - - G T P A A T T S E T T A                                                     194OV-GO_116.pro
Decoration 'Decoration #1': Box residues that match OV-NZ2_116.pro exactly.
Figure 3.2. Clustal W alignment of ORFV ORF116 amino acid sequences. Amino acid sequence of OV-NZ2 ORF116 is aligned with ORF116 of ORFV strains: OV-IA82, 
OV-D1701, OV-SY17, OV-B029, OV-OV-HN3/12, OV-NA1/11, OV-SA00, OV-NA17, OV-SJ1, OV-YX, OV-GO. See Appendix: Table 9.2 for accession numbers. Amino 
acids identical to those of OV-NZ2 ORF116 are boxed. Numbers on the right indicate amino acid positions. The consensus sequences of basic positively charged amino acids 
are boxed in red. The consensus sequences of hydrophobic amino acids are boxed in green.         





3.3 Generation of Revertant 116 virus 
3.3.1 Overview  
DNA homologous recombination is a naturally occurring event in virus-infected cells 
(Fenner, F., 1959; Fenner, F. et al., 1958). Homologous recombination is widely used to 
generate recombinant poxviruses (Moss, B., 1991). It involves designing a transfer vector 
that has the gene of interest under a poxvirus promoter, flanking regions derived from 
poxvirus genome and a selection marker. The permissive cells are infected with the virus and 
transfected with the vector. Homologous recombination will occur between the vector and 
virus genome which will subsequently incorporate the gene into the virus genome as depicted 
in Figure 3.3. The resulting recombinant virus is selected and subjected to several rounds of 
plaque purification.     
There are a number of methods for selecting and screening the resultant recombinant virus. 
The choice of selection method depends on the purpose of generating the recombinant virus. 
The most widely used method for VACV is utilizing homologous recombination into the 
thymidine kinase (tk) gene of VACV. An insertion of the gene of interest at the locus of the 
tk gene will disrupt the tk gene function and provide a means of selecting the recombinant 
virus with a tk- phenotype in a tk- cell line in the presence of 5-bromodeoxyuridine (BrdU) 
(Byrd, C. M. et al., 2004). Other methods of selection include antibiotic resistance through 
the use of a suitable antibiotic resistance gene for instance neomycin or hygromycin in which 
only the resulting recombinant virus will replicate in the presence of the respective antibiotic 
(Franke, C. A. et al., 1985).  
In this study, the E. coli ß-galactosidase reporter gene was chosen as a selection marker. The 
ß-galactosidase gene was incorporated into the transfer vector to facilitate the identification 
of recombinant virus through the production of blue colour in the presence of X-Gal. OV-
NZ2∆116 virus, previously produced, has been used as a parental virus to generate the OV-
NZ2-Rev116 virus. The knockout-116 contains an E. coli ß-glucuronidase reporter gene 
(gusA) to identify the virus through the production of blue colour in the presence of X-Gluc. 
An OV-NZ2-Rev116 revertant virus was generated in which the ORF116 gene was re-
inserted into the OV-NZ2∆116 knockout at the same original locus of ORF116 along with 
the reporter gene LacZ under the poxvirus PF1 promoter. Firstly the transfer vector carrying 





into the same locus of OV-NZ2∆116 virus genome by homologous recombination. The 
resultant OV-NZ2-Rev116 virus was selected and purified in the presence of X-Gal staining 
then characterized. Finally, the expression levels of ISGs were investigated in OV-NZ2-, OV-
NZ2∆116- or OV-NZ2-Rev116-infected HeLa cell. 
Figure 3.3. Generation of OV-NZ2-Rev116 by homologous recombination. 
Figure 3.3. Generation of OV-NZ2-Rev116 by homologous recombination. LT cells were 
seeded at 2x10
6
 cell per 25-cm
2
 flask. The cells were infected with OV-NZ2116 at an MOI 0.5 
for 2 hrs. Then 3 g of the plasmid transfer vector containing ORF116 was transfected into the 
LT cells and incubated overnight. The next day, 4 ml of MEM 2% FCS was added into the flask 
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3.3.2 Construction of Transfer Vector Containing ORFV ORF116 and Reporter Gene 
The transfer vector plasmid was constructed by genetic manipulation of several plasmids as 
detailed in materials and methods. A 1.255 kb HindIII-KpnI subfragment containing the left 
arm and ORF116 except the last 13 nucleotides at the C-terminus was digested from pOV1-
EcoRI-D then cloned into pTZ19R vector. This step was followed by incorporation of a linker 
which introduced KpnI and EcoRI restriction sites, the 13 nucleotides not within the 
restriction fragment, a stop codon and a poxvirus early transcription termination signal T5NT 
resulting in a DNA fragment containing the full length sequence of the 116 gene with HindIII 
and EcoRI restriction sites. This fragment was removed from pTZ19 and cloned into pV32 
vector at the same sites. The right arm was PCR amplified and EcoRI and SacI sites were 
introduced then cloned into pV32 at the EcoRI and SacI restriction sites. Finally, the E. coli 
β-galactosidase gene (lacZ) placed under the control of a strong ORFV late promoter PF1 
(Fleming, S. B. et al., 1993) was cloned as a reporter gene into the EcoRI site located between 
the ORF116 gene and the right arm. The schematic representation of the final construct is 
shown in Figure 3.4 A. 
In every step of cloning, restriction analysis was conducted to confirm the presence of a 
cloned fragment. The final transfer vector was thoroughly characterized in which the vector 
was subjected to restriction analysis as shown in Figure 3.4 B to confirm the correctness and 
intactness of all restriction fragments within the construct. The restriction analysis has shown 
the presence of all fragments. HindIII/KpnI (left arm and ORF116), KpnI/EcoRI (linker), 
EcoRI (LacZ gene) and EcoRI/SacI (right arm) digestions have produced fragment sizes of 
1.2 kb, 0.03 kb, 3.4 kb and 0.53 kb respectively. Although the linker band 0.03 kb generated 
from KpnI/EcoRI digestion is not visible maybe due to the low amount of DNA, this band 
was clearly visualized in the early steps of cloning.  
Screening for clones carrying the correct orientation of the LacZ gene was conducted in order 
to obtain a construct harbouring ORF116 and LacZ that transcribed in the same direction. 
Colony PCR for clones was performed as explained in material and methods and the correct 
orientation of the LacZ gene clone was selected (data not shown). This was further confirmed 
by performing restriction analysis using either NdeI or SacI restriction enzyme. These two 
enzymes can produce distinguishable bands from a single digestion of the construct. NdeI or 
SacI digestion produced two distinguishable bands in the correct orientation of the LacZ gene 





Before the construct was used for generating the recombinant virus, the construct was 
sequenced using primers indicated in the schematic map of the construct in Figure 3.4 A and 
the sequencing data has shown the intactness of the construct (data not shown). The LacZ 
gene functionality and capability of producing blue colour in the presence of X-Gal was also 
tested. From the Figure 3.4 D, it is clear that the LacZ gene was functional and a blue colour 
was produced in the presence of X-Gal.   
3.3.3 Generation of Revertant-116 Virus  
Revertant-116 virus was generated from the parental knockout-116 virus as described in 
materials and methods and has been identified and selected by their blue plaque phenotype in 
the presence of X-Gal and lack of blue colour in the presence of X-Gluc. The putative 
revertant-116 was subjected to several rounds of single plaque selection until a pure revertant 
virus was obtained as shown in the plaque assay in Figure 3.5. This result also confirmed that 
homologous recombination has replaced the GUS gene in the parental virus with the ORF116 
and LacZ gene cassette at the same locus as the resultant revertant virus was detectable by the 
X-Gal stain but not by X-Gluc and vice versa with the parental knockout-116 virus. This data 









Figure 3.4. Characterization of Transfer Vector. 
Figure 3.4. Restriction analysis of final construct. (A) Diagram showing the final construct 
used for generating OV-NZ2 ORF116 revertant. Red arrows indicated primers used for construct 
sequencing. (B) and (C) The construct was digested with the indicated restriction enzymes and 
separated by electrophoresis on a 1% agarose gel. A DNA molecular weight marker was run in 
parallel. The size of DNA fragments are indicated in kb. (D) The construct functionality was 
checked. LT cells were either mock infected or infected with ORFV wild type at an MOI 5 for 
2 hrs then transfected with 1µg of construct per well for 48 hrs. The cells were stained with 70 






3.3.4 Characterization of OV-NZ2-Rev116 virus 
Restriction Analysis of Recombinant Viral DNA  
Attempts were made to characterize the genomic DNA of OV-NZ2-Rev116 by restriction 
analysis to ensure no major changes to the genome apart from the targeted region had 
occurred and also to confirm no duplication or translocation of one genome end to the other 
had occurred (Fleming, S. B. et al., 1995). HindIII digestion was used as it produced 
distinguishable bands. A HindIII cleavage map of OV-NZ-Rev116 genome is shown in 
Figure 3.6. HindIII-H digest was predicted to produce a shift from 4.75 kb in the OV-
NZ2Δ116 (Appendix: Figure 9.2) to 6.28 kb in the OV-NZ2-Rev116 in the insertion site as 
proposed in Figure 3.6. Viral DNA of OV-NZ2-Rev116 including OV-NZ2 wild type and 
OV-NZ2Δ116 viruses was isolated as described in materials and methods and subjected to 
HindIII digestion, then the fragments were resolved on an agarose gel. However, DNA 
fragments were barely visible on the gel, due to technical difficulties in producing the large 
Figure 3.5. OV-NZ2-Rev116 virus selection and purification. 
Figure 3.5. OV-NZ2-Rev116 virus selection and purification. The infected and transfected 
cells were subjected to 3 freeze-thaw cycles and screened for revertant virus plaques in a 6-well 
plate by staining with X-Gal. After three rounds of single plaque selection, a pure revertant virus 





amount of viral DNA required to perform this analysis. Several attempts were made to extract 
sufficient DNA from the three viruses and subject them to endonuclease digestion.  
PCR analysis of Recombinant Viral DNA 
PCR analysis of viral DNA was conducted to characterize the OV-NZ2-Rev116 genome 
along the with OV-NZ2 wild type and OV-NZ2Δ116 genomes. The sequences of 
HindIII/EcoRI fragments and primer targets for OV-NZ2 wild type, OV-NZ2Δ116 and OV-
NZ2-Rev116 are depicted in Appendix: Figures 9.3, 9.4 and 9.5 respectively. PCR 
amplification of the entire cassette was conducted for the OV-NZ2-Rev116 genome and also 
for OV-NZ2 wild type and OV-NZ2Δ116 genomes by using one set of primers (1_F and 
5_R). This set of primers spans the ORF116 locus and the flanking regions to produce PCR 
product sizes of 1.57 kb, 3.47 kb and 5.01 kb from the OV-NZ2 wild type, OV-NZ2Δ116 and 
OV-NZ2-Rev116 respectively (Figure 3.7 A, B and C). PCR amplification showed PCR 
products from all the viral genome templates and they had migrated at the expected sizes 
(Figure 3.8 A) despite faint bands obtained from OV-NZ2Δ116 and OV-NZ2-Rev116 
genomes. Attempts were made to optimize the PCR reaction using the same set of primers 
(1_F and 5_R) but none were successful to obtain clearer bands from either viruses templates 
although this set of primers has shown efficient PCR amplification from plasmids and 
produced strong bands with the expected size (data not shown). Nevertheless, this result 
confirmed the insertion of the cassette within the OV-NZ2-Rev116 genome and replacement 
of the GUS gene from the parental virus OV-NZ2Δ116.   
Two sets of primers were designed to target two regions of the ORF116 locus where genetic 
modification took place to the OV-NZ2-Rev116 genome as shown in Figure 3.7 C (See 
Appendix 9.5 for the targeted nucleotide sequences and sets of primers used). Primer 6_F and 
7_R were used to span upstream of the ORF116 gene (left arm region) to the 5’- terminal end 
of the LacZ gene. The PCR amplification produced one product that migrated at the expected 
size of 0.99 kb (Figure 3.8 B lane 4). Primers 8_F and 5_R were used to target the region 
from the 3’- terminal end of LacZ gene to the right arm. Similarly, PCR amplification 
produced only one band that migrated at the expected size of 1.37 kb (Figure 3.8 B lane 6). 
This further confirmed the correct insertion of the DNA fragments in the ORF116 locus and 
















Figure 3.6. Restriction endonuclease maps of OV-NZ2, OV-NZ2Δ116 and OV-NZ2-Rev116 genomes. HindIII fragments of OV-NZ2 wild type (WT), 
OV-NZ2Δ116 (KO-116) and OV-NZ2-Rev116 (Rev-116) genomes were calculated using SeqBuilder (DNAStar Inc.). An asterisk indicates the fragment 
that would have been visualized with different sizes in all three viruses.  





It was shown from the plaque assay (Figure 3.5) that the constructed OV-NZ2-Rev116 virus 
was pure and it was proposed that the homologous recombination during construction of the 
virus replaced the GUS gene in the OV-NZ2Δ116 parental virus with the ORF116 gene and 
the LacZ gene at the same locus. To further confirm this, a pair of primes 4_F and 3_R was 
designed that recognizes only the GUS gene. PCR amplification of genomic DNA for all 
viruses using the same set of primers was performed and the PCR amplification produced 
only one band in the OV-NZ2Δ116 virus (Figure 3.8 B lane 8) but not in the OV-NZ2-Rev116 
(Figure 3.8 B lane 9) or OV-NZ2 wild type (Figure 3.8 B lane 7) and that the fragment 
migrated at the expected size of 0.53 kb. This data confirmed that the OV-NZ2-Rev116 virus 
is pure and that the insertion has taken place at the correct locus.         
PCR analysis of OV-NZ2Δ116 was also included. Two sets of primers (1_F and 3_R) and 
(4_F and 5_R) were designed to target the locus of ORF116 in the OV-NZ2Δ116 virus where 
the deletion of ORF116 occurred as indicated in Figure 3.7 B (See Appendix 9.4 for the 
targeted nucleotide sequences and sets of primers used). Primer 1_F and 3_R were used to 
span the upstream region of the ORF116 gene (left arm region) to the 5’- terminal end of the 
GUS gene. PCR amplification produced one product that migrated at the expected size of 
1.67 kb (Figure 3.8 B lane 3). Whereas primers 4_F and 5_R were used to target the region 
from downstream of the 5’- terminal end of the GUS gene to the right arm. Similarly the PCR 
amplification produced only one band that migrated at the expected size of 2.26 kb (Figure 
3.8 B lane 5). The genomic DNA from OV-NZ2 wild type virus produced one band of 1.212 
kb as predicted from primer 1_F and primer 2_R (Figure 3.8 B lane 2) (See Appendix 9.3 for 
the targeted nucleotide sequences and set of primers used). 
PCR analysis have clearly shown that all the PCR products fit with the predicted sizes and 
has confirmed the correct insertion of the cassette. In addition, all PCR products were gel 
purified and sequenced. The sequencing showed the presence and intactness of the gene 































































































Figure 3.7. Schematic representation of the ORF116 locus within the OV-NZ2, OV-
NZ2Δ116 and OV-NZ2-Rev116 genomes. (A) The solid line above ORF116 indicates 675 nt 
deleted from ORF116 during the construction of the OV-NZ2Δ116 virus and replacement with 
the GUS gene under the control of a vaccinia virus late promoter PH5 as shown in (B). (B) A 
schematic map of the OV-NZ2Δ116 virus. (C) OV-NZ2-Rev116 virus was constructed using 
the OV-NZ2Δ116 virus as a parental virus in which the GUS gene was replaced with a cassette 
containing ORF116 and the LacZ gene under the control of an ORFV virus late promoter PF1. 
Primers sets used in the characterization by PCR are indicated in red numbered arrows (also see 






Figure 3.8. PCR analysis of viral DNA of wild type, knockout-116 and revertant-116. 
    
Figure 3.8. PCR analysis of viral DNA of OV-NZ2, OV-NZ2Δ116 and OV-NZ2-Rev116 
genomes. Confirmation and characterization of purified OV-NZ2-Rev116 virus was conducted 
by PCR analysis. The PCR products derived from ORF116 loci of OV-NZ2 wild type, OV-
NZ2Δ116 and OV-NZ2-Rev116 templates are shown using one set of primers (1_F and 5_R) 
targeting the whole loci (see Figure 3.7) (A) or different sets of primers targeting upstream or 
downstream regions as indicated by arrowheads in Figure 3.7, lane 2 (1_F and 2_R), lane 3 (1_F 
and 3_R), lane 4 (6_F and 7_R), lane 5 (4_F and 5_R), lane 6 (8_F and 5_R), lanes 7, 8 and 9 





ORF116 is expressed early in OV-NZ2- and OV-NZ2-Rev116-infected cells 
The kinetics of ORF116 transcription was investigated using reverse-transcription PCR. The 
cells were infected with OV-NZ2, OV-NZ2∆116 or OV-NZ2-Rev116 at an MOI 10 in the 
presence or absence of cycloheximide (100 ng/ml). Cells were harvested at 0, 2, 4 and 6 h.p.i. 
Total RNA was isolated and subjected to RT-PCR. ORF116 (0.69 kb) was detected at 2 h.p.i. 
in the presence of cycloheximide in only OV-NZ2 and OV-NZ2Rev116 infections but not in 
OV-NZΔ116 infection and the level of expression increased at 4 and 6 hours post-infection 
as shown in Figure 3.9. Non-specific bands smaller than ORF116 bands were detected in 
three virus infections. Similarly, the expression of ORF116 in the absence of cycloheximide 
was detected in OV-NZ2 and OV-NZ2-Rev116 but not in OV-NZ2Δ116, albeit the bands are 
so faint due to weak staining with ethidium bromide. The RT-PCR data of ORF116 
expression level in OV-NZ2 infection is relatively lower than the expression level of ORF116 
in OV-NZ2-Rev116 at all time points and that could be due to differences in virus titre. A 
PCR product corresponding to transcription of the ORF116 gene was not detected in OV-
NZ2∆116 infection indicating the deletion of ORF116 in the OV-NZ2∆116. This result has 
shown that ORF116 is intact and expressed at an early stage of OV-NZ2-Rev116 virus 
replication.      
Figure 3.9. Transcription kinetic analysis of the ORF116 gene by RT-PCR. 
Figure 3.9. Transcription kinetics analysis of the ORF116 gene by RT-PCR. hNDF cells 
were either mock infected or infected with OV-NZ2 wt, OV-NZ2Δ116 or OV-NZ2Rev-116 virus 
at an MOI of 10 pfu per cell in the presence or absence cycloheximide (100 μg / ml). Total RNA 
was isolated at 0, 2, 4 and 6 h.p.i. Total RNA was treated with DNase I and purified. 
Transcriptional analysis of ORF116 was performed by Reverse Transcription-PCR. Five 
hundred ng of total RNA was reverse transcribed into cDNA. One μl of cDNA product was PCR 
amplified, then 10 μl of PCR product was separated by electrophoresis on a 1% agarose gel 
containing ethidium bromide.  











Viruses Growth analysis   
The growth of the OV-NZ2-Rev116 was characterized and compared to OV-NZ2 and OV-
NZ2∆116. The cells were infected with a low MOI 0.05 of virus to characterize the virus over 
multiple cycles. The cells were harvested at various time points and the virus progeny titrated 
in LT cells by plaque assay. The exponential phase was seen at 24 hours post-infection and 
the growth reached a plateau by 72 hours post-infection. OV-NZ2 replicated to higher levels 
than OV-NZ2-Rev116 and OV-NZ2∆116. However, re-insertion of the ORF116 into the OV-
NZ2∆116 virus restored the phenotype of wild type replication to that of OV-NZ2 at 48 hours 
post-infection (Figure 3.10).     
  
Figure 3.10. Growth analysis of OV-NZ2, OV-NZ2Δ116 and OV-NZ2-Rev116. 
Figure 3.10. Growth analysis of OV-NZ2, OV-NZ2Δ116 and OV-NZ2-Rev116. hNDF cells 
were infected at an MOI of 0.05 pfu per cell with either OV-NZ2 wt, OV-NZ2Δ116 or OV-NZ2-
Rev116 viruses. The virus progeny was determined on LT cells. Virus plaques were visualized 
by staining then counted and virus titres determined. Statistical analysis was performed using a 
student’s t test. Data are representative of one experiment of three independent experiments. 
Error bars represent mean ±SD. Asterisks indicate probability 
*
P ≤ 0.05 that were calculated 
from technical triplicates from one experiment.   
 













M O I  0 .0 5











O V -N Z 2
O V -N Z 2 1 1 6







3.4 OV-NZ2 ORF116 Gene Modulation of the Type I Interferon Response 
Having established that the OV-NZ2-Rev116 restored the growth phenotype of the wild type, 
the expression levels of ISGs were examined in HeLa cells infected with either OV-NZ2, 
OV-NZ2Δ116 or OV-NZ2Rev116. The three viruses were sucrose purified to remove any 
cytokines that might be present in the media.   
HeLa cells were infected with either OV-NZ2, OV-NZ2Δ116 or OV-NZ2Rev116 at a MOI 
10 for 0, 2, 4 and 6 hours post-infection, then total RNA was isolated from infected cells. 
Having met the accuracy and precision of the primers, the expression levels of ISGs (IFI44, 
IFI16, RIG-I, IFIH1, IFIT2, IFIT1, OAS1, OASL, DDX60, IL-6, IL-8, ISG20) were 
measured by qRT-PCR. The mRNA expression levels of these ISGs were normalized to the 
mRNA level of GAPDH gene then the fold change in mRNA level was calculated relative to 
the mRNA level of mock-infected cells. GAPDH gene expression was shown to remain stable 
across all time points and virus infections in HeLa cells so it was an ideal internal control in 
this study. Because fold differences were variable across biological replicates, only one of 
three biological replicates was presented. 
qRT-PCR analysis revealed a change in the mRNA levels of the ISGs that was observed at 6 
hours post-infection except for IL-8 and IFI16 at 2 and 4 hours post-infection. The qRT-PCR 
data of differential ISGs expression showed high expression levels in OV-NZΔ116 infection 
across all selected genes except DDX60. However, OV-NZ2-Rev116 infection restored the 
phenotype of the OV-NZ2 in which those ISGs have been altered and down-regulated at 2 
and 4 h.p.i. for IL-8 and IFI16 and at 6 hours post-infection for ISG20, OASL, IL-6, IFIH1, 
RIG-I, IFIT2, IFI44 genes to the level similar to OV-NZ2, except DDX60 (Figure 3.11). The 
expression levels of ISGs OASL, IL-8, IFIH1, RIG-I, IFIT2 and IFI16 were restored by the 
revertant virus whereas the ISGs ISG20, IL-6 and IFI44 were partially restored by the virus.  
With regard to the genes IFIT1 and OAS1, although they have not been altered in HeLa 
infected with OV-NZ2, their expression levels were altered in HeLa-infected with OV-NZ2-
Rev116. All the fold changes in the three viral infections related to mock infection or related 
to wild type infection from three independent experiments are shown in Table 3.2, 3.3, 3.4, 
3.5, 3.6 and 3.7.  
These results strongly suggest that ORF116 plays a role in modulating the IFN response and 





unintended mutation introduced during the construction of the mutant virus. The modulation 
by antiviral effectors was more likely due to blocking the production of type I IFN response 
from infected cells or blocking the expression of ISGs or both. In the following chapters, an 
investigation was conducted to examine whether or not ORFV blocks type I IFN production 
from cells stimulated with either poly(dA:dT) or poly(I:C). Finally, ORF116 gene was 
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Figure 3.11. Analysis of change in the expression levels of ISGs.
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Figure 3.11. Analysis of change in the expression levels of ISGs after infecting HeLa cells 
with wild type virus OV-NZ2, knockout virus OV-NZ2Δ116 or revertant virus OV-NZ2-
Rev116. HeLa cells were mock infected or infected with the indicated virus at an MOI of 10 pfu 
per cell. Infected cells were harvested at 0, 2, 4 and 6 hours post-infection and total RNA was 
extracted. qRT-PCR was performed in triplicate of technical replicate to quantify relative 
expression levels of the indicated genes. Data were normalized against GAPDH and are 
presented relative to mock-infected cells. Data are representative of experiment one of three 
independent experiments. Error bars represent mean ±SD. Statistical analysis was performed 
using two-way ANOVA. Asterisks indicate probability: *P ≤ 0.0332, **P ≤ 0.0021, ***P ≤ 0.0002, 
****P ≤ 0.0001. P value was calculated from qRT-PCR triplicate of technical replicate of 








Table 3.2. Expression levels of interferon-stimulated genes (ISGs) in HeLa-infected cells from experiment one.  
  mRNA expression analyzed by qRT-Real Time-PCR in HeLa cells infected with indicated virus relative to mock infection 
  OV-NZ2  OV-NZ2Δ116  OV-NZ2Rev116 
ISGs GenBank 0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i. 
IFI44 NM_006417 0.82 0.28 0.94 6.12  0.79 0.22 0.40 9.74  0.45 0.30 0.85 7.85 
RIG-I NM_014314 0.97 1.22 1.34 1.86  1.29 1.95 1.74 3.62  1.22 1.54 1.27 1.41 
IFI16 NM_001206567 0.90 1.13 1.05 0.38  1.30 1.79 1.85 0.61  1.20 1.38 0.86 0.23 
IFIH1 NM_022168 1.06 1.53 1.44 3.42  1.32 1.64 1.61 4.45  1.29 1.76 1.25 3.28 
IFIT1 NM_001548 0.92 0.75 1.34 3.22  1.30 0.72 1.03 3.40  0.96 0.61 1.08 2.21 
IFIT2 NM_001547 0.90 0.87 1.14 5.42  1.53 0.87 0.83 7.80  1.12 0.71 0.75 3.31 
OAS1 NM_001032409 1.16 0.90 1.23 2.88  1.18 0.82 0.97 2.20  1.16 0.66 1.14 1.70 
OASL NM_001261825 1.17 0.89 0.94 1.42  1.10 1.09 1.01 1.98  1.03 0.92 0.81 1.07 
DDX60 NM_017631 1.21 0.75 0.65 1.47  1.00 0.73 0.70 1.26  0.96 0.86 0.72 1.55 
ISG20 NM_002201 0.79 0.85 0.97 1.45  0.84 1.02 1.16 3.62  0.80 1.03 1.10 2.65 
IL-8 NM_000584 0.64 3.39 1.73 2.87  0.73 5.96 7.09 3.06  0.72 3.18 2.33 2.02 
IL-6 NM_0006000 0.96 1.81 1.55 1.40  1.11 3.23 2.06 8.54  1.10 2.44 1.78 3.61 
Differentially expressed genes are indicated in bold.  












Table 3.3. Fold change of interferon-stimulated genes (ISGs) determined by qRT-PCR relative to wild type from experiment one. 
  
Fold Change determined by qRT-PCR in HeLa cells infected with indicated virus relative 
to wild type virus infection 
  OV-NZ2Δ116  OV-NZ2Rev116 
ISGs GenBank 0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i. 
IFI44 NM_006417 0.96 0.78 0.42 1.59  0.54 1.07 0.90 1.28 
RIG-I NM_014314 1.32 1.59 1.29 1.94  1.25 1.26 0.94 0.75 
IFI16 NM_001206567 1.44 1.58 1.76 1.60  1.33 1.22 0.81 0.60 
IFIH1 NM_022168 1.24 1.07 1.11 1.30  1.21 1.15 0.86 0.95 
IFIT1 NM_001548 1.41 0.96 0.76 1.05  1.04 0.81 0.80 0.68 
IFIT2 NM_001547 1.70 1.00 0.72 1.43  1.24 0.81 0.65 0.61 
OAS1 NM_001032409 1.01 0.91 0.78 0.76  1.00 0.73 0.92 0.59 
OASL NM_001261825 0.94 1.22 1.07 1.39  0.88 1.03 0.86 0.75 
DDX60 NM_017631 0.82 0.97 1.07 0.85  0.79 1.14 1.10 1.05 
ISG20 NM_002201 1.06 1.20 1.19 2.49  1.01 1.21 1.13 1.82 
IL-8 NM_000584 1.14 1.75 4.09 1.06  1.12 0.93 1.34 0.70 
IL-6 NM_0006000 1.15 1.78 1.32 6.10  1.14 1.34 1.14 2.57 
Differentially expressed genes are indicated in bold. 












Table 3.4. Expression levels of interferon-stimulated genes (ISGs) in HeLa-infected cells from experiment two.  
  mRNA expression analyzed by qRT-Real Time-PCR in HeLa cells infected with indicated virus relative to mock infection 
  OV-NZ2  OV-NZ2Δ116  OV-NZ2Rev116 
ISGs GenBank 0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i. 
IFI44 NM_006417 0.91 1.11 1.21 1.88  1.21 0.77 0.91 3.40  1.16 1.23 0.96 2.09 
RIG-I NM_014314 1.61 1.75 1.67 3.23  1.71 1.90 1.25 4.69  1.68 2.13 1.63 3.41 
IFI16 NM_001206567 0.95 0.82 0.91 0.62  0.97 0.89 0.92 0.55  1.15 0.94 1.08 0.71 
IFIH1 NM_022168 0.51 0.28 0.29 3.13  0.38 0.40 0.47 4.87  0.53 0.32 0.25 4.39 
IFIT1 NM_001548 0.56 1.11 1.39 1.19  0.52 0.45 0.84 2.42  0.45 0.92 0.98 1.17 
IFIT2 NM_001547 1.25 098 0.71 3.18  1.29 0.65 1.42 6.19  0.97 0.40 0.90 2.89 
OAS1 NM_001032409 1.61 1.10 1.50 1.29  1.42 1.06 1.39 1.90  1.07 1.01 1.06 1.47 
OASL NM_001261825 1.20 1.36 0.85 1.08  1.20 1.66 0.99 1.02  1.30 1.48 0.86 1.20 
DDX60 NM_017631 1.25 1.02 0.64 1.22  1.04 0.91 0.86 1.05  1.07 1.10 0.79 1.52 
ISG20 NM_002201 0.86 1.93 2.08 2.74  0.79 2.06 1.67 3.34  0.94 2.35 2.14 2.88 
IL-8 NM_000584 0.83 3.49 12.94 2.79  0.68 29.94 14.03 5.66  1.27 8.63 6.83 4.85 
IL-6 NM_0006000 
1.76 2.96 3.29 2.98 
 2.06 2.66 3.36 3.85  2.05 3.54 3.37 2.51 
































Fold Change determined by qRT-PCR in HeLa cells infected with indicated virus 
relative to wild type virus infection 
  OV-NZ2Δ116  OV-NZ2Rev116 
ISGs GenBank 0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i. 
IFI44 NM_006417 1.32 0.69 0.74 1.80  1.27 1.10 0.79 1.10 
RIG-I NM_014314 1.06 1.08 0.75 1.45  1.04 1.21 0.97 1.05 
IFI16 NM_001206567 1.01 1.08 1.01 0.87  1.20 1.14 1.18 1.13 
IFIH1 NM_022168 0.75 1.41 1.60 1.55  1.05 1.10 0.86 1.40 
IFIT1 NM_001548 0.92 0.41 0.60 2.03  0.80 0.82 0.70 0.98 
IFIT2 NM_001547 1.03 0.66 1.98 1.94  0.77 0.41 1.26 0.90 
OAS1 NM_001032409 0.88 0.96 0.92 1.46  0.66 0.92 0.70 1.13 
OASL NM_001261825 1.00 1.22 1.16 0.94  1.08 1.09 1.00 1.11 
DDX60 NM_017631 0.83 0.89 1.34 0.86  0.85 1.07 1.24 1.24 
ISG20 NM_002201 0.91 1.06 0.80 1.22  1.09 1.21 1.03 1.06 
IL-8 NM_000584 0.82 8.55 1.08 2.02  1.52 2.46 0.52 1.73 
IL-6 NM_0006000 1.17 0.89 0.71 1.29  1.16 1.19 1.02 0.84 









Table 3.6. Expression levels of interferon-stimulated genes (ISGs) in HeLa-infected cells from experiment three. 
  mRNA expression analyzed by qRT-Real Time-PCR in HeLa cells infected with indicated virus relative to mock infection 
  OV-NZ2  OV-NZ2Δ116  OV-NZ2Rev116 
ISGs GenBank 0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i. 
IFI44 NM_006417 0.80 0.77 0.74 1.36  0.77 0.87 0.87 1.93  0.79 0.84 0.79 1.36 
RIG-I NM_014314 0.85 0.84 1.09 2.06  0.92 0.99 0.86 1.86  0.92 0.99 0.99 1.98 
IFI16 NM_001206567 0.85 1.01 0.77 0.66  0.67 1.07 0.92 0.91  0.77 1.02 0.85 0.59 
IFIH1 NM_022168 0.86 0.75 0.76 2.16  0.87 0.91 0.88 2.59  0.89 0.88 0.81 1.75 
IFIT1 NM_001548 1.04 0.83 0.72 2.11  0.97 0.89 0.87 2.59  0.98 0.91 0.90 1.94 
IFIT2 NM_001547 1.01 0.74 0.52 2.02  1.02 0.93 0.71 2.57  1.03 0.80 0.55 1.85 
OAS1 NM_001032409 0.53 0.72 0.47 1.03  0.81 1.23 1.43 1.65  0.72 0.94 1.39 1.03 
OASL NM_001261825 1.16 0.84 0.88 1.09  1.23 1.05 0.91 1.64  1.14 0.85 0.96 1.12 
DDX60 NM_017631 0.97 0.65 0.95 0.72  0.71 0.62 0.76 0.73  0.68 0.56 0.73 0.73 
ISG20 NM_002201 0.52 0.60 0.80 1.09  0.56 0.64 0.84 2.41  0.67 0.54 0.90 1.17 
IL-8 NM_000584 0.80 3.07 1.15 0.80  0.75 3.83 1.48 0.84  0.70 3.44 1.35 0.84 
IL-6 NM_0006000 1.06 1.76 0.99 1.18  1.09 2.72 0.99 1.10  1.06 1.90 1.06 0.97 















Table 3.7. Fold change of interferon-stimulated genes (ISGs) determined by qRT-PCR relative to wild type from experiment three. 
  
Fold Change determined by qRT-PCR in HeLa cells infected with indicated virus relative to 
wild type virus infection 
  OV-NZ2Δ116  OV-NZ2Rev116 
ISGs GenBank 0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i.  0 h.p.i. 2 h.p.i. 4 h.p.i. 6 h.p.i. 
IFI44 NM_006417 0.96 1.12 1.17 1.42  0.99 1.07 1.06 1.00 
RIG-I NM_014314 1.08 1.17 0.79 0.89  1.08 1.17 0.91 0.95 
IFI16 NM_001206567 0.78 1.05 1.20 1.38  0.91 1.01 1.10 0.90 
IFIH1 NM_022168 1.00 1.21 1.16 1.19  1.03 1.17 1.06 0.81 
IFIT1 NM_001548 0.93 1.06 1.21 1.22  0.93 1.09 1.24 0.92 
IFIT2 NM_001547 1.01 1.25 1.35 1.26  1.02 1.08 1.05 0.91 
OAS1 NM_001032409 1.51 1.70 3.01 1.60  1.35 1.31 2.94 1.00 
OASL NM_001261825 1.06 1.25 1.03 1.50  0.98 1.01 1.09 1.02 
DDX60 NM_017631 0.73 0.94 0.80 1.01  0.70 0.85 0.77 1.01 
ISG20 NM_002201 1.06 1.06 1.04 2.20  1.28 0.89 1.11 1.01 
IL-8 NM_000584 0.93 1.24 1.28 1.05  0.87 1.11 1.17 1.05 
IL-6 NM_0006000 1.02 1.54 1.00 0.99  0.99 1.08 1.06 0.82 






3.5 Discussion  
In this study, a novel gene ORF116 expressed by OV-NZ2 was discovered that plays a role 
in innate immune modulation. ORF116 is highly conserved within ORFV strains and no 
homologues were found outside the Parapoxvirus genus. It is located within the right terminal 
region of the OV-NZ2 genome amongst a cluster of genes that are involved in 
immunomodulation. Amino acid sequence analysis of ORF116 shows that it lacks a peptide 
signal sequence which strongly suggests that this protein acts intracellularly and like the other 
genes in this region, is expressed early before DNA replication.  
Previously, transcriptome analysis of HeLa cells infected with OV-NZ2 wild type or with 
OV-NZ2Δ116 knockout mutant by microarray revealed an up-regulation of a number of ISGs 
in knockout mutant virus-infected cells to higher levels than in OV-NZ2 wild type-infected 
cells, suggesting a major role played by ORF116 in modulating the IFN response (AlDaif, 
B., 2013). This observation prompted us to validate its role by making a revertant virus in 
which the ORF116 was re-inserted at the same locus in the mutant virus. The revertant virus 
was generated as described in materials and methods and its genome was characterized by 
PCR analysis. The analysis has shown the re-insertion of ORF116 gene along with the LacZ 
reporter gene and virus purity was confirmed. The transcription of ORF116 gene was detected 
at 2 h.p.i. by RT-PCR and it was expressed early before viral DNA replication since 
cycloheximide did not inhibit its expression. Growth of the wild type virus, knockout mutant 
and revertant in cell culture showed that the growth of revertant virus was restored compared 
to the knockout mutant virus, albeit not as efficiently as wild type virus. From three 
independent experiments, it has been shown that the expression levels of a number of ISGs 
(IFI44, IFI16, RIG-I, IFIT2, IFIT1, OAS1, OASL, IFIH1, IL-6, IL-8, ISG20, but not DDX60) 
analyzed by qRT-PCR in infected HeLa cells showed a differential expression pattern. The 
expression level of the selected ISG mRNAs except DDX60 were significantly higher in OV-
NZ2Δ116 than OV-NZ2-infected cells and importantly than the OV-NZ2Rev116 revertant 
virus. It was clear that the re-insertion of the ORF116 gene in the revertant restored the 
phenotype of wild type virus. The differential expression of these ISGs was detected at 6 h.p.i 
except for both IL-8 and IFI16 at 2 and 4 h.p.i. DDX60 has shown upregulation at 6 h.p.i. 
with no significant differential expression among the three viruses. Nevertheless, these data 
have confirmed the role of ORF116 in modulating the IFN response. In addition, the data 





direct interaction, or by interfering with the type I IFN signalling pathways, or by inhibiting 
the induction of type 1 IFN or all of the above.  
The deletion of ORF116 from OV-NZ2 caused a slight attenuation in the growth of the mutant 
virus and from previous examination, the CPE was much slower and size of the virus plaques 
were smaller despite similar plaque morphology to wild type. All these observations could 
explain the up-regulation of ISGs examined and their action on virus replication. It is unlikely 
that ORF116 is a host range gene since the deletion showed a small effect on suppressing 
virus growth. A number of host range genes have been identified in poxviruses such as K1L, 
C7L, E3L and K3L which are essential for virus replication in a cell-type specific manner 
(Beattie, Elizabeth et al., 1995; Langland, J. O. et al., 2002; Meng, X. et al., 2012; Nájera, J. 
L. et al., 2006; Perkus, M. E. et al., 1990; Shisler, J. L. et al., 2004). K1L and C7L have been 
shown to target the IFN effector response (Meng, X. et al., 2009). Taken together, the 
elevated levels of ISGs could explain its reduced replication levels in cell culture.  
The analysis of the amino acid sequence of OV-NZ2 ORF116 has shown no evidence of a 
secretary signal peptide, but it was found that there is a tentative classical signal peptide for 
protein localization to mitochondria and nucleus. A clearer insight as to where the ORF116 
protein localizes could be elucidated by co-localization studies. Further characterization of 
ORF116 protein was considered essential in understanding its role either by expressing 
ORF116 with a tag from a construct or constructing another recombinant virus that expresses 
ORF116 with a tag under its natural promoter as there was no antibody available against the 
protein. Given that the ORF116 protein acts intracellularly, it is more likely targeting 
signalling pathways. Sequence analysis of the promoter region of the altered ISGs has shown 
a number of GAAAN(N)(N)GAAA sequences within the region upstream of the TATA box, 
indicating a putative IRF-binding site. The promoter region of IFN-β contains an ISRE 
consisting of four sets of overlapping PRDII, PRDIII-I and PRDIV that are recognized by the 
transcription factors NF-κB, IRF3/7 and ATF-2/c-Jun respectively and many ISGs harbour 
ISRE-like sequences in their promoter region too. Sequence similarity was found between 




T/C) of IFN-β and the 5’ flanking AA sequence (in bold) is 
essential for the recognition by IRFs, not NF-κB (Darnell, J. et al., 1994; Tanaka, N. et al., 
1993). These findings could be encouraging to investigate whether ORF116 is targeting IRF3 





It has not been determined yet whether the expression of those altered ISGs in the present 
study has been an effect of virus infection or IFN induction. Identifying how these ISGs 
induced could assist determining which pathways the ORF116 protein is targeting. ISGs are 
different in their inducibility in which some could be induced only by IFN such as IFITM1, 
some could be induced by both IFN and virus such as IFI15, and others could be induced only 
by virus such as ISG56 as IFN-β does. There is no definitive signature that determines 
whether a particular ISG gene is virus-inducible or IFN-inducible. DNA-protein binding 
studies could define the exact relationship by means of e.g. electrophoretic mobility shift 
assay (EMSA), footprinting or even crystal structure studies. Biochemists speculate that 
ISREs that contain only two repeats of GAAA is induced by IFN whereas those that contain 
three or four repeats is induced by IFN and virus (Maniatis, T. et al., 1998). In addition, 
Wathelet, M. G. et al. (1992) provide an explanation for this dilemma by the existence of 
additional virus-inducible elements like PRDII and PRDIV.                 
A number of other virus infection studies, that have also shown manipulation of many of the 
ISGs were observed in this study. A comparison of NYVAC and MVA (a highly attenuated 
virus in which a 25 kb fragment containing non-essential genes is deleted) infections in either 
MDDC or HeLa cells at 6 h.p.i. revealed a distinct pattern in gene expression. The expression 
level of IFIT1, IFIT4, ISG15 and ISG20 was higher in MVA-infected MDDC than in 
NYVAC-infected MDDC (Guerra, S. et al., 2007). Studies on Papillomavirus (HPV) type 31 
has revealed downregulation of a number of ISGs including MX1, MX2, IFI27, IFIT1, IFIT2, 
OAS2, STAT1 and IFITM3 (Chang, Y. E. et al., 2000). On the other hand, IFI44 and DDX60 
were up-regulated in cells transfected with the genome of HPV type 11, 16 and 45 
(Kaczkowski, B. et al., 2012). Moreover, HIV-1-infected MDDC showed 18 ISGs that were 
up-regulated with no change in IFN expression (Harman, A. N. et al., 2011).  
From analysis of over 300 known ISGs we are gaining a clearer picture of which ISGs are 
specifically targeted by viruses, although the antiviral properties of many of them has not 
been delineated yet (Sadler, A. J. et al., 2008). Those ISGs that are specifically manipulated 
by the ORFV ORF116 and that are also targeted by other viruses are discussed in detail below.  
IFI16 is a member of the PYHIN protein family that act as a DNA sensor and recruits STING 
for IFN-β induction (Fernandes-Alnemri, T. et al., 2009; Hornung, V. et al., 2009; Rathinam, 
V. A. K. et al., 2010; Unterholzner, L. et al., 2010). IFI16 was up-regulated by OV-NZ2Δ116 





used by OV-NZ2 to evade the DNA sensing pathway. At 6 h.p.i, the three viruses have 
downregulated IFI16 below the basal level at 6 h.p.i., suggesting virus-mediated IFI16 
transcript depletion. IFI44 is induced by virus and IFN-α/β and localizes within the 
cytoplasm. It functions to aggregate microtubules, affecting early intracellular viral transport 
(Hallen, L. C. et al., 2007; Honda, Y. et al., 1990; Kitamura, A. et al., 1994; Moens, B. et al., 
2012). The yield of Bunyamwera orthobunyavirus from cells expressing IFI44 was inhibited 
≥ 10-fold (Carlton-Smith, C. et al., 2012). Furthermore, the IFI44 expression level was 
increased by about 4 times in the knockout HSV-1Δ34.5-infected MEF cells compared with 
the wild type (Pasieka, T. J. et al., 2006).  
RIG-I and MDA5 are cytosolic antiviral molecules that play a major role in cytoplasmic 
sensing of virus RNA either from genome, replication by-products or transcripts (Yoneyama, 
M. et al., 2004). Upon viral RNA recognition by RIG-I or MDA5, signalling cascades are 
triggered through MAVS leading to induction of type I IFN. They can play a major role in 
sensing DNA viruses. MYXV induces IFN-β expression in primary human macrophages 
(pHMs), but this expression was reduced in RIG-I-deficient pHMs (Wang, F. et al., 2008). 
HSV-1 and adenovirus have shown more efficient replication in RIG-I mutant Huh-7.5.1 cells 
than wild type Huh-7 cells (Cheng, G. et al., 2007). The role of MDA5 in sensing DNA 
viruses can be variable (Delaloye, J. et al., 2009; Gitlin, L. et al., 2006). The observations 
found in this study showed that OV-NZ2 is manipulating the transcriptional levels of both 
RIG-I and IFIH1 with a stronger effect on RIG-I expression. It would be interesting to study 
in depth the effect of ORF116 at the molecular level and understand the mechanism adopted 
by this gene to affect the RLR signalling cascade.  
OAS is a family of ISGs consisting three enzymes OAS1-3 and OASL. OAS1-3 and 2-5A-
dependent RNase (RNaseL) function in an antiviral role by initiating RNA degradation and 
inducing IFN expression (Kristiansen, H. et al., 2011), whereas OASL is related to the OAS 
by its N-terminal OAS-like domain but lacks 2’-5’ oligoadenylate synthetase activity. OASL 
is rapidly induced by virus infection or IFN and acts as an antiviral effector via its ubiquitin-
like domain (UBL) (Hartmann, R. et al., 1998; Marques, J. et al., 2008; Melchjorsen, J. et al., 
2009). It has been also shown that OASL enhances RIG-I-mediated signalling (Zhu, J. et al., 
2014). This could suggest an interplay between OASL and RIG-I, observed in this study, in 





The ISG56/IFIT1 gene family is comprised of four members: ISG56/IFIT1, ISG54/IFIT2, 
ISG60/IFIT3 and ISG58/IFIT5 and they can be induced by IFN or virus infection to mediate 
translation inhibition (Fensterl, V. et al., 2011). Their antiviral role against poxvirus has been 
recently demonstrated. A C9-deleted VACV mutant was IFN resistant in IFIT1/2/3 knockout 
cells and C9 mediates proteolysis of IFIT1/2/3 proteins without affecting their mRNAs levels 
(Liu, R. et al., 2018; Liu, R. et al., 2019). ORFV targets IFIT1 and IFIT2 but at the 
transcriptional level, suggesting different strategies of ISG antagonism amongst poxviruses. 
ISG20 is a 3′ → 5′ exoribonuclease that degrades ssRNA and acts as an antiviral effector 
(Espert, L. et al., 2005; Espert, L. et al., 2004; Gongora, C. et al., 2000). It is also believed 
that ISG20 can act as regulator through upregulation of IFIT1 and other ISGs (Weiss, C. M. 
et al., 2018).  
DDX60 contains a DEXD/H box RNA helicase domain and is involved in the antiviral 
response. In this study, DDX60 has not been altered by ORF116 and slightly upregulated at 
6 h.p.i in all viruses. It could be altered by other viral factors or this ISG is not affecting 
ORFV replication. Its antiviral effect was shown in poliovirus-infected HeLa cells at 14 h.p.i 
and VSV-infected HEK293 cells (Miyashita, M. et al., 2011).  
Cytokines and chemokines are induced in response to infection to modulate the immune cells 
and attract them to the site of infection. IL-8 is a chemokine regulated by the transcription 
factor NF-κB and is rapidly induced in response to viral infection and other stimuli. It appears 
that the expression of ORF116 was important at a very early stage of infection (2 and 4 h.p.i) 
to inhibit IL-8 action, then masked by other viral factors after 4 h.p.i., indicating the 
importance of temporal activation of virus and host genes to fight for supremacy. The 
manipulation of IL-8 expression was also observed in OV-IA82-infected OFTu cells by 
ORF024 at the same time points 2 and 4 h.p.i (Diel, D. G. et al., 2010). IL-6 is a pro-
inflammatory cytokine induced at an early stage of infection and its manipulation was 
observed in CPXV and MPXV-infected HeLa cells at 6 h.p.i. (Bourquain, D. et al., 2013).  
To summarise, the role of the ORFV ORF116 gene was addressed in this part of the study 
and the results have shown its potential to modulate the IFN response. So far the results have 
shown that a number of ISGs are manipulated by ORF116 and prompted further studies to 
track its inhibitory effect and to determine its exact target within the IFN signalling pathway 
and delineate the precise mechanism of its action within the complex IFN system. Those ISGs 





they act as restriction factors against ORFV. ORF116 could have a direct specific effect on 
ISG expression, in particular it could be targeting IRF-3 within infected cells or it could have 
a role in inhibiting type I IFN production or signalling again by targeting IRF-3. From the 
above results a decision was made to look at the effect of ORFV infection on IFN-β 
production (see next two Chapters) as it would address an important aspect of ORFV biology 
in the first instance and in addition to examine the specific effects of ORF116 on IFN-β 
production in the context of the virus and from a protein expression vector.  
 











4 RESULTS II: Effect of ORFV Infection on IFN- Expression (RIG-I-
Dependent Pathway) 
4.1 Overview  
It is widely believed that replication of viruses, including OV-NZ2 virus, can generate dsRNA 
in the cytoplasm as a byproduct formed by base-pairing between converging intermediate 
viral transcripts during virus genome transcription. The generated dsRNA can be recognized 
by cytosolic RNA sensors leading to the expression of type I interferon.   
To investigate the effect of OV-NZ2 virus infection on type I interferon expression, the 
HEK293 cell was chosen to represent a model of RNA-dependent IFN-β induction. As 
reported previously, HEK293 cells are known to lack DNA sensors except RNA polymerase 
III. RNA polymerase III recognizes dsDNA such as poly(dA:dT) and converts it into 5’-
triphosphate dsRNA which is then solely recognized by RIG-I and not MDA5.  These cells 
do not express the ER-residing STING adaptor and fail to respond to c-di-GMP, cyclic 
dinucleotide detected by STING (Burdette, D. L. et al., 2011; McWhirter, S. M. et al., 2009). 
Toll-like receptors (TLRs) are not expressed in this cell line either, however, it does express 
cytosolic RIG-I and MDA5 sensors. Only RIG-I, but not MDA5, detects 5’-triphosphate 
dsRNA derived from poly(dA:dT) by polymerase III. Recognition of nucleic acid material by 
the RIG-I receptor will trigger the RNA-dependent signalling pathway that leads to 
expression of type I interferon as shown in Figure 4.1. 
4.2 Induction of IFN-β Expression in HEK293 Cells 
An investigation was conducted to establish in the first instance the cellular response of 
HEK293 cell to exogenous nucleic acid material and detection of IFN-β expression. Synthetic 
dsDNA poly(dA:dT) or synthetic dsRNA poly(I:C) were used to stimulate the cytosolic RNA 
sensing pathway. The cells were transfected with either poly(dA:dT) or poly(I:C) and the 
induction of IFN-β was quantified by qRT-PCR. Kinetic analysis was performed to assess 
the time course of type I IFN induction and also to determine the optimal dose of nucleic acid 
to produce the IFN response. qRT-PCR data was normalized to the expression level of 
GAPDH, then compared to mock samples in each of the corresponding time points. 





stimulation in HEK293 cells. Then, fold change of IFN-β induction was calculated as 
described in materials and methods.     
The cells responded to both transfected poly(dA:dT) (Figure 4.2 A) and poly(I:C) (Figure 4.3 
A) in which the induction of IFN-β expression was detected after 4 hours post stimulation 
and the induction increased reaching more than 7000 fold and 400 fold respectively at 25 
hours post stimulation. The induction did not increase much beyond 25 hours post stimulation 
in either poly(dA:dT) or poly(I:C) treated cells (data not shown). Accordingly, the time point 
of 20 hours post stimulation was chosen in this study at which a strong IFN response was 
seen. The nucleic acid dose response was also investigated in HEK293 cells and the 
appropriate concentration required was also determined. The cells were stimulated with either 
poly(dA:dT) or poly(I:C) at different concentrations and harvested at different time points. 
Figure 4.1.Experimental model to study RIG-I/MDA5 pathways involved in the induction of IFN-β in 
HEK293 cells. 
Figure 4.1. Experimental model to study RIG-I/MDA5 pathways involved in the induction of 
IFN-ß in HEK293 cells. RIG-like receptors are localized in the cytosol. RIG-I receptor senses 
short dsRNA and also ppp-dsRNA derived from polymerase III-transcribed poly(dA:dT), whereas 
MDA5 senses long dsRNA. Upon ligand binding, RLRs engage the adaptor MAVS located on the 
outer membrane of mitochondria then lead to the downstream signalling to TBK1/IKKε-





















Poly(dA:dT) stimulation showed that the IFN response was dose-dependent and the 
concentration of 0.5 μg/ml was sufficient to produce a strong response and accordingly this 
concentration was chosen in this study (Figure 4.2 B). Similarly, poly(I:C) stimulation 
showed a marked increase in response from 10 to 20 hours post stimulation (Figure 4.3 B and 
Figure 4.2. Induction of IFN-β by poly(dA:dT) in HEK293 cells. 
Figure 4.2. Induction of IFN-β by poly(dA:dT) in HEK293 cells. (A) and (B) HEK293 cells 
were seeded at 4x10
5
 cells in 6-well plates and stimulated with poly(dA:dT) at concentration 
indicated. Total RNA was isolated from cells at the time shown and IFN-β mRNA was quantified 
by qRT-PCR in triplicate. Expression fold was calculated as described in materials and methods. 
Data are from one representative experiment of four (A) and three (B) independent experiments 
conducted with technical replicate. Error bars represent mean ±SD.  
A. 
B. 
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C) and a concentration 1 μg/ml was sufficient to produce a strong response; accordingly the 
concentration of 1 μg/ml was chosen in this study.  
HEK293 cells does not express the TLR3 receptor, as reported previously (de Bouteiller, O. 
et al., 2005). It is a receptor that recognize dsRNA from either the extracellular or intracellular 
environment and triggers signalling through the endosomal pathway. In this study it has been 
hypothesized that poly(I:C) triggers the intracellular RNA sensing pathway through the 
cytosolic sensor. The transfection reagent LyoVec is known to deliver poly(I:C) into the cell 
cytosol resulting in exposing poly(I:C) to the cytosolic dsRNA sensor. To examine this 
hypothesis, poly(I:C) was delivered into HEK293 cells either complexed with cationic lipid 
LyoVec or without, then IFN-β mRNA was quantified by qRT-PCR. As expected, poly(I:C) 
alone did not induce IFN-β expression in comparison with poly(I:C) complexed with cationic 
lipid LyoVec (Figure 4.3 C). This result suggests that RNA sensing and signalling in HEK293 
cells dose not involve the TLR3 receptor, or TLR3 does not recognize poly(I:C) or HEK293 
cells do not express TLR3.           
4.3 Poly(dA:dT)-mediated IFN-β Expression in HEK293 Cells through RNA 
Polymerase III             
As HEK293 cells lack the expression of DNA sensors, however investigators have identified 
that RNA Polymerase III is expressed in these cells that can transcribe AT-rich dsDNA into 
5’triphosphate dsRNA (Ablasser, A. et al., 2009; Chiu, Y.-H. et al., 2009) that serves as a 
ligand for the detection by RIG-I (Hornung, V. et al., 2006). Therefore, the induction of IFN-
β observed above was presumably through RIG-I/MDA5 and not through DNA sensors when 
the cells were stimulated with poly(dA:dT). This assumption was examined by inhibiting the 
function of RNA Polymerase III that is responsible for converting dsDNA to 5’-triphosphate 
dsRNA using an RNA Polymerase III inhibitor (ML-60218). HEK293 cells were treated with 
ML-60218 then stimulated with poly(dA:dT) or poly(I:C) and the induction of IFN-β 
quantified by qRT-PCR.  
In poly(dA:dT)-stimulated ML-60218-treated cells, the induction of IFN-β expression was 
enhanced slightly at low concentrations of ML-60218 but then suppressed significantly at 
higher concentrations of ML-60218 in a dose-dependent manner (Figure 4.4), consistent with 
a previous report (Valentine, R. et al., 2010). This slight enhancement of IFN-β induction in 





2012). On the other hand, poly(I:C)-mediated IFN-β expression has not been affected by ML-
60218 treatment and the IFN-β expression has remained stable at all concentrations (Figure 
4.4). The inhibition of IFN-β induction in poly(dA:dT) stimulation was not due to potential 
toxicity of ML-60218, since the induction of IFN-β expression in poly(I:C) stimulation has 
Figure 4.3. Induction of IFN-β by poly(I:C) in HEK293 cells. 
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Figure 4.3 Induction of IFN-β by poly(I:C) in HEK293 cells. (A), (B) and (C) HEK293 cells 
were seeded at 4x10
5
 cells in 6-well plates and stimulated with poly(I:C) complexed with LyoVec 
(A), (B) and (C) or without LyoVec (C) at concentration indicated. Total RNA was isolated from 
cells at the time shown and IFN-β mRNA was quantified by qRT-PCR in triplicate. Expression 
fold was calculated as described in materials and methods. Data are from one representative 
experiment of three (A), three (B) and one (C) independent experiments conducted with technical 





not been affected even at 100 μM. Besides, the cells’ viability was examined visually under 
light microscopy and was not adversely affected. As DMSO was used as a solvent for ML-
60218 and it was included in this assay as a control to exclude the notion of IFN-β induction 
was by DMSO. These results have shown that inhibition of RNA Polymerase III blocked the 
production of IFN-β through the suppression of 5’-triphosphate dsRNA production and have 
demonstrated that the poly(dA:dT) was transcribed to 5’-triphosphate dsRNA and triggers 
the induction of type I interferon through RIG-I in HEK293 cells. 
Figure 4.4. RNA Polymerase III is required for poly(dA:dT)-mediated IFN-β induction in HEK293 cells. igure .4. RNA Polymera e III is required for poly(dA:dT) me iated IFN-β induction in 
HEK293 cells. HEK293 cells were seeded at 4x105 in a 6-well plate. The cells were treated with 
ML-60218 at the indicated concentration for two hours and then stimulated with either poly(dA:dT) 
at a concentration of 0.5 µg/ml or poly(I:C) at a concentration of 1 µg/ml. The induction of IFN-ß 
expression was assessed by qRT-PCR after 24 hours post stimulation. qRT-PCR assay was 
conducted in triplicate. The level of IFN-β mRNA in untreated sample was considered 1 to compare 
the treated samples. Data are from three independent experiments conducted with technical 
replicate. Error bars represent mean ±SD. Statistical analysis was performed using Student’s t test. 
Asterisks indicate probability: 
ns
P ≥ 0.1234, 
****
P ≤ 0.0001. 
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4.4 Inhibitory Effect of OV-NZ2 Infection on IFN-β Expression in poly(dA:dT)-
stimulated HEK293 Cells  
It has been shown that HEK293 cells respond to transfected synthetic dsDNA and produce 
IFN-β through cytosolic nucleic acid sensing. Next, an investigation was conducted to test 
whether OV-NZ2 infection has an effect on type I interferon expression. HEK293 cells were 
stimulated with poly(dA:dT) at a concentration of 0.5 μg/ml for 4 hours, then the cells were 
infected with OV-NZ2 at different multiplicities of infection for 20 hours. qRT-PCR analysis 
was conducted from total RNA isolated from cells. The results showed that OV-NZ2 infection 
significantly suppressed IFN-β mRNA levels in HEK293 in a dose-dependent manner (Figure 
4.5 A). The inhibition of IFN-β expression was highly significant at an MOI 5 and was used 
hereafter. The duration of OV-NZ2 IFN antagonism was investigated over 20 hours of virus 
infection. The cells were first stimulated for 4 hours with poly(dA:dT), then infected with 
OV-NZ2 at an MOI 5. The cells were harvested at different intervals and total RNA isolated. 
It has been shown that the inhibitory effect of OV-NZ2 lasted throughout the time course of 
the experiment (Figure 4.5 B). OV-NZ2 infection only, without stimulation, was also 
included and showed no noticeable induction of IFN-β expression (Figure 4.5 B). This result 
strongly suggested that the virus encodes factors that play a role in interfering with type I 
interferon expression. 
4.5 Inhibitory Effect of OV-NZ2 Infection on IFN-β Expression in poly(I:C)-
stimulated HEK293 Cells 
It was also shown above that HEK293 cells produce IFN-β in response to a transfected 
synthetic viral mimic of dsRNA. Virus replication can produce an intermediate dsRNA in 
infected cells and could potentially be recognized by RNA sensors. The poly(I:C) used in this 
study was relatively small, about 0.3 kb (data not shown). It has been shown that RIG-I and 
MDA5 have differential preferences for the type of RNA molecules. MDA5 recognizes long 
poly(I:C) about 7 kb and RIG-I recognizes short poly(I:C) about 0.3 kb (Kato, H. et al., 2008). 
HEK293 cells were first infected with OV-NZ2 for four hours, then stimulated with synthetic 
dsRNA poly(I:C). The cells were harvested and IFN-β mRNA was quantified by qRT-PCR. 
The data have shown that OV-NZ2 infection caused a significant inhibition in IFN-β 
expression in poly(I:C)-stimulated HEK293 cells and an MOI 5 was sufficient for the 
inhibitory effect as shown in Figure 4.6 A. Next, the duration of the OV-NZ2 inhibitory effect 





then stimulated with poly(I:C) and incubated until harvesting time. Similar to the inhibitory 
effect of OV-NZ2 infection in poly(dA:dT)-stimulated cells, OV-NZ2 inhibited the 
Figure 4.5. Inhibitory effect of OV-NZ2 infection in IFN-β induction in poly(dA:dT)-stimulated HEK293 
cells. 
Figur  .5. Inhibitory effect of OV-NZ2 I fectio  on IFN-β Induction in poly(dA:dT)-
stimulated HEK293 cells. HEK293 cells were seeded at 4x10
5
 cells in 6-well plates and stimulated 
with poly(dA:dT) at concentration of 0.5 μg/ml for 4 hours. Then the cells were infected with virus 
for 20 hours at different MOI’s as indicated in (A) or infected with the virus for indicated times at 
an MOI of 5 in (B). Total RNA was isolated from cells and IFN-β mRNA was quantified by qRT-
PCR in triplicate. The level of IFN-β mRNA in uninfected sample was considered 1 to compare 
the infected samples. Data are from three independent experiments. Statistical analysis was 
performed using Student’s t test in (A) and two-way ANOVA in (B). Error bars represent mean 
±SD. Asterisks indicate probability 
****
P ≤ 0.0001. 
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expression of IFN-β in poly(I:C)-stimulated HEK293 cells over the time course of the 
experiment as shown in Figure 4.6 B.  
It appears that OV-NZ2 has a different mechanism to counteract the poly(I:C)-induced IFN 
response that differs from the poly(dA:dT)-induced IFN response. The virus was able to 
Figure 4.6. Inhibitory effect of OV-NZ2 infection on IFN-β induction in poly(I:C)-stimulated HEK293 cells. Figure 4.6 Inhibitory effect of OV-NZ2 Infection on IFN-β Induction in poly(I:C)-stimulated 
HEK293 cells. HEK293 cells were seeded at 4x10
5
 cells in a 6-well plate and first infected with 
OV-NZ2 for 4 hours at different MOI’s as indicated in (A) or at an MOI of 5 in (B). After 4 hours 
post infection, the cells were stimulated with poly(I:C) at a concentration of 1 μg/ml and incubated 
for 20 hours in (A) or at the indicated time in (B). Total RNA was isolated from cells and IFN-β 
mRNA was quantified by qRT-PCR in triplicate.  The level of IFN-β mRNA in uninfected sample 
was considered 1 to compare the infected samples. Data are from three independent experiments. 
Statistical analysis was performed using a Student’s t test in (A) and two-way ANOVA in (B). 
Error bars represent mean ±SD. Asterisks indicate probability 
****
P ≤ 0.0001. 
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significantly suppress the expression of type I interferon in poly(dA:dT)-stimulated HEK293 
Figure 4.7. OV-NZ2 infection is required first to inhibit poly(I:C)-induced IFN-β expression in HEK293 cells. Figure 4.7. OV-NZ2 infection is required first to inhibit poly(I:C)-induced IFN-β expression 
in HEK293 cells. (A) HEK293 cells were seeded at 4x10
5
 cells in 6-well plates and stimulated 
with poly(I:C) at 1 μg/ml for 4 hours. Then the cells were mock infected or infected with OV-NZ2 
at different MOI’s indicated then the cells incubated for 20 hours post infection. Total RNA was 
isolated from the cells and IFN-ß mRNA was quantified by qRT-PCR in triplicate of technical 
replicate. The level of IFN-β mRNA in uninfected sample was considered 1 to compare the infected 
samples. Statistical analysis was performed using Student’s t test. Data are from three independent 
experiments. Error bars represent mean ±SD. ns indicates probability
 ns
P ≥ 0.1234. (B) HEK293 
cells were seeded at 4x10
5
 cells in 6-well plates and stimulated with poly(I:C) at the concentrations 
indicated for 4 hours. Then the cells were mock infected or infected with OV-NZ2 at an MOI of 5 
then the cells incubated for 20 hours post infection. Total RNA was isolated from the cells and 
IFN-ß mRNA was quantified by qRT-PCR in triplicate of technical replicate. Data are from one 
experiment. Error bars represent mean ±SD. 
A.
B.
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cells following stimulation. On the other hand, the virus could not significantly suppress the 
poly(I:C)-induced IFN response when infection follows stimulation (Figure 4.7 A) and that 
was not because of an excessive response that the virus could not counteract (Figure 4.7 B). 
This may indicate that infection needs to precede poly(I:C) stimulation to express a specific 
antagonist to counteract the dsRNA-induced IFN response.    
4.6 RIG-I Receptor is Required for IFN- Expression in HEK293 Cells 
RIG-I encodes a protein that contains DExD/H box RNA helicase and a caspase recruitment 
domain and it has been shown that this protein plays an essential role in regulation of dsRNA-
induced signalling that leads to expression of type I interferon (Yoneyama, M. et al., 2004).  
From the results of IFN-β induction reported above, it was more likely that the RIG-I receptor 
plays a major role in the induction of IFN- expression in HEK293 cells when stimulated 
with poly(dA:dT) or poly(I:C). The involvement of RIG-I in the IFN response was further 
investigated by using RNA interference (RNAi). Three different predesigned synthetic small 
interfering RNAs duplex (siRNA) were used to minimize the possibility of off-target effects. 
They were short 19 nucleotide siRNA with 2-base 3’ overhangs and these features enable 
siRNA to bypass any possible interferon induction triggered by dsRNA transfection 
(Marques, J. T. et al., 2006; Sioud, M., 2006). 
It was anticipated that endogenous RIG-I is constantly expressed in the cytosol of HEK293 
cells in order to detect any danger signal and then its level is increased by interferon upon 
induction. Western blot analysis has shown no sign of RIG-I protein detection in unstimulated 
cells (Figure 4.8 A) and this was consistent with previously published studies (Kok, K.-H. et 
al., 2011; Zhu, J. et al., 2014). However, immunoprecipitation using antibody against 
endogenous RIG-I showed a weak signal of RIG-I protein expression in some cases, 
indicating that the protein is present but at a very low level (Figure 4.8 A). The expression of 
endogenous RIG-I protein in poly(dA:dT)-stimulated HEK293 cells was barely detected at 
15 hours post-stimulation but it was detectable at 24 hours post stimulation, whereas in 
poly(I:C) stimulation it was neither detectable at 15 nor at 24  hours post-stimulation (data 
not shown). It was speculated that HEK293 cells do not express STING, an adaptor for the 
DNA signalling pathway (see next Chapter for more detail). To exclude this possibility, 





either in mock or stimulated cells (Figure 4.8 B), consistent with observations by Zhang, Y. 
et al. (2014), and as expected the cells do express IRF3 and TBK1 molecules (Figure 4.8 B).      
Next, an optimization of RIG-I siRNA transfection was conducted to determine the optimal 
conditions and concentrations of siRNA transfection that lead to depletion of RIG-I protein 
expression in HEK293 cells. It was found that siRNA#2 at 100 nM was sufficient to deplete 
the expression of RIG-I protein (data not shown). HEK293 cells were transiently transfected 
with three siRNA individually targeting distinct regions in RIG-I mRNA along with an 
siRNA negative control (NC) and absence of siRNA (none). Then the cells were stimulated 
either with poly(dA:dT) or poly(I:C) and IFN- expression examined by qRT-PCR. The 
transfection of RIG-I siRNA caused a depletion in RIG-I protein in poly(dA:dT)-stimulated 
cells of about 70% (Figure 4.9 A and B). In addition, siRNA-mediated RIG-I silencing caused 






































Figure 4.8. Detection of signalling proteins in HEK293 cells by western blotting. (A) 
HEK293 cell lysates were immunoprecipitated (IP) with anti-RIG-I antibody or IgG as a 
negative control and protein detected by anti-RIG-I. (B) HEK293 cells were mock stimulated or 
stimulated with 0.5 μg/ml of poly(dA:dT) or with 1 μg/ml of poly(I:C) for 15 hours. Cells were 
harvested and lysed. Ten μg of cell lysate was resolved on a 10 % SDS-polyacrylamide gel and 
proteins transferred onto nitrocellulose membrane. The membrane was incubated with antibody 





about 70 – 80% of RIG-I mRNA depletion in either poly(dA:dT)- or poly(I:C)-stimulated 
HEK293 cells (Figure 4.9 C and D). As expected, the induction of IFN- mRNA was 
abolished in both poly(dA:dT)- and poly(I:C)-stimulated cells after depleting RIG-I mRNA 
(Figure 4.10 A and B). These results strongly suggest that the RIG-I receptor is involved in 







Figure 4.9. siRNA knockdown of RIG-I gene in HEK293 cells. Figure 4.9. siRNA knockdown of RIG-I gene in HEK293 cells. HEK293 cells were transfected 
for 48 hours with three different siRNAs (100 nM) targeting distinct regions in mRNA of the RIG-
I gene. Control conditions include mock transfection in the absence of siRNA (none) or transfection 
with a non-targeting control siRNA (NC). At 48 h.p.t., the transfected cells were stimulated with 
either poly(dA:dT) 0.5 µg/ml or poly(I:C) 1 µg/ml for 24 hrs. (A) Transfected cells were lysed in 
lysis buffer for western blot analysis of RIG-I protein expression using 40 µg of total protein. 
Western blot data is from one representative experiment of three independent experiments. (B) 
Expression of RIG-I protein was quantified from western blot and relative RIG-I expression levels 
were obtained by normalizing to a tubulin loading control then to a mock transfection control. (C) 
and (D) Expression level of RIG-I mRNA was determined in siRNA-transfected cells by qRT-PCR 
in triplicate of technical replicate either induced by poly(I:C) (C) or poly(dA:dT) (D). Data are 
from three independent experiments. Statistical analysis was performed using a Student’s t test. 
Error bars represent mean ±SD. Asterisks indicate probability 
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The involvement of RIG-I in dsRNA-induced IFN-β in HEK293 cells was further confirmed 
by transient expression of the receptor. RIG-I protein was transiently expressed from pEF-
BOS-RIG-I-flag in HEK293 cells at increasing amounts for 24 hours and the linearized empty 
vector was included as a control as well. Then the cells were mock stimulated or stimulated 
with poly(dA:dT) or poly(I:C) for 24 hours and cells harvested for total RNA and protein 
detection. qRT-PCR data showed that expression of RIG-I alone triggered the IFN signalling 
pathway at 0.5 and 1 μg, however, this induction of IFN- was significantly enhanced by 
poly(dA:dT) or poly(I:C) stimulation by 5 and 10 fold respectively compared to untransfected 
cells and that was not observed in cells transfected with empty vector (Figure 4.11). These 
results further confirmed the involvement of RIG-I in dsRNA-induced IFN-β and the only 
sensor that poly(dA:dT) is working through is RIG-I. The expression of RIG-I protein from 
Figure 4.10. RIG-I is required in HEK293 cells for IFN-β induction. Figure 4.10 RIG-I is required in HEK293 cells for IFN-ß induction. HEK293 cells were 
transfected for 48 hours with three different siRNAs (100 nM) targeting distinct regions in mRNA 
of RIG-I gene. Control conditions include mock transfection in the absence of siRNA (none) or 
transfection with a non-targeting control siRNA (NC). At 48 h.p.t., the transfected cells were 
stimulated either with poly(I:C) 1 µg/ml (A) or poly(dA:dT) 0.5 µg/ml (B)  for 24 hrs. Then the 
induction of IFN-ß expression was assessed by qRT-PCR in triplicate of technical replicate. Data 
are from three independent experiments. Statistical analysis was performed using Student’s t test. 
Error bars represent mean ±SD. Asterisks indicate probability 
****
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the vector was also confirmed by western blotting using antibodies against flag or RIG-I 
(Figure 4.11).    
Figure 4.11. RIG-I is involved in the induction of IFN-β in HEK293 cells stimulated with either poly(dA:dT) or poly(I:C). 
Figure 4.11 RIG-I is involved in the induction of IFN-β in HEK293 cells stimulated with either 
poly(dA:dT) or poly(I:C). HEK293 cells were seeded at 4x105 in 6-well plates and transiently 
transfected either with human pEF-BOS-RIG-I full-Flag or linearized empty pEF-BOS as a control 
for 24 hrs at the indicated amounts. Then cells were either mock stimulated or stimulated with 
poly(dA:dT) 0.5 μg/ml or poly(I:C) 1 μg/ml for 24 hrs. The cells were harvested and lysed for total 
RNA and total protein. Induction of IFN-β mRNA was assessed in cells by qRT-PCR and 
expression fold was calculated as described in materials and methods. RIG-I protein expression 
level from the vector was also assessed by immunoblotting using either anti-flag or anti-RIG-I 
antibody. Data are from one experiment with technical replicate and qRT-PCR conducted in 
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4.7 Role of OV-NZ2 ORF020 (E3L homologue) on RIG-I-Dependent Signalling  
A homolog of the VACV interferon resistance gene E3L, ORF020, was discovered in OV-
NZ2 (McInnes, C. J. et al., 1998). ORF020 is transcribed towards the left terminus of the 
virus genome. ORF020 was found to bind dsRNA; but not ssRNA, ssDNA or dsDNA and 
inhibits the activation of dsRNA-dependent protein kinase (PKR) (Haig, D. M. et al., 1998). 
VACV E3L was shown to have the ability to inhibits the luciferase activity of an IFN-β-
dependent promoter in  poly(dA:dT)- stimulated 293T and HeLa cells (Valentine, R. et al., 
2010).  
These reports raised the question whether OV-NZ2 ORF020 could be responsible, or partially 
responsible, for the inhibition of IFN-β expression observed in this study and more likely 
through interfering with RIG-I-dependent signalling (Figure 4.12). Transient expression of 
OV-NZ2 ORF020 could give a clearer insight as to how OV-NZ2 manipulates the IFN 
response. Therefore, an investigation was undertaken to examine the effect of ORF020 gene 
on RIG-I-dependent signalling by expression of ORF020 from a vector in HEK293 cells then 
stimulated with dsDNA poly(dA:dT) or dsRNA poly(I:C) and induction of IFN- measured 
by qRT-PCR.  
Firstly, a plasmid construct expressing OV-NZ2 ORF020 was generated in which the 
ORF020 gene was PCR amplified from a pVU2015 KpnI-F fragment (Figure 4.13 A) and 
cloned into a pAPEX3-Flag vector at the AscI restriction site as described in materials and 
methods. The correct orientation of ORF020 was confirmed by restriction analysis (data not 
shown) and the final construct was sequenced to confirm the integrity of the construct. Upon 
24 hour post transfection, the expression of ORF020 was detected in HEK293 cells by 
western blotting using anti-flag antibody and the size of the band was around 24 kDa (Figure 
4.13 B). ORF020 protein was previously expressed in E. coli as a thioredoxin fusion protein 
from the pTrxFus expression vector and produced a protein with a size about 41 kDa on 
Coomassie gel (Haig, D. M. et al., 1998).     
Secondly, the investigation determined the effect of OV-NZ2 ORF020 on IFN-β expression. 
ORF020 was expressed in HEK293 cells at increasing amount for 24 hours then cells 





expression was detected by western blotting using anti-flag antibody. Expression of ORF020 
without stimulation did not induce IFN signalling. However, IFN-β expression was inhibited 
by ORF020 in poly(dA:dT)- or poly(I:C)-stimulated cells in a dose-dependent manner 
compared to mock transfectants (Figure 4.14). Ideally this assay could have been improved 
by incorporating an empty vector control, however the preliminary finding implies that 
ORF020 plays a role in counteracting the IFN response by targeting RIG-I-like receptor-
dependent signalling.  
Having established that RIG-I expression enhanced IFN signalling and ORF020 expression 
suppressed the signalling, it was speculated that ORF020 has a role on RIG-I. An approach 
was taken to investigate the effect of ORF020 on RIG-I-dependent signalling by co-
expressing an increasing amount of ORF020 and 0.1 μg of RIG-I-expressing plasmid in 
HEK293 cells and then observed the induction of IFN-β expression after stimulation with 
Figure 4.12. Schematic representation of potential effect of OV-NZ2 ORF020 on the induction of IFN-β 
in HEK293 cells. 
Figure 4.12 Schematic representation of potential effect of OV-NZ2 ORF020 on the induction 
of IFN-ß in HEK293 cells. Upon stimulation with poly(dA:dT), polymerase III will convert it to 
ppp-dsRNA then detected by RIG-I receptor leading to expression of IFN-β. Poly(I:C) stimulation 
will trigger RLR-dependent signalling pathway that leads to expression of IFN-β. OV-NZ2 
ORF020 has a potential effect on the expression of IFN-β by targeting RLR signalling through 






















poly(dA:dT) or poly(I:C). The amount of plasmid expressing ORF020 was increased up to 
2.5 μg in this assay rather than up to 1 μg as shown in Figure 4.14, whereas the amount of 
plasmid expressing RIG-I remained the same of 0.1 μg as this amount did not elicit the IFN 
response as shown in Figure 4.11. As shown in Figure 4.15, the expression of ORF020 in 
poly(dA:dT)- or poly(I:C)-stimulated cells transfected with RIG-I-expressing plasmid caused 
Figure 4.13. Electrophoresis of PCR amplified OV-NZ2 ORF020 gene and transient expression in HEK293 cells. 
Figure 4.13. Electrophoresis of PCR amplified OV-NZ2 ORF020 gene and transient 
expression in HEK293 cells. (A) OV-NZ2 ORF020 was PCR amplified from the pVU215 plasmid 
using primers containing the AscI site. PCR amplified ORF020 was firstly digested with AscI then 
gel purified. The ORF020 was cloned into the vector pAPEX3-flag at the AscI restriction site that 
included a start codon, downstream kozak sequence and stop codon downstream of the flag tag. 
The correct orientation of ORF020 gene was confirmed by restriction analysis and the integrity of 
the gene was also confirmed by sequencing. (B) Detection of ORF020 protein was assessed by 
western blot analysis. Two micrograms of the construct was transfected into HEK293 cell at 
different transfection ratios for 24 hours. Then 20 l of cell lysate was resolved on a 10% of SDS-










































a suppression in IFN-β expression and it seems that the ORF020 protein has compromised 
RIG-I activity in enhancing IFN-β signalling. Taken together, these results have determined 
a new role for ORF020 in counteracting RLR-dependent signalling.  
Due to the time constraints, the IFN assays that involved expression of RIG-I, ORF020 or 
RIG-I/ORF020 were only carried out once.  
Figure 4.14. Effect of OV-NZ2 ORF020 expression on the induction of IFN-β in HEK293 cells stimulated 
with poly(dA:dT) or poly(I:C). Figure 4.14. Effect of OV-NZ2 ORF020 expression on the induction of IFN-β in HEK293 cells 
stimulated with poly(dA:dT) or poly(I:C). Indicated amounts of OV-NZ2 ORF020 was 
expressed in HEK293 cells for 24 hours. Then cells were mock stimulated or stimulated with 
poly(dA:dT) or poly(I:C) for 24 hours. The induction of IFN-β mRNA was quantified by qRT-PCR 
in triplicate of technical replicate and expression fold was calculated as described in materials and 
methods. Data are from one experiment. Error bars represent mean ±SD. Equal amounts of total 
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4.8 Detection of Phosphorylated-TBK and Phosphorylated-IRF3 in HEK293 Cells 
IFN signalling pathways play a vital role in the regulation of the innate immune response. 
Upon recognition of PAMP through PRR, signalling pathways are activated leading to 
induction of type I IFN. Several signalling molecules are involved in this signalling cascade. 
TBK1 and IRF3 are an indisputably critical signalling axis and their involvement are 
supported by many lines of evidence. TBK1 is a critical kinase that gets auto-phosphorylated 
before transducing the signal to IRF3. IRF-3 is expressed constitutively in almost all cell 
types whereas most IRF family members are expressed only in specialized cell types. IRF-3 
is known to regulate expression of IFN-β and interferon-stimulated genes upon its activation 
determined by phosphorylation, dimerization and translocation to the nucleus, hallmarks of 
Figure 4.15. Effect of OV-NZ2 ORF020 expression on RIG-I-dependent sensing in HEK293 cells. 
Figure 4.15 Effect of OV-NZ2 ORF020 expression on RIG-I-dependent sensing in HEK293 
cells. Human RIG-I and OV-NZ2 ORF020 were co-expressed in HEK293 cells at concentration 
indicated for 24 hours. Then the cells were stimulated with poly(dA:dT) or poly(I:C) at 
concentration indicated for 24 hours. The induction of IFN-β was assessed in cells by qRT-PCR in 
triplicate of technical replicate and expression fold was calculated as described in materials and 
methods. Data are from one experiment. Error bars represent mean ±SD. 
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its activation. Therefore, it is not uncommon that viruses evolve to encode proteins that 
antagonize the function of TBK1 and IRF3.    
It has been clearly shown that OV-NZ2 inhibits IFN-β expression. An attempt was made to 
understand the underlying mechanism and determine how the virus targets the IFN response. 
It was hypothesized that the virus either avoids cell receptor recognition or interferes with the 
signalling molecules. To test this hypothesis, an attempt was made to develop an assay and 
examine the activation of the signalling molecules (TBK1 and IRF-3) in HEK293 cells 
infected with OV-NZ2 by using western blot analysis. In the first instance, efforts were made 
to detect the phosphorylated forms of TBK1 and IRF-3 proteins in HEK293 cells upon 
stimulation with different concentrations of nucleic acid stimuli for different times points. 
However, none of these efforts were successful in detecting p-TBK1 or p-IRF-3 (data not 
shown). The Phosphorylated-TBK1 antibody used in this study detects Ser172 and it was 
intact as it was able to detect phosphorylated-TBK1 in THP-1 cells stimulated with LPS 
(Appendix: Figure 9.6), while phosphorylated-IRF-3 antibody detects Ser396. A previous 
report has shown differential phosphorylation of IRF-3 serine sites (Ser396 or Ser386) in 
HEK293 cells when stimulated with DNA or RNA molecules (Burleigh, K. et al., 2019). It 
seems that TBK1 or IRF-3 are phosphorylated at low levels in some cell types when 
stimulated with poly(dA:dT) making the phosphorylated protein hardly detectable by western 
blotting (personal communication).      
4.9 Early Viral Gene Synthesis was Required for Inhibition of IFN- Expression in 
HEK293 Cells 
It was hypothesized that the inhibitory effect of OV-NZ2 on IFN-β expression observed was 
caused by newly synthesized viral protein. An investigation was conducted to test this 
hypothesis and also to assist in identifying the virus gene(s) involved. A well-established 
approach widely used in poxvirus studies was undertaken in which the translation of early 
poxvirus gene transcripts is inhibited without interfering with virus gene transcription.  
Of these inhibitors, adenosine N1-oxide (ANO) is a potent and selective inhibitor of poxvirus 
early protein synthesis due to selective incorporation of the adenosine analogue into viral 
mRNA resulting in inhibition of viral protein synthesis, consequently inhibiting viral DNA 
replication and late gene expression. In this study, the detection of OV119 by western blotting 
was used as an indication of virus early gene production. OV119 is a characterized OV-NZ2 





ANO was first determined in HEK293 cells infected with OV-NZ2 and it was found that a 
concentration of 5 μg/ml caused strong inhibition of OV 119 protein production (Appendix: 
Figure 9.7). Then IFN-β induction was assessed in ANO-treated HEK293 cells. From the data 
obtained, ANO seemed to interfere with IFN-β signalling (data not shown); therefore, the 
option of ANO treatment was excluded in this study.  
Cycloheximide (CHX) is a common protein synthesis inhibitor that blocks the elongation 
phase of eukaryotic translation by binding the ribosome resulting in inhibition of eEF2-
mediated translocation, leading to inhibition of virus and host protein synthesis. It is 
important to note that the required proteins to be inhibited in this study were virus proteins 
not host proteins. CHX will inhibit cellular protein translation and there might be newly 
synthesized host proteins required in IFN-β signalling. This notion was supported by work 
by Smith, E. J. et al. (2001). Their work was about testing the requirement for protein 
synthesis for activation of IRF7 in HEK293T cells upon infection with NDV, they found that 
cycloheximide treatment for more than 3 hours caused inhibition of IRF7 phosphorylation 
and they attributed this to the potential blockage of short-lived cellular protein synthesis. 
From the above findings, a CHX approach was also excluded in this study. 
Cytosine arabinoside (AraC) is an inhibitor of viral DNA replication and therefore late protein 
expression, while early protein expression remains intact. However, prolonged exposure of 
cells to AraC is unknown and the cells in the proposed assay would need to be incubated for 
a lengthy time upon stimulation to see a response.   
Ultraviolet (UV) light is a practical tool to generate non-replicating virus in which the viral 
genome gets cross-linked after exposure to UV (Tsung, K. et al., 1996). However, this 
approach was not appropriate in this study as protein synthesis inhibition by UV treatment is 
proportional to the size of virus genes and that may cause a blockage in transcription of other 
early viral genes (Pelham, H. R. B., 1977; Tsung, K. et al., 1996). Therefore, the investigation 
using UV treatment was not included in this study.   
Lastly, inactivating virus by heat has been shown to render VACV non-infectious (Kaplan, 
C., 1958). Non-infectious particles generated from heat treatment have been characterized 
previously (Harper, J. M. et al., 1978). They have shown that the machinery of gene 
transcription of the virus was relatively insensitive and virus could infect the cell and 
transcribe early genes but their protein synthesis was impaired. Besides, this approach has 





al., 2012) and it has been used also in an influenza virus study (Diebold, S. S. et al., 2004). 
Since the life cycle of ORFV parallels VACV, it was encouraging to utilize a heat inactivation 
approach in this study to inactivate early protein synthesis of OV-NZ2. These reports have 
shown that the optimal temperature and duration of heat treatment is 55 °C for 1 hour, 
accordingly, these parameters were used in this study to inactivate OV-NZ2.  
First of all, the growth of the OV-NZ2 wild type was characterized in HEK293 cells. The 
cells were infected with the virus at an MOI of 5, then the cells were harvested at various 
time points and the virus progeny quantified by plaque assay on LT cells. OV-NZ2 shows 
efficient replication in HEK293 cells (Figure 4.16). The virus showed a distinguishable 
eclipse phase at 6 hours post infection and exponential growth started at 12 hours post 
infection until 48 hours post infection then reached a plateau from day 2 giving about 100-
fold increase in the virus progeny. This growth characteristics of OV-NZ2 in HEK293 cells 
was identical to growth in primary host LT cells and HeLa cells (unpublished data).   
OV-NZ2 virus inocula were prepared at a multiplicity of infection 5 then the inocula were 
split into two in which one was treated with heat at 55 °C for 1 hour (referred to as heat 
inactivated virus) and the other left without treatment (referred to as untreated virus). The 
early viral gene protein synthesis in HEK293 cells infected either with untreated or heat 
inactivated virus was examined using OV119 protein as an indicator. The cells were either 
infected with untreated virus or heat inactivated virus then the cells harvested at 0, 2, 4 and 6 
hour post infection. The cell lysates were subjected to western blotting using anti-OV119 
antibody. The synthesis of OV119 was detected at 4 hours post infection and the level of 
OV119 protein increased at 6 hours post infection as shown in Figure 4.17. However, the 
induction of OV119 protein was completely abolished with heat inactivated virus that has 
lost early protein synthesis (Figure 4.17). The cytopathic effect (CPE) of infected HEK293 
cells was also examined under light microscope. Untreated virus induced clear CPE at 4 hours 
post infection and increased at 6 hours post infection, whereas, as expected, the heat 
inactivated virus did not induce CPE (data not shown).  
Having established the above, the investigation then assessed the induction of IFN-β 
expression in HEK293 cells infected with untreated or heat inactivated virus infection. The 
OV-NZ2-Rev116 virus and OV-NZ2Δ116 were included in this assay to assess whether 
ORF116 gene has any direct effect on IFN-β induction (see Chapter 3). The cells were 





poly(I:C) stimulation. Same virus preparations were used in poly(dA:dT)- and poly(I:C)-
stimulated cells and equal amount was assured. Then IFN-β mRNA was quantified by qRT-
PCR. The data showed that all live viruses were able to significantly inhibit the induction of 
IFN-β expression when cells were stimulated with poly(dA:dT) or poly(I:C) and this ability 
was not retained when cells were infected with heat inactivated virus (Figures 4.18). None of 
the viruses, untreated or heat inactivated, have induced the expression of IFN-β in un-
stimulated cells. These data demonstrated that the virus gene responsible is an early gene(s) 
and the IFN inhibitory effect requires de novo synthesis early viral proteins. With regard to 
the role of ORF116, the induction of IFN-β has shown no significant difference among the 




Figure 4.16. One step growth analysis of OV-NZ2 in HEK293. 
Figure 4.16. One-step growth analysis of OV-NZ2 in HEK293. HEK293 cells were seeded at 
4x10
5
 and incubated overnight. At the day of infection, cells were washed with PBS then infected 
at an MOI of 5 pfu per cell with OV-NZ2 wild type. After 1hr adsorption, cells were washed 
with PBS to remove unattached virus then 2 ml of DMEM 2 % FCS was added. At various times 
post-infection, media and infected cells were collected. After three cycles of freezing and 
thawing, the virus was sonicated and viral titres determined by serial dilution and infection of 
LT cells. Virus plaques were visualized by staining with neutral red, counted then PFU/ml 
calculated.   





























Figure 4.17. Detection of ORFV early protein synthesis in HEK293 cells infected with heat inactivated or untreated 
virus. 
Figure 4.17 Detection of ORFV early protein synthesis in HEK293 cells infected with heat 
inactivated or untreated virus. HEK293 cells were seeded at 4x104 in a 24-well plate. On the 
day of infection, virus inocula of OV-NZ2, OV-NZ2Δ116 or OV-NZ2Rev116 were prepared at 
an MOI of 5, then split into two. One was subjected to heat treatment in water bath at 55 °C for 
1 hour and the other one left untreated. HEK293 cells were infected with heat inactivated or 
untreated OV-NZ2, OV-NZ2Δ116 or OV-NZ2Rev116. The cells were harvested and lyzed at 0, 
1, 2, 4 and 6 hour post infection. Five microgram of total protein was resolved on a 10 % SDS-
polyacrylamide gel and proteins transferred onto nitrocellulose membrane. The membrane was 
incubated with anti-OV119 antibody and proteins detected by chemiluminescence. The 


































Figure 4.18. Induction of IFN-β by poly(dA:dT) or poly(I:C) in HEK293 cells infected with heat inactivated or untreated 
virus. Figure 4.18 Induction of IFN-β by poly(dA:dT) or poly(I:C) in HEK293 cells infected with 
heat- inactivated or untreated virus. HEK293 cells were seeded at 4x10
4
 cells in a 24-well plate. 
(A) Cells were stimulated with poly(dA:dT) at 0.5 μg/ml and incubated for 4 hours then cells 
infected with either heat-inactivated or untreated virus:OV-NZ2, OV-NZ2Δ116 or OV-NZ2-
Rev116 at an MOI of 5 and incubated for 20 hours. (B) Cells were infected with either heat-
inactivated or untreated virus: OV-NZ2, OV-NZ2Δ116 or OV-NZ2-Rev116 at an MOI of 5 for 4 
hours then cells stimulated with poly(I:C) at 1 μg/ml or left unstimulated and incubated for 20 
hours. After incubation, cells were harvested and total RNA was isolated from the cells and IFN-ß 
mRNA was quantified by qRT-PCR in triplicate of technical replicate. The level of IFN-β mRNA 
in uninfected sample was considered 1 to compare the infected samples. Data are from three 
independent experiments. Error bars represent mean ±SD. Statistical analysis was performed using 
a Student’s t test. Asterisks indicate probability: 
 ns
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4.10 Effect of Stably Expressed ORF116 on the Induction of Type I Interferon  
The manipulation of ISGs observed in the presence of ORF116 suggests that ORF116 is 
playing a role in modulating the IFN response and it was speculated either by blocking the 
production of type I interferon from infected cells or directly blocking ISG expression or both 
(see Chapter 3). However the data obtained from the infection of OV-NZ2, OV-NZ2Δ116 or 
OV-NZ2-Rev116 was not conclusive about the role of ORF116 on the inhibition of IFN-β 
(Figure 4.18). To delineate this further the role of ORF116 in isolation from other virus genes 
was investigated by making cell lines that stably express ORF116 then stimulated with either 
poly(dA:dT) or poly(I:C). Generating a cell line stably expressing the protein of interest 
would avoid introducing foreign nucleic acid material into the cells which may elicit an 
immune response.  
A construct of pAPEX3-ORF116-Flag was utilized in which ORF116 was cloned into 
pAPEX3-Flag at the BamHI restriction site. The construct was first characterized by 
restriction analysis and sequencing, and the transient expression of ORF116 was detectable 
in HEK293 cells by immunoblotting analysis using anti-flag antibody. The predicted size 
from the amino acid sequence is about 25 kDa, however the size of the peptide detected was 
larger, probably due to post-translational modification. In addition to this, based on the 
observations shown in Figures 4.14 and 4.15, OV-NZ2 ORF020 and human RIG-I genes were 
also included in this assay.   
Attempts were made to stably express ORF116 and ORF020 individually in HeLa cells or 
with RIG-I in HEK293 cells. Generating a stable expressing cell line in HeLa cells would 
further validate the data obtained from OV-NZ2Δ116 infection in HeLa (Figure 3.11). 
Whereas generating a stable expressing cell line in HEK293 would provide insight into how 
the virus manipulates the induction of type I IFN.  
pAPEX3 transfectants were selected with hygromycin B at a concentration of 0.1 mg/ml as 
this concentration was determined previously and shown to be suitable for selection of 
resistant clones that can kill non-transfectants without causing toxicity to the transfectants. 
pEF-BOS transfectants were selected with geneticin (G418) at a concentration of 1 mg/ml as 
determined from the kill curve in this study, consistent with previous reports. Co-transfection 





lines were incubated in complete selection media for three months to insure resistant clones 
were generated.           
The transient expression of the three proteins from constructs was confirmed, then cell lines 
were generated as detailed in material and methods. HeLa cells were transfected either with 
ORF116 or ORF020 and then subjected to antibiotic selection. Whereas HEK293 cells were 
transfected either with ORF116, ORF020 or RIG-I or co-transfected with RIG-I then 
subjected to antibiotic selection. In pAPEX3 transfection, the cell death in control transfection 
was observed within a week then complete death was observed within two weeks. Whereas 
same sign of cell death was noticed in pEF-BOS transfection in the first week, complete death 
was observed after three weeks. After cell lines were generated, they were subjected to 
western blot analysis to detect the expression of proteins using anti-flag antibody as shown 
in Figure 4.19 A. Both HeLa-transfected 116 and HeLa-transfected 020 cell lines have shown 
hygromycin B resistance, but the expression of both proteins was not detectable, more likely 
the genes were silenced. HEK293-020 and HEK293-RIG-I have also shown hygromycin B 
and geneticin resistance respectively, but no proteins were detectable on western blot. 
Nevertheless, HEK293-116 has shown hygromcin B resistance and the protein was 
detectable. The co-transfection of ORF116 and RIG-I in HEK293 cells has shown only 
ORF116 protein expression but not RIG-I protein, whereas in the co-transfection of ORF020 
and RIG-I in HEK293, neither of the proteins were detectable (Figure 4.19 A).      
The only cell line that successfully generated stably expressing protein was in HEK293 cells 
that express the OV-NZ2 ORF116 protein. This cell line was then used to investigate whether 
ORF116 has a role on the inhibition of type I IFN. The mock cells or cells expressing ORF116 
were mock stimulated or stimulated with poly(dA:dT) or poly(I:C) then IFN-β mRNA was 
quantified by qRT-PCR. The data has shown that ORF116 suppressed the induction of IFN-
β expression by about 50% either in poly(dA:dT)- or poly(I:C)-stimulated ORF116-
expressing cells (Figure 4.19 B). This data strongly suggests a role played by ORF116 on 
IFN-β expression and the data in Figure 4.18 could suggest that ORF116 function was masked 























































































Figure 4.19. Effect of stable protein expression on the induction of IFN-β. (A) Detection of 
stable protein expression from cell lines by w stern bl t. HeLa or HEK293 cells were stably 
transfected with indicated plasmids as described in materials and methods. One hundred μg of 
total protein was resolved on 10 % SDS-PAGE and proteins detected using anti-flag antibody. 
(B) Induction of IFN-ß by poly(dA:dT) and poly(I:C) in HEK293 cell line stably expressing 
ORF116. The cells were seeded at 4x10
5
 cells in a 6-well plate and stimulated with poly(dA:dT) 
or poly(I:C) and incubated for 20 hours post stimulation. Total RNA was isolated from cells and 
IFN-ß mRNA was quantified by qRT-PCR. The level of IFN-β mRNA in untransfected sample 
was considered 1 to compare the transfected samples. Data are from three independent 
experiments. Error bars represent mean ±SD. Statistical analysis was performed using the 
Student’s t test. Asterisks indicate probability 
***







4.11 Discussion  
This is the first study that demonstrates inhibition of IFN-β expression by ORFV, a critical 
cytokine in the host antiviral response. Since ORFV replicates in the cytoplasm of the host 
cell and likely produces dsRNA from convergent transcription, makes it a potential target for 
cytosolic RNA-dependent sensing. Here, the objective of this part of the study was to 
investigate the effect of ORFV infection on type I IFN expression upon dsRNA sensing by 
RIG-I. HEK293 cells proved to be an excellent model to carry out this study in which they 
were permissive for ORFV, only expressed cytoplasmic RNA sensors RIG-I and MDA-5, 
responsive to exogenously delivered synthetic dsRNA that mimics virally produced dsRNA 
and importantly they do not express Toll-like Receptors or cytoplasmic DNA sensors, except 
for RNA Polymerase III, a feature that was exploited in this study. 
Here, it was shown that ORFV clearly interferes with IFN signalling in HEK293 cells 
triggered either by poly(dA:dT) or poly(I:C) causing significant inhibition of IFN-β 
expression. These results strongly suggest that ORFV produces molecules that interfere with 
the signalling pathway leading to expression of IFN-β. It is likely that those viral molecules 
are synthesised early, and are not structural proteins as demonstrated in assays using heat-
inactivated virus. Inhibition of signalling could be direct or it could be indirect. Poxviruses in 
particular orthopoxviruses directly target pathways that led to IFN production and suggests 
that the inhibition observed in our assays is likely to be direct although indirect mechanisms 
may also be possible. The inhibitory effect on IFN-β by ORFV in this study does not appear 
to be because of a general shutdown of transcription by the virus as the expression of the 
internal control GAPDH did not change in mock cells compared with infected cells. It is 
important to note that an attempt to detect IFN-β protein secretion was not conducted because 
the focus of this study was to investigate the effect of virus infection on IFN signalling 
pathway that lead to IFN-β expression but not the positive feedback loop effect of IFN. qRT-
PCR technique was used to provide accurate quantification of mRNA and provided 
physiological relevance across different sample conditions.     
ORFV, as for other poxviruses, encodes multiple factors at an early stage of infection to 
counteract the innate immune response at multiple levels including type I IFN induction. It 
was not unexpected that ORFV infection does not induce type I IFN expression and this could 
be due to the expression of viral inhibitors or failing to trigger IFN signalling in cell culture. 





the virus could inhibit the IFN response or not. In this study, synthetic dsDNA poly(dA:dT) 
and synthetic dsRNA poly(I:C) were chosen as inducers on the basis of their ability to activate 
the cytosolic DNA- or RNA-dependent IFN pathways respectively and mimic viral nucleic 
acids.  
The data of kinetic induction of IFN-β has shown that the induction of this cytokine by 
poly(dA:dT) or poly(I:C) was marginal at early time points post stimulation, then the response 
was enhanced from 6 hours and increased up to 20 - 25 hours. Poly(dA:dT) induced the 
expression of IFN-β by about 8000 fold whereas poly(I:C) induced the response by about 500 
fold. This fold difference in stimulation could be attributed to the continuous production of 
dsRNA through the polymerase III-dependent pathway in poly(dA:dT)-transfected HEK293 
cells. It was observed that where cells were first stimulated with poly(dA:dT) for four hours 
then infected with the virus that this resulted in more than 50% and 80% inhibition in IFN-β 
production by 15 and 20 hours post-infection respectively whereas using poly(I:C) 
stimulation, in which cells were first infected with virus then stimulated led to more than 80% 
and 90% inhibition of IFN-β production at 15 and 20 hours post infection respectively.  
Surprisingly, it was observed that when infection followed poly(I:C) stimulation, the virus 
could not significantly inhibit the response and the possible explanation for this could be that 
the virus might need first to express factors such as ORF020 (VACV E3L homologue) to 
sequester dsRNA and interfere with dsRNA engagement with receptors. From a comparison 
between the inhibitory effect of poly(dA:dT)- and poly(I:C)-stimulated cells, it was found 
that when virus infection preceded stimulation, stronger inhibition was found. It would have 
been interesting to have conducted the poly(dA:dT) assay by infecting cells before 
stimulating with poly(dA:dT) to determine whether there was even greater inhibition of IFN. 
To the best of our knowledge, there are few studies that have utilized a stimulation-infection 
approach to investigate the effect of virus on the IFN response, apart from assays involving 
transient expression of individual virus genes. Huang, J. et al. (2018) and Marq, J.-B. et al. 
(2009) have utilized this approach in their study, however, the virus infection was prior 
dsDNA stimulation. Studies have shown that IFN-α/β mRNA is constitutively expressed but 
at a very low level in the absence of virus or other inducers and this low level of induction is 
believed to provide weak signalling critical to elicit a stronger response upon virus infection 
or nucleic acid detection (Takaoka, A. et al., 2006). Thus, when cells are stimulated first, this 





increased above the basal level. Here, the cells were infected with the virus at 4 hours post 
stimulation with poly(dA:dT) which was sufficient time to allow the virus to express all the 
necessary factors before the induction of IFN-β enters the exponential phase.       
It was of great interest to examine specifically where ORFV was inhibiting the dsRNA 
signalling pathway. The aim was to simplify the model used to a single signalling pathway if 
possible and to subsequently investigate points of intervention by the virus. The fact that 
HEK293 cells express RNA polymerase III made this possible using poly(dA:dT). This 
allowed studies to be carried out specifically on the RIG-I pathway. The RNA polymerase III 
was blocked to see if this was the case using a specific RNA polymerase III inhibitor (ML-
60218), the results showed that poly(I:C) could stimulate but poly(dA:dT) could not in which 
the induction decreased from about 400 fold to 100 fold. Furthermore, siRNA effectively 
knocked down RIG-I and blocked IFN-β induction by poly(dA:dT) and poly(I:C), besides, 
overexpression of RIG-I from a construct remarkably enhanced signalling by poly(dA:dT) or 
poly(I:C) further confirming the involvement of the RIG-I sensor. In addition its likely that 
poly(I:C) stimulated RIG-I and not MDA-5 because of its small size. The unavailability of 
constructs expressing full length MDA-5 or other intermediate signalling molecules 
prevented studies to examine the effects of ORFV on molecules involved in the IFN 
signalling pathway. Assays involving the co-expression signalling molecules with ORFV 
individual genes could also help to provide insight into which signalling factors ORFV targets 
and the viral genes responsible. Nevertheless, this data narrowed it down to the RIG-I 
pathway only, via RIG-I sensing and RNA polymerase III-dsDNA sensing pathways.  
My data strongly suggested that the inhibition of IFN-β induction was through the RIG-I-
dependent pathway in HEK293 cells. This pathway is well defined and operates through 
MAVS-TBK1/IKKε-IRF3. IRF3 is a key transcription factor for type I IFN induction and it 
is ubiquitously and constitutively expressed in many cell types. Many studies suggest that the 
primary role of IRF3 is to initiate the induction of IFN-β at an early stage of the response and 
is more favoured than IRF7. It is generally believed that the induction of IFN-β is mediated 
first through IRF3 whereas IRF7 is induced by IFN-β at a later stage and participates in 
initiating the expression of IFN-α by way of a positive-feedback loop as demonstrated in 
IRF3-/- or IFN-β-/- deficient mice studies (Erlandsson, L. et al., 1998; Sato, M. et al., 2000). 
When IRF3 is activated, it undergoes sequential posttranslational modification including 





(Fitzgerald, K. A. et al., 2003; Hemmi, H. et al., 2004; Sharma, S. et al., 2003). These kinases 
form complexes upon activation with other subunits NAP1, SINTBAD, TANK and DDX3 
through TRAF3 downstream of the MAVS adaptor (Kawai, T. et al., 2005; Meylan, E. et al., 
2005).  
It has been shown that VACV produces multiple factors that block this IFN signalling 
pathway. For example, C6 interferes with the subunits NAP1, SINTBAD, TANK and 
prevents TBK1/IKKε-dependent activation of IRF3 and IRF7 (Unterholzner, L. et al., 2011), 
whereas K7 can interfere with IRF3 activation by interacting with DDX3, an adaptor of 
TBK1/IKKε (Oda, S. et al., 2009; Schröder, M. et al., 2008; Soulat, D. et al., 2008). N2 acts 
downstream of IRF3 phosphorylation and inhibits activation of IRF3 after translocation into 
the nucleus through an unknown mechanism (Ferguson, B. J. et al., 2013). ORFV encodes a 
number of novel unknown genes and it is possible that some of the factors produced are 
involved in the blockage of IFN-β production. The block in IFN-β caused by ORFV was 
striking and it was felt that it was worth attempting to find where the block might have 
occurred by examining the phosphorylation status of proteins in the signalling cascade.  
In this study, attempts were made to detect the phosphorylated forms of endogenous TBK1 
and IRF3 in order to track down at which stage of the cytosolic signalling pathway of type I 
IFN induction the virus was targeting, however, it proved difficult to detect the physiological 
levels of both proteins in HEK293 cells in response to poly(dA:dT) stimulation. This reflected 
a limitation of the tools available for this work and not necessarily a technical issue. Poly(I:C) 
stimulation in the same cells was not tested in this study to investigate TBK1 and IRF3 
phosphorylation. The antibodies anti-S396 and anti-S172 have been widely used in many 
studies to detect phosphorylated IRF3 and TBK1 respectively and to the best of our 
knowledge, only a few have reported the detection of poly(dA:dT)-induced phosphorylated 
IRF3 and TBK1 by these antibodies (Liu, D. et al., 2019; Yang, K. et al., 2015). The C-
terminal region of human IRF3 has several phosphorylation sites organized into two clusters: 
two serine sites Ser385/Ser386 and five serine-threonine sites: 
Ser396/Ser398/Ser402/Thr404/Ser405. Servant, M. J. et al. (2003) have found that the S396 
residue is sufficient to activate IRF3 whereas Mori, M. et al. (2004) found S386 to be a critical 
residue however, these two studies did not use poly(dA:dT) as an inducer for IRF3 activation. 
Further anti-S386 as used against phosphorylated IRF3 by Burleigh, K. et al. (2019) in 





detected here were that phosphorylation of IRF3 residues is stimulus- and cell type-dependent 
or possibly the phosphorylated IRF3 level was well below the detectable limit. This could 
also be the case for phosphorylated TBK1. An Enzyme-linked immunosorbent assay (ELISA) 
technique for the detection of protein phosphorylation could be an alternative approach. It is 
more sensitive than western blotting and detects precisely low abundant phosphorylated 
proteins. Besides, it can accurately quantify phosphorylated proteins across different sample 
treatments. In addition assays for IRF3 dimerization and nuclear translocation in the context 
of ORFV infection could be conducted to determine signalling events.      
In an attempt to determine gene(s) involved in the inhibition of IFN-β induction, the 
manipulation of ISGs by ORF116 prompted an investigation to examine whether this gene 
modulates IFN-β production. Preliminary data showed that ORF116 expressed from a cell 
line caused about a 50% reduction in IFN-β induction in poly(dA:dT)- or poly(I:C)-
stimulated cells compared to mock stimulated cells. Although the result was promising 
unfortunately an empty vector control had not been made at the time the assay was conducted 
which would have provided strong evidence that this gene inhibits IFN-β production. In 
contrast the ORF116 deletion mutant showed no difference in IFN-β inhibition in comparison 
with OV-NZ2 wt and OV-NZ2-Rev116 in poly(dA:dT)- or poly(I:C)-stimulated cells. A 
possible explanation could be that the ORF116 effect is masked by other factors expressed 
by the virus acting on the RIG-I signalling pathway. An intriguing possibility is that ORF116 
is targeting IRF-3 as both the RIG-I signalling pathway and direct induction of ISG 
expression (IFN independent) both operate through IRF-3. 
Assays were undertaken to determine whether IFN-β inhibition requires new virus protein 
synthesis. A heat inactivation approach was utilized over chemical inactivation e.g. binary 
ethyleneimine and β-propiolactone to inhibit virus early protein synthesis without affecting 
viral particle fusion and the early gene transcriptional machinery. The heat-inactivated virus 
failed to inhibit the expression of IFN-β in cells stimulated with poly(dA:dT) or poly(I:C), 
suggesting that inhibition requires new virus protein synthesis. Interestingly some variation 
were observed in fold change of IFN-β induction between the three heat-inactivated viruses 
in poly(I:C)-stimulated cells. The heat-inactivated virus preparation used in poly(I:C)-
stimulated was the same as in poly(dA:dT)-stimulated; besides, equal amounts of input virus 
was assured. This difference in IFN-β induction was more likely due to genetic differences 





recombinant viruses or between low MOI or high MOI has been reported by other 
investigators (Büttner, M. et al., 1995).  
ORF020 is a dsRNA-binding protein expressed early during virus infection. The strategy of 
dsRNA sequestration is not only used by poxviruses but also by other dsDNA viruses such 
as HSV (US11) (Poppers, J. et al., 2000) and RNA viruses such as IAV (NS1) (Lu, Y. et al., 
1995) to prevent the activation of PKR and OAS. ORF020 was shown to bind dsRNA and 
prevent the activation of PKR and OAS, however, its importance in blocking dsRNA-
mediated induction of type I IFN was not investigated. A number of viruses that have been 
reported to block the induction of IFN may do so by sequestering dsRNA such as HBV core 
antigen (Twu, J. S. et al., 1989; Whitten, T. M. et al., 1991). Here, ORF020 was studied in 
isolation of other virus genes by expressing it from a vector in HEK293 cells. From the 
ectopic expression of ORF020, the gene was able to block the production of IFN-β in a dose-
dependent manner in cells stimulated with poly(I:C) or poly(dA:dT) and this observation was 
consistent with those of shown for VACV E3L (Marq, J.-B. et al., 2009; Valentine, R. et al., 
2010). In addition, ORF020 was found to compete with RIG-I signalling in a co-expression 
experiment. Although the experiment needs to be repeated and include an empty vector 
control, these two observations imply a critical role played by this gene in manipulating the 
RIG-I-dependent IFN response. The exact mechanism of IFN-β inhibition has yet to be 
elucidated, however, possible effects of ORF020 could be predicted based on studies of the 
VACV E3L homologue (Chang, H. W. et al., 1992). Besides dsRNA-binding activity, E3L 
has multiple functions including inhibition of IRF3 and IRF7 activation and preventing the 
induction of type I IFN (Smith, E. J. et al., 2001; Xiang, Y. et al., 2002). It has been shown 
that the activation of IRF3 during VACV infection was PKR-dependent and that response 
was antagonized by VACV E3L (Zhang, P. et al., 2008). The role of E3L as an IFN antagonist 
was further demonstrated in E3-transgenic mice that showed resistance to viruses (Domingo-
Gil, E. et al., 2008). It is speculated that ORF020 could act similarly to VACV E3L in 
antagonizing the IFN response. Further studies on ORF020 will provide further insight into 
the mechanism of ORFV evasion of cytosolic RNA sensing. Further studies could involve 
screening ORFV early genes by cloning them into expression vectors and determining their 
potential to inhibit IFN-β expression and also using pull-down experiments to find their 





In summary, the effect of ORFV infection on the dsRNA-dependent IFN response was 
investigated and it was found for first time that the virus was able to block IFN-β production 
at the transcriptional level. Furthermore, the IFN antagonism employed by the virus has been 
caused by viral early genes. It was also shown that IFN-β inhibition was via RIG-I-dependent 
signalling in HEK293 cells. The exact mechanism that ORFV employs to interfere with RIG-
I-dependent signalling and cellular molecules targeted by the virus are not yet known. 
Whether simply sequestering dsRNA is the main strategy or whether other as yet unknown 
factors such as the range of factors that VACV employs (A46, C6, K7, and N2) has yet to be 











5 RESULTS III: Effect of ORFV Infection on IFN- Expression (DNA 
Sensor-Dependent Pathway) 
5.1 Overview  
Upon ORFV infection, genomic DNA is exposed to the cytoplasm after the viral core is 
uncoated. Recent reports have shown that viral genomic DNA, such as VACV, can elicit an 
IFN response by inducing type I interferons in a TLR9-independent manner. This observation 
suggested that there is another mechanism of DNA sensing that can recognize DNA in the 
cytosol (Hochrein, H. et al., 2004; Ishii, K. J. et al., 2006). TLR9 recognizes only 
unmethylated CpG DNA in the endosome and requires a specific pathway to elicit the IFN 
response: MyD88/IRAK1 and IRAK4/TRAF6/IRF7 (Honda, K. et al., 2004; Kawai, T. et al., 
2004). Besides, its expression is predominantly in immune cells such as plasmacytoid 
dendritic cells (Ishii, K. J. et al., 2006; Stetson, D. B. et al., 2006).  
It has previously been shown that double stranded DNA oligonucleotides such as a 70-base 
pair oligonucleotide from VACV or IFN-stimulatory DNA (ISD) induce type I IFN in 
macrophages through STING (Ishikawa, H. et al., 2009; Unterholzner, L. et al., 2010). The 
STING adaptor is an ER resident protein that facilitates an innate immune response. It has 
been clearly shown that detection of intracellular DNA by DNA receptors results in induction 
of type I interferon in a STING-dependent manner through the STING-TBK1-IRF3 axis 
(Figure 5.1) (Burdette, D. L. et al., 2012; Ishikawa, H. et al., 2008; Ishikawa, H. et al., 2009). 
In order to investigate the effect of OV-NZ2 infection on the DNA sensing pathway, an 
appropriate cell type was sought to provide an ideal model system of DNA-dependent sensing 
in which they respond to poly(dA:dT) and provide a consistent measurement of the effect of 
stimulation and most importantly these cell types are permissive for virus growth, at least 
viral early gene synthesis.  
ORFV causes an infection in the skin of the natural host and the predominant cell type 
residing in the epidermis are keratinocytes. Keratinocytes are highly specialized cells 
triggering the innate immune response and work as immune sentinels. HaCaT cells are a 
human keratinocyte cell line and it was initially tested and showed a strong induction of IFN-
β expression upon stimulation with poly(dA:dT), but it showed no sign of OV-NZ2 infection, 
no early gene synthesis or virus replication (Appendix: Figure 9.8). Accordingly, this cell line 





THP-1 is a human leukemia monocytic cell line and is commonly used in cytosolic DNA 
sensing studies (Jønsson, K. L. et al., 2017; Unterholzner, L. et al., 2010). THP-1 cells were 
first examined in their response to poly(dA:dT) and OV-NZ2 infectivity. They have shown a 
strong immune response upon stimulation with poly(dA:dT) and although the virus 
synthesizes its early proteins, it does not replicate in these cells.  
Human neonatal dermal fibroblast (hNDF) cells were found to be an appropriate model in 
this study to investigate the effect of OV-NZ2 virus on STING-dependent IFN- expression. 
This cell type expresses STING and respond to poly(dA:dT) transfection, besides, they are 
permissive for virus replication. The investigation carried out in this part of the study to 
examine the effect of OV-NZ2 infection on the DNA-sensing pathway were mostly 
conducted on hNDF cells. These highly specialized cells not only express STING-dependent 
DNA sensors but also express RNA sensors and those sensors either work through the 
endosomal pathway such as TLR3 or cytosolic pathway such as RIG-I and MDA5, which 
makes the system more complex to investigate (Figure 5.1).  
5.2 Induction of IFN- Expression in THP-1 Cells stimulated with Poly(dA:dT) 
The cellular response to synthetic dsDNA poly(dA:dT) and induction of IFN-β expression 
were first investigated in THP-1 cells. THP-1 are a monocyte-like suspension cell line and 
they need to be differentiated into macrophage-like cells to respond to the stimulus. The cells 
were differentiated by PMA, a widely used reagent, and the cell morphological phenotype 
was examined by light microscopy determined by adherence to the surface, their macrophage-
like phenotype and that they had stopped proliferating.  
Determination of the PMA concentration was essential to determine the optimal priming 
conditions. THP-1 cells were primed with an increasing amount of PMA (5, 50, 100 and 300 
ng/ml) for 3, 24, 48, 72 or 96 hours before being washed with PBS followed by resting the 
cells for up to 96 hours. The cells phenotype was assessed every day by light microscopy. At 
24 hours, macrophage-like cells started to appear and the cells appeared more macrophage-
like at 48-72 hours and this observation was observed irrespective of the presence or absence 
of PMA. By 96 hours of priming, the cells started to become larger in size and behave as 
activated macrophages (data not shown). With regard to the concentration, below 100 ng/ml 
of PMA was not enough to prime the cells even up to 4 days while above 100 ng/ml was 





300 ng/ml of PMA for 3 hours of exposure then the cells were washed and incubated for 2 to 
3 days of resting. Similar conditions are described by Starr, T. et al. (2018).  
The investigation then assessed the cellular response to poly(dA:dT) and its ability to 
stimulate cytosolic DNA sensing pathways in THP-1 cells. The cells were first primed with 
PMA, then transfected with poly(dA:dT) and the induction of IFN-β mRNA was quantified 
Figure 5.1. Experimental model to study the effect of OV-NZ2 on STING-dependent pathway. 
Figure 5.1. Experimental model to study the effect of OV-NZ2 on STING-dependent pathway 
of IFN-ß expression. A diagram representing DNA sensing mechanism and RNA-sensing 
mechanism. The DNA sensors cGAS, DAI, IFI16, DNA-PK and Pol III are localized in the cytosol 
and utilized the adaptor STING residing on the endoplasmic reticulum. They detect DNA in the 
cytosol and trigger the STING-dependent signalling leading to the activation of TBK1/IKKε and 
IRF3 that result in IFN-β expression. A unique feature with cGAS in which it synthesize the 
production of cGAMP dinucleotides that bind STING. RIG-like receptors are localized in the 
cytosol and utilize the adaptor MAVS. RIG-I receptor senses short dsRNA and also ppp-dsRNA 
derived from polymerase III-transcribed poly(dA:dT), whereas MDA5 senses long dsRNA. Upon 
ligand binding, RLRs engage the adaptor MAVS located on the outer membrane of mitochondria 
then lead to the downstream signalling to TBK1/IKKε-phosphorylating IRF3 and IFN expression. 
TLR3 is localized in the endosome and utilizes the adaptor TRIF. Upon recognising dsRNA, it can 
































by qRT-PCR. Kinetic analysis was also performed to assess the time course of type I IFN 
induction. It was shown that the induction of IFN-β was detectable at about 2 hours post-
stimulation then continued to accumulate up to 15 to 20 hours post-stimulation reaching about 
800 fold followed by a slight increase over the next 5 hours (Figure 5.2 A). The optimal dose 
of poly(dA:dT) was also determined in THP-1 cells in which the primed cells were transfected 
with increasing amounts of poly(dA:dT) then IFN-β mRNA was quantified by qRT-PCR at 
various time points. The induction of IFN-β was detected at 2 hours post stimulation and 
increased over 10 and 15 hours. A distinguishable dose-dependent difference was observed 
at 10 hours post stimulation for poly(dA:dT) whereas at 15 hours the responses of all 
poly(dA:dT) concentrations (0.1, 0.5 and 1 μg/ml) had reached a similar level (Figure 5.2 B). 
Fold change of IFN-β induction was calculated as described in materials and methods. 
Because fold differences were huge and that have led to large differences across biological 
replicates, p values could not be used and one of three biological replicates is presented.     
5.3 Inhibitory Effect of ORFV Infection on IFN- Expression in THP-1 Cells 
stimulated with Poly(dA:dT) 
As expected, THP-1 cells responded to poly(dA:dT) and produced type I interferon. Next, 
the effect of OV-NZ2 infection on IFN- expression was investigated in THP-1 cells. The 
cells were primed with PMA and treated with poly(dA:dT) then infected with OV-NZ2 and 
IFN-β expression examined. Initially, the stimulation was conducted at intervals of 2, 4, 6, 
10, 15 and 20 hours post infection and it was found that the virus showed to some extent an 
inhibitory effect on IFN-β expression with a bimodal pattern (data not shown). Attempts were 
made to thoroughly optimize the assay by looking at the duration of poly(dA:dT) stimulation 
before infecting cells or vice versa and by looking at the duration of virus infection before 
stimulating cells with poly(dA:dT). None of these attempts showed any differences (data not 
shown). Nevertheless, it was noticed that from three biological repeats the virus showed a 
consistent inhibition of IFN-β expression specifically at 10 hours post infection (Figure 5.3). 
OV-NZ2 can infect PMA-primed THP-1 cells and synthesize early viral proteins (Figure 5.4 
A) but the cells were not permissive for virus replication (Figure 5.4 B). Other reports have 
shown the synthesis of a VACV late gene D8 in THP-1 infected with VACV strains COP or 
WR but not MVA (Georgana, I. et al., 2018; Meade, N. et al., 2019). These data have shown 
that OV-NZ2 counteracts the IFN response triggered by DNA sensing signalling. As the virus 
does not replicate in THP-1 but can express early genes, this IFN response antagonism 







Figure 5.2. IFN-β induction in THP-1 cells 
Figure 5.2 IFN-β induction in THP-1 cells. (A) and (B) THP-1 cells were seeded at 1x10
6
 cells 
in 6-well plates. After overnight incubation, the cells were first primed with PMA (300 ng/ml) 
for three hours then the medium changed and left for resting for three days. At day 3, cells were 
stimulated with poly(dA:dT) at a concentration of 0.5 μg/ml (A) or 0.1, 0.5 or 1 μg/ml (B) and 
incubated until the harvesting times indicated. Total RNA was isolated from the cells and IFN-
β mRNA was quantified by qRT-PCR in triplicate of technical replicate. Expression fold was 
calculated as described in materials and methods. Data are from one representative experiment 
of three independent experiments. Error bars represent mean ±SD.     
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5.4 OV-NZ2 does not Inhibit IL-1β Release from Poly(dA:dT)-stimulated THP-1 
Cells 
Cytosolic DNA sensing can also activate the inflammasome pathway leading to the secretion 
of IL-1ß and IL-18 (Hornung, V. et al., 2009). They are pro-inflammatory cytokines and 
initiate the immune response when they bind to their receptors (Sims, J. E. et al., 2010). Pro-
inflammatory stimuli such as MPA and LPS induce expression of inactive pro-forms of IL-
1β and IL-18. Maturation of these precursors requires the proteolytic cleavage of caspase-1 
in particular, after it gets activated by the inflammasome, to release active forms of IL-1β and 
IL-18. Activation of the inflammasome AIM2-ASC pathway was found to be crucial for 
Figure 5.3. OV-NZ2 infection effect on IFN-β induction in THP-1 cells. 
Figure 5.3. Effect of OV-Z2 virus infection effect on IFN-β Induction in THP-1 cells. THP-
1 cells were seeded at 1x10
6
 cells in 6-well plates. After overnight incubation, the cells were first 
primed with PMA (300 ng/ml) for three hours then the medium changed and left for three days. 
At day 3, cells were stimulated with 0.5 μg/ml poly(dA:dT) and incubated for 4 hours. Then 
cells were infected at an MOI of 5 with OV-NZ2. At 6 and 10 hours post-infection, total RNA 
was isolated from cells and IFN-β mRNA was quantified by qRT-PCR. qPCR was conducted in 
triplicate. The level of IFN-β mRNA in uninfected sample was considered 1 to compare the 
infected samples. Statistical analysis was performed using Student’s t test. Data are from three 





P ≤ 0.0001.            
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innate immunity to DNA viruses (Rathinam, V. A. K. et al., 2010). Therefore, it was of 
interest to investigate the effect of OV-NZ2 on inflammasome signalling.  
Figure 5.4. Characteritics of OV-NZ2 early protein synthesis and virus replication in THP-
1 cells. 
Figure 5.4. Characteristics of OV-NZ2 early gene protein synthesis and virus replication 
in THP-1 cells. THP-1 cells were seeded at 1x10
6
 cells in 6-well plates. After overnight 
incubation, the cells were first primed with PMA (300 ng/ml) for three hours then the medium 
changed and left for three days. (A) Cells were washed with PBS then infected with OV-NZ2 at 
am MOI of 10. Cells were lysed at the indicated times and 10 μl of cell lysate was resolved on a 
10 % SDS-polyacrylamide gel for western blotting. The membrane was incubated with anti-
OV119 antibody and proteins detected by chemiluminescence. Tubulin was used as a protein 
loading control. (B) THP-1 cells were infected at an MOI of 5 with OV-NZ2. At various times 
post-infection, media and infected cells were collected. After three cycles of freezing and 
thawing, the virus was sonicated and viral titres determined by serial dilution and infection of 
LT cells. Virus plaques were visualized by staining with neutral red and counted, then PFU/ml 
calculated.   
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THP-1 is the most commonly used cell type for the study of inflammasome activation. The 
investigation was conducted by measuring the release of IL-1β into the medium. THP-1 cells 
were primed with PMA before carrying out the experiment to promote monocytic 
differentiation and induce pro-IL-1ß expression. The kinetics of IL-1β secretion was first 
examined in THP-1 cells in which the cells were stimulated with an increasing amount of 
poly(dA:dT) and cell media collected at intervals. The secretion of IL-1β was determined by 
ELISA. From the Figure 5.5 A, the secretion of IL-1β was detected at about 4 to 6 hours post 
stimulation then accumulated over time until it reached a plateau by 20 hours post stimulation 
in a dose-dependent manner.      
Having established the above, an investigation of the virus effect on inflammasome signalling 
was conducted. The cells were either unstimulated or stimulated with poly(dA:dT) for 4 
hours, then either mock infected or infected with OV-NZ2. After 20 hours of incubation, the 
secretion of IL-1β was measured by ELISA. As shown in Figure 5.5 B, the virus did not 
inhibit the release of IL-1β in poly(dA:dT)-stimulated cells as there was no difference in IL-
1β levels between uninfected and infected stimulated cells, and this observation was seen 
even at a lower dose of virus or poly(dA:dT) used (data not shown). It was not entirely 
unexpected that OV-NZ2 has induced the release of IL-1β. VACV (Western Reserve strain) 
was found to trigger the inflammasome and induced the release of IL-1ß from bone marrow-
derived macrophage cells (Rathinam, V. A. K. et al., 2010); however, VACV expresses 
secretory soluble viral receptors (B15R and B18R) that sequester IL-1β and disable it from 
binding to its receptors (Alcami, A. et al., 1992; Smith, G. L. et al., 1991).  
5.5 Detection of Phosphorylated-TBK in THP-1 Cells 
As explained in section 4.8, efforts were made to detect the phosphorylated-forms of TBK1 
proteins in THP-1 cells upon stimulation with poly(dA:dT). None of these efforts were 
successful to detect p-TBK1 in poly(dA:dT)-stimulated cells but it was detectable in LPS-






Figure 5.5. OV-NZ2 does not inhibit the release of IL-1β from THP-1 cells. 
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Figure 5.5 OV-NZ2 does not inhibit the release of IL-1β from THP-1 cells. (A) The THP-1 
cells were primed with PMA (300 ng/ml) for 3 hours. After three days, the cells were 
unstimulated or stimulated with poly(dA:dT) 0.5, 1 or 2 μg/ml for the indicated time. (B) The 
THP-1 cells were primed with PMA (300 ng/ml) for 3 hours. After three days, the cells were 
unstimulated or stimulated with poly(dA:dT) 0.5 μg/ml for four hours, then cells mock infected 
or infected with the virus at an MOI of 5 and incubated for 20 hours. Supernatants in (A and B) 
were collected and analysed for IL-1β secretion by using ELISA. ELISA was conducted in 
duplicate. Statistical analysis was performed using a Student’s t test. Data are from two 
independent experiments with three ELISA assays (A) and three independent experiments (B). 
Error bars represent mean ±SD. ns indicates probability 
ns







5.6 Induction of IFN- Expression in hNDF Cells stimulated with Poly(dA:dT) or 
Poly(I:C) 
Human neonatal dermal fibroblast (hNDF) cells were another cell type used to represent the 
model of cytosolic DNA sensing in this study. In first instance, the cellular response to 
poly(dA:dT) or poly(I:C) and induction of type I IFN in these cells was assessed. The cells 
were transfected with poly(dA:dT) or poly(I:C) and the induction of IFN-ß was quantified by 
qRT-PCR. Kinetic analysis of IFN induction was also performed to assess the time course 
for type I IFN induction. Fold change of IFN-β induction was calculated as described in 
materials and methods. Because fold differences were huge and that have led to large 
differences across biological replicates, p values could not be used and one of three biological 
replicates was presented.  
It was shown that poly(dA:dT) induced IFN-β expression at about 4 hours post-stimulation 
and IFN- expression continued to accumulate up to 10 hours post stimulation with a slight 
increase at 15 hours reaching more than 10000 fold (Figure 5.6 A). The strongest response 
was observed at 10 to 15 hours of post-stimulation irrespective of slight decrease or increase 
at 20 hours post stimulation across the biological replicates. The optimal dose response for 
poly(dA:dT) was also assessed in hNDF cells, in which the cells were transfected with 
increasing amounts of poly(dA:dT) then IFN-β mRNA quantified by qRT-PCR at various 
time. Poly(dA:dT) induced a distinguishable dose-dependent response at 10 hours post-
stimulation and the concentration of 0.5 μg/ml was sufficient to produce a strong response 
with no difference compared to 1 μg/ml (Figure 5.6 B). At 15 hours post stimulation across 
biological replicates, the three doses have produced variable levels of response in which they 
produced similar pattern as in 10 hours post stimulation or produced similar level of 
responses.   
With regard to poly(I:C) stimulation, poly(I:C) induced IFN-β expression in hNDF cells that 
was detectable at 4 hours post-stimulation, then increased over time to 15 hours post-
stimulation reaching about 2000 fold (Figure 5.7 A). A dose response assay was also 
conducted that showed a distinguishable dose-dependent response at 10 hours post 
stimulation and the concentration of 1 μg/ml was sufficient to produce a strong response 
(Figure 5.7 B). At 15 hours post stimulation, poly(I:C) produced a similar pattern to 
poly(dA:dT). There was no difference in the level of response beyond the concentration of 1 





As explained in section 4.2, poly(I:C) was delivered into hNDF cells either complexed to 
Figure 5.6. IFN-β induction in hNDF cells with poly(dA:dT). 
Figure 5.6 IFN-β Induction in hNDF cells with poly(dA:dT). (A) and (B) hNDF cells were 
seeded at 4x10
5
 cells in 6-well plates. Cells were stimulated with poly(dA:dT) at a concentration 
of 0.5 μg/ml (A) or 0.1, 0.5 or 1 μg/ml (B) and incubated for the times indicated. Total RNA was 
isolated from the cells and IFN-β mRNA was quantified by qRT-PCR in triplicate of technical 
replicate. Expression fold was calculated as described in materials and methods. Data are from 
one representative experiment of three independent experiments. Error bars represent mean ±SD. 
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cationic lipid LyoVec, or not, then IFN-β mRNA was quantified by qRT-PCR. Poly(I:C) 
activated the IFN signalling pathway when complexed to LyoVec. In contrast, free poly(I:C) 
did not lead to induction of IFN-β expression (Figure 5.7 C). This result suggests that the 
TLR3 receptor does not detect the poly(I:C) in this assay system and that the IFN-β 
expression observed was through cytosolic RNA receptors. TLR3 detects dsRNA not only in 
the endosome, but also from the extracellular environment, and then is taken-up through the 
endosomal pathway. The cationic lipid LyoVec transfection reagent consists of a combination 
of phosphonoloipid DTCPTA for cell membrane interaction and neutral lipid DiPPE for 
nucleic acid fusion with the cell membrane. The mechanism of nucleic acid uptake into the 
cell using these types of cationic lipids was proposed previously in which the lipid facilitates 
the nucleic acid transfection and escape from the endosome into the cytoplasm (Fasbender, 
A. et al., 1997; Guillaume-Gable, C. et al., 1998).  
5.7 Inhibitory Effect of ORFV Infection on IFN- Expression in hNDF Cells 
stimulated with Poly(dA:dT)  
Having established that hNDF cells responded to transfected synthetic dsDNA and produce 
type I interferon, next an investigation was conducted to test whether OV-NZ2 infection has 
an effect on type I interferon expression. hNDF cells were stimulated with poly(dA:dT) at a 
concentration of 0.5 μg/ml for 4 hours then infected with OV-NZ2 at different MOI’s for 10 
hours. qRT-PCR analysis was conducted from total RNA isolated. The data have shown that 
OV-NZ2 infection significantly suppressed IFN-β expression in a dose-dependent manner 
(Figure 5.8 A). The inhibition of IFN-β expression was highly effective at an MOI of 5 and 
was used hereafter.  
The duration of OV-NZ2 IFN antagonism was also investigated over 15 hours of virus 
infection. The cells were first stimulated with poly(dA:dT) for 4 hours then infected with OV-
NZ2 at an MOI of 5. It was shown that the inhibitory effect was significant at 10 hours post 
infection (Figure 5.8 B). OV-NZ2 infection in unstimulated cells was included to examine 
whether the virus induces interferon or not. As shown in Figure 5.8 B, infection did not induce 
IFN-β expression in unstimulated cells across all time points. Overall, this result strongly 
suggests that the virus encodes modulatory proteins that play a role in interfering with type I 









Figure 5.7. IFN-β induction in hNDF cells with poly(I:C). 
Figure 5.7. IFN-ß Induction in hNDF cells with poly(I:C). (A), (B) and (C) hNDF cells were 
seeded at 4x10
5
 cells in 6-well plates and stimulated with poly(I:C) complexed with LyoVec 
(A), (B) and (C) or without LyoVec (C) at concentration indicated. Total RNA was isolated 
from cells at the time shown and IFN-β mRNA was quantified by qRT-PCR in triplicate of 
technical replicate. Expression fold was calculated as described in materials and methods. Data 
are from one representative experiment of three (A), three (B) and one (C) independent 
experiments conducted with technical duplicate. Error bars represent mean ±SD. 
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Figure 5.8. Inhibitory effect of OV-NZ2 infection on IFN-β induction in hNDF cells stimulated with 
poly(dA:dT). 
Figure 5.8. Inhibitory effect of OV-NZ2 infection on IFN-β induction in hNDF cells stimulated 
with poly(dA:dT). hNDF cells were seeded at 4x10
5
 cells in 6-well plates and stimulated with 
poly(dA:dT) (500 ng/ml) for 4 hrs. Then cells were infected with the virus at multiple MOIs as 
indicated for 10 hours (A) or at an MOI of 5 for indicated times (B). Total RNA was isolated from 
cells and IFN-ß mRNA was quantified by qRT-PCR in triplicate of technical replicate. The level 
of IFN-β mRNA in uninfected sample was considered 1 to compare the infected samples. Statistical 
analysis was performed using Student’s t test (A) and two-way ANOVA (B). Data are from three 
independent experiments. Error bars represent mean ±SD. Asterisks indicate probability
 ****
P ≤ 
0.0001.      
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5.8 Inhibitory Effect of ORFV Infection on IFN- Expression in hNDF Cells 
stimulated with Poly(I:C) 
hNDF cells respond to transfected poly(I:C) by producing type I IFN. Although this chapter 
primarily investigates the effect of OV-NZ2 infection in poly(dA:dT)-stimulated hNDF cells, 
poly(I:C) stimulation was included so as to better understand virus manipulation of the IFN 
response because it is known that this cell type expresses RNA sensors that could detect an 
intermediate dsRNA produced  during virus replication.  
hNDF cells were first infected with OV-NZ2 at different MOI’s for 4 hours then stimulated 
with synthetic dsRNA poly(I:C) and IFN-β mRNA quantified by qRT-PCR. The data show 
that OV-NZ2 infection caused a slight increase in the induction of IFN-β expression in 
poly(I:C)-stimulated hNDF cells at an MOI of 0.25 to 1 then a significant inhibition at 10 
(Figure 5.9 A). This virus dose-dependent increase of IFN-β expression observed at MOIs 
0.25, 0.5 and 1 was probably due to dsRNA intermediates generated during virus replication 
that elicit the IFN response and could not be counteracted unless the cells were infected with 
a higher dose of virus. Next, the duration of the OV-NZ2 inhibitory effect was addressed. 
The cells were first infected with OV-NZ2 at a multiplicity of infection 10 for 4 hours then 
stimulated with poly(I:C). Similar to the inhibitory effect of OV-NZ2 infection in 
poly(dA:dT)-stimulated cells, OV-NZ2 inhibited the expression of IFN-β induced by 
poly(I:C) and inhibition occurred across all time points (Figure 5.9 B).  
Similar to the observation found in HEK293 cells, when poly(I:C) stimulation preceded virus 
infection (see Section 4.5), the virus could not inhibit the expression of IFN-β in hNDF cells 
(Figure 5.10 A and B). This observation may indicate that the virus might have another 






Figure 5.9. Inhibitory effect of OV-NZ2 infection on IFN-β induction in hNDF cells stimulated with poly(I:C). 
Figure 5.9. Inhibitory effect of OV-NZ2 infection on IFN-β Induction in hNDF cells 
stimulated with poly(I:C). hNDF cells were seeded at 4x10
5
 cells in 6-well plates. The cells were 
mock infected or infected with OV-NZ2 at different MOI’s as indicated (A) or an MOI of 10 (B) 
for 4 hours then stimulated with 1 μg/ml of poly(I:C). The cells were incubated for 10 hours (A) or 
for times indicated (B). Total RNA was isolated and IFN-β mRNA quantified by qRT-PCR in 
triplicate of technical replicate. The level of IFN-β mRNA in uninfected sample was considered 1 
to compare the infected samples. Statistical analysis was performed using the Student’s t test (A) 
and two-way ANOVA (B). Data are from three independent experiments. Error bars represent 
mean ±SD. Asterisks indicate probability 
****
P ≤ 0.0001.      
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Figure 5.10. OV-NZ2 infection is required first to inhibit the IFN-β induction in poly(I:C)-stimulated hNDF cells. 
Figure 5.10. OV-NZ2 infection is required first to inhibit the IFN-β induction in poly(I:C)-
stimulated hNDF cells. (A) hNDF cells were seeded at 4x10
5
 cells in 6-well plates and stimulated 
with poly(I:C) at 1 μg/ml for 4 hours. Then the cells were mock infected or infected with OV-NZ2 
at different MOI’s indicated then the cells incubated for 10 hours post infection. Total RNA was 
isolated from the cells and IFN-ß mRNA was quantified by qRT-PCR in triplicate. The level of 
IFN-β mRNA in uninfected sample was considered 1 to compare the infected samples. Statistical 
analysis was performed using student t test. Data are from three independent experiments. Error 
bars represent mean ±SD. Asterisks indicate probability
 ns
P ≥ 0.1234. (B) hNDF cells were seeded 
at 4x10
5
 cells in 6-well plates and stimulated with poly(I:C) at the concentration indicated for 4 
hours. Then the cells were mock infected or infected with OV-NZ2 at an MOI of 10 then the cells 
incubated for 10 hours post infection. Total RNA was isolated from the cells and IFN-ß mRNA 
was quantified by qRT-PCR in triplicate. Data are from one experiments. Error bars represent mean 
±SD.  
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5.9 Detection of STING and RIG-I Expression Proteins in hNDF Cells  
Several receptors have been proposed to be important for cytosolic DNA detection and those 
receptors depend on STING. It is a critical component in the DNA sensing pathway that 
conveys the upstream DNA sensing to downstream signalling events leading to induction of 
type I IFN.  
Detection of STING and RIG-I protein expression in hNDF cells were investigated by 
western blotting in mock cells or cells stimulated with either poly(dA:dT) or poly(I:C). 
STING was detectable in unstimulated cells and it was noticed that the levels changed when 
the cells were stimulated with poly(dA:dT) or poly(I:C) (Figure 5.11). The STING level 
decreased when cells were stimulated with poly(dA:dT). A similar observation was found in 
poly(dA:dT)-stimulated HeLa cells (data not shown) and poly(dA:dT)-stimulated MEF cells 
(Abe, T. et al., 2014; Liu, D. et al., 2019), more likely due to ubiquitination of STING as 
reported previously (Ni, G. et al., 2017). The IRF3 level also decreased when cells were 
stimulated with poly(dA:dT), a similar observation found in poly(dA:dT)-stimulated HeLa 
cells (data not shown). On the other hand, STING increased when cells were stimulated with 
poly(I:C), possibly due to autocrine and paracrine effects of type I IFN induction as found by 
Liu, Y. et al. (2016). RIG-I protein expression was not detectable in unstimulated hNDF cells 
but the protein was strongly induced in poly(dA:dT)- or poly(I:C)-stimulated hNDF cells 
(Figure 5.11). Similar to the observation found in HEK293 cells, the RIG-I protein was 
inducible in hNDF cells.    
The regulation of STING is complex and involves several events to function. Upon cGAS-
produced 2’3’-cGAMP, binding to STING results in translocation of STING from the 
endoplasmic reticulum compartment to the perinuclear region where autophosphorylated 
TBK1 is recruited to STING, allowing the phosphorylation of STING. Phosphorylated 
STING recruits IRF3 where IRF3 is phosphorylated by TBK1 leading to IRF3 dimerization, 
nuclear translocation and eventually induction of type I IFN (Liu, S. et al., 2015; Tanaka, Y. 
et al., 2012). In this study, attempts were made to investigate the effect of OV-NZ2 on the 
STING-TBK1-IRF3 axis of the DNA-sensing pathway by examining the phosphorylation 
events of these proteins in the context of virus infection. However, none of phospho-STING, 







5.10 Poly(dA:dT)-mediated IFN- Expression is through the STING Adaptor in 
hNDF Cells 
The importance of the STING-dependent pathway in mediating DNA-induced type I 
interferon was investigated in this study by knocking down the STING gene using RNAi then 
to examine the induction of type I interferon in response to poly(dA:dT). It is important to 
mention that since the transfected poly(dA:dT) could be transcribed by RNA polymerase III 
to 5’ppp-dsRNA and recognized by RIG-I leading to activation of the RNA-dependent 
pathway, RIG-I gene knockdown or STING/RIG-I double knockdown was included. 
Interestingly, an immunoprecipitation study on 293T cells has shown that RIG-I, but not 
MDA5, could bind with STING in a co-transfection experiment, suggesting that they function 
cooperatively (Ishikawa, H. et al., 2008).  
In this study, three different predesigned synthetic small interfering RNAs duplex (siRNA) 
targeting either STING or RIG-I genes were used to minimize the possibility of off-target 
effects. They were 19 nucleotide siRNA with 2-base 3’ overhangs and these features enable 
Figure 5.11. Detection of RIG-I, STING and IRF3 molecules in hNDF cells by western blotting. 
Figure 5.11. Detection of RIG-I, STING and IRF3 molecules in hNDF cells by western 
blotting. hNDF cells were mock or stimulated with either 0.5 μg/ml of poly(dA:dT) or poly(I:C) 
for 15 hrs. Equal amounts of cell lysate were resolved on a 10 % SDS-polyacrylamide gel for 
western blotting. Proteins were detected with the antibodies indicated. Proteins were visualized 
































siRNA to bypass any possible interferon induction triggered by dsRNA transfection 
(Marques, J. T. et al., 2006; Sioud, M., 2006). The optimal concentration of STING siRNA 
required to efficiently silence the gene without producing toxicity was determined in which 
the cells were transfected with a series of STING siRNA amounts (10, 50, 100, 200 and 300 
nM) and cells incubated for two days post transfection. From western blotting, it was found 
that 100 nM siRNA produced maximal depletion of the STING protein and a concentration 
beyond 100 nM did not cause further depletion in STING (data not shown).    
hNDF cells were either transiently mock transfected (none) or negative control (NC) or 
transfected with three siRNAs individually targeting STING. Then after 2 days post 
transfection, the protein level was examined by western blotting and the protein band 
quantified. Western blot analysis showed a depletion of STING (Figure 5.12 A). The protein 
bands were quantified by imageStudioLite and it was found that about a one third depletion 
was caused by siRNA #1 and about a half depletion was caused by siRNA #2 (Figure 5.12 
B). The depletion was not caused by off-target effects as siRNA #3 did not deplete STING. 
The level of STING mRNA was also examined and found to be consistent with the protein 
level (Figure 5.12 C).         
Having established this, IFN- induction was examined in STING knockdown cells after 
stimulation with either poly(dA:dT) or poly(I:C). As expected, the induction of IFN- mRNA 
reduced significantly in the poly(dA:dT)-stimulated STING-depleted cells by about 50% 
compared to controls but not completely, more likely due to the involvement of the RIG-I-
dependent sensing through the cytosolic DNA-dependent RNA polymerase III response 
(Figure 5.12 E). On the other hand, the induction of IFN-β expression did not change in 
poly(I:C)-stimulated STING-depleted cells, indicating other RNA sensors, such as RIG-I, are 
involved in IFN-β expression in hNDFs (Figure 5.12 D). This result strongly suggests that 
STING-dependent sensing is involved in the induction of IFN- by poly(dA:dT) and STING 
is required to induce the IFN response in hNDF cells and might suggest that the inhibitory 
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  Figure 5.12. STING is required for IFN-β induction in poly(dA:dT)-stimulated hNDF cells, 
but not with poly(I:C). hNDF cells were transfected with siRNA (100 nM) targeting the STING 
gene for 48 hrs. Three siRNAs were used to minimize the possibility of off-target effects. Control 
conditions included mock transfection in the absence of siRNA (none) or transfection with a non-
targeting control siRNA (NC). At 48 h.p.t., the transfected cells were stimulated with either 
poly(dA:dT) 0.5 µg/ml for 15 hours or poly(I:C) 1 µg/ml for 20 hrs. Transfected cells were lyzed 
for analysis of target protein expression by western blotting (A).Target protein band intensity was 
quantified and plotted after being normalized to the loading control (B) and the mRNA level of 
STING was assessed (C). The induction of IFN-β was assessed in the transfected cells by qRT-
PCR after 20 hours post stimulation with poly(I:C) (D) and 15 hours post stimulation with 
poly(dA:dT) (E). qRT-PCR was conducted in triplicate of technical replicate. Statistical analysis 
was performed using two-way ANOVA. Data are from three independent experiments. Error bars 
represent mean ±SD. Asterisks indicate probability: 
ns
P ≥ 0.1234, 
**
P ≤ 0.0021, 
***
P ≤ 0.0002, 
****
P 





5.11 Other RNA Sensors are Involved in IFN- Expression in hNDF Cells 
Due to the complexity of nucleic acid detection and signalling in the cytosol of hNDFs, RNA 
sensors were considered in this study. It was speculated that the RIG-I receptor plays a major 
role in the induction of IFN- expression in these cells when stimulated with poly(dA:dT) or 
poly(I:C). To test this hypothesis, knockdown of RIG-I by siRNA was conducted. Three 
different predesigned synthetic small interfering RNAs (siRNA) were used to minimize the 
possibility of off-target effects. The optimal concentration of RIG-I siRNA required in hNDF 
cells was also determined by transfecting the cells with a series of RIG-I siRNA amounts (10, 
50 and 100 nM). The western blotting data showed that a concentration of 100 nM siRNA#2 
produced significant depletion in RIG-I protein in hNDFs (data not shown).  
hNDF cells were transiently transfected with siRNA targeting RIG-I then the RIG-I protein 
level was determined by western blot analysis 2 days post transfection. Before western 
blotting was conducted, stimulation was required to induce RIG-I expression in transfected 
cells. RIG-I siRNA transfection caused a noticeable protein depletion compared to the control 
(Figure 5.13 A) and that depletion was about 70% as shown in Figure 5.13 B. The level of 
RIG-I mRNA in the transfected cells was examined in poly(dA:dT)- or poly(I:C)-stimulated 
cells and it was found that the level RIG-I mRNA was reduced by about 50% in both 
poly(dA:dT) and poly(I:C) stimulation (Figure 5.13 C and D).      
The induction of IFN- expression was examined in the RIG-I-depleted cells after stimulation 
with either poly(dA:dT) or poly(I:C). The RIG-I-depleted cells showed no significant 
reduction in IFN-β expression when cells were stimulated with poly(dA:dT) (Figure 5.13 F), 
but only a slight decrease, possibly because a proportion of poly(dA:dT) was transcribed to 
5’ppp-dsRNA but could not trigger the RNA-sensing pathway through RIG-I. On the other 
hand, the induction of IFN-β expression in RIG-I-depleted cells did not change when 
stimulated with poly(I:C) (Figure 5.13 E), suggesting other RNA sensors involved 
independently of TLR3 such as protein kinase R (PKR) (Diebold, S. S. et al., 2003; Yang, Y. 










Figure 5.13. RIG-I siRNA knockdown has no significant effect on poly(dA:dT) effect on poly(dA:dT)- or 
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Figure 5.13 RIG-I siRNA knockdown has no significant effect on poly(dA:dT)- or poly(I:C)-
induced IFN-ß  in hNDF cells. hNDF cells were transfected with siRNA (100 nM) targeting the 
RIG-I gene for 48 hrs. Three siRNAs were used to minimize the possibility of off-target effects. 
Control conditions included mock transfection in the absence of siRNA (none) or transfection with 
a non-targeting control siRNA (NC). At 48 h.p.t., the transfected cells were stimulated with either 
poly(dA:dT) 0.5 µg/ml for 15 hours or poly(I:C) 1 µg/ml for 20 hours. Transfected cells were lyzed 
for analysis of target protein expression by western blotting (A) and qPCR (C and D). Target protein 
band intensity was quantified and plotted after being normalized to the loading control (B). The 
induction of IFN-β was assessed in the transfected cells by qRT-PCR after 20 hours post stimulation 
with poly(I:C) (E) and 15 hours post stimulation with poly(dA:dT) (F). qRT-PCR was conducted 
in triplicate of technical replicate. Statistical analysis was performed using two-way ANOVA. Data 
are from three independent experiments. Error bars represent mean ±SD. Asterisks indicate 
probability: 
ns
P ≥ 0.1234, 
**
P ≤ 0.0021, 
****





5.12 Stronger Reduction of IFN-β Expression in hNDF Cells with Double Knockdown 
of STING and RIG-I When Stimulated with Poly(dA:dT) 
RNA interference data have shown that knockdown of STING has caused a reduction in IFN-
β expression but not complete suppression and that was probably because poly(dA:dT) has 
been converted to 5’pppdsRNA by RNA polymerase III making it a ligand for RIG-I. This 
assumption was tested by conducting a double knockdown targeting STING and RIG-I genes 
resulting in shut down of DNA-dependent and RIG-I-dependent pathways when stimulated 
with poly(dA:dT). Then the induction of IFN-β expression was examined.  
hNDF cells were transfected with pooled siRNAs#2 of STING and RIG-I for 2 days post 
transfection. Then the level of target proteins was determined by western blotting upon 24 
hours of poly(I:C) stimulation. From the double knockdown, the level of STING protein was 
reduced by about 80% and the level of RIG-I was undetectable (Figure 5.14 A and B). The 
mRNA levels of both genes in STING/RIG-I-depleted cells was also determined after 
stimulation with poly(dA:dT) or poly(I:C). The mRNA level of both genes reduced by more 
than 50% for both poly(dA:dT) and poly(I:C) (Figure 5.14 C and D).  
The induction of IFN-β expression was then investigated in the STING/RIG-I-depleted hNDF 
cells after stimulation with poly(dA:dT) or poly(I:C). As expected, a significant reduction in 
IFN-β induction was observed in poly(dA:dT)-stimulated cells after depleting STING and 
RIG-I simultaneously (Figure 5.14 E) and this reduction was even stronger than for STING 
only-depleted cells (Figure 5.13 E). This result strongly suggests that poly(dA:dT) is working 
only through STING-dependent and RIG-I-dependent pathways. On the other hand, poly(I:C) 
stimulation did not cause a significant reduction in IFN-β expression in STING/RIG-I-
depleted hNDFs (Figure 5.14 F) and reduced slightly compared to a single knockdown as 
shown in Figure 5.12 D and Figure 5.13 E. The inhibitory effect of OV-NZ2 has not been 
affected even in STING/RIG-I-depleted cells either after stimulation with poly(dA:dT) or 






Figure 5.14. STING/RIG-I siRNA double knockdown has a significant effect on poly(dA:dT)-induced IFN-β 
expression in hNDF cells. 
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Figure 5.14. STING/RIG-I siRNA double knockdown has a significant effect on poly(dA:dT)-
induced IFN-ß expression in hNDF cells. hNDF cells were co-transfected with siRNA (100 nM) 
targeting the STING and RIG-I genes for 48 hrs. Three siRNAs were used to minimize the 
possibility of off-target effects. Control conditions included mock transfection in the absence of 
siRNA (none) or transfection with a non-targeting control siRNA (NC). At 48 h.p.t., the transfected 
cells were stimulated with either poly(dA:dT) 0.5 µg/ml for 15 hours or poly(I:C) 1 µg/ml for 20 
hrs. Transfected cells were lysed for analysis of target protein expression by western blotting (A) 
and mRNA by qRT-PCR (C and D). Target protein band intensity was quantified and plotted after 
normalization to the loading control (B). The induction of IFN-ß was assessed in the siRNA 
transfected cells by qRT-PCR in triplicate after 15 hours post stimulation with poly(dA:dT) (E) and 
20 hours post stimulation with poly(I:C) (F) in infected or uninfected cells. Statistical analysis was 
performed using two-way ANOVA. Data are from three independent experiments. Error bars 
represent mean ±SD. Asterisks indicate probability: 
ns
P ≥ 0.1234, 
***
P ≤ 0.0002, 
****





5.13 Virus Early Gene Synthesis is Required to Inhibit IFN- Expression in hNDF 
Cells 
An investigation was carried out to determine whether the virus inhibitory effect observed in 
hNDF cells, when stimulated with poly(dA:dT), required new early viral gene protein 
synthesis. The approach of heat inactivation was utilized (as explained in Section 4.9) to 
inactivate early viral protein synthesis of OV-NZ2 including OV-NZ2Rev116 and OV-
NZ2Δ116 (see Chapter 3) in an attempt to identify whether ORF116 has a role in the 
inhibitory effect on IFN-β expression in hNDF cells.      
One-step growth of OV-NZ2 wild type was characterized in hNDF cells in which the cells 
were infected with virus at an MOI of 5. Then the cells were harvested at various times and 
the virus progeny quantified by plaque assay on LT cells. The virus showed exponential 
growth starting at 12 hours post infection until 48 hours post infection, then reached a plateau 
from day 2 until day 4 giving about a 5-fold increase in the virus progeny (Figure 5.15).    
Next, early viral gene protein synthesis in hNDF cells infected with either OV-NZ2, OV-
NZ2-Rev116 or OV-NZ2Δ116 was investigated using the OV119 protein as an indicator 
(Harfoot, R. T., 2015). Virus inocula were prepared at an MOI of 5 then the inocula were 
split into two in which one was treated with heat at 55 °C for 1 hour and the other was left 
without heat treatment. The cells were either infected with untreated virus or heat inactivated 
virus then the cells harvested at 0, 2, 4 and 6 hour post infection. The cell lysates were 
subjected to western blotting using anti-OV119 antibody. As shown in Figure 5.16, the 
synthesis of OV119 was detected at 4 hours post infection and increased further at 6 hours 
post infection. However, the induction of OV119 protein was completely abolished in heat 
inactivated virus infection indicating that heat inactivation destroyed early protein synthesis. 
It is worth noting that the cytopathic effect (CPE) of infected hNDF cells was also examined 
under light microscopy and found that the untreated virus induced a clear CPE at 4 hours post 
infection that increased at 6 hours post infection, whereas the heat inactivated virus did not 
induce CPE (data not shown).  
Given that the heat inactivation has inactivated virus early gene protein synthesis, the 
investigation then assessed the induction of IFN-β expression in hNDF cells infected with 
untreated or heat inactivated virus. The cells were infected with either untreated or heat 





mRNA was quantified by qRT-PCR. As seen in Figure 5.17 A and B, the untreated viruses 
were able to significantly inhibit the induction of IFN-β expression in poly(dA:dT)- or 
poly(I:C)-stimulated cells. On the other hand, the ability of IFN-β inhibition was not retained 
in stimulated cells infected with the heat inactivated viruses indicating that the inhibitory 
effect of OV-NZ2 on IFN-β expression requires de novo early viral proteins (Figure 5.17 A 
and B). Unlike in HEK293 cells (see Figure 4.18), all heat-inactivated viruses induced the 
expression of IFN-β in un-stimulated cells, more likely due to the presence of virus RNA 
generated from gene transcription which may further validate the intactness of virus 
transcription machinery even after heat treatment. It is important to note that the variation in 
level of IFN-β induction in unstimulated cells infected with heat inactivated viruses was not 
because of an inhibitory effect caused by the virus as the same preparations of viruses have 
not caused variations in poly(dA:dT)- or poly(I:C)-stimulated cells. Overall, the data 
demonstrate that the gene responsible for the inhibitory effect was an early gene(s) and this 
effect was not caused by viral structural proteins. In addition, ORF116 did not seem to have 
a direct effect on IFN-β induction or it does but masked by other viral factors.   
Figure 5.15. One-step growth analysis of OV-NZ2 in hNDF cells 
Figure 5.15. One-step growth analysis of OV-NZ2 in hNDF cells. hNDFs were seeded at 
4x10
5
 and incubated overnight. Cells were infected at an MOI of 5 with OV-NZ2. After 1hr 
adsorption, cells were washed with PBS to remove unattached virus then 2 ml of DMEM 2 % 
FCS was added to hNDF infected cells. At various times post-infection, media and infected cells 
were collected. After three cycles of freezing and thawing, the virus was sonicated and viral titres 
determined by serial dilution and plaque assay on LT cells.  


































Figure 5.16. Detection of ORFV early protein synthesis in hNDF cells infected with heat 
inactivated or untreated virus. hNDF cells were seeded at 4x104 in a 24-well plate. On the day 
of infection, virus inocula of OV-NZ2, OV-NZ2Δ116 or OV-NZ2Rev116 were prepared at an 
MOI of 5, then split into two. One half was subjected to heat treatment at 55 °C for 1 hour and 
the other half left untreated and the cells were then infected with the heat inactivated or untreated 
virus. The cells were harvested and lyzed at time points 0, 1, 2, 4 and 6 hour post infection. Equal 
amounts of total protein were resolved on a 10% SDS-polyacrylamide gel for western blotting. 
The membrane was incubated with anti-OV119 antibody or anti-tubulin antibody as a loading 
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Figure 5.17. Induction of IFN-β by poly(dA:dT) or poly(I:C) in hNDF cells infected with heat-
inactivated or untreated virus. 
Figure 5.17. Induction of IFN-β by poly(dA:dT) or poly(I:C) in hNDF cells infected with heat 
-inactivated or untreated virus. hNDFs were seeded at 4x10
4
 cells in a 24-well plate. (A) Cells 
were stimulated with poly(dA:dT) at 0.5 μg/ml and incubated for 4 hours then cells infected with 
either heat-inactivated or untreated virus: OV-NZ2, OV-NZ2Δ116 or OV-NZ2-Rev116 at an MOI 
of 5 and incubated for 15 hours. (B) Cells were infected with either heat-inactivated or untreated 
virus: OV-NZ2, OV-NZ2Δ116 or OV-NZ2-Rev116 at an MOI of 10 for 4 hours then cells 
stimulated with poly(I:C) at 1 μg/ml or left unstimulated and incubated for 20 hours. After 
incubation, cells were harvested and total RNA was isolated from the cells and IFN-ß mRNA was 
quantified by qRT-PCR in triplicate of technical replicate. The level of IFN-β mRNA in uninfected 
sample was considered 1 to compare the infected samples. Data are from three independent 
experiments. Error bars represent mean ±SD. Statistical analysis was performed using a Student’s 
t test. Asterisks indicate probability: 
ns
P ≥ 0.1234, 
****






5.14 Discussion  
ORFV replicates in the cytoplasm of the host cell and the release of its genomic DNA into 
the cytoplasm, makes it a potential target for cytosolic DNA-dependent recognition. Here, 
the objective of this part of the study was to investigate the effect of ORFV infection on type 
I IFN expression upon cytosolic dsDNA sensing. The dsDNA sensing pathway was studied 
in hNDF cells, a primary cell type in which a strong IFN-β response could be induced by 
poly(dA:dT) and in which ORFV replicates. It was shown that ORFV interferes with the IFN 
response in these cells induced by poly(dA:dT) causing potent inhibition of IFN-β expression. 
This study shows for first time that ORFV has evolved a strategy to evade DNA-dependent 
signalling that requires the adaptor STING. These results strongly suggest that ORFV 
produces molecules that interfere with the signalling pathway leading to expression of IFN-
β and it is likely that those molecules are synthesised early, as demonstrated in assays using 
heat-inactivated virus. This inhibition could be direct or it could be indirect. Poxviruses in 
particular orthopoxviruses directly target pathways that lead to IFN production and suggests 
that the inhibition observed in the present study is likely to be direct although indirect 
mechanisms may also be possible.  
ORFV virus infects the skin of its host and specifically replicates in keratinocytes (Fleming, 
S. B. et al., 2015). Primary keratinocytes reside in the epidermal layer of skin forming more 
than 90% of epidermal cells. Beneath the epidermis is the underlying dermal layer which 
harbours dermal fibroblasts. These two cell types act as sentinel cells and have the capability 
to activate the innate immune response against DNA viruses (Nestle, F. O. et al., 2009). An 
appropriate cell type was sought to provide a model for this study to investigate the effect of 
ORFV infection on cytosolic DNA-mediated IFN-β expression. Because primary 
keratinocytes, which have been shown to be a strong producer of IFN-α/β (Fujisawa, H. et 
al., 1997) were not available, the investigation initially made use of a keratinocyte (HaCaT) 
cell line. Although they are responsive to poly(dA:dT) by high production of IFN-β peaking 
at 6 hours post stimulation (Almine, J. F. et al., 2017), they were not permissive for ORFV 
replication. Here, hNDFs were chosen as a model for this study for the following reasons. 
They express STING, are permissive for ORFV replication and importantly their DNA 
sensors were responsive to poly(dA:dT). It is almost impossible to find a cell type or cell line 
that expresses only cytosolic STING-dependent DNA sensors without RNA sensors. Other 





was also used in this study since other investigators have used these cells to study the 
interaction between DNA virus infection and cytosolic DNA sensing (Jønsson, K. L. et al., 
2017; Unterholzner, L. et al., 2010). In natural infection, immune cells such as monocytes, 
cDCs and pDCs infiltrate into the ORFV lesion and get abortively infected by ORFV. Other 
poxviruses such as PPVO and myxoma virus abortively infect pDCs and induce the 
expression of IFN-β (Dai, P. et al., 2011; von Buttlar, H. et al., 2014) and other poxviruses 
such as VACV and modified vaccinia virus Ankara (MVA) infect pDCs and inhibit the 
production of IFN-β owing to multiple viral inhibitors (Dai, P. et al., 2014).  
As noted from the kinetics of IFN-β induction in hNDF cells, the exponential phase of IFN-
β was observed at 4 hours post-poly(dA:dT) stimulation, whereas there was a further delay 
of about two hours upon poly(I:C) stimulation, indicating a stronger activation of the pathway 
by poly(dA:dT) than poly(I:C), consistent with studies by Unterholzner, L. et al. (2011). 
Poly(dA:dT) caused faster and stronger stimulation of IFN-β induction than poly(I:C), 
possibly due to the fact that poly(dA:dT) stimulation can lead to activation not only of the 
cytosolic DNA sensing pathways but also cytosolic RNA sensing pathways by the conversion 
of poly(dA:dT) to dsRNA via RNA polymerase III. This period of time before the exponential 
phase of IFN-β induction appears to have given the virus time to express its early genes and 
block the pathway. Unfortunately in this study phosphorylated TBK1 and IRF3 could not be 
detected by western blotting, and hence the kinetics of TBK1 and IRF3 phosphorylation could 
not be determined. This may have provided clues as to, if, where and when the virus blocked 
signalling.  
The critical adaptor for DNA-mediated signalling is STING, that conveys upstream DNA 
sensing to the downstream signalling pathway through the kinases TBK1/IKKε and 
IKKα/IKKβ and transcription factors IRF3 and NF-κB (Ishikawa, H. et al., 2009). STING 
regulation is complex and takes place through different regulatory mechanisms. It undergoes 
different post-translational modifications upon activation: dimerization, translocating from 
the ER to the signalling compartment, phosphorylation by TBK1 and further trafficking for 
subsequent degradation (Dobbs, N. et al., 2015; Ishikawa, H. et al., 2009). In this study, I 
attempted to investigate the effect of ORFV infection on STING-dependent signalling. 
Firstly, efforts were made to detect the phosphorylated forms of TBK1 and IRF3 in hNDF 
cells by western blotting upon stimulation with poly(dA:dT), but none of these attempts were 





on to investigate STING in hNDF cells. The total protein was detected in untreated cells but 
the phosphorylated form could not be detected upon stimulating cells with poly(dA:dT).  The 
phosphorylated form of endogenous STING has been detected by others in THP-1 cells when 
cells were stimulated with herring testis DNA (HT-DNA) (Liu, S. et al., 2015). The approach 
to overcome this issue could be by expressing STING from a construct as shown in other 
studies. The antibody used against phosphorylated STING was anti-Ser366 and this residue 
was shown to be important for IRF3 activation and type I IFN induction (Liu, S. et al., 2015; 
Tanaka, Y. et al., 2012). Interestingly, it was noticed that endogenous total STING protein 
was degraded at 15 hours post stimulation with poly(dA:dT), but not with poly(I:C), in 
hNDFs. This observation has also been seen by others in which total STING was degraded 
when cells were stimulated with dsDNA or infected with HSV-1 (Konno, H. et al., 2013). 
Fifteen hours of stimulation produced strong induction of IFN-β and it would have been 
interesting to have examined the kinetics of STING protein regulation in hNDF cells over 
this time course and then to have assessed this in ORFV-infected cells. It is believed that this 
mechanism of STING regulation acts as a negative regulator to prevent the deleterious 
consequences of the innate immune response on the host (Abe, T. et al., 2013). In addition, a 
STING dimerization assay could have been performed to investigate the effect of ORFV 
infection on the activity of STING. If constructs expressing full length of IFN signalling molecules 
such as STING were available during the course of this study, this tool could have also been used to 
investigate the effects of ORFV on signalling. 
An RNA interference (RNAi) strategy was applied to dissect out critical elements of the 
signalling pathways that led to the induction of IFN-β in hNDF cells by poly(dA:dT) and 
poly(I:C). Single or double knockdown of STING and RIG-I by siRNA showed no effect on 
the production of IFN-β when cells were stimulated with poly(I:C), indicating involvement 
of STING-independent pathways and other RNA sensors operating. The TLR3-TRIF 
dependent signalling pathway was not assessed and the assumption of TLR3 activation by 
poly(I:C) was not investigated. Importantly STING was shown to be involved when knocked 
down and cells stimulated with poly(dA:dT) in which the production of IFN-β decreased by 
~50%, although it was not definitively shown that the pathway studied here was a cytoplasmic 
dsDNA sensing pathway. Complete inhibition of IFN-β production in the STING-depleted 
cells was improbable due to other pathways operating but could be due to the incomplete 





ambiguity by gene knockout. The data have shown that ORFV blocked the signalling of 
STING-dependent pathways however, further investigations are required to confirm this.  
As discussed in the previous chapter, the inhibitory effect by ORFV observed in this study 
was not because of a cytotoxic effect induced by infection or general cellular shutdown of 
transcription. It has been shown by others that poly(dA:dT) stimulation can lead to not only 
induction of IFN-β and inflammasome activation but also to pyroptoic cell death with signs 
of plasma membrane swelling and blebbing by light microscopy. This phenomena only 
happens in immune cells that express ASC and caspase-1, critical signalling molecules for 
inflammasome activation (Fernandes-Alnemri, T. et al., 2009; Hornung, V. et al., 2009; 
Rathinam, V. A. K. et al., 2010). Here, a viability assay for poly(dA:dT)-stimulated hNDF 
cells was not conducted, however, the cells were examined by light microscopy during the 
time course of IFN-β induction and signs of swelling and blebbing of the plasma membrane 
or cell death were not observed. 
Assays were undertaken to determine whether IFN-β inhibition requires new virus protein 
synthesis. A heat inactivation approach was utilized over chemical inactivation e.g. binary 
ethyleneimine and β-propiolactone to inhibit virus early protein synthesis without affecting 
viral particle fusion and early gene transcriptional machinery as described previously.  Heat-
inactivated OV-NZ2 including OV-NZ2Δ116 and OV-NZ2-Rev116 failed to inhibit the 
expression of IFN-β in cells stimulated with poly(dA:dT) or poly(I:C), suggesting that the 
inhibition requires virus new protein synthesis. Surprisingly, poly(I:C)-induced IFN-β in cells 
infected with heat-inactivated viruses was higher than mock-infected cells by about half for 
some unknown reason. The approach of heat inactivation of VACV has been studied in detail 
previously and it was shown that the viral transcripts produced were long uncapped partially 
double stranded RNA and untranslatable (Harper, J. M. et al., 1978) and it has been used 
previously for such studies (Parekh, N. J. et al., 2019). Furthermore Cao, H. et al. (2012) have 
confirmed inhibition of early viral gene synthesis from VACV expressing GFP under control 
p7.5 promoter. The GFP expression was significantly reduced upon heat inactivation 
indicating abolished early viral protein production. Here, the inhibition of early viral gene 
synthesis during heat-inactivated ORFV infection was confirmed by western blotting. 
Unlike untreated ORFV, heat-inactivated ORFVs OV-NZ2, OV-NZ2Δ116, and OV-NZ2-
Rev116 induced the expression of type I IFN in unstimulated cells. It could be that this was 





presumably intact. Alternatively, heat-inactivated ORFV has been taken up by endosomes 
and the viral particles processed then the viral DNA released into the cytoplasm and sensed 
by cytosolic DNA sensors. Interestingly inactivated parapoxvirus ovis (PPVO, Orf virus 
strain D1701), known as Baypamun, is used to treat disease susceptible livestock, the basis 
of which is its immunostimulatory and antiviral activity (Siegemund, S. et al., 2009; von 
Buttlar, H. et al., 2014; Weber, O. et al., 2003). 
It was of interest to identify ORFV genes involved in inhibiting IFN-β expression. A potential 
candidate ORF116 was included in this study. There was no difference between the ORF116 
deletion mutant compared with OV-NZ2 wild type and OV-NZ2-Rev116 in either 
poly(dA:dT)- or poly(I:C)-stimulated cells. This assay might not be sufficient to draw a 
definitive conclusion about the role of ORF116 because its effect could be masked by other 
factors expressed by the virus acting on the DNA signalling pathway. Like other poxviruses, 
it is possible that ORFV could encode multiple proteins that target the same signalling 
pathway to close-down the innate immune response. VACV is known to encode several 
proteins targeting distinct components involved in the signalling of type I IFN. Other 
approaches to address this question could involve expressing ORF116 from a construct in a 
DNA-signalling dependent cell system. Although the RNA binding protein ORF020 (E3L 
homologue) was shown to inhibit IFN-β expression in HEK293 cells, it was not considered 
in this part of study as it does not bind dsDNA (McInnes, C. J. et al., 1998) and does not 
contain an N-terminal Z-DNA binding domain.  
A molecular gene screen of ORFV factors that inhibit IFN-β could help to identify those 
factors that inhibit signalling. This approach has been used for other poxviruses. Based on 
the results obtained here, strongly suggests that ORFV targets the DNA sensing pathway(s). 
VACV devotes a considerable number of factors that target this pathway. DNA-PK is a 
heterotrimeric complex consisting of heterodimer Ku70 and Ku80 and catalytic subunit 
DNA-PKcs. Besides its DNA repair function, it acts as a DNA sensor operating via STING 
(Ferguson, B. J. et al., 2012). VACV C16 and C4 were shown to antagonize the activation of 
DNA-PK by interacting with the Ku heterodimer and thereby disrupting the binding of the 
Ku heterodimer to DNA, resulting in inhibition of DNA-PK-mediated DNA sensing (Peters, 
N. E. et al., 2013; Scutts, S. R. et al., 2018). Interestingly, the VACV vv811 strain lacking 55 
ORFs including C16 was effective at inhibiting DNA-induced STING activation, albeit with 





1991). To the best of our knowledge, this is the only DNA sensor identified so far to be 
directly targeted by poxviruses. VACV N1L is another viral protein that has been shown to 
interfere with DNA sensing by inhibiting the activation of TBK1. N1L, expressed from MVA, 
caused a reduction in IFN-β expression, possibly through STING (DiPerna, G. et al., 2004). 
VACV C6 was described as an inhibitor of IFN-β expression by preventing activation of 
IRF3 and IRF7 at the level of TBK1/IKKε and interfering with kinase-associated scaffold 
proteins NAP1, TANK and SINTBAD (Unterholzner, L. et al., 2011). Georgana, I. et al. 
(2018) have found that poxviruses like VACV, CPXV and ECTV, but not MVA, were able 
to interfere with DNA-induced STING signalling by inhibiting STING dimerization and 
phosphorylation. ORFV does not have homologs of the above VACV factors that are known 
to target the DNA sensing pathway, however, based on the findings of this study ORFV 
appears to be targeting cytosolic DNA sensing pathway(s) and it is possible that some of the 
unknown genes in ORFV are involved. The STING-mediated antiviral response is also 
targeted by DNA viruses replicating in the nucleus. HSV-1 did not induce the expression of 
IFN-β in HFF cells and antagonized the response by encoding VP22 protein acting upstream 
of the cGAS/STING pathway by interfering with enzymatic activity of cGAS (Huang, J. et 
al., 2018), whereas KSHV vIRF1/K9 disrupts the TBK1-STING interaction resulting in 
inhibition of STING function (Ma, Z. et al., 2015). The data obtained in the present study are 
consistent with the published reports for other poxviruses and other DNA viruses 
The transfection of THP-1 cells with dsDNA poly(dA:dT) induces the expression of pro-
inflammatory cytokines in THP-1 cells via activation of the inflammasome. Assays were 
performed to investigate whether or not ORFV blocked the secretion of IL-1β; however, this 
was found not to be the case. It was shown that the virus could express its early genes in THP-
1 cells but could not replicate. Despite the above results, ORFV has however evolved 
strategies to block inflammatory cytokine production. It encodes a vIL-10 that inhibits the 
synthesis of pro-inflammatory cytokines IL-1β and TNF from LPS-stimulated PMA-primed 
THP-1 cells and many other cell types (Fleming, S. B. et al., 1997; Imlach, W. et al., 2002; 
Wise, L. et al., 2007).        
An important aspect of dsDNA sensor activation that was not followed up here, would be to 
demonstrate whether ORFV DNA induces the expression of IFN-β and which region of the 
virus genome acts as a PAMP. Experimental work could have included testing ORFV repeat 





expression of IFN-β was observed upon transfection with one repeat (70 bp) from the left 
terminus of the VACV (WR) genome (Almine, J. F. et al., 2017; Unterholzner, L. et al., 
2010). A similar observation was also found in murine γ-herpesvirus 68 in which a 100-bp 
repetitive region within its genome containing a high percentage of GC content was found to 
be required and sufficient to induce type I IFN (Sanchez, D. J. et al., 2008). ORFV encodes 
many repeats within the termini and such fragments could have been used to test their 
inducibility of IFN-β. Obtaining pure intact virus genomic DNA and efficient transfection of 
virus DNA molecules are both essential factors to conduct this assay successfully and that 
could be the reason for the majority of studies that have focused on inducibility of type I IFN 
using synthetic DNA or a fragment of the genome and not natural complete virus DNA. Upon 
identifying the direct involvement of virus DNA in induction of IFN, might also contribute 
towards identifying potential DNA sensor(s). The mechanism of the cytosolic DNA sensing 
system has not been fully elucidated and those DNA sensors discovered so far are not fully 
characterized, however, a possible approach would be to carry out a single or multiple gene 
knockdown or over-expression for those known cytosolic DNA sensors in several cell types 
then assess IFN induction.  
In summary, IFN-β is a key cytokine of the innate antiviral response that is produced early 
during viral infection, thus poxviruses encode factors to disrupt IFN signalling at multiple 
levels. Here, this study provides preliminary evidence to show that ORFV possesses a 
mechanism to target IFN signalling in hNDF cells induced by poly(dA:dT) however it is yet 
to be proven that this is through cytoplasmic dsDNA sensing.  
 












6 GENERAL DISCUSSION 
Despite the differences of mammalian viruses in structure, diseases they induce and 
replication strategies, they all trigger common cellular components during infection to initiate 
an innate immune response to a lesser or greater degree. An essential component of this 
response is induction of type I interferon. The IFN response, a powerful cellular defence 
against viral infection, results in the up-regulation of many ISGs whose products have 
antiviral activity. Not surprisingly, viruses have evolved a variety of strategies to evade the 
IFN response. Studies with poxviruses have demonstrated the role of multiple viral 
modulators that control the host IFN response by targeting type I IFN producing signalling 
pathways that are activated through cytosolic nucleic acid PRRs. ORFV has evolved 
strategies to counteract type I IFN expression. In this study, IFN-β was investigated 
specifically because it is a key cytokine produced early by most cell types, particularly 
fibroblasts, as a first line of defence against viral infection during the innate immune response. 
It has been shown for the first time that ORFV has the ability to inhibit signalling pathways 
that lead to the production of IFN-β that involve cytoplasmic RNA and DNA sensors. In 
addition, IFN antagonism employed by the virus involves the expression of early genes, 
however, the exact mechanism that ORFV employs to interfere with signalling are not yet 
known. It is likely that the inhibition of IFN-β will reflect a general inhibition of the type I 
IFN response in the cell types used in this study and this could be a reflection of such 
inhibition in vivo. The data presented here provide a new evasion mechanism for ORFV virus 
that allows it to replicate in the complex skin immune environment. Many other viruses also 
target type I IFN. VACV also utilizes early gene factors to inhibit IFN-β (Waibler, Z. et al., 
2009). Mouse cytomegalovirus, a DNA herpesvirus, inhibits IFN-β by targeting IRF3 
activation (Le, V. T. K. et al., 2008) and some RNA viruses such as dengue virus target IFN-
β at the transcriptional level (Rodriguez-Madoz, J. R. et al., 2010).  
HEK293 and hNDF cells were used in this study as model systems to investigate the effects 
of ORFV infection on RNA sensing and DNA sensing respectively. For HEK293 cells I was 
able to define accurately the RNA sensing pathway that IFN-β induction operates through, 
whereas in the model of DNA sensing system, it still requires thorough examination to 
determine precisely the sensors and pathways involved. hNDF cells are more specialised than 
HEK293 cells as they express multiple nucleic acid sensing systems that lead to expression 





of IFN-β expression. In HEK293 cells, it was clearly shown that poly(dA:dT) triggered RIG-
I-dependent signalling via Polymerase III, whereas it was not established whether poly(I:C) 
triggered RIG-I or the MDA5 sensor or both in HEK293 cells. hNDF cells express multiple 
RNA sensors, apart from RIG-I and MDA5, and these sensors have different properties (see 
Tables 1.4, 1.5 and 1.6), as a result, it could not be concluded which RNA sensors were 
involved in poly(I:C)-stimulated hNDF cells. Sentinel cells, including hNDF cells, express a 
range of DNA sensors in cytosol or endosome and it is not known yet the exact signature of 
DNA molecules that these sensors recognize. Having said that, it has been shown previously 
that poly(dA:dT) was recognized by many cytosolic DNA sensors in different cell types (see 
Table 1.3). As time permitted, the involvement of STING and RIG-I in the induction of IFN-
β in HEK293 and hNDF cells were examined. Unlike HEK293, hNDF cells express STING 
that is critical for signalling where cytosolic DNA sensors are involved and it was shown that 
a reduction of IFN-β induction occurred when STING was depleted in poly(dA:dT) 
stimulated cells. Depletion of RIG-I alone did not cause significant inhibition in IFN-β 
expression when both STING and RIG-I were depleted in hNDF cells. In contrast, 
knockdown of RIG-I or inhibition of Polymerase III in HEK293 cells significantly altered the 
expression of IFN-β in poly(dA:dT)-stimulated cells. In both models, the synthesis of virus 
early proteins was required to inhibit the expression of IFN-β.              
ORFV exclusively replicates in the cytoplasm of infected cells, rendering exposure to the 
host cytosolic nucleic acid detection system. TLRs, on the other hand, may play less of a role 
as they are located in endosomal compartments. Skin-resident keratinocytes act as sentinel 
cells that have the capability to activate the innate immune response against DNA viruses 
(Fleming, S. B. et al., 2015; Nestle, F. O. et al., 2009) and it has been shown that these cells 
are strong producers of IFN-α/β (Almine, J. F. et al., 2017; Fujisawa, H. et al., 1997; 
Schnipper, L. E. et al., 1984; Torseth, J. W. et al., 1987). Primary keratinocytes express a 
number of cytosolic DNA sensors such as ZBP1(DAI), IFI16, cGAS, STING and AIM2 and 
also TLRs such as TLR3 and TLR9 (Almine, J. F. et al., 2017; Devos, M. et al., 2020; 
Kopfnagel, V. et al., 2011; Lebre, M. C. et al., 2007). In spite of this, ORFV infects 
keratinocytes and causes a localized infection that persists for weeks. The above PRRs, 
strongly suggests that ORFV virus counteracts signalling that is either triggered by DNA or 
RNA in the cytoplasm perhaps the most important target being DNA sensing as the virus 
DNA will be first exposed to the cytoplasm, whereas dsRNA byproducts are generated post 





The ORFV genome has about 64 %  G-C content, and this is possibly due to mutational bias 
from unknown evolutionary pressures (Singer, G. A. C. et al., 2000; Sueoka, N., 1988). TLR9 
recognizes unmethylated CpG-containing ssDNA and it was found previously that ORFV 
detection was TLR9-dependent (von Buttlar, H. et al., 2014), however, the virus was 
chemically inactive and the underlying mechanism might be different from live virus. The 
DNA or RNA structure of virus nucleic acids does not always reveal the class of sensors 
involved in viral nucleic acid detection since there are DNA viruses found to target RNA 
sensors and RNA viruses that target DNA sensors (Ma, Z. et al., 2016). In time investigations 
will determine the sensors involved in virus detection, and structural analysis of nucleic acids 
sensors will unravel their sequence specificity. In my study although the DNA used for the 
model was AT rich and not GC rich, ORFV was nevertheless able to inhibit signalling which 
suggests that the target molecule(s) is where the DNA sensory pathways converge possibly 
at IRF-3 or a factor common to all the DNA sensory signalling pathways. 
It is unknown whether IFN-β inhibition in this study was exerted by a single gene or multiple 
genes and whether targeting was directed at one component or several components of the 
signalling pathways. There are so far two early genes, ORF020 and ORF116, that have been 
shown to be potentially responsible for the inhibition of IFN. ORF116 was clearly shown to 
manipulate ISG expression by a mechanism that could be either a direct specific effect on 
ISGs or could have a role in inhibiting IFN-β production or signalling. It is intriguing to 
speculate that ORF116 could be targeting IRF-3 that is involved in both a direct induction of 
ISGs (type I IFN independent) and IFN-β production signalling pathways. It is strongly 
believed that ORF020 has an inhibitory effect on RIG-I-dependent signalling that leads to the 
expression of type I IFN. Nevertheless, further functional characterization of the interaction 
between ORF116 and ORF020 and the host is required to better understand their role on IFN 
modulation. There are likely to be many more ORFV genes involved in inhibiting type I IFN 
expression based on studies from other poxviruses. For instance, VACV encodes several 
genes A46, C6, C16, C4, K7, N1 and N2 that target different components of IFN signalling 
that leads to expression of type I IFN. ORFV could possess a similar mechanism to target 
factors where IFN signalling pathways converge. A large scale screen of ORFV ORFs is 
required to identify those gene(s) that inhibit type I IFN induction. In this study, it was 
confirmed that the inhibitory effect was caused by an early gene and the ORFs located in the 
terminal regions might be selected, as these two regions are rich in immunomodulatory genes. 





mammalian expression vectors then transfected individually into cells and the expression of 
type I IFNs assessed upon stimulation.  
It is now clear from this study that ORFV has the ability to target all arms of the IFN response. 
The data presented here has revealed the potency of ORFV to inhibit IFN-β expression even 
when cells are stimulated with mimetic synthetic nucleic acids dsRNA or dsDNA however 
recent findings suggest that ORFV does not have the same potency to inhibit other arms of 
the IFN response such as those involved in effector immunity. VACV KIL and C7L were 
shown to have a role in inhibiting the IFN effector response by targeting SAMD9, a potent 
inhibitor of poxvirus replication that targets viral protein synthesis and deletion of these two 
genes makes the virus sensitive to IFN (Meng, X. et al., 2009; Meng, X. et al., 2012). 
Unusually members of the parapoxvirus genus lack homologues of KIL and C7L however 
despite this, ORFV can partially restore the growth phenotype of a VACV C7L/K1L deletion 
mutant in HeLa cells (Riad, S. et al., 2020) suggesting that it has evolved an alternative 
strategy to target SAMD9. Moreover the potency of the IFN inhibitory effect was not found 
to be as strong as VACV and may partly explain why ORFV does not cause systemic infection 
and is restricted to the skin only. In addition ORFV does encode ORFV ORF020 an 
orthologue of VACV E3L that binds dsRNA and inhibits the activation of PKR (Haig, D. M. 
et al., 1998; McInnes, C. J. et al., 1998) however its role as a virulence factor is unknown and 
this study has identified a new factor ORF116 that manipulates a number of ISGs expressed 
in HeLa cells, but its direct effect is yet to be determined. ORFV has also been shown to 
inhibit type I IFN signalling. The IFN-α/β receptor, JAK1, Tyk2, STAT1 and STAT2 are the 
major components of type I IFN signalling and it is not surprising that at least one or more of 
these components are targeted by almost all viruses (Fleming, S. B., 2016). ORFV does not 
produce soluble IFN receptor homologues or IFN binding proteins to disable the IFN from 
binding to its receptor that are encoded by orthopoxviruses (Colamonici, O. R. et al., 1995) 
however ORFV encodes a homologue of VH1 that targets STAT1 and ORFV potently 
inhibits the JAK/STAT signalling pathway (Harvey, R. et al., 2015).   
Poxviruses are some of the largest of the DNA viruses harbouring from 130 to 200 genes. 
Relatively, half of those are involved in host range, virulence and immunomodulation. It is 
believed that the virus may require many inhibitors to target all possible signalling pathways 
that ultimately lead to the induction of type I IFN. There is a general view that multiple viral 





needs to counteract the complex signalling pathways and any cross talk between different 
pathways. As some poxviruses have a broad host range, this will require encoding different 
viral inhibitors tailored to target specific signalling pathways or components or at different 
stages of infection. It is possible that each viral inhibitor could have multiple functions. 
Future studies could focus on the underlying mechanisms by which the ORFV causes IFN 
inhibition and the IFN signalling components targeted to obtain further insight into the nature 
of this virus-host interaction. Expressing IFN signalling molecules individually from vectors 
in cells could aid the identification of components of the RIG-I-dependent sensing signalling 
pathways targeted by ORFV. Further work is needed to conclusively demonstrate that ORFV 
targets cytoplasmic DNA sensor signalling pathways and also to identify which DNA sensors 
are involved in detecting ORFV. This could be demonstrated by utilizing knockout cells that 
are deficient in expressing critical cytosolic DNA signalling molecules or DNA sensors. 
Overall, understanding those underlying mechanisms will not only unravel viral strategies to 












7 FUTURE DIRECTIONS 
The novel observations reported in this thesis have opened up many research questions for 
future study and some are listed below in order of priority:  
 Investigate the colocalization of 116 protein in the infected cell.  
 Conduct 116 binding protein pull-down assays and identify 116 protein partners by 
mass spectrometry.  
 Look at the effect of 116 gene expression from vector on the production of IFN-β 
released with dsDNA such as poly(dA:dT) and viral DNA.  
 Determine the mechanism of how the virus inhibits the IFN induction and which 
factors, interfere with the signalling molecules that lead to IFN induction and ISG 
expression. 
 Look at the effect of ORFV virus on signalling pathways that lead to IFN production 
primarily those pathways that require DNA sensors and whether there are any 
differences between different cell types. 
 A series of siRNA knockdown for RNA or DNA sensors to determine any potential 
receptors involved in ORFV virus detection.  
 Identify endogenous active forms of the pathways that ORFV virus is targeting in 
different cell types by using western immunoblotting. 
 Examine the cellular transcriptome from viral infection of other cell lines e.g. hNDF 
and HEK293 using wild type, knockout and revertant viruses and looking at gene 
expression levels of specific ISGs using qPCR.  
 Examine cellular gene expression and transcriptome by applying new advanced 
technology e.g. RNA-seq or NanoString technology. Deep RNA sequencing will 
enable us to obtain high resolution data of both the viral and cellular transcriptome 
simultaneously.        
 Produce an antibody against ORF116 to detect it in the infected cells.  
 Knocking down the affected ISGs genes using siRNA could determine the antiviral 
effectors targeted by ORF116.  
 Conduct an in vivo study on animal models to determine the virulence of ORF116 
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9 APPENDICES   
9.1 Solutions for Preparation and Transformation of E. coli Competent Cells  
a. 2-YT Broth in 1 Litre  
Reagent  Amount required/Litre Final Concentration  
Tryptone  16 g - 
Yeast Extract 10 g - 
Sodium Chloride (NaCl)  5 g - 
The medium was dissolved in 1 L of Milli-Q H2O and pH adjusted to 7.5 then autoclaved     
   
b. 2-YT Agar in 1 Litre  
Reagent  Amount required/Litre Final Concentration  
Tryptone  16 g - 
Yeast Extract 10 g - 
Sodium Chloride (NaCl)  5 g - 
Agar 15 g - 
The medium was dissolved in 1 L of Milli-Q H2O and pH adjusted to 7.5, then agar added and autoclaved.      
   
c. SOB medium in 1 litre  
Reagent Amount Required/Litre Final Concentration  
Yeast Extract       5 g 0.5% (w/v) 
Tryptone 20 g 2% (w/v) 
Sodium Chloride (NaCl)     0.584 g 10 mM 
Potassium Chloride (KCl)    0.186 g 2.5 mM 
Magnesium Sulfate  (MgSO4)    2.4 g 20 mM 
All contents were dissolved in Milli-Q H2O and then autoclaved.  
   
d. Transformation Buffer   
Reagent Amount Required/Litre  Final Concentration 
Potassium Acetate (KOAc) pH 7.5     - 10 mM 
Calcium Chloride (CaCl. 2H2O) - 80 mM 
Manganese Chloride (MnCl2. 4H2O) - 20 mM 
Magnesium Chloride ( MgCl2. 6H2O) - 10 mM 
Glycerol - 10% 









9.2 Solutions for Alkaline Lysis Preparation of Plasmid DNA  
a. Glucose/Tris/EDTA Solution in 100 ml 
Reagent  Amount required Final Concentration  
Glucose  - 50 mM 
Tris-HCl, pH 8 - 25 mM 
EDTA - 10 mM 
The solution was made up to 100 ml with Milli-Q H2O then autoclaved.      
   
b. NaOH/SDS Solution in 100 ml    
Reagent  Amount required Final Concentration  
Sodium Hydroxide (NaOH) 1 M  20 ml 0.2 M 
Sodium Dodecyl Sulfate (SDS) 10% 10 ml 1% 
The solution was made up to 100 with Milli-Q H2O. The solution was made freshly.    
   
c. Potassium Acetate Solution (pH 5) in 40 ml  
Reagent Amount Required Final Concentration  
Potassium Acetate, 5 M  25 ml - 
Absolute Glacial Acetic Acid 4.8 ml 12% 







9.3 Solutions for DNA Gel Electrophoresis  
a. Agarose Gel  
Reagent  Amount required Final Concentration  
Agarose Gel  1 g  1 % (w/v)  
The solution was made up to 100 ml with TAE buffer and heated to dissolve, cooled at about 60 °C and ethidium 
bromide added to final concentration of 0.5 µg/ml before casting.  
   
b. DNA Loading Dye  
Reagent  Amount required Final Concentration  
Bromophenol blue  25 mg 0.25 % (w/v)  
Xylene  25 mg  0.25 % (w/v) 
Glycerol  5 ml  50 % 
EDTA  0.05 M  
The solution was made up to 10 ml with MilliQ H2O and stored at room temperature.   
   
c. 50X Tris-Acetate (TAE) buffer  
Reagent Amount Required Final Concentration  
Tris-base   242 g - 
Glacial acetic acid  57.1 ml  - 
EDTA pH 8.0, 0.5 M 100 ml - 
The solution was made up to 1L with MilliQ H2O and stored at room temperature. For working solution, the buffer 
was diluted 50X with MilliQ H2O.     
 
d. Ethidium Bromide 10 mg/ml 
Reagent Amount Required Final Concentration  
Ethidium Bromide  50 mg 10 mg/ml 














Table 9.1. Reagents used in this study. 
Reagents  Source  Catalog No.  Solvent 
LyoVec 
Cationic lipid 
InvivoGen lyec-12, lyec-22 Milli-Q H2O 
Poly(dA:dT) naked  
Double-stranded B-DNA  
deoxyadenylic-deoxythymidlic acid 




Double-stranded RNA  
polyinosinic-polycytidylic acid 
Sigma-Aldrich P9582 Milli-Q H2O 
Phorbol 12-Myristate 13-Acetate (PMA) Sigma Aldrich P8139-1MG DMSO 
RNA Polymerase III inhibitor (ML60218) Calbiochem 557403-10MG DMSO 
EZview Red Protein G Affinity Gel          Sigma-Aldrich E3403 - 
Adenosine N’-Oxide (ANO) Sigma-Aldrich A-8540 Milli-Q H2O 
Escherichia coli O55:B5 
lipopolysaccharide (LPS) 
Sigma-Aldrich  L2880 Milli-Q H2O 
Lipofectamine 2000 ThermoFisher 11668019 - 
Phosphosafe Extraction reagent  Merck Millipore 71296 - 





Table 9.2. Accession numbers of virus strains used in ORF116 sequence analysis. 
  GenBank Accession Number  





Orf Virus (ORFV) NZ2 DQ184476 ABA00634.1 (Mercer, A. A. et al., 2006) 
 IA82 AY386263 AAR98211.1 (Delhon, G. et al., 2004) 
 D1701 HM133903.1 ADY76829.1 (McGuire, M. J. et al., 2012) 
 SY17 MG712417  AYN61062.1 - 
 B029 KF837136 AHH34301.1 (Friederichs, S. et al., 2014) 
 HN3/12 KY053526.1 ASY92413.1 - 
 NA1/11 KF234407.1 AHZ33814.1 - 
 SA00 AY386264.1 AAR98341.1 (Delhon, G. et al., 2004) 
 NA17 MG674916.2 AYM26057.1 - 
 SJ1 KP010356.1 AKU76994.1 (Chi, X. et al., 2015) 
 YX KP010353.1 AKU76606.1 (Chi, X. et al., 2015) 
 GO KP010354.1 AKU76738.1 (Chi, X. et al., 2015) 
Pseudocowpoxvirus (PC) VR634 GQ329670.1 ADC54019.1 (Hautaniemi, M. et al., 2010) 







Figure 9.2. HindIII restriction analysis of wild type OV-NZ2 and knockout-116 OV-NZ2Δ116. 
  
Figure 9.2. HindIII restriction analysis of wild type and knockout-116 virus DNA. Genomic 
DNA of wild type and knockout-116 virus was digested with the restriction endonucleases 
HindIII and the fragments were separated by gel electrophoresis. Size marker bacteriophage 
lambda λ DNA was digested with EcoRI and HindIII. Genomic restriction endonuclease 
fragments of wild type are indicated with their sizes in kb. The HindIII-H fragments in the wild 
type virus is indicated by white dot with size shown in kb and the HindIII 4.75 kb fragment 
produced in the ORF116 knockout virus is indicated by white arrow with size shown in kb. This 
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Figure 9.6. Detection of p-TBK1 molecules in THP-1 cells by western blotting. The cells 
were mock or stimulated with either 1 μg/ml of poly(dA:dT) or with LPS for indicated times. 
Cells were harvested and lyzed in phophosafe reagent buffer then equal amount of cell lysate 
was resolved on a 10 % SDS-polyacrylamide gel and proteins transferred onto nitrocellulose 
membrane. Proteins were detected with antibodies against e-TBK1 or p-TBK1. Proteins were 
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Figure 9.7. Inhibitory Effect of ANO on OV-NZ2 early protein synthesis in HEK293 cells. 
The cells were pre-treated with either ANO for 6 hours at indicated concentration. Then the cells 
were infected with Orf virus at MOI of 5 for HEK293 4 hrs. Cells were harvested and lyzed for 
OV119 protein detection. Equal amount of cell lysate was resolved on a 10 % SDS-
polyacrylamide gel and proteins transferred onto nitrocellulose membrane. The membrane was 
incubated with rabbit anti-OV119 Ab (Harfoot, R. T., 2015) and anti-tubulin antibody as loading 






Figure 9.8. Characterization of OV-NZ2 growth in HaCaT cells. 
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Figure 9.8. Characterization of OV-NZ2 growth in HaCaT cells. (A) Cells were stimulated with 0.5 
μg/ml of poly(dA:dT) in 6-well plate and incubated for indicated times. Cells were harvested by 
trypsinization and total RNA isolated. IFN-β induction was quantified by qPCR. qPCR was conducted in 
duplicate and data represent one experiment of two independent experiments. Error bars represent mean 
±SD. (B) Cells were infected with OV-NZ2 at an MOI of 5 pfu per cell in 6-well plate and incubated until 
harvesting time indicated. Cells were lyzed and 10 μl of cell lysate was resolved on SDS-PAGE gel and 
proteins transferred onto nitrocellulose membrane. The membrane was incubated with anti-OV119 Ab or 
anti-tubulin as loading control and proteins detected by chemiluminescence. This data represent two 
experiments. (C) Cells were infected at an MOI of 5 with OV-NZ2. After 1hr adsorption, cells were washed 
with PBS then 2 ml of DMEM 2 % FCS then cells incubated for indicated times. Medium and infected 
cells were harvested and subjected to three cycles of freezing and thawing, the virus was sonicated and viral 
titres determined on LT cells. Data represent one experiment and Error bars represent mean ±SD. 






9.4 Tissue Culture Media  
a. Minimal Essential Medium (MEM), (GIBCO, Invitrogen) 
Reagent  Amount required/Litre Final Concentration  
Sigma MEM         1 packet - 
MilliQ H2O        950 ml - 
NaHCO3                       2.2 g - 
The medium was made up to 1 L then filtered into sterile bottles with positive pressure. Store at 37 °C for 
overnight to check sterility, then store at 4 °C until used. 
   
b. Dulbecco's Modified Eagle Medium (DMEM), (GIBCO, Invitrogen)  
Reagent  Amount required/Litre Final Concentration  
Sigma DMEM  1 packet - 
NaHCO3   3.7 g - 
Hepes.              4.77 g - 
MilliQ H2O     950 ml - 
2-mercaptoethanol  1.5 μl - 
The pH was adjusted to 7.4 and made up to 1 L, then medium filtered into sterile bottles with positive pressure. 
Store at 37 °C for overnight to check sterility, then store at 4 °C until used.  
   
c. RPMI 1670 Medium (GIBCO, Invitrogen)  
Reagent Amount Required/Litre Final Concentration  
RPMI  1 packet - 
NaHCO3   2 g - 
MilliQ H2O     950 ml - 
The pH was adjusted to 7.0-7.4 and made up to 1 L, then medium filtered into sterile bottles with positive pressure. 
Store at 37 °C for overnight to check sterility, then store at 4 °C until used. 
   
d. Supplement/additives   
Reagent Amount Required/Litre  Final Concentration 
Fetal Calf Serum (FCS)   - 2 or 10 % 
Penicillin   - 500 U/ml 
Streptomycin  - 0.5 mg/ml 











9.5 Maintenance of Tissue Culture  
a. Phosphate Buffered Saline (PBS) 
Reagent  Amount required/Litre Final Concentration  
PBS 1 tablet  - 
MilliQ H2O 100 ml - 
One tablet of PBS was dissolved in 100 ml MilliQ H2O, then autoclaved and stored at 4 °C. 
   
b. Trypsin 0.25% 
Reagent  Amount required/Litre Final Concentration  
Phosphate Buffered Saline (PBS) 100 ml - 
Trypsin 0.25 g - 
0.5M EDTA 80 μl - 
0.4% Phenol Red 0.5 ml - 
The solution was dissolved and filtered then aliquated. The solution was stored at -20 °C until used and once 
opened stored at 4 °C. 
   
c. Trypan Blue (0.2 %) 
Reagent Amount Required/Litre Final Concentration  
Trypan blue powder 0.2 g - 
PBS  100 ml - 
The trypan blue powder was dissolved in 100 ml PBS and store at room temperature. 
   
d. Splitting and setting up plates or flasks with cells 
When cell monolayer was confluent, using aseptic technique, the medium aspirated and cell monolayer washed 
with PBS twice. Appropriate amount of Trypsin was added then discarded. Another same amount of trypsin was 
added and the flask was incubated at 37 °C to trypsinize until detach from the surface of the flask for about 10 min 
and let this on the cell until they can be seen to be leaving the side of the flask. Appropriate amount of complete 
medium was added 9 ml and the cell suspension was pipetted up and down to break up the clumps of cells. The 
cell suspension was divided into the required ratio and make up with appropriate volume of complete medium then 











9.6 Solutions for Preparation of Gel for SDS-PAGE  
a. 1.5 M Tris-HCl, pH 8.8 
Reagent  Amount required Final Concentration  
Tris  27.23 g 1.5 1.5 M 
MilliQ H2O 80 ml - 
The pH of the solution was adjusted to 8.8 with 6N HCl then volume made up to 150 ml with MilliQ 
H2O.  
 
   
b. 1 M Tris-HCl, pH 6.8 
Reagent  Amount required Final Concentration  
Tris  7.26 g 1 M 
MilliQ H2O  60 ml - 
The pH of the solution was adjusted to 6.8 with 6N HCl then volume made up to 100 ml with H2O.  
   
c. 10 % Sodium Dodecyl Sulfate (SDS)  
Reagent Amount Required Final Concentration  
SDS 10 g 10 % 
MilliQ H2O 100 ml - 
 
d. 10 % Ammonium Persulfate (APS) 
Reagent Amount Required Final Concentration  
APS 0.5 g 10 % 
MilliQ H2O 5 ml - 
The solution was made and aliquoted then stored at -20 °C until used. 
 
e. 30 % Acrylamide  
   
f. TEMED 
   
g. Resolving Gel, 10 %  
Reagents Amount Required  Final Concentration 
MilliQ H2O 5.9 ml - 
SDS, 10 % 150 μl - 
1.5 M Tris (pH 8.8) 3.8 ml - 
Acrylamide, 30 % 5 ml 10 % 
APS  150 μl - 
TEMED  6 μl - 
The components were mixed to cast the gel.  
 
h. Stacking gel, 5 % 
Reagent Amount Required Final Concentration 
MilliQ H2O 6.8 ml - 
SDS, 10 % 100 μl - 
1 M Tris (pH 6.8) 1.25 ml - 
Acrylamide, 30 % 1.7 ml 5 % 





TEMED 10 μl - 
The components were mixed to cast the gel.  
   
i. Casting the gel 
The gel was set by siding two plates into the casting frame and then placed on the casting stand. Firstly 
the resolving gel was poured up to 1 cm below the comb, then the gel was covered with water. After 
30 min of polymerization, the water was discarded and stacking gel was poured immediately on top 
of the polymerized resolving gel up to the top. The comb was inserted and allowed for 30 min to 
polymerize. 







9.7 Solutions for Western Blotting  
a. 10 X Running Buffer  
Reagents Amount Required Final Concentration 
Tris-base 30 g - 
Glycine 144 g - 
SDS 10 g - 
The volume made up to 1 L with MilliQ H2O. The buffer was diluted at 1 X for electrophoresis.    
   
b. Transfer Buffer 
Reagent Amount Required Final Concentration 
Tris-base  12.12 g - 
Glycine  57.63 g - 
Methanol 700 ml - 
Distilled H2O  3.2 L  - 
The solution was kept at 4 °C.  
   
c. Tris, 1 M, pH 7.4 
Reagent Amount Required Final Concentration 
Tris base  60.57 g 1 M  
MilliQ H2O  500 ml - 
pH was adjusted to 7.4 with HCl.  
   
d. NaCl, 5 M 
Reagent Amount Required Final Concentration 
NaCl 146.1 g 5 M 
MilliQ H2O  500 ml - 
   
e. Tris-Buffered Saline (TBS), pH 7.4  
Reagent Amount Required Final Concentration 
1M Tris, pH 7.4 25 ml - 
5M NaCl 15 ml - 
MilliQ H2O 460 ml  - 
The components were mixed and stored at room temperature.   
   
f. TBS-T 
Reagent Amount Required Final Concentration 
TBS  500 ml - 
Tween20  1 ml  - 























   
g. Blocking Buffer using skimmed milk 
Reagent Amount Required Final Concentration 
TBS-T  20 ml - 
Skimmed milk powder  1 g 5 %  
The buffer was freshly prepared.   
   
h. Blocking Buffer using bovine serum albumin ( BSA) 
Reagent Amount Required Final Concentration 
TBS-T  20 ml 
BSA 1 g 5 %  
The buffer was freshly prepared.   
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